id	sid	tid	token	lemma	pos
fnp-4692	1	1	neurooncology	neurooncology	NOUN
fnp-4692	1	2	:	:	PUNCT
fnp-4692	1	3	2023	2023	NUM
fnp-4692	1	4	update	update	NOUN
fnp-4692	1	5	feel	feel	VERB
fnp-4692	1	6	free	free	ADJ
fnp-4692	1	7	to	to	PART
fnp-4692	1	8	add	add	VERB
fnp-4692	1	9	comments	comment	NOUN
fnp-4692	1	10	by	by	ADP
fnp-4692	1	11	clicking	click	VERB
fnp-4692	1	12	these	these	DET
fnp-4692	1	13	icons	icon	NOUN
fnp-4692	1	14	on	on	ADP
fnp-4692	1	15	the	the	DET
fnp-4692	1	16	sidebar	sidebar	NOUN
fnp-4692	1	17	free	free	ADJ
fnp-4692	1	18	neuropathology	neuropathology	NOUN
fnp-4692	1	19	4:4	4:4	NUM
fnp-4692	1	20	(	(	PUNCT
fnp-4692	1	21	2023	2023	NUM
fnp-4692	1	22	)	)	PUNCT
fnp-4692	1	23	review	review	VERB
fnp-4692	1	24	neurooncology	neurooncology	NOUN
fnp-4692	1	25	:	:	PUNCT
fnp-4692	1	26	2023	2023	NUM
fnp-4692	1	27	update	update	NOUN
fnp-4692	1	28	michel	michel	PROPN
fnp-4692	1	29	mittelbronn1	mittelbronn1	PROPN
fnp-4692	1	30	-	-	PUNCT
fnp-4692	1	31	6	6	NUM
fnp-4692	1	32	national	national	ADJ
fnp-4692	1	33	center	center	NOUN
fnp-4692	1	34	of	of	ADP
fnp-4692	1	35	pathology	pathology	NOUN
fnp-4692	1	36	(	(	PUNCT
fnp-4692	1	37	ncp	ncp	PROPN
fnp-4692	1	38	)	)	PUNCT
fnp-4692	1	39	,	,	PUNCT
fnp-4692	1	40	laboratoire	laboratoire	PROPN
fnp-4692	1	41	national	national	PROPN
fnp-4692	1	42	de	de	X
fnp-4692	1	43	santé	santé	X
fnp-4692	1	44	(	(	PUNCT
fnp-4692	1	45	lns	lns	PROPN
fnp-4692	1	46	)	)	PUNCT
fnp-4692	1	47	,	,	PUNCT
fnp-4692	1	48	dudelange	dudelange	NOUN
fnp-4692	1	49	,	,	PUNCT
fnp-4692	1	50	luxembourg	luxembourg	PROPN
fnp-4692	1	51	luxembourg	luxembourg	PROPN
fnp-4692	1	52	center	center	PROPN
fnp-4692	1	53	of	of	ADP
fnp-4692	1	54	neuropathology	neuropathology	NOUN
fnp-4692	1	55	(	(	PUNCT
fnp-4692	1	56	lcnp	lcnp	NOUN
fnp-4692	1	57	)	)	PUNCT
fnp-4692	1	58	,	,	PUNCT
fnp-4692	1	59	luxembourg	luxembourg	PROPN
fnp-4692	1	60	department	department	PROPN
fnp-4692	1	61	of	of	ADP
fnp-4692	1	62	oncology	oncology	NOUN
fnp-4692	1	63	(	(	PUNCT
fnp-4692	1	64	donc	donc	ADJ
fnp-4692	1	65	)	)	PUNCT
fnp-4692	1	66	,	,	PUNCT
fnp-4692	1	67	luxembourg	luxembourg	PROPN
fnp-4692	1	68	institute	institute	PROPN
fnp-4692	1	69	of	of	ADP
fnp-4692	1	70	health	health	PROPN
fnp-4692	1	71	(	(	PUNCT
fnp-4692	1	72	lih	lih	PROPN
fnp-4692	1	73	)	)	PUNCT
fnp-4692	1	74	,	,	PUNCT
fnp-4692	1	75	luxembourg	luxembourg	PROPN
fnp-4692	1	76	,	,	PUNCT
fnp-4692	1	77	luxembourg	luxembourg	PROPN
fnp-4692	1	78	department	department	PROPN
fnp-4692	1	79	of	of	ADP
fnp-4692	1	80	life	life	PROPN
fnp-4692	1	81	sciences	science	NOUN
fnp-4692	1	82	and	and	CCONJ
fnp-4692	1	83	medicine	medicine	NOUN
fnp-4692	1	84	,	,	PUNCT
fnp-4692	1	85	university	university	NOUN
fnp-4692	1	86	of	of	ADP
fnp-4692	1	87	luxembourg	luxembourg	PROPN
fnp-4692	1	88	,	,	PUNCT
fnp-4692	1	89	esch	esch	PROPN
fnp-4692	1	90	sur	sur	PROPN
fnp-4692	1	91	alzette	alzette	PROPN
fnp-4692	1	92	,	,	PUNCT
fnp-4692	1	93	luxembourg	luxembourg	PROPN
fnp-4692	1	94	luxembourg	luxembourg	PROPN
fnp-4692	1	95	centre	centre	PROPN
fnp-4692	1	96	for	for	ADP
fnp-4692	1	97	systems	system	NOUN
fnp-4692	1	98	biomedicine	biomedicine	NOUN
fnp-4692	1	99	(	(	PUNCT
fnp-4692	1	100	lcsb	lcsb	PROPN
fnp-4692	1	101	)	)	PUNCT
fnp-4692	1	102	,	,	PUNCT
fnp-4692	1	103	university	university	NOUN
fnp-4692	1	104	of	of	ADP
fnp-4692	1	105	luxembourg	luxembourg	PROPN
fnp-4692	1	106	,	,	PUNCT
fnp-4692	1	107	esch	esch	PROPN
fnp-4692	1	108	-	-	PUNCT
fnp-4692	1	109	sur	sur	PROPN
fnp-4692	1	110	-	-	PUNCT
fnp-4692	1	111	alzette	alzette	PROPN
fnp-4692	1	112	,	,	PUNCT
fnp-4692	1	113	luxembourg	luxembourg	PROPN
fnp-4692	1	114	faculty	faculty	NOUN
fnp-4692	1	115	of	of	ADP
fnp-4692	1	116	science	science	NOUN
fnp-4692	1	117	,	,	PUNCT
fnp-4692	1	118	technology	technology	NOUN
fnp-4692	1	119	and	and	CCONJ
fnp-4692	1	120	medicine	medicine	NOUN
fnp-4692	1	121	(	(	PUNCT
fnp-4692	1	122	fstm	fstm	PROPN
fnp-4692	1	123	)	)	PUNCT
fnp-4692	1	124	,	,	PUNCT
fnp-4692	1	125	university	university	NOUN
fnp-4692	1	126	of	of	ADP
fnp-4692	1	127	luxembourg	luxembourg	PROPN
fnp-4692	1	128	,	,	PUNCT
fnp-4692	1	129	esch	esch	PROPN
fnp-4692	1	130	-	-	PUNCT
fnp-4692	1	131	sur	sur	PROPN
fnp-4692	1	132	-	-	PUNCT
fnp-4692	1	133	alzette	alzette	NOUN
fnp-4692	1	134	,	,	PUNCT
fnp-4692	1	135	luxembourg	luxembourg	PROPN
fnp-4692	1	136	corresponding	corresponding	ADJ
fnp-4692	1	137	author	author	NOUN
fnp-4692	1	138	:	:	PUNCT
fnp-4692	1	139	michel	michel	PROPN
fnp-4692	1	140	mittelbronn	mittelbronn	PROPN
fnp-4692	1	141	·	·	PUNCT
fnp-4692	1	142	national	national	ADJ
fnp-4692	1	143	center	center	NOUN
fnp-4692	1	144	of	of	ADP
fnp-4692	1	145	pathology	pathology	NOUN
fnp-4692	1	146	(	(	PUNCT
fnp-4692	1	147	ncp	ncp	PROPN
fnp-4692	1	148	)	)	PUNCT
fnp-4692	1	149	and	and	CCONJ
fnp-4692	1	150	luxembourg	luxembourg	PROPN
fnp-4692	1	151	center	center	PROPN
fnp-4692	1	152	of	of	ADP
fnp-4692	1	153	neuropathology	neuropathology	NOUN
fnp-4692	1	154	(	(	PUNCT
fnp-4692	1	155	lcnp	lcnp	NOUN
fnp-4692	1	156	)	)	PUNCT
fnp-4692	1	157	·	·	PUNCT
fnp-4692	2	1	laboratoire	laboratoire	PROPN
fnp-4692	2	2	national	national	PROPN
fnp-4692	2	3	de	de	X
fnp-4692	2	4	santé	santé	X
fnp-4692	2	5	(	(	PUNCT
fnp-4692	2	6	lns	lns	PROPN
fnp-4692	2	7	)	)	PUNCT
fnp-4692	2	8	·	·	PUNCT
fnp-4692	2	9	1	1	X
fnp-4692	2	10	,	,	PUNCT
fnp-4692	2	11	rue	rue	X
fnp-4692	2	12	louis	louis	NOUN
fnp-4692	2	13	rech	rech	NOUN
fnp-4692	2	14	·	·	PUNCT
fnp-4692	2	15	3555	3555	NUM
fnp-4692	2	16	dudelange	dudelange	NOUN
fnp-4692	2	17	·	·	PUNCT
fnp-4692	2	18	luxembourg	luxembourg	PROPN
fnp-4692	2	19	·	·	PUNCT
fnp-4692	2	20	luxembourg	luxembourg	PROPN
fnp-4692	2	21	michel.mittelbronn@lns.etat.lu	michel.mittelbronn@lns.etat.lu	PROPN
fnp-4692	2	22	submitted	submit	VERB
fnp-4692	2	23	:	:	PUNCT
fnp-4692	2	24	12	12	NUM
fnp-4692	2	25	february	february	NOUN
fnp-4692	2	26	2023	2023	NUM
fnp-4692	2	27	accepted	accept	VERB
fnp-4692	2	28	:	:	PUNCT
fnp-4692	2	29	14	14	NUM
fnp-4692	2	30	march	march	NOUN
fnp-4692	2	31	2023	2023	NUM
fnp-4692	2	32	copyedited	copyedit	VERB
fnp-4692	2	33	by	by	ADP
fnp-4692	2	34	:	:	PUNCT
fnp-4692	2	35	vanessa	vanessa	PROPN
fnp-4692	2	36	goodwill	goodwill	NOUN
fnp-4692	2	37	published	publish	VERB
fnp-4692	2	38	:	:	PUNCT
fnp-4692	2	39	20	20	NUM
fnp-4692	2	40	march	march	NOUN
fnp-4692	2	41	2023	2023	NUM
fnp-4692	2	42	https://doi.org/10.17879/freeneuropathology-2023-4692	https://doi.org/10.17879/freeneuropathology-2023-4692	PROPN
fnp-4692	2	43	keywords	keyword	NOUN
fnp-4692	2	44	:	:	PUNCT
fnp-4692	2	45	neuro	neuro	NOUN
fnp-4692	2	46	-	-	PUNCT
fnp-4692	2	47	oncology	oncology	NOUN
fnp-4692	2	48	,	,	PUNCT
fnp-4692	2	49	neuropathology	neuropathology	NOUN
fnp-4692	2	50	,	,	PUNCT
fnp-4692	2	51	brain	brain	NOUN
fnp-4692	2	52	tumors	tumor	NOUN
fnp-4692	2	53	,	,	PUNCT
fnp-4692	2	54	glioblastoma	glioblastoma	NOUN
fnp-4692	2	55	,	,	PUNCT
fnp-4692	2	56	brain	brain	NOUN
fnp-4692	2	57	metastasis	metastasis	NOUN
fnp-4692	2	58	,	,	PUNCT
fnp-4692	2	59	meningioma	meningioma	NOUN
fnp-4692	2	60	abstract	abstract	NOUN
fnp-4692	2	61	this	this	DET
fnp-4692	2	62	article	article	NOUN
fnp-4692	2	63	presents	present	VERB
fnp-4692	2	64	some	some	PRON
fnp-4692	2	65	of	of	ADP
fnp-4692	2	66	the	the	DET
fnp-4692	2	67	author	author	NOUN
fnp-4692	2	68	’s	’s	PART
fnp-4692	2	69	neuropathological	neuropathological	ADJ
fnp-4692	2	70	highlights	highlight	NOUN
fnp-4692	2	71	in	in	ADP
fnp-4692	2	72	the	the	DET
fnp-4692	2	73	field	field	NOUN
fnp-4692	2	74	on	on	ADP
fnp-4692	2	75	neuro	neuro	NOUN
fnp-4692	2	76	-	-	PUNCT
fnp-4692	2	77	oncology	oncology	NOUN
fnp-4692	2	78	research	research	NOUN
fnp-4692	2	79	encountered	encounter	VERB
fnp-4692	2	80	in	in	ADP
fnp-4692	2	81	2022	2022	NUM
fnp-4692	2	82	.	.	PUNCT
fnp-4692	3	1	major	major	ADJ
fnp-4692	3	2	advances	advance	NOUN
fnp-4692	3	3	were	be	AUX
fnp-4692	3	4	made	make	VERB
fnp-4692	3	5	in	in	ADP
fnp-4692	3	6	the	the	DET
fnp-4692	3	7	development	development	NOUN
fnp-4692	3	8	of	of	ADP
fnp-4692	3	9	more	more	ADV
fnp-4692	3	10	precise	precise	ADJ
fnp-4692	3	11	,	,	PUNCT
fnp-4692	3	12	faster	fast	ADV
fnp-4692	3	13	,	,	PUNCT
fnp-4692	3	14	easier	easy	ADJ
fnp-4692	3	15	,	,	PUNCT
fnp-4692	3	16	less	less	ADV
fnp-4692	3	17	invasive	invasive	ADJ
fnp-4692	3	18	and	and	CCONJ
fnp-4692	3	19	unbiased	unbiased	ADJ
fnp-4692	3	20	diagnostic	diagnostic	ADJ
fnp-4692	3	21	tools	tool	NOUN
fnp-4692	3	22	ranging	range	VERB
fnp-4692	3	23	from	from	ADP
fnp-4692	3	24	immunohistochemical	immunohistochemical	ADJ
fnp-4692	3	25	prediction	prediction	NOUN
fnp-4692	3	26	of	of	ADP
fnp-4692	3	27	1p/19q	1p/19q	ADJ
fnp-4692	3	28	loss	loss	NOUN
fnp-4692	3	29	in	in	ADP
fnp-4692	3	30	diffuse	diffuse	ADJ
fnp-4692	3	31	glioma	glioma	NOUN
fnp-4692	3	32	,	,	PUNCT
fnp-4692	3	33	methylation	methylation	NOUN
fnp-4692	3	34	analyses	analysis	NOUN
fnp-4692	3	35	in	in	ADP
fnp-4692	3	36	csf	csf	ADJ
fnp-4692	3	37	samples	sample	NOUN
fnp-4692	3	38	,	,	PUNCT
fnp-4692	3	39	molecular	molecular	ADJ
fnp-4692	3	40	profiling	profiling	NOUN
fnp-4692	3	41	for	for	ADP
fnp-4692	3	42	cns	cns	NOUN
fnp-4692	3	43	lymphoma	lymphoma	NOUN
fnp-4692	3	44	,	,	PUNCT
fnp-4692	3	45	proteomic	proteomic	ADJ
fnp-4692	3	46	analyses	analysis	NOUN
fnp-4692	3	47	of	of	ADP
fnp-4692	3	48	recurrent	recurrent	ADJ
fnp-4692	3	49	glioblastoma	glioblastoma	NOUN
fnp-4692	3	50	,	,	PUNCT
fnp-4692	3	51	integrated	integrate	VERB
fnp-4692	3	52	molecular	molecular	ADJ
fnp-4692	3	53	diagnostics	diagnostic	NOUN
fnp-4692	3	54	for	for	ADP
fnp-4692	3	55	better	well	ADJ
fnp-4692	3	56	stratification	stratification	NOUN
fnp-4692	3	57	in	in	ADP
fnp-4692	3	58	meningioma	meningioma	NOUN
fnp-4692	3	59	,	,	PUNCT
fnp-4692	3	60	intraoperative	intraoperative	ADJ
fnp-4692	3	61	profiling	profiling	NOUN
fnp-4692	3	62	making	making	NOUN
fnp-4692	3	63	use	use	NOUN
fnp-4692	3	64	of	of	ADP
fnp-4692	3	65	raman	raman	ADJ
fnp-4692	3	66	effect	effect	NOUN
fnp-4692	3	67	or	or	CCONJ
fnp-4692	3	68	methylation	methylation	NOUN
fnp-4692	3	69	analysis	analysis	NOUN
fnp-4692	3	70	,	,	PUNCT
fnp-4692	3	71	to	to	ADP
fnp-4692	3	72	finally	finally	ADV
fnp-4692	3	73	,	,	PUNCT
fnp-4692	3	74	the	the	DET
fnp-4692	3	75	assessment	assessment	NOUN
fnp-4692	3	76	of	of	ADP
fnp-4692	3	77	histological	histological	ADJ
fnp-4692	3	78	slides	slide	NOUN
fnp-4692	3	79	by	by	ADP
fnp-4692	3	80	means	mean	NOUN
fnp-4692	3	81	of	of	ADP
fnp-4692	3	82	machine	machine	NOUN
fnp-4692	3	83	learning	learn	VERB
fnp-4692	3	84	for	for	ADP
fnp-4692	3	85	the	the	DET
fnp-4692	3	86	prediction	prediction	NOUN
fnp-4692	3	87	of	of	ADP
fnp-4692	3	88	molecular	molecular	ADJ
fnp-4692	3	89	tumor	tumor	NOUN
fnp-4692	3	90	features	feature	NOUN
fnp-4692	3	91	.	.	PUNCT
fnp-4692	4	1	in	in	ADP
fnp-4692	4	2	addition	addition	NOUN
fnp-4692	4	3	,	,	PUNCT
fnp-4692	4	4	as	as	SCONJ
fnp-4692	4	5	the	the	DET
fnp-4692	4	6	discovery	discovery	NOUN
fnp-4692	4	7	of	of	ADP
fnp-4692	4	8	a	a	DET
fnp-4692	4	9	new	new	ADJ
fnp-4692	4	10	tumor	tumor	NOUN
fnp-4692	4	11	entity	entity	NOUN
fnp-4692	4	12	may	may	AUX
fnp-4692	4	13	also	also	ADV
fnp-4692	4	14	be	be	AUX
fnp-4692	4	15	a	a	DET
fnp-4692	4	16	highlight	highlight	NOUN
fnp-4692	4	17	for	for	ADP
fnp-4692	4	18	the	the	DET
fnp-4692	4	19	neuropathology	neuropathology	NOUN
fnp-4692	4	20	community	community	NOUN
fnp-4692	4	21	,	,	PUNCT
fnp-4692	4	22	the	the	DET
fnp-4692	4	23	newly	newly	ADV
fnp-4692	4	24	described	describe	VERB
fnp-4692	4	25	high	high	ADJ
fnp-4692	4	26	-	-	PUNCT
fnp-4692	4	27	grade	grade	NOUN
fnp-4692	4	28	glioma	glioma	NOUN
fnp-4692	4	29	with	with	ADP
fnp-4692	4	30	pleomorphic	pleomorphic	ADJ
fnp-4692	4	31	and	and	CCONJ
fnp-4692	4	32	pseudopapillary	pseudopapillary	ADJ
fnp-4692	4	33	features	feature	NOUN
fnp-4692	4	34	(	(	PUNCT
fnp-4692	4	35	hpap	hpap	NOUN
fnp-4692	4	36	)	)	PUNCT
fnp-4692	4	37	has	have	AUX
fnp-4692	4	38	been	be	AUX
fnp-4692	4	39	selected	select	VERB
fnp-4692	4	40	for	for	ADP
fnp-4692	4	41	this	this	DET
fnp-4692	4	42	article	article	NOUN
fnp-4692	4	43	.	.	PUNCT
fnp-4692	5	1	regarding	regard	VERB
fnp-4692	5	2	new	new	ADJ
fnp-4692	5	3	innovative	innovative	ADJ
fnp-4692	5	4	treatment	treatment	NOUN
fnp-4692	5	5	approaches	approach	NOUN
fnp-4692	5	6	,	,	PUNCT
fnp-4692	5	7	a	a	DET
fnp-4692	5	8	drug	drug	NOUN
fnp-4692	5	9	screening	screen	VERB
fnp-4692	5	10	platform	platform	NOUN
fnp-4692	5	11	for	for	ADP
fnp-4692	5	12	brain	brain	NOUN
fnp-4692	5	13	metastasis	metastasis	NOUN
fnp-4692	5	14	is	be	AUX
fnp-4692	5	15	presented	present	VERB
fnp-4692	5	16	.	.	PUNCT
fnp-4692	6	1	although	although	SCONJ
fnp-4692	6	2	diagnostic	diagnostic	ADJ
fnp-4692	6	3	speed	speed	NOUN
fnp-4692	6	4	and	and	CCONJ
fnp-4692	6	5	precision	precision	NOUN
fnp-4692	6	6	is	be	AUX
fnp-4692	6	7	steadily	steadily	ADV
fnp-4692	6	8	increasing	increase	VERB
fnp-4692	6	9	,	,	PUNCT
fnp-4692	6	10	clinical	clinical	ADJ
fnp-4692	6	11	prognosis	prognosis	NOUN
fnp-4692	6	12	for	for	ADP
fnp-4692	6	13	patients	patient	NOUN
fnp-4692	6	14	with	with	ADP
fnp-4692	6	15	malignant	malignant	ADJ
fnp-4692	6	16	tumors	tumor	NOUN
fnp-4692	6	17	affecting	affect	VERB
fnp-4692	6	18	the	the	DET
fnp-4692	6	19	nervous	nervous	ADJ
fnp-4692	6	20	system	system	NOUN
fnp-4692	6	21	remains	remain	VERB
fnp-4692	6	22	largely	largely	ADV
fnp-4692	6	23	unchanged	unchanged	ADJ
fnp-4692	6	24	over	over	ADP
fnp-4692	6	25	the	the	DET
fnp-4692	6	26	last	last	ADJ
fnp-4692	6	27	decade	decade	NOUN
fnp-4692	6	28	,	,	PUNCT
fnp-4692	6	29	therefore	therefore	ADV
fnp-4692	6	30	future	future	ADJ
fnp-4692	6	31	neuro	neuro	NOUN
fnp-4692	6	32	-	-	PUNCT
fnp-4692	6	33	oncological	oncological	ADJ
fnp-4692	6	34	research	research	NOUN
fnp-4692	6	35	focus	focus	NOUN
fnp-4692	6	36	should	should	AUX
fnp-4692	6	37	be	be	AUX
fnp-4692	6	38	put	put	VERB
fnp-4692	6	39	on	on	ADP
fnp-4692	6	40	how	how	SCONJ
fnp-4692	6	41	the	the	DET
fnp-4692	6	42	amazing	amazing	ADJ
fnp-4692	6	43	developments	development	NOUN
fnp-4692	6	44	presented	present	VERB
fnp-4692	6	45	in	in	ADP
fnp-4692	6	46	this	this	DET
fnp-4692	6	47	article	article	NOUN
fnp-4692	6	48	can	can	AUX
fnp-4692	6	49	be	be	AUX
fnp-4692	6	50	more	more	ADV
fnp-4692	6	51	sustainably	sustainably	ADV
fnp-4692	6	52	applied	apply	VERB
fnp-4692	6	53	to	to	AUX
fnp-4692	6	54	positively	positively	ADV
fnp-4692	6	55	impact	impact	VERB
fnp-4692	6	56	patient	patient	ADJ
fnp-4692	6	57	prognosis	prognosis	NOUN
fnp-4692	6	58	.	.	PUNCT
fnp-4692	7	1	introduction	introduction	NOUN
fnp-4692	7	2	for	for	ADP
fnp-4692	7	3	this	this	DET
fnp-4692	7	4	top	top	ADJ
fnp-4692	7	5	ten	ten	NUM
fnp-4692	7	6	series	series	NOUN
fnp-4692	7	7	regarding	regard	VERB
fnp-4692	7	8	the	the	DET
fnp-4692	7	9	neuro	neuro	NOUN
fnp-4692	7	10	-	-	PUNCT
fnp-4692	7	11	oncological	oncological	ADJ
fnp-4692	7	12	highlights	highlight	NOUN
fnp-4692	7	13	of	of	ADP
fnp-4692	7	14	the	the	DET
fnp-4692	7	15	year	year	NOUN
fnp-4692	7	16	2022	2022	NUM
fnp-4692	7	17	,	,	PUNCT
fnp-4692	7	18	the	the	DET
fnp-4692	7	19	author	author	NOUN
fnp-4692	7	20	aimed	aim	VERB
fnp-4692	7	21	at	at	ADP
fnp-4692	7	22	selecting	select	VERB
fnp-4692	7	23	pioneering	pioneer	VERB
fnp-4692	7	24	work	work	NOUN
fnp-4692	7	25	with	with	ADP
fnp-4692	7	26	a	a	DET
fnp-4692	7	27	direct	direct	ADJ
fnp-4692	7	28	link	link	NOUN
fnp-4692	7	29	to	to	ADP
fnp-4692	7	30	neuropathology	neuropathology	NOUN
fnp-4692	7	31	.	.	PUNCT
fnp-4692	8	1	apart	apart	ADV
fnp-4692	8	2	from	from	ADP
fnp-4692	8	3	previously	previously	ADV
fnp-4692	8	4	read	read	VERB
fnp-4692	8	5	papers	paper	NOUN
fnp-4692	8	6	,	,	PUNCT
fnp-4692	8	7	the	the	DET
fnp-4692	8	8	author	author	NOUN
fnp-4692	8	9	was	be	AUX
fnp-4692	8	10	inspired	inspire	VERB
fnp-4692	8	11	by	by	ADP
fnp-4692	8	12	discussions	discussion	NOUN
fnp-4692	8	13	with	with	ADP
fnp-4692	8	14	colleagues	colleague	NOUN
fnp-4692	8	15	and	and	CCONJ
fnp-4692	8	16	finally	finally	ADV
fnp-4692	8	17	screened	screen	VERB
fnp-4692	8	18	hundreds	hundred	NOUN
fnp-4692	8	19	of	of	ADP
fnp-4692	8	20	articles	article	NOUN
fnp-4692	8	21	limited	limit	VERB
fnp-4692	8	22	to	to	ADP
fnp-4692	8	23	the	the	DET
fnp-4692	8	24	year	year	NOUN
fnp-4692	8	25	2022	2022	NUM
fnp-4692	8	26	in	in	ADP
fnp-4692	8	27	pubmed	pubmed	PROPN
fnp-4692	8	28	.	.	PUNCT
fnp-4692	9	1	in	in	ADP
fnp-4692	9	2	addition	addition	NOUN
fnp-4692	9	3	,	,	PUNCT
fnp-4692	9	4	the	the	DET
fnp-4692	9	5	author	author	NOUN
fnp-4692	9	6	“	"	PUNCT
fnp-4692	9	7	googled	google	VERB
fnp-4692	9	8	”	"	PUNCT
fnp-4692	9	9	by	by	ADP
fnp-4692	9	10	using	use	VERB
fnp-4692	9	11	the	the	DET
fnp-4692	9	12	key	key	ADJ
fnp-4692	9	13	words	word	NOUN
fnp-4692	9	14	“	"	PUNCT
fnp-4692	9	15	neurooncology	neurooncology	NOUN
fnp-4692	9	16	”	"	PUNCT
fnp-4692	9	17	or	or	CCONJ
fnp-4692	9	18	“	"	PUNCT
fnp-4692	9	19	neuropathology	neuropathology	NOUN
fnp-4692	9	20	”	"	PUNCT
fnp-4692	9	21	in	in	ADP
fnp-4692	9	22	combination	combination	NOUN
fnp-4692	9	23	with	with	ADP
fnp-4692	9	24	different	different	ADJ
fnp-4692	9	25	tumor	tumor	NOUN
fnp-4692	9	26	entity	entity	NOUN
fnp-4692	9	27	names	name	NOUN
fnp-4692	9	28	or	or	CCONJ
fnp-4692	9	29	laboratory	laboratory	NOUN
fnp-4692	9	30	techniques	technique	NOUN
fnp-4692	9	31	,	,	PUNCT
fnp-4692	9	32	as	as	SCONJ
fnp-4692	9	33	it	it	PRON
fnp-4692	9	34	has	have	AUX
fnp-4692	9	35	been	be	AUX
fnp-4692	9	36	shown	show	VERB
fnp-4692	9	37	that	that	SCONJ
fnp-4692	9	38	for	for	ADP
fnp-4692	9	39	some	some	DET
fnp-4692	9	40	questions	question	NOUN
fnp-4692	9	41	in	in	ADP
fnp-4692	9	42	the	the	DET
fnp-4692	9	43	biomedical	biomedical	ADJ
fnp-4692	9	44	field	field	NOUN
fnp-4692	9	45	,	,	PUNCT
fnp-4692	9	46	google	google	PROPN
fnp-4692	9	47	scholar	scholar	NOUN
fnp-4692	9	48	search	search	NOUN
fnp-4692	9	49	may	may	AUX
fnp-4692	9	50	help	help	VERB
fnp-4692	9	51	to	to	PART
fnp-4692	9	52	retrieve	retrieve	VERB
fnp-4692	9	53	up	up	ADP
fnp-4692	9	54	to	to	PART
fnp-4692	9	55	twice	twice	ADV
fnp-4692	9	56	more	more	ADV
fnp-4692	9	57	relevant	relevant	ADJ
fnp-4692	9	58	articles	article	NOUN
fnp-4692	9	59	than	than	ADP
fnp-4692	9	60	a	a	DET
fnp-4692	9	61	classic	classic	ADJ
fnp-4692	9	62	pubmed	pubmed	NOUN
fnp-4692	9	63	search	search	NOUN
fnp-4692	9	64	or	or	CCONJ
fnp-4692	9	65	information	information	NOUN
fnp-4692	9	66	that	that	PRON
fnp-4692	9	67	is	be	AUX
fnp-4692	9	68	otherwise	otherwise	ADV
fnp-4692	9	69	almost	almost	ADV
fnp-4692	9	70	unretrievable	unretrievable	ADJ
fnp-4692	10	1	[	[	X
fnp-4692	10	2	1	1	NUM
fnp-4692	10	3	,	,	PUNCT
fnp-4692	10	4	2	2	NUM
fnp-4692	10	5	]	]	PUNCT
fnp-4692	10	6	.	.	PUNCT
fnp-4692	11	1	apart	apart	ADV
fnp-4692	11	2	from	from	ADP
fnp-4692	11	3	a	a	DET
fnp-4692	11	4	high	high	ADJ
fnp-4692	11	5	number	number	NOUN
fnp-4692	11	6	of	of	ADP
fnp-4692	11	7	pure	pure	ADJ
fnp-4692	11	8	clinical	clinical	ADJ
fnp-4692	11	9	or	or	CCONJ
fnp-4692	11	10	neuroradiological	neuroradiological	ADJ
fnp-4692	11	11	papers	paper	NOUN
fnp-4692	11	12	or	or	CCONJ
fnp-4692	11	13	case	case	NOUN
fnp-4692	11	14	reports	report	NOUN
fnp-4692	11	15	that	that	PRON
fnp-4692	11	16	did	do	AUX
fnp-4692	11	17	not	not	PART
fnp-4692	11	18	directly	directly	ADV
fnp-4692	11	19	touch	touch	VERB
fnp-4692	11	20	the	the	DET
fnp-4692	11	21	field	field	NOUN
fnp-4692	11	22	of	of	ADP
fnp-4692	11	23	neuropathology	neuropathology	NOUN
fnp-4692	11	24	and	and	CCONJ
fnp-4692	11	25	were	be	AUX
fnp-4692	11	26	therefore	therefore	ADV
fnp-4692	11	27	excluded	exclude	VERB
fnp-4692	11	28	from	from	ADP
fnp-4692	11	29	this	this	DET
fnp-4692	11	30	highlight	highlight	NOUN
fnp-4692	11	31	list	list	NOUN
fnp-4692	11	32	,	,	PUNCT
fnp-4692	11	33	the	the	DET
fnp-4692	11	34	year	year	NOUN
fnp-4692	11	35	2022	2022	NUM
fnp-4692	11	36	can	can	AUX
fnp-4692	11	37	(	(	PUNCT
fnp-4692	11	38	maybe	maybe	ADV
fnp-4692	11	39	once	once	ADV
fnp-4692	11	40	again	again	ADV
fnp-4692	11	41	)	)	PUNCT
fnp-4692	11	42	be	be	AUX
fnp-4692	11	43	summarized	summarize	VERB
fnp-4692	11	44	under	under	ADP
fnp-4692	11	45	the	the	DET
fnp-4692	11	46	motto	motto	NOUN
fnp-4692	11	47	“	"	PUNCT
fnp-4692	11	48	profiling	profiling	ADJ
fnp-4692	11	49	,	,	PUNCT
fnp-4692	11	50	profiling	profiling	NOUN
fnp-4692	11	51	,	,	PUNCT
fnp-4692	11	52	profiling	profiling	NOUN
fnp-4692	11	53	”	"	PUNCT
fnp-4692	11	54	frequently	frequently	ADV
fnp-4692	11	55	in	in	ADP
fnp-4692	11	56	combination	combination	NOUN
fnp-4692	11	57	with	with	ADP
fnp-4692	11	58	machine	machine	NOUN
fnp-4692	11	59	learning	learn	VERB
fnp-4692	11	60	approaches	approach	NOUN
fnp-4692	11	61	to	to	PART
fnp-4692	11	62	increase	increase	VERB
fnp-4692	11	63	diagnostic	diagnostic	ADJ
fnp-4692	11	64	velocity	velocity	NOUN
fnp-4692	11	65	and	and	CCONJ
fnp-4692	11	66	precision	precision	NOUN
fnp-4692	11	67	.	.	PUNCT
fnp-4692	12	1	on	on	ADP
fnp-4692	12	2	the	the	DET
fnp-4692	12	3	other	other	ADJ
fnp-4692	12	4	hand	hand	NOUN
fnp-4692	12	5	,	,	PUNCT
fnp-4692	12	6	research	research	NOUN
fnp-4692	12	7	work	work	NOUN
fnp-4692	12	8	with	with	ADP
fnp-4692	12	9	promising	promise	VERB
fnp-4692	12	10	treatment	treatment	NOUN
fnp-4692	12	11	approaches	approach	NOUN
fnp-4692	12	12	making	make	VERB
fnp-4692	12	13	use	use	NOUN
fnp-4692	12	14	of	of	ADP
fnp-4692	12	15	the	the	DET
fnp-4692	12	16	new	new	ADJ
fnp-4692	12	17	molecular	molecular	ADJ
fnp-4692	12	18	data	datum	NOUN
fnp-4692	12	19	was	be	AUX
fnp-4692	12	20	relatively	relatively	ADV
fnp-4692	12	21	poor	poor	ADJ
fnp-4692	12	22	being	be	AUX
fnp-4692	12	23	in	in	ADP
fnp-4692	12	24	line	line	NOUN
fnp-4692	12	25	with	with	ADP
fnp-4692	12	26	an	an	DET
fnp-4692	12	27	almost	almost	ADV
fnp-4692	12	28	unchanged	unchanged	ADJ
fnp-4692	12	29	prognosis	prognosis	NOUN
fnp-4692	12	30	for	for	ADP
fnp-4692	12	31	the	the	DET
fnp-4692	12	32	majority	majority	NOUN
fnp-4692	12	33	of	of	ADP
fnp-4692	12	34	patients	patient	NOUN
fnp-4692	12	35	with	with	ADP
fnp-4692	12	36	malignant	malignant	ADJ
fnp-4692	12	37	brain	brain	NOUN
fnp-4692	12	38	tumors	tumor	NOUN
fnp-4692	12	39	.	.	PUNCT
fnp-4692	13	1	certainly	certainly	ADV
fnp-4692	13	2	,	,	PUNCT
fnp-4692	13	3	more	more	ADJ
fnp-4692	13	4	time	time	NOUN
fnp-4692	13	5	is	be	AUX
fnp-4692	13	6	needed	need	VERB
fnp-4692	13	7	to	to	PART
fnp-4692	13	8	decipher	decipher	NOUN
fnp-4692	13	9	precisely	precisely	ADV
fnp-4692	13	10	which	which	PRON
fnp-4692	13	11	of	of	ADP
fnp-4692	13	12	these	these	DET
fnp-4692	13	13	multitudes	multitude	NOUN
fnp-4692	13	14	of	of	ADP
fnp-4692	13	15	new	new	ADJ
fnp-4692	13	16	potential	potential	ADJ
fnp-4692	13	17	therapeutic	therapeutic	ADJ
fnp-4692	13	18	targets	target	NOUN
fnp-4692	13	19	,	,	PUNCT
fnp-4692	13	20	that	that	SCONJ
fnp-4692	13	21	nowadays	nowadays	ADV
fnp-4692	13	22	can	can	AUX
fnp-4692	13	23	be	be	AUX
fnp-4692	13	24	detected	detect	VERB
fnp-4692	13	25	almost	almost	ADV
fnp-4692	13	26	in	in	ADP
fnp-4692	13	27	real	real	ADJ
fnp-4692	13	28	-	-	PUNCT
fnp-4692	13	29	time	time	NOUN
fnp-4692	13	30	,	,	PUNCT
fnp-4692	13	31	will	will	AUX
fnp-4692	13	32	make	make	VERB
fnp-4692	13	33	it	it	PRON
fnp-4692	13	34	into	into	ADP
fnp-4692	13	35	future	future	ADJ
fnp-4692	13	36	clinical	clinical	ADJ
fnp-4692	13	37	application	application	NOUN
fnp-4692	13	38	.	.	PUNCT
fnp-4692	14	1	for	for	ADP
fnp-4692	14	2	single	single	ADJ
fnp-4692	14	3	topics	topic	NOUN
fnp-4692	14	4	,	,	PUNCT
fnp-4692	14	5	the	the	DET
fnp-4692	14	6	author	author	NOUN
fnp-4692	14	7	co	co	VERB
fnp-4692	14	8	-	-	VERB
fnp-4692	14	9	selected	select	VERB
fnp-4692	14	10	two	two	NUM
fnp-4692	14	11	studies	study	NOUN
fnp-4692	14	12	due	due	ADP
fnp-4692	14	13	to	to	ADP
fnp-4692	14	14	their	their	PRON
fnp-4692	14	15	similarity	similarity	NOUN
fnp-4692	14	16	or	or	CCONJ
fnp-4692	14	17	complementarity	complementarity	NOUN
fnp-4692	14	18	.	.	PUNCT
fnp-4692	15	1	the	the	DET
fnp-4692	15	2	author	author	NOUN
fnp-4692	15	3	’s	’s	PART
fnp-4692	15	4	“	"	PUNCT
fnp-4692	15	5	charts	chart	NOUN
fnp-4692	15	6	of	of	ADP
fnp-4692	15	7	2022	2022	NUM
fnp-4692	15	8	”	"	PUNCT
fnp-4692	15	9	in	in	ADP
fnp-4692	15	10	neurooncology	neurooncology	NOUN
fnp-4692	15	11	reads	read	VERB
fnp-4692	15	12	as	as	SCONJ
fnp-4692	15	13	follows	follow	VERB
fnp-4692	15	14	(	(	PUNCT
fnp-4692	15	15	not	not	PART
fnp-4692	15	16	meant	mean	VERB
fnp-4692	15	17	in	in	ADP
fnp-4692	15	18	a	a	DET
fnp-4692	15	19	hierarchical	hierarchical	ADJ
fnp-4692	15	20	manner	manner	NOUN
fnp-4692	15	21	but	but	CCONJ
fnp-4692	15	22	rather	rather	ADV
fnp-4692	15	23	in	in	ADP
fnp-4692	15	24	a	a	DET
fnp-4692	15	25	progression	progression	NOUN
fnp-4692	15	26	from	from	ADP
fnp-4692	15	27	neuropathological	neuropathological	ADJ
fnp-4692	15	28	core	core	NOUN
fnp-4692	15	29	work	work	NOUN
fnp-4692	15	30	to	to	ADP
fnp-4692	15	31	early	early	ADJ
fnp-4692	15	32	clinical	clinical	ADJ
fnp-4692	15	33	application	application	NOUN
fnp-4692	15	34	):	):	PUNCT
fnp-4692	15	35	new	new	ADJ
fnp-4692	15	36	brain	brain	NOUN
fnp-4692	15	37	tumor	tumor	NOUN
fnp-4692	15	38	entity	entity	NOUN
fnp-4692	15	39	:	:	PUNCT
fnp-4692	15	40	high	high	ADJ
fnp-4692	15	41	-	-	PUNCT
fnp-4692	15	42	grade	grade	NOUN
fnp-4692	15	43	glioma	glioma	NOUN
fnp-4692	15	44	with	with	ADP
fnp-4692	15	45	pleomorphic	pleomorphic	ADJ
fnp-4692	15	46	and	and	CCONJ
fnp-4692	15	47	pseudopapillary	pseudopapillary	ADJ
fnp-4692	15	48	features	feature	NOUN
fnp-4692	15	49	(	(	PUNCT
fnp-4692	15	50	hpap	hpap	NOUN
fnp-4692	15	51	)	)	PUNCT
fnp-4692	16	1	[	[	X
fnp-4692	16	2	3	3	NUM
fnp-4692	16	3	]	]	PUNCT
fnp-4692	16	4	.	.	PUNCT
fnp-4692	17	1	prediction	prediction	NOUN
fnp-4692	17	2	of	of	ADP
fnp-4692	17	3	1p/19q	1p/19q	PROPN
fnp-4692	17	4	status	status	NOUN
fnp-4692	17	5	by	by	ADP
fnp-4692	17	6	immunohistochemistry	immunohistochemistry	NOUN
fnp-4692	17	7	in	in	ADP
fnp-4692	17	8	idh	idh	NOUN
fnp-4692	17	9	-	-	PUNCT
fnp-4692	17	10	mutant	mutant	NOUN
fnp-4692	17	11	glioma	glioma	NOUN
fnp-4692	17	12	[	[	X
fnp-4692	17	13	4	4	NUM
fnp-4692	17	14	]	]	PUNCT
fnp-4692	17	15	.	.	PUNCT
fnp-4692	18	1	prediction	prediction	NOUN
fnp-4692	18	2	of	of	ADP
fnp-4692	18	3	molecular	molecular	ADJ
fnp-4692	18	4	tumor	tumor	NOUN
fnp-4692	18	5	features	feature	VERB
fnp-4692	18	6	from	from	ADP
fnp-4692	18	7	histology	histology	NOUN
fnp-4692	18	8	by	by	ADP
fnp-4692	18	9	machine	machine	NOUN
fnp-4692	18	10	learning	learn	VERB
fnp-4692	18	11	[	[	X
fnp-4692	18	12	5	5	NUM
fnp-4692	18	13	]	]	PUNCT
fnp-4692	18	14	.	.	PUNCT
fnp-4692	19	1	histomolecular	histomolecular	ADJ
fnp-4692	19	2	grading	grade	VERB
fnp-4692	19	3	for	for	ADP
fnp-4692	19	4	meningioma	meningioma	NOUN
fnp-4692	19	5	[	[	X
fnp-4692	19	6	6	6	NUM
fnp-4692	19	7	]	]	PUNCT
fnp-4692	19	8	.	.	PUNCT
fnp-4692	20	1	molecular	molecular	ADJ
fnp-4692	20	2	profiling	profiling	NOUN
fnp-4692	20	3	of	of	ADP
fnp-4692	20	4	cns	cns	PROPN
fnp-4692	20	5	lymphoma	lymphoma	NOUN
fnp-4692	20	6	[	[	X
fnp-4692	20	7	7	7	NUM
fnp-4692	20	8	]	]	PUNCT
fnp-4692	20	9	.	.	PUNCT
fnp-4692	21	1	proteomic	proteomic	ADJ
fnp-4692	21	2	landscape	landscape	NOUN
fnp-4692	21	3	of	of	ADP
fnp-4692	21	4	primary	primary	ADJ
fnp-4692	21	5	and	and	CCONJ
fnp-4692	21	6	recurrent	recurrent	ADJ
fnp-4692	21	7	glioblastoma	glioblastoma	NOUN
fnp-4692	21	8	[	[	X
fnp-4692	21	9	8	8	NUM
fnp-4692	21	10	]	]	PUNCT
fnp-4692	21	11	.	.	PUNCT
fnp-4692	22	1	methylome	methylome	PROPN
fnp-4692	22	2	-	-	PUNCT
fnp-4692	22	3	based	base	VERB
fnp-4692	22	4	brain	brain	NOUN
fnp-4692	22	5	tumor	tumor	NOUN
fnp-4692	22	6	diagnostics	diagnostic	NOUN
fnp-4692	22	7	in	in	ADP
fnp-4692	22	8	csf	csf	ADJ
fnp-4692	22	9	liquid	liquid	ADJ
fnp-4692	22	10	biopsies	biopsy	NOUN
fnp-4692	22	11	[	[	X
fnp-4692	22	12	9	9	NUM
fnp-4692	22	13	]	]	PUNCT
fnp-4692	22	14	.	.	PUNCT
fnp-4692	23	1	intraoperative	intraoperative	ADJ
fnp-4692	23	2	diagnostics	diagnostic	NOUN
fnp-4692	23	3	for	for	ADP
fnp-4692	23	4	brain	brain	NOUN
fnp-4692	23	5	tumors	tumor	NOUN
fnp-4692	23	6	based	base	VERB
fnp-4692	23	7	on	on	ADP
fnp-4692	23	8	raman	raman	ADJ
fnp-4692	23	9	effect	effect	NOUN
fnp-4692	23	10	[	[	X
fnp-4692	23	11	10	10	NUM
fnp-4692	23	12	,	,	PUNCT
fnp-4692	23	13	11	11	NUM
fnp-4692	23	14	]	]	PUNCT
fnp-4692	23	15	.	.	PUNCT
fnp-4692	24	1	intraoperative	intraoperative	ADJ
fnp-4692	24	2	molecular	molecular	ADJ
fnp-4692	24	3	tumor	tumor	NOUN
fnp-4692	24	4	profiling	profiling	NOUN
fnp-4692	24	5	[	[	X
fnp-4692	24	6	12	12	NUM
fnp-4692	24	7	,	,	PUNCT
fnp-4692	24	8	13	13	NUM
fnp-4692	24	9	]	]	PUNCT
fnp-4692	24	10	.	.	PUNCT
fnp-4692	25	1	drug	drug	NOUN
fnp-4692	25	2	screening	screen	VERB
fnp-4692	25	3	platform	platform	NOUN
fnp-4692	25	4	for	for	ADP
fnp-4692	25	5	brain	brain	NOUN
fnp-4692	25	6	metastasis	metastasis	NOUN
fnp-4692	25	7	[	[	X
fnp-4692	25	8	14	14	NUM
fnp-4692	25	9	]	]	PUNCT
fnp-4692	25	10	.	.	PUNCT
fnp-4692	26	1	the	the	DET
fnp-4692	26	2	author	author	NOUN
fnp-4692	26	3	invites	invite	VERB
fnp-4692	26	4	you	you	PRON
fnp-4692	26	5	on	on	ADP
fnp-4692	26	6	a	a	DET
fnp-4692	26	7	joint	joint	ADJ
fnp-4692	26	8	journey	journey	NOUN
fnp-4692	26	9	across	across	ADP
fnp-4692	26	10	some	some	PRON
fnp-4692	26	11	of	of	ADP
fnp-4692	26	12	the	the	DET
fnp-4692	26	13	most	most	ADV
fnp-4692	26	14	recent	recent	ADJ
fnp-4692	26	15	neurooncological	neurooncological	ADJ
fnp-4692	26	16	developments	development	NOUN
fnp-4692	26	17	touching	touch	VERB
fnp-4692	26	18	the	the	DET
fnp-4692	26	19	field	field	NOUN
fnp-4692	26	20	of	of	ADP
fnp-4692	26	21	neuropathology	neuropathology	NOUN
fnp-4692	26	22	.	.	PUNCT
fnp-4692	27	1	of	of	ADP
fnp-4692	27	2	course	course	ADV
fnp-4692	27	3	,	,	PUNCT
fnp-4692	27	4	this	this	DET
fnp-4692	27	5	selection	selection	NOUN
fnp-4692	27	6	is	be	AUX
fnp-4692	27	7	highly	highly	ADV
fnp-4692	27	8	subjective	subjective	ADJ
fnp-4692	27	9	,	,	PUNCT
fnp-4692	27	10	however	however	ADV
fnp-4692	27	11	,	,	PUNCT
fnp-4692	27	12	the	the	DET
fnp-4692	27	13	author	author	NOUN
fnp-4692	27	14	aimed	aim	VERB
fnp-4692	27	15	at	at	ADP
fnp-4692	27	16	selecting	select	VERB
fnp-4692	27	17	very	very	ADV
fnp-4692	27	18	diverse	diverse	ADJ
fnp-4692	27	19	studies	study	NOUN
fnp-4692	27	20	from	from	ADP
fnp-4692	27	21	different	different	ADJ
fnp-4692	27	22	neurooncological	neurooncological	ADJ
fnp-4692	27	23	subfields	subfield	NOUN
fnp-4692	27	24	so	so	SCONJ
fnp-4692	27	25	that	that	SCONJ
fnp-4692	27	26	the	the	DET
fnp-4692	27	27	majority	majority	NOUN
fnp-4692	27	28	of	of	ADP
fnp-4692	27	29	the	the	DET
fnp-4692	27	30	readership	readership	NOUN
fnp-4692	27	31	of	of	ADP
fnp-4692	27	32	free	free	ADJ
fnp-4692	27	33	neuropathology	neuropathology	NOUN
fnp-4692	27	34	may	may	AUX
fnp-4692	27	35	at	at	ADV
fnp-4692	27	36	least	least	ADJ
fnp-4692	27	37	partly	partly	ADV
fnp-4692	27	38	be	be	AUX
fnp-4692	27	39	able	able	ADJ
fnp-4692	27	40	to	to	PART
fnp-4692	27	41	share	share	VERB
fnp-4692	27	42	the	the	DET
fnp-4692	27	43	author	author	NOUN
fnp-4692	27	44	’s	’s	PART
fnp-4692	27	45	enthusiasm	enthusiasm	NOUN
fnp-4692	27	46	about	about	ADP
fnp-4692	27	47	the	the	DET
fnp-4692	27	48	presented	present	VERB
fnp-4692	27	49	studies	study	NOUN
fnp-4692	27	50	.	.	PUNCT
fnp-4692	28	1	1	1	X
fnp-4692	28	2	.	.	X
fnp-4692	28	3	new	new	ADJ
fnp-4692	28	4	brain	brain	NOUN
fnp-4692	28	5	tumor	tumor	NOUN
fnp-4692	28	6	entity	entity	NOUN
fnp-4692	28	7	:	:	PUNCT
fnp-4692	28	8	high	high	ADJ
fnp-4692	28	9	-	-	PUNCT
fnp-4692	28	10	grade	grade	NOUN
fnp-4692	28	11	glioma	glioma	NOUN
fnp-4692	28	12	with	with	ADP
fnp-4692	28	13	pleomorphic	pleomorphic	ADJ
fnp-4692	28	14	and	and	CCONJ
fnp-4692	28	15	pseudopapillary	pseudopapillary	ADJ
fnp-4692	28	16	features	feature	NOUN
fnp-4692	28	17	(	(	PUNCT
fnp-4692	28	18	hpap	hpap	NOUN
fnp-4692	28	19	)	)	PUNCT
fnp-4692	29	1	[	[	X
fnp-4692	29	2	3	3	X
fnp-4692	29	3	]	]	PUNCT
fnp-4692	29	4	even	even	ADV
fnp-4692	29	5	after	after	SCONJ
fnp-4692	29	6	the	the	DET
fnp-4692	29	7	neuropathological	neuropathological	ADJ
fnp-4692	29	8	community	community	NOUN
fnp-4692	29	9	has	have	AUX
fnp-4692	29	10	molecularly	molecularly	ADV
fnp-4692	29	11	profiled	profile	VERB
fnp-4692	29	12	a	a	DET
fnp-4692	29	13	huge	huge	ADJ
fnp-4692	29	14	amount	amount	NOUN
fnp-4692	29	15	of	of	ADP
fnp-4692	29	16	brain	brain	NOUN
fnp-4692	29	17	tumor	tumor	NOUN
fnp-4692	29	18	cases	case	NOUN
fnp-4692	29	19	worldwide	worldwide	ADV
fnp-4692	29	20	,	,	PUNCT
fnp-4692	29	21	while	while	SCONJ
fnp-4692	29	22	also	also	ADV
fnp-4692	29	23	mainly	mainly	ADV
fnp-4692	29	24	using	use	VERB
fnp-4692	29	25	the	the	DET
fnp-4692	29	26	same	same	ADJ
fnp-4692	29	27	brain	brain	NOUN
fnp-4692	29	28	tumor	tumor	NOUN
fnp-4692	29	29	methylation	methylation	NOUN
fnp-4692	29	30	classifier	classifier	NOUN
fnp-4692	29	31	,	,	PUNCT
fnp-4692	29	32	we	we	PRON
fnp-4692	29	33	still	still	ADV
fnp-4692	29	34	struggle	struggle	VERB
fnp-4692	29	35	from	from	ADP
fnp-4692	29	36	time	time	NOUN
fnp-4692	29	37	to	to	ADP
fnp-4692	29	38	time	time	NOUN
fnp-4692	29	39	with	with	ADP
fnp-4692	29	40	providing	provide	VERB
fnp-4692	29	41	precise	precise	ADJ
fnp-4692	29	42	diagnoses	diagnosis	NOUN
fnp-4692	29	43	for	for	ADP
fnp-4692	29	44	particular	particular	ADJ
fnp-4692	29	45	cerebral	cerebral	ADJ
fnp-4692	29	46	tumors	tumor	NOUN
fnp-4692	29	47	.	.	PUNCT
fnp-4692	30	1	pratt	pratt	PROPN
fnp-4692	30	2	et	et	PROPN
fnp-4692	30	3	al	al	PROPN
fnp-4692	30	4	.	.	PROPN
fnp-4692	30	5	made	make	VERB
fnp-4692	30	6	use	use	NOUN
fnp-4692	30	7	of	of	ADP
fnp-4692	30	8	the	the	DET
fnp-4692	30	9	brain	brain	NOUN
fnp-4692	30	10	tumor	tumor	NOUN
fnp-4692	30	11	methylation	methylation	NOUN
fnp-4692	30	12	classifier	classifier	NOUN
fnp-4692	31	1	[	[	X
fnp-4692	31	2	https://www.molecularneuropathology.org/mnp	https://www.molecularneuropathology.org/mnp	PROPN
fnp-4692	31	3	based	base	VERB
fnp-4692	31	4	on	on	ADP
fnp-4692	31	5	15	15	NUM
fnp-4692	31	6	]	]	PUNCT
fnp-4692	31	7	combined	combine	VERB
fnp-4692	31	8	with	with	ADP
fnp-4692	31	9	a	a	DET
fnp-4692	31	10	next	next	ADJ
fnp-4692	31	11	generation	generation	NOUN
fnp-4692	31	12	sequencing	sequence	VERB
fnp-4692	31	13	approach	approach	NOUN
fnp-4692	31	14	using	use	VERB
fnp-4692	31	15	both	both	CCONJ
fnp-4692	31	16	an	an	DET
fnp-4692	31	17	amplicon	amplicon	NOUN
fnp-4692	31	18	-	-	PUNCT
fnp-4692	31	19	based	base	VERB
fnp-4692	31	20	brain	brain	NOUN
fnp-4692	31	21	tumor	tumor	NOUN
fnp-4692	31	22	specific	specific	ADJ
fnp-4692	31	23	panel	panel	NOUN
fnp-4692	32	1	[	[	X
fnp-4692	32	2	16	16	NUM
fnp-4692	32	3	]	]	X
fnp-4692	32	4	,	,	PUNCT
fnp-4692	32	5	as	as	ADV
fnp-4692	32	6	well	well	ADV
fnp-4692	32	7	as	as	ADP
fnp-4692	32	8	the	the	DET
fnp-4692	32	9	commercial	commercial	ADJ
fnp-4692	32	10	trusight	trusight	VERB
fnp-4692	32	11	oncology	oncology	NOUN
fnp-4692	32	12	500	500	NUM
fnp-4692	32	13	panel	panel	NOUN
fnp-4692	32	14	(	(	PUNCT
fnp-4692	32	15	tso	tso	PROPN
fnp-4692	32	16	500	500	NUM
fnp-4692	32	17	,	,	PUNCT
fnp-4692	32	18	illumina	illumina	PROPN
fnp-4692	32	19	,	,	PUNCT
fnp-4692	32	20	san	san	PROPN
fnp-4692	32	21	diego	diego	PROPN
fnp-4692	32	22	,	,	PUNCT
fnp-4692	32	23	usa	usa	PROPN
fnp-4692	32	24	)	)	PUNCT
fnp-4692	33	1	[	[	X
fnp-4692	33	2	3	3	NUM
fnp-4692	33	3	]	]	PUNCT
fnp-4692	33	4	.	.	PUNCT
fnp-4692	34	1	with	with	ADP
fnp-4692	34	2	this	this	DET
fnp-4692	34	3	approach	approach	NOUN
fnp-4692	34	4	,	,	PUNCT
fnp-4692	34	5	the	the	DET
fnp-4692	34	6	authors	author	NOUN
fnp-4692	34	7	were	be	AUX
fnp-4692	34	8	able	able	ADJ
fnp-4692	34	9	to	to	PART
fnp-4692	34	10	classify	classify	VERB
fnp-4692	34	11	31	31	NUM
fnp-4692	34	12	previously	previously	ADV
fnp-4692	34	13	non	non	ADJ
fnp-4692	34	14	-	-	ADJ
fnp-4692	34	15	classifiable	classifiable	ADJ
fnp-4692	34	16	brain	brain	NOUN
fnp-4692	34	17	tumors	tumor	NOUN
fnp-4692	34	18	(	(	PUNCT
fnp-4692	34	19	median	median	ADJ
fnp-4692	34	20	patient	patient	NOUN
fnp-4692	34	21	age	age	NOUN
fnp-4692	34	22	was	be	AUX
fnp-4692	34	23	46.5	46.5	NUM
fnp-4692	34	24	years	year	NOUN
fnp-4692	34	25	)	)	PUNCT
fnp-4692	34	26	,	,	PUNCT
fnp-4692	34	27	mainly	mainly	ADV
fnp-4692	34	28	but	but	CCONJ
fnp-4692	34	29	not	not	PART
fnp-4692	34	30	exclusively	exclusively	ADV
fnp-4692	34	31	localized	localize	VERB
fnp-4692	34	32	in	in	ADP
fnp-4692	34	33	cortical	cortical	ADJ
fnp-4692	34	34	areas	area	NOUN
fnp-4692	34	35	,	,	PUNCT
fnp-4692	34	36	with	with	ADP
fnp-4692	34	37	highly	highly	ADV
fnp-4692	34	38	diverse	diverse	ADJ
fnp-4692	34	39	morphological	morphological	ADJ
fnp-4692	34	40	features	feature	NOUN
fnp-4692	34	41	,	,	PUNCT
fnp-4692	34	42	including	include	VERB
fnp-4692	34	43	those	those	PRON
fnp-4692	34	44	of	of	ADP
fnp-4692	34	45	pleomorphic	pleomorphic	ADJ
fnp-4692	34	46	xanthoastrocytoma	xanthoastrocytoma	NOUN
fnp-4692	34	47	(	(	PUNCT
fnp-4692	34	48	pxa	pxa	NOUN
fnp-4692	34	49	)	)	PUNCT
fnp-4692	34	50	,	,	PUNCT
fnp-4692	34	51	astroblastoma	astroblastoma	NOUN
fnp-4692	34	52	,	,	PUNCT
fnp-4692	34	53	ependymoma	ependymoma	NOUN
fnp-4692	34	54	,	,	PUNCT
fnp-4692	34	55	polymorphous	polymorphous	ADJ
fnp-4692	34	56	neuroepithelial	neuroepithelial	ADJ
fnp-4692	34	57	tumor	tumor	NOUN
fnp-4692	34	58	of	of	ADP
fnp-4692	34	59	the	the	DET
fnp-4692	34	60	young	young	ADJ
fnp-4692	34	61	(	(	PUNCT
fnp-4692	34	62	plnty	plnty	NOUN
fnp-4692	34	63	)	)	PUNCT
fnp-4692	34	64	,	,	PUNCT
fnp-4692	34	65	as	as	ADV
fnp-4692	34	66	well	well	ADV
fnp-4692	34	67	as	as	ADP
fnp-4692	34	68	idh	idh	NOUN
fnp-4692	34	69	wildtype	wildtype	NOUN
fnp-4692	34	70	glioblastoma	glioblastoma	NOUN
fnp-4692	34	71	.	.	PUNCT
fnp-4692	35	1	one	one	NUM
fnp-4692	35	2	important	important	ADJ
fnp-4692	35	3	morphological	morphological	ADJ
fnp-4692	35	4	feature	feature	NOUN
fnp-4692	35	5	was	be	AUX
fnp-4692	35	6	the	the	DET
fnp-4692	35	7	mainly	mainly	ADV
fnp-4692	35	8	non	non	ADJ
fnp-4692	35	9	-	-	ADJ
fnp-4692	35	10	infiltrative	infiltrative	ADJ
fnp-4692	35	11	growth	growth	NOUN
fnp-4692	35	12	pattern	pattern	NOUN
fnp-4692	35	13	observed	observe	VERB
fnp-4692	35	14	in	in	ADP
fnp-4692	35	15	hpap	hpap	NOUN
fnp-4692	35	16	.	.	PUNCT
fnp-4692	36	1	in	in	ADP
fnp-4692	36	2	the	the	DET
fnp-4692	36	3	brain	brain	NOUN
fnp-4692	36	4	methylation	methylation	NOUN
fnp-4692	36	5	classifier	classifier	NOUN
fnp-4692	36	6	,	,	PUNCT
fnp-4692	36	7	these	these	DET
fnp-4692	36	8	brain	brain	NOUN
fnp-4692	36	9	tumors	tumor	NOUN
fnp-4692	36	10	did	do	AUX
fnp-4692	36	11	not	not	PART
fnp-4692	36	12	cluster	cluster	VERB
fnp-4692	36	13	with	with	ADP
fnp-4692	36	14	any	any	PRON
fnp-4692	36	15	of	of	ADP
fnp-4692	36	16	the	the	DET
fnp-4692	36	17	known	know	VERB
fnp-4692	36	18	methylation	methylation	NOUN
fnp-4692	36	19	classes	class	NOUN
fnp-4692	36	20	in	in	ADP
fnp-4692	36	21	v11.4	v11.4	PROPN
fnp-4692	36	22	,	,	PUNCT
fnp-4692	36	23	however	however	ADV
fnp-4692	36	24	were	be	AUX
fnp-4692	36	25	closest	close	ADJ
fnp-4692	36	26	to	to	ADP
fnp-4692	36	27	pxa	pxa	VERB
fnp-4692	36	28	,	,	PUNCT
fnp-4692	36	29	mn1	mn1	NOUN
fnp-4692	36	30	-	-	PUNCT
fnp-4692	36	31	altered	alter	VERB
fnp-4692	36	32	astroblastoma	astroblastoma	NOUN
fnp-4692	36	33	and	and	CCONJ
fnp-4692	36	34	plnty	plnty	NOUN
fnp-4692	36	35	.	.	PUNCT
fnp-4692	37	1	apart	apart	ADV
fnp-4692	37	2	from	from	ADP
fnp-4692	37	3	several	several	ADJ
fnp-4692	37	4	frequently	frequently	ADV
fnp-4692	37	5	encountered	encounter	VERB
fnp-4692	37	6	mutations	mutation	NOUN
fnp-4692	37	7	in	in	ADP
fnp-4692	37	8	these	these	DET
fnp-4692	37	9	brain	brain	NOUN
fnp-4692	37	10	tumors	tumor	NOUN
fnp-4692	37	11	,	,	PUNCT
fnp-4692	37	12	such	such	ADJ
fnp-4692	37	13	as	as	ADP
fnp-4692	37	14	tp53	tp53	PROPN
fnp-4692	37	15	,	,	PUNCT
fnp-4692	37	16	rb1	rb1	PROPN
fnp-4692	37	17	,	,	PUNCT
fnp-4692	37	18	nf1	nf1	NOUN
fnp-4692	37	19	or	or	CCONJ
fnp-4692	37	20	less	less	ADV
fnp-4692	37	21	frequently	frequently	ADV
fnp-4692	37	22	nf2	nf2	ADJ
fnp-4692	37	23	or	or	CCONJ
fnp-4692	37	24	braf	braf	NOUN
fnp-4692	37	25	-	-	PUNCT
fnp-4692	37	26	v600e	v600e	NOUN
fnp-4692	37	27	expression	expression	NOUN
fnp-4692	37	28	,	,	PUNCT
fnp-4692	37	29	a	a	DET
fnp-4692	37	30	frequent	frequent	ADJ
fnp-4692	37	31	chromosomal	chromosomal	ADJ
fnp-4692	37	32	aneuploidy	aneuploidy	NOUN
fnp-4692	37	33	was	be	AUX
fnp-4692	37	34	observed	observe	VERB
fnp-4692	37	35	,	,	PUNCT
fnp-4692	37	36	with	with	ADP
fnp-4692	37	37	a	a	DET
fnp-4692	37	38	very	very	ADV
fnp-4692	37	39	high	high	ADJ
fnp-4692	37	40	rate	rate	NOUN
fnp-4692	37	41	of	of	ADP
fnp-4692	37	42	a	a	DET
fnp-4692	37	43	monosomy	monosomy	NOUN
fnp-4692	37	44	13	13	NUM
fnp-4692	37	45	,	,	PUNCT
fnp-4692	37	46	detected	detect	VERB
fnp-4692	37	47	in	in	ADP
fnp-4692	37	48	28	28	NUM
fnp-4692	37	49	of	of	ADP
fnp-4692	37	50	31	31	NUM
fnp-4692	37	51	cases	case	NOUN
fnp-4692	37	52	analyzed	analyze	VERB
fnp-4692	37	53	.	.	PUNCT
fnp-4692	38	1	of	of	ADP
fnp-4692	38	2	note	note	NOUN
fnp-4692	38	3	,	,	PUNCT
fnp-4692	38	4	mgmt	mgmt	PROPN
fnp-4692	38	5	promoter	promoter	NOUN
fnp-4692	38	6	methylation	methylation	NOUN
fnp-4692	38	7	was	be	AUX
fnp-4692	38	8	only	only	ADV
fnp-4692	38	9	detected	detect	VERB
fnp-4692	38	10	in	in	ADP
fnp-4692	38	11	1	1	NUM
fnp-4692	38	12	patient	patient	NOUN
fnp-4692	38	13	,	,	PUNCT
fnp-4692	38	14	and	and	CCONJ
fnp-4692	38	15	a	a	DET
fnp-4692	38	16	cdkn2a	cdkn2a	PROPN
fnp-4692	38	17	/	/	SYM
fnp-4692	38	18	b	b	NOUN
fnp-4692	38	19	deletion	deletion	NOUN
fnp-4692	38	20	in	in	ADP
fnp-4692	38	21	2	2	NUM
fnp-4692	38	22	patients	patient	NOUN
fnp-4692	38	23	of	of	ADP
fnp-4692	38	24	this	this	DET
fnp-4692	38	25	cohort	cohort	NOUN
fnp-4692	38	26	.	.	PUNCT
fnp-4692	39	1	as	as	ADP
fnp-4692	39	2	a	a	DET
fnp-4692	39	3	working	work	VERB
fnp-4692	39	4	entity	entity	NOUN
fnp-4692	39	5	name	name	NOUN
fnp-4692	39	6	,	,	PUNCT
fnp-4692	39	7	the	the	DET
fnp-4692	39	8	authors	author	NOUN
fnp-4692	39	9	suggested	suggest	VERB
fnp-4692	39	10	“	"	PUNCT
fnp-4692	39	11	high	high	ADJ
fnp-4692	39	12	-	-	PUNCT
fnp-4692	39	13	grade	grade	NOUN
fnp-4692	39	14	glioma	glioma	NOUN
fnp-4692	39	15	with	with	ADP
fnp-4692	39	16	pleomorphic	pleomorphic	ADJ
fnp-4692	39	17	and	and	CCONJ
fnp-4692	39	18	pseudopapillary	pseudopapillary	ADJ
fnp-4692	39	19	features	feature	NOUN
fnp-4692	39	20	(	(	PUNCT
fnp-4692	39	21	hpap	hpap	NOUN
fnp-4692	39	22	)	)	PUNCT
fnp-4692	39	23	”	"	PUNCT
fnp-4692	39	24	.	.	PUNCT
fnp-4692	40	1	the	the	DET
fnp-4692	40	2	authors	author	NOUN
fnp-4692	40	3	proposed	propose	VERB
fnp-4692	40	4	2	2	NUM
fnp-4692	40	5	molecular	molecular	ADJ
fnp-4692	40	6	subtypes	subtype	NOUN
fnp-4692	40	7	(	(	PUNCT
fnp-4692	40	8	a	a	PRON
fnp-4692	40	9	and	and	CCONJ
fnp-4692	40	10	b	b	NOUN
fnp-4692	40	11	)	)	PUNCT
fnp-4692	40	12	without	without	ADP
fnp-4692	40	13	any	any	DET
fnp-4692	40	14	specific	specific	ADJ
fnp-4692	40	15	associated	associated	ADJ
fnp-4692	40	16	genetic	genetic	ADJ
fnp-4692	40	17	or	or	CCONJ
fnp-4692	40	18	morphological	morphological	ADJ
fnp-4692	40	19	features	feature	NOUN
fnp-4692	40	20	being	be	AUX
fnp-4692	40	21	associated	associate	VERB
fnp-4692	40	22	with	with	ADP
fnp-4692	40	23	those	those	DET
fnp-4692	40	24	subclasses	subclass	NOUN
fnp-4692	40	25	,	,	PUNCT
fnp-4692	40	26	however	however	ADV
fnp-4692	40	27	significantly	significantly	ADV
fnp-4692	40	28	older	old	ADJ
fnp-4692	40	29	patients	patient	NOUN
fnp-4692	40	30	in	in	ADP
fnp-4692	40	31	subtype	subtype	NOUN
fnp-4692	40	32	a	a	DET
fnp-4692	40	33	as	as	ADP
fnp-4692	40	34	compared	compare	VERB
fnp-4692	40	35	to	to	ADP
fnp-4692	40	36	b.	b.	VERB
fnp-4692	40	37	although	although	SCONJ
fnp-4692	40	38	some	some	PRON
fnp-4692	40	39	of	of	ADP
fnp-4692	40	40	the	the	DET
fnp-4692	40	41	histologically	histologically	NOUN
fnp-4692	40	42	described	describe	VERB
fnp-4692	40	43	morphological	morphological	ADJ
fnp-4692	40	44	features	feature	NOUN
fnp-4692	40	45	rather	rather	ADV
fnp-4692	40	46	indicated	indicate	VERB
fnp-4692	40	47	a	a	DET
fnp-4692	40	48	high	high	ADJ
fnp-4692	40	49	-	-	PUNCT
fnp-4692	40	50	grade	grade	NOUN
fnp-4692	40	51	glioma	glioma	NOUN
fnp-4692	40	52	,	,	PUNCT
fnp-4692	40	53	the	the	DET
fnp-4692	40	54	overall	overall	ADJ
fnp-4692	40	55	survival	survival	NOUN
fnp-4692	40	56	was	be	AUX
fnp-4692	40	57	not	not	PART
fnp-4692	40	58	significantly	significantly	ADV
fnp-4692	40	59	different	different	ADJ
fnp-4692	40	60	from	from	ADP
fnp-4692	40	61	pilocytic	pilocytic	ADJ
fnp-4692	40	62	astrocytoma	astrocytoma	NOUN
fnp-4692	40	63	,	,	PUNCT
fnp-4692	40	64	pxa	pxa	NOUN
fnp-4692	40	65	and	and	CCONJ
fnp-4692	40	66	high	high	ADJ
fnp-4692	40	67	-	-	PUNCT
fnp-4692	40	68	grade	grade	NOUN
fnp-4692	40	69	astrocytoma	astrocytoma	NOUN
fnp-4692	40	70	with	with	ADP
fnp-4692	40	71	piloid	piloid	PROPN
fnp-4692	40	72	features	feature	NOUN
fnp-4692	40	73	,	,	PUNCT
fnp-4692	40	74	however	however	ADV
fnp-4692	40	75	,	,	PUNCT
fnp-4692	40	76	was	be	AUX
fnp-4692	40	77	significantly	significantly	ADV
fnp-4692	40	78	better	well	ADJ
fnp-4692	40	79	than	than	ADP
fnp-4692	40	80	the	the	DET
fnp-4692	40	81	group	group	NOUN
fnp-4692	40	82	of	of	ADP
fnp-4692	40	83	idh	idh	PROPN
fnp-4692	40	84	wildtype	wildtype	NOUN
fnp-4692	40	85	glioblastomas	glioblastoma	NOUN
fnp-4692	40	86	,	,	PUNCT
fnp-4692	40	87	therefore	therefore	ADV
fnp-4692	40	88	,	,	PUNCT
fnp-4692	40	89	molecularly	molecularly	ADV
fnp-4692	40	90	suggesting	suggest	VERB
fnp-4692	40	91	a	a	DET
fnp-4692	40	92	biologically	biologically	ADV
fnp-4692	40	93	less	less	ADV
fnp-4692	40	94	malignant	malignant	ADJ
fnp-4692	40	95	tumor	tumor	NOUN
fnp-4692	40	96	entity	entity	NOUN
fnp-4692	40	97	.	.	PUNCT
fnp-4692	41	1	as	as	SCONJ
fnp-4692	41	2	the	the	DET
fnp-4692	41	3	histological	histological	ADJ
fnp-4692	41	4	picture	picture	NOUN
fnp-4692	41	5	is	be	AUX
fnp-4692	41	6	highly	highly	ADV
fnp-4692	41	7	variable	variable	ADJ
fnp-4692	41	8	and	and	CCONJ
fnp-4692	41	9	patient	patient	ADJ
fnp-4692	41	10	survival	survival	NOUN
fnp-4692	41	11	not	not	PART
fnp-4692	41	12	impaired	impair	VERB
fnp-4692	41	13	by	by	ADP
fnp-4692	41	14	morphological	morphological	ADJ
fnp-4692	41	15	features	feature	NOUN
fnp-4692	41	16	of	of	ADP
fnp-4692	41	17	atypia	atypia	PROPN
fnp-4692	41	18	or	or	CCONJ
fnp-4692	41	19	anaplasia	anaplasia	PROPN
fnp-4692	41	20	,	,	PUNCT
fnp-4692	41	21	the	the	DET
fnp-4692	41	22	authors	author	NOUN
fnp-4692	41	23	did	do	AUX
fnp-4692	41	24	not	not	PART
fnp-4692	41	25	provide	provide	VERB
fnp-4692	41	26	definite	definite	ADJ
fnp-4692	41	27	diagnostic	diagnostic	ADJ
fnp-4692	41	28	criteria	criterion	NOUN
fnp-4692	41	29	,	,	PUNCT
fnp-4692	41	30	however	however	ADV
fnp-4692	41	31	,	,	PUNCT
fnp-4692	41	32	recommended	recommend	VERB
fnp-4692	41	33	to	to	PART
fnp-4692	41	34	base	base	VERB
fnp-4692	41	35	diagnosis	diagnosis	NOUN
fnp-4692	41	36	on	on	ADP
fnp-4692	41	37	the	the	DET
fnp-4692	41	38	following	follow	VERB
fnp-4692	41	39	features	feature	NOUN
fnp-4692	41	40	:	:	PUNCT
fnp-4692	41	41	a	a	X
fnp-4692	41	42	)	)	PUNCT
fnp-4692	41	43	no	no	DET
fnp-4692	41	44	match	match	NOUN
fnp-4692	41	45	with	with	ADP
fnp-4692	41	46	a	a	DET
fnp-4692	41	47	known	know	VERB
fnp-4692	41	48	brain	brain	NOUN
fnp-4692	41	49	tumor	tumor	NOUN
fnp-4692	41	50	methylation	methylation	NOUN
fnp-4692	41	51	class	class	NOUN
fnp-4692	41	52	in	in	ADP
fnp-4692	41	53	the	the	DET
fnp-4692	41	54	v11.4	v11.4	PROPN
fnp-4692	41	55	(	(	PUNCT
fnp-4692	41	56	or	or	CCONJ
fnp-4692	41	57	more	more	ADV
fnp-4692	41	58	recently	recently	ADV
fnp-4692	41	59	also	also	ADV
fnp-4692	41	60	v12.5	v12.5	ADJ
fnp-4692	41	61	)	)	PUNCT
fnp-4692	41	62	classifier	classifier	NOUN
fnp-4692	41	63	,	,	PUNCT
fnp-4692	41	64	b	b	NOUN
fnp-4692	41	65	)	)	PUNCT
fnp-4692	41	66	monosomy	monosomy	NOUN
fnp-4692	41	67	of	of	ADP
fnp-4692	41	68	chromosome	chromosome	NOUN
fnp-4692	41	69	13	13	NUM
fnp-4692	41	70	and	and	CCONJ
fnp-4692	41	71	c	c	NOUN
fnp-4692	41	72	)	)	PUNCT
fnp-4692	41	73	lack	lack	NOUN
fnp-4692	41	74	of	of	ADP
fnp-4692	41	75	cdkn2a	cdkn2a	PROPN
fnp-4692	41	76	/	/	SYM
fnp-4692	41	77	b	b	NOUN
fnp-4692	41	78	loss	loss	NOUN
fnp-4692	41	79	.	.	PUNCT
fnp-4692	42	1	given	give	VERB
fnp-4692	42	2	the	the	DET
fnp-4692	42	3	mutational	mutational	ADJ
fnp-4692	42	4	constellation	constellation	NOUN
fnp-4692	42	5	(	(	PUNCT
fnp-4692	42	6	e.g.	e.g.	ADV
fnp-4692	42	7	braf	braf	NOUN
fnp-4692	42	8	or	or	CCONJ
fnp-4692	42	9	rb1	rb1	ADJ
fnp-4692	42	10	mutations	mutation	NOUN
fnp-4692	42	11	)	)	PUNCT
fnp-4692	42	12	,	,	PUNCT
fnp-4692	42	13	some	some	PRON
fnp-4692	42	14	of	of	ADP
fnp-4692	42	15	the	the	DET
fnp-4692	42	16	hpap	hpap	NOUN
fnp-4692	42	17	patients	patient	NOUN
fnp-4692	42	18	might	might	AUX
fnp-4692	42	19	be	be	AUX
fnp-4692	42	20	eligible	eligible	ADJ
fnp-4692	42	21	for	for	ADP
fnp-4692	42	22	targeted	target	VERB
fnp-4692	42	23	treatment	treatment	NOUN
fnp-4692	42	24	approaches	approach	NOUN
fnp-4692	42	25	(	(	PUNCT
fnp-4692	42	26	for	for	ADP
fnp-4692	42	27	comprehensive	comprehensive	ADJ
fnp-4692	42	28	summary	summary	NOUN
fnp-4692	42	29	of	of	ADP
fnp-4692	42	30	the	the	DET
fnp-4692	42	31	hpap	hpap	NOUN
fnp-4692	42	32	characteristics	characteristic	NOUN
fnp-4692	42	33	,	,	PUNCT
fnp-4692	42	34	please	please	INTJ
fnp-4692	42	35	see	see	VERB
fnp-4692	42	36	table	table	NOUN
fnp-4692	42	37	1	1	NUM
fnp-4692	42	38	)	)	PUNCT
fnp-4692	42	39	.	.	PUNCT
fnp-4692	43	1	table	table	NOUN
fnp-4692	43	2	1	1	NUM
fnp-4692	43	3	:	:	PUNCT
fnp-4692	43	4	histopathological	histopathological	ADJ
fnp-4692	43	5	and	and	CCONJ
fnp-4692	43	6	molecular	molecular	ADJ
fnp-4692	43	7	features	feature	NOUN
fnp-4692	43	8	of	of	ADP
fnp-4692	43	9	high	high	ADJ
fnp-4692	43	10	-	-	PUNCT
fnp-4692	43	11	grade	grade	NOUN
fnp-4692	43	12	glioma	glioma	NOUN
fnp-4692	43	13	with	with	ADP
fnp-4692	43	14	pleomorphic	pleomorphic	ADJ
fnp-4692	43	15	and	and	CCONJ
fnp-4692	43	16	pseudopapillary	pseudopapillary	ADJ
fnp-4692	43	17	features	feature	NOUN
fnp-4692	43	18	(	(	PUNCT
fnp-4692	43	19	hpap	hpap	NOUN
fnp-4692	43	20	)	)	PUNCT
fnp-4692	43	21	histological	histological	ADJ
fnp-4692	43	22	features	feature	VERB
fnp-4692	43	23	very	very	ADV
fnp-4692	43	24	heterogenous	heterogenous	ADJ
fnp-4692	43	25	,	,	PUNCT
fnp-4692	43	26	mainly	mainly	ADV
fnp-4692	43	27	non	non	ADJ
fnp-4692	43	28	-	-	ADJ
fnp-4692	43	29	infiltrative	infiltrative	ADJ
fnp-4692	43	30	comprising	comprising	NOUN
fnp-4692	43	31	features	feature	NOUN
fnp-4692	43	32	of	of	ADP
fnp-4692	43	33	pleomorphic	pleomorphic	ADJ
fnp-4692	43	34	xanthoastrocytoma	xanthoastrocytoma	NOUN
fnp-4692	43	35	(	(	PUNCT
fnp-4692	43	36	pxa	pxa	NOUN
fnp-4692	43	37	)	)	PUNCT
fnp-4692	43	38	,	,	PUNCT
fnp-4692	43	39	astroblastoma	astroblastoma	NOUN
fnp-4692	43	40	,	,	PUNCT
fnp-4692	43	41	anaplastic	anaplastic	ADJ
fnp-4692	43	42	ependymoma	ependymoma	NOUN
fnp-4692	43	43	,	,	PUNCT
fnp-4692	43	44	polymorphous	polymorphous	ADJ
fnp-4692	43	45	neuroepithelial	neuroepithelial	ADJ
fnp-4692	43	46	tumor	tumor	NOUN
fnp-4692	43	47	of	of	ADP
fnp-4692	43	48	the	the	DET
fnp-4692	43	49	young	young	ADJ
fnp-4692	43	50	(	(	PUNCT
fnp-4692	43	51	plnty	plnty	NOUN
fnp-4692	43	52	)	)	PUNCT
fnp-4692	43	53	and	and	CCONJ
fnp-4692	43	54	glioblastoma	glioblastoma	NOUN
fnp-4692	43	55	.	.	PUNCT
fnp-4692	44	1	methylation	methylation	NOUN
fnp-4692	44	2	classifier	classifier	NOUN
fnp-4692	44	3	(	(	PUNCT
fnp-4692	44	4	v11.4	v11.4	PROPN
fnp-4692	44	5	and	and	CCONJ
fnp-4692	44	6	v12.5	v12.5	NOUN
fnp-4692	44	7	)	)	PUNCT
fnp-4692	44	8	*	*	PUNCT
fnp-4692	45	1	no	no	DET
fnp-4692	45	2	match	match	NOUN
fnp-4692	45	3	mutations	mutation	NOUN
fnp-4692	45	4	tp53	tp53	PROPN
fnp-4692	45	5	(	(	PUNCT
fnp-4692	45	6	57	57	NUM
fnp-4692	45	7	%	%	NOUN
fnp-4692	45	8	)	)	PUNCT
fnp-4692	45	9	,	,	PUNCT
fnp-4692	45	10	rb1	rb1	PROPN
fnp-4692	45	11	(	(	PUNCT
fnp-4692	45	12	26	26	NUM
fnp-4692	45	13	%	%	NOUN
fnp-4692	45	14	)	)	PUNCT
fnp-4692	45	15	,	,	PUNCT
fnp-4692	45	16	nf1	nf1	NOUN
fnp-4692	45	17	(	(	PUNCT
fnp-4692	45	18	26	26	NUM
fnp-4692	45	19	%	%	NOUN
fnp-4692	45	20	)	)	PUNCT
fnp-4692	45	21	,	,	PUNCT
fnp-4692	45	22	nf2	nf2	ADJ
fnp-4692	45	23	(	(	PUNCT
fnp-4692	45	24	14	14	NUM
fnp-4692	45	25	%	%	NOUN
fnp-4692	45	26	)	)	PUNCT
fnp-4692	45	27	,	,	PUNCT
fnp-4692	45	28	braf	braf	NOUN
fnp-4692	45	29	-	-	PUNCT
fnp-4692	45	30	v600e	v600e	NOUN
fnp-4692	45	31	(	(	PUNCT
fnp-4692	45	32	12	12	NUM
fnp-4692	45	33	%	%	NOUN
fnp-4692	45	34	)	)	PUNCT
fnp-4692	45	35	,	,	PUNCT
fnp-4692	45	36	cdkn2a	cdkn2a	PROPN
fnp-4692	45	37	/	/	SYM
fnp-4692	45	38	b	b	PROPN
fnp-4692	45	39	(	(	PUNCT
fnp-4692	45	40	6	6	NUM
fnp-4692	45	41	%	%	NOUN
fnp-4692	45	42	)	)	PUNCT
fnp-4692	45	43	mgmt	mgmt	NOUN
fnp-4692	45	44	promoter	promoter	NOUN
fnp-4692	45	45	methylation	methylation	NOUN
fnp-4692	45	46	mainly	mainly	ADV
fnp-4692	45	47	unmethylated	unmethylate	VERB
fnp-4692	45	48	(	(	PUNCT
fnp-4692	45	49	97	97	NUM
fnp-4692	45	50	%	%	NOUN
fnp-4692	45	51	)	)	PUNCT
fnp-4692	45	52	chromosomal	chromosomal	ADJ
fnp-4692	45	53	alterations	alteration	NOUN
fnp-4692	45	54	frequent	frequent	ADJ
fnp-4692	45	55	aneuploidy	aneuploidy	NOUN
fnp-4692	45	56	,	,	PUNCT
fnp-4692	45	57	loss	loss	NOUN
fnp-4692	45	58	of	of	ADP
fnp-4692	45	59	chromosome	chromosome	NOUN
fnp-4692	45	60	13	13	NUM
fnp-4692	45	61	(	(	PUNCT
fnp-4692	45	62	90	90	NUM
fnp-4692	45	63	%	%	NOUN
fnp-4692	45	64	)	)	PUNCT
fnp-4692	45	65	,	,	PUNCT
fnp-4692	45	66	otherwise	otherwise	ADV
fnp-4692	45	67	losses	loss	NOUN
fnp-4692	45	68	of	of	ADP
fnp-4692	45	69	chr	chr	PROPN
fnp-4692	45	70	.	.	PROPN
fnp-4692	46	1	3	3	NUM
fnp-4692	46	2	,	,	PUNCT
fnp-4692	46	3	6	6	NUM
fnp-4692	46	4	,	,	PUNCT
fnp-4692	46	5	10	10	NUM
fnp-4692	46	6	-	-	SYM
fnp-4692	46	7	15	15	NUM
fnp-4692	46	8	,	,	PUNCT
fnp-4692	46	9	17	17	NUM
fnp-4692	46	10	,	,	PUNCT
fnp-4692	46	11	18	18	NUM
fnp-4692	46	12	,	,	PUNCT
fnp-4692	46	13	22	22	NUM
fnp-4692	46	14	;	;	PUNCT
fnp-4692	46	15	gains	gain	NOUN
fnp-4692	46	16	of	of	ADP
fnp-4692	46	17	chr	chr	PROPN
fnp-4692	46	18	.	.	PUNCT
fnp-4692	47	1	4q	4q	NOUN
fnp-4692	47	2	,	,	PUNCT
fnp-4692	47	3	5	5	NUM
fnp-4692	47	4	,	,	PUNCT
fnp-4692	47	5	7	7	NUM
fnp-4692	47	6	,	,	PUNCT
fnp-4692	47	7	19	19	NUM
fnp-4692	47	8	*	*	SYM
fnp-4692	47	9	v11.4	v11.4	PROPN
fnp-4692	47	10	was	be	AUX
fnp-4692	47	11	indicated	indicate	VERB
fnp-4692	47	12	by	by	ADP
fnp-4692	47	13	the	the	DET
fnp-4692	47	14	authors	author	NOUN
fnp-4692	47	15	,	,	PUNCT
fnp-4692	47	16	however	however	ADV
fnp-4692	47	17	,	,	PUNCT
fnp-4692	47	18	also	also	ADV
fnp-4692	47	19	the	the	DET
fnp-4692	47	20	most	most	ADV
fnp-4692	47	21	recent	recent	ADJ
fnp-4692	47	22	brain	brain	NOUN
fnp-4692	47	23	tumor	tumor	NOUN
fnp-4692	47	24	methylation	methylation	NOUN
fnp-4692	47	25	classifier	classifier	NOUN
fnp-4692	47	26	version	version	PROPN
fnp-4692	47	27	v12.5	v12.5	PROPN
fnp-4692	47	28	does	do	AUX
fnp-4692	47	29	not	not	PART
fnp-4692	47	30	yet	yet	ADV
fnp-4692	47	31	recognize	recognize	VERB
fnp-4692	47	32	this	this	DET
fnp-4692	47	33	tumor	tumor	NOUN
fnp-4692	47	34	entity	entity	NOUN
fnp-4692	47	35	.	.	PUNCT
fnp-4692	48	1	2	2	X
fnp-4692	48	2	.	.	X
fnp-4692	48	3	prediction	prediction	NOUN
fnp-4692	48	4	of	of	ADP
fnp-4692	48	5	1p/19q	1p/19q	NOUN
fnp-4692	48	6	status	status	NOUN
fnp-4692	48	7	by	by	ADP
fnp-4692	48	8	immunohistochemistry	immunohistochemistry	NOUN
fnp-4692	48	9	in	in	ADP
fnp-4692	48	10	idh	idh	NOUN
fnp-4692	48	11	-	-	PUNCT
fnp-4692	48	12	mutant	mutant	NOUN
fnp-4692	48	13	glioma	glioma	NOUN
fnp-4692	48	14	[	[	X
fnp-4692	48	15	4	4	NUM
fnp-4692	48	16	]	]	PUNCT
fnp-4692	48	17	nowadays	nowadays	ADV
fnp-4692	48	18	,	,	PUNCT
fnp-4692	48	19	comprehensive	comprehensive	ADJ
fnp-4692	48	20	molecular	molecular	ADJ
fnp-4692	48	21	profiling	profiling	NOUN
fnp-4692	48	22	is	be	AUX
fnp-4692	48	23	equal	equal	ADJ
fnp-4692	48	24	or	or	CCONJ
fnp-4692	48	25	(	(	PUNCT
fnp-4692	48	26	for	for	ADP
fnp-4692	48	27	some	some	DET
fnp-4692	48	28	tumor	tumor	NOUN
fnp-4692	48	29	types	type	NOUN
fnp-4692	48	30	)	)	PUNCT
fnp-4692	48	31	ever	ever	ADV
fnp-4692	48	32	superior	superior	ADJ
fnp-4692	48	33	to	to	ADP
fnp-4692	48	34	histopathology	histopathology	NOUN
fnp-4692	48	35	,	,	PUNCT
fnp-4692	48	36	the	the	DET
fnp-4692	48	37	previous	previous	ADJ
fnp-4692	48	38	gold	gold	NOUN
fnp-4692	48	39	standard	standard	NOUN
fnp-4692	48	40	.	.	PUNCT
fnp-4692	49	1	however	however	ADV
fnp-4692	49	2	,	,	PUNCT
fnp-4692	49	3	broader	broad	ADJ
fnp-4692	49	4	molecular	molecular	ADJ
fnp-4692	49	5	testing	testing	NOUN
fnp-4692	49	6	is	be	AUX
fnp-4692	49	7	far	far	ADV
fnp-4692	49	8	from	from	ADP
fnp-4692	49	9	being	be	AUX
fnp-4692	49	10	available	available	ADJ
fnp-4692	49	11	in	in	ADP
fnp-4692	49	12	all	all	DET
fnp-4692	49	13	health	health	NOUN
fnp-4692	49	14	care	care	NOUN
fnp-4692	49	15	systems	system	NOUN
fnp-4692	49	16	across	across	ADP
fnp-4692	49	17	the	the	DET
fnp-4692	49	18	world	world	NOUN
fnp-4692	49	19	.	.	PUNCT
fnp-4692	50	1	therefore	therefore	ADV
fnp-4692	50	2	,	,	PUNCT
fnp-4692	50	3	it	it	PRON
fnp-4692	50	4	is	be	AUX
fnp-4692	50	5	not	not	PART
fnp-4692	50	6	only	only	ADV
fnp-4692	50	7	important	important	ADJ
fnp-4692	50	8	to	to	PART
fnp-4692	50	9	promote	promote	VERB
fnp-4692	50	10	cutting	cutting	NOUN
fnp-4692	50	11	-	-	PUNCT
fnp-4692	50	12	edge	edge	NOUN
fnp-4692	50	13	technology	technology	NOUN
fnp-4692	50	14	,	,	PUNCT
fnp-4692	50	15	but	but	CCONJ
fnp-4692	50	16	also	also	ADV
fnp-4692	50	17	to	to	PART
fnp-4692	50	18	come	come	VERB
fnp-4692	50	19	up	up	ADP
fnp-4692	50	20	with	with	ADP
fnp-4692	50	21	simple	simple	ADJ
fnp-4692	50	22	,	,	PUNCT
fnp-4692	50	23	fast	fast	ADJ
fnp-4692	50	24	and	and	CCONJ
fnp-4692	50	25	cheap	cheap	ADJ
fnp-4692	50	26	analytic	analytic	ADJ
fnp-4692	50	27	tools	tool	NOUN
fnp-4692	50	28	that	that	PRON
fnp-4692	50	29	can	can	AUX
fnp-4692	50	30	be	be	AUX
fnp-4692	50	31	applied	apply	VERB
fnp-4692	50	32	in	in	ADP
fnp-4692	50	33	all	all	DET
fnp-4692	50	34	types	type	NOUN
fnp-4692	50	35	of	of	ADP
fnp-4692	50	36	socio	socio	NOUN
fnp-4692	50	37	-	-	PUNCT
fnp-4692	50	38	economic	economic	ADJ
fnp-4692	50	39	systems	system	NOUN
fnp-4692	50	40	.	.	PUNCT
fnp-4692	51	1	felix	felix	PROPN
fnp-4692	51	2	et	et	PROPN
fnp-4692	51	3	al	al	PROPN
fnp-4692	51	4	.	.	PROPN
fnp-4692	51	5	started	start	VERB
fnp-4692	51	6	with	with	ADP
fnp-4692	51	7	a	a	DET
fnp-4692	51	8	mass	mass	ADJ
fnp-4692	51	9	spectrometric	spectrometric	ADJ
fnp-4692	51	10	approach	approach	NOUN
fnp-4692	51	11	to	to	PART
fnp-4692	51	12	evaluate	evaluate	VERB
fnp-4692	51	13	the	the	DET
fnp-4692	51	14	most	most	ADV
fnp-4692	51	15	differentially	differentially	ADV
fnp-4692	51	16	expressed	express	VERB
fnp-4692	51	17	proteins	protein	NOUN
fnp-4692	51	18	in	in	ADP
fnp-4692	51	19	a	a	DET
fnp-4692	51	20	series	series	NOUN
fnp-4692	51	21	of	of	ADP
fnp-4692	51	22	more	more	ADJ
fnp-4692	51	23	than	than	ADP
fnp-4692	51	24	100	100	NUM
fnp-4692	51	25	frozen	frozen	ADJ
fnp-4692	51	26	and	and	CCONJ
fnp-4692	51	27	formalin	formalin	NOUN
fnp-4692	51	28	-	-	PUNCT
fnp-4692	51	29	fixed	fix	VERB
fnp-4692	51	30	,	,	PUNCT
fnp-4692	51	31	paraffin	paraffin	NOUN
fnp-4692	51	32	-	-	PUNCT
fnp-4692	51	33	embedded	embed	VERB
fnp-4692	51	34	diffuse	diffuse	ADJ
fnp-4692	51	35	glioma	glioma	NOUN
fnp-4692	51	36	samples	sample	NOUN
fnp-4692	51	37	with	with	ADP
fnp-4692	51	38	known	know	VERB
fnp-4692	51	39	idh	idh	NOUN
fnp-4692	51	40	and	and	CCONJ
fnp-4692	51	41	1p/19q	1p/19q	NOUN
fnp-4692	51	42	status	status	NOUN
fnp-4692	51	43	[	[	X
fnp-4692	51	44	4	4	NUM
fnp-4692	51	45	]	]	PUNCT
fnp-4692	51	46	.	.	PUNCT
fnp-4692	52	1	out	out	ADP
fnp-4692	52	2	of	of	ADP
fnp-4692	52	3	a	a	DET
fnp-4692	52	4	larger	large	ADJ
fnp-4692	52	5	set	set	NOUN
fnp-4692	52	6	of	of	ADP
fnp-4692	52	7	differentially	differentially	ADV
fnp-4692	52	8	regulated	regulated	ADJ
fnp-4692	52	9	candidate	candidate	NOUN
fnp-4692	52	10	proteins	protein	NOUN
fnp-4692	52	11	that	that	PRON
fnp-4692	52	12	could	could	AUX
fnp-4692	52	13	have	have	AUX
fnp-4692	52	14	been	be	AUX
fnp-4692	52	15	used	use	VERB
fnp-4692	52	16	as	as	ADP
fnp-4692	52	17	targets	target	NOUN
fnp-4692	52	18	for	for	ADP
fnp-4692	52	19	subsequent	subsequent	ADJ
fnp-4692	52	20	immunohistochemical	immunohistochemical	ADJ
fnp-4692	52	21	(	(	PUNCT
fnp-4692	52	22	ihc	ihc	PROPN
fnp-4692	52	23	)	)	PUNCT
fnp-4692	52	24	analyses	analysis	NOUN
fnp-4692	52	25	,	,	PUNCT
fnp-4692	52	26	the	the	DET
fnp-4692	52	27	authors	author	NOUN
fnp-4692	52	28	selected	select	VERB
fnp-4692	52	29	the	the	DET
fnp-4692	52	30	ones	one	NOUN
fnp-4692	52	31	for	for	ADP
fnp-4692	52	32	which	which	PRON
fnp-4692	52	33	best	good	ADJ
fnp-4692	52	34	staining	staining	ADJ
fnp-4692	52	35	results	result	NOUN
fnp-4692	52	36	were	be	AUX
fnp-4692	52	37	obtained	obtain	VERB
fnp-4692	52	38	,	,	PUNCT
fnp-4692	52	39	namely	namely	ADV
fnp-4692	52	40	vimentin	vimentin	NOUN
fnp-4692	52	41	for	for	ADP
fnp-4692	52	42	non-1p/19q	non-1p/19q	ADV
fnp-4692	52	43	-	-	PUNCT
fnp-4692	52	44	codeleted	codelete	VERB
fnp-4692	52	45	astrocytomas	astrocytoma	NOUN
fnp-4692	52	46	and	and	CCONJ
fnp-4692	52	47	hip1r	hip1r	NUM
fnp-4692	52	48	(	(	PUNCT
fnp-4692	52	49	huntingtin	huntingtin	ADJ
fnp-4692	52	50	interacting	interact	VERB
fnp-4692	52	51	protein	protein	NOUN
fnp-4692	52	52	1	1	NUM
fnp-4692	52	53	related	relate	VERB
fnp-4692	52	54	)	)	PUNCT
fnp-4692	52	55	for	for	ADP
fnp-4692	52	56	1p/19q	1p/19q	NOUN
fnp-4692	52	57	-	-	PUNCT
fnp-4692	52	58	codeleted	codelete	VERB
fnp-4692	52	59	oligodendrogliomas	oligodendroglioma	NOUN
fnp-4692	52	60	.	.	PUNCT
fnp-4692	53	1	with	with	ADP
fnp-4692	53	2	this	this	DET
fnp-4692	53	3	simple	simple	ADJ
fnp-4692	53	4	immunohistochemistry	immunohistochemistry	NOUN
fnp-4692	53	5	-	-	PUNCT
fnp-4692	53	6	based	base	VERB
fnp-4692	53	7	approach	approach	NOUN
fnp-4692	53	8	,	,	PUNCT
fnp-4692	53	9	the	the	DET
fnp-4692	53	10	authors	author	NOUN
fnp-4692	53	11	were	be	AUX
fnp-4692	53	12	able	able	ADJ
fnp-4692	53	13	to	to	PART
fnp-4692	53	14	predict	predict	VERB
fnp-4692	53	15	1p/19q	1p/19q	ADJ
fnp-4692	53	16	status	status	NOUN
fnp-4692	53	17	in	in	ADP
fnp-4692	53	18	diffuse	diffuse	ADJ
fnp-4692	53	19	gliomas	glioma	NOUN
fnp-4692	53	20	with	with	ADP
fnp-4692	53	21	high	high	ADJ
fnp-4692	53	22	accuracy	accuracy	NOUN
fnp-4692	53	23	(	(	PUNCT
fnp-4692	53	24	figure	figure	NOUN
fnp-4692	53	25	1	1	NUM
fnp-4692	53	26	)	)	PUNCT
fnp-4692	53	27	.	.	PUNCT
fnp-4692	54	1	this	this	DET
fnp-4692	54	2	approach	approach	NOUN
fnp-4692	54	3	could	could	AUX
fnp-4692	54	4	therefore	therefore	ADV
fnp-4692	54	5	also	also	ADV
fnp-4692	54	6	be	be	AUX
fnp-4692	54	7	applied	apply	VERB
fnp-4692	54	8	in	in	ADP
fnp-4692	54	9	laboratories	laboratory	NOUN
fnp-4692	54	10	without	without	ADP
fnp-4692	54	11	state	state	NOUN
fnp-4692	54	12	-	-	PUNCT
fnp-4692	54	13	of	of	ADP
fnp-4692	54	14	-	-	PUNCT
fnp-4692	54	15	the	the	DET
fnp-4692	54	16	art	art	NOUN
fnp-4692	54	17	molecular	molecular	ADJ
fnp-4692	54	18	pathological	pathological	ADJ
fnp-4692	54	19	pipelines	pipeline	NOUN
fnp-4692	54	20	or	or	CCONJ
fnp-4692	54	21	in	in	ADP
fnp-4692	54	22	less	less	ADV
fnp-4692	54	23	developed	develop	VERB
fnp-4692	54	24	countries	country	NOUN
fnp-4692	54	25	without	without	ADP
fnp-4692	54	26	broad	broad	ADJ
fnp-4692	54	27	accessibility	accessibility	NOUN
fnp-4692	54	28	to	to	ADP
fnp-4692	54	29	modern	modern	ADJ
fnp-4692	54	30	molecular	molecular	ADJ
fnp-4692	54	31	testing	testing	NOUN
fnp-4692	54	32	methods	method	NOUN
fnp-4692	54	33	.	.	PUNCT
fnp-4692	55	1	figure	figure	VERB
fnp-4692	55	2	1	1	NUM
fnp-4692	55	3	:	:	PUNCT
fnp-4692	55	4	algorithm	algorithm	NOUN
fnp-4692	55	5	for	for	ADP
fnp-4692	55	6	a	a	DET
fnp-4692	55	7	2	2	NUM
fnp-4692	55	8	-	-	PUNCT
fnp-4692	55	9	step	step	NOUN
fnp-4692	55	10	immunohistochemical	immunohistochemical	ADJ
fnp-4692	55	11	prediction	prediction	NOUN
fnp-4692	55	12	of	of	ADP
fnp-4692	55	13	the	the	DET
fnp-4692	55	14	1p/19q	1p/19q	ADJ
fnp-4692	55	15	status	status	NOUN
fnp-4692	55	16	in	in	ADP
fnp-4692	55	17	idh	idh	NOUN
fnp-4692	55	18	-	-	PUNCT
fnp-4692	55	19	mutant	mutant	ADJ
fnp-4692	55	20	gliomas	glioma	NOUN
fnp-4692	55	21	(	(	PUNCT
fnp-4692	55	22	positivity	positivity	NOUN
fnp-4692	55	23	of	of	ADP
fnp-4692	55	24	tumor	tumor	NOUN
fnp-4692	55	25	cells	cell	NOUN
fnp-4692	55	26	is	be	AUX
fnp-4692	55	27	evaluated	evaluate	VERB
fnp-4692	55	28	)	)	PUNCT
fnp-4692	55	29	.	.	PUNCT
fnp-4692	56	1	for	for	ADP
fnp-4692	56	2	each	each	DET
fnp-4692	56	3	staining	stain	VERB
fnp-4692	56	4	,	,	PUNCT
fnp-4692	56	5	four	four	NUM
fnp-4692	56	6	different	different	ADJ
fnp-4692	56	7	expression	expression	NOUN
fnp-4692	56	8	levels	level	NOUN
fnp-4692	56	9	were	be	AUX
fnp-4692	56	10	defined	define	VERB
fnp-4692	56	11	.	.	PUNCT
fnp-4692	57	1	hip1r	hip1r	NUM
fnp-4692	58	1	staining	stain	VERB
fnp-4692	58	2	was	be	AUX
fnp-4692	58	3	considered	consider	VERB
fnp-4692	58	4	positive	positive	ADJ
fnp-4692	58	5	if	if	SCONJ
fnp-4692	58	6	expression	expression	NOUN
fnp-4692	58	7	was	be	AUX
fnp-4692	58	8	observed	observe	VERB
fnp-4692	58	9	in	in	ADP
fnp-4692	58	10	the	the	DET
fnp-4692	58	11	cytoplasm	cytoplasm	NOUN
fnp-4692	58	12	or	or	CCONJ
fnp-4692	58	13	at	at	ADP
fnp-4692	58	14	the	the	DET
fnp-4692	58	15	cell	cell	NOUN
fnp-4692	58	16	membrane	membrane	NOUN
fnp-4692	58	17	.	.	PUNCT
fnp-4692	59	1	scores	score	NOUN
fnp-4692	59	2	h0	h0	PROPN
fnp-4692	59	3	to	to	ADP
fnp-4692	59	4	h3	h3	NOUN
fnp-4692	59	5	were	be	AUX
fnp-4692	59	6	defined	define	VERB
fnp-4692	59	7	as	as	SCONJ
fnp-4692	59	8	follows	follow	VERB
fnp-4692	59	9	:	:	PUNCT
fnp-4692	59	10	h0	h0	NOUN
fnp-4692	59	11	:	:	PUNCT
fnp-4692	59	12	less	less	ADJ
fnp-4692	59	13	than	than	ADP
fnp-4692	59	14	10	10	NUM
fnp-4692	59	15	%	%	NOUN
fnp-4692	59	16	of	of	ADP
fnp-4692	59	17	tumor	tumor	NOUN
fnp-4692	59	18	cells	cell	NOUN
fnp-4692	59	19	are	be	AUX
fnp-4692	59	20	weakly	weakly	ADV
fnp-4692	59	21	positive	positive	ADJ
fnp-4692	59	22	;	;	PUNCT
fnp-4692	59	23	h1	h1	X
fnp-4692	59	24	:	:	PUNCT
fnp-4692	59	25	10%-75	10%-75	NUM
fnp-4692	59	26	%	%	NOUN
fnp-4692	59	27	of	of	ADP
fnp-4692	59	28	tumor	tumor	NOUN
fnp-4692	59	29	cells	cell	NOUN
fnp-4692	59	30	are	be	AUX
fnp-4692	59	31	positive	positive	ADJ
fnp-4692	59	32	,	,	PUNCT
fnp-4692	59	33	however	however	ADV
fnp-4692	59	34	,	,	PUNCT
fnp-4692	59	35	less	less	ADJ
fnp-4692	59	36	than	than	ADP
fnp-4692	59	37	30	30	NUM
fnp-4692	59	38	%	%	NOUN
fnp-4692	59	39	are	be	AUX
fnp-4692	59	40	strongly	strongly	ADV
fnp-4692	59	41	positive	positive	ADJ
fnp-4692	59	42	;	;	PUNCT
fnp-4692	59	43	h2	h2	NOUN
fnp-4692	59	44	:	:	PUNCT
fnp-4692	59	45	more	more	ADJ
fnp-4692	59	46	than	than	ADP
fnp-4692	59	47	50	50	NUM
fnp-4692	59	48	%	%	NOUN
fnp-4692	59	49	of	of	ADP
fnp-4692	59	50	the	the	DET
fnp-4692	59	51	tumor	tumor	NOUN
fnp-4692	59	52	cells	cell	NOUN
fnp-4692	59	53	are	be	AUX
fnp-4692	59	54	positive	positive	ADJ
fnp-4692	59	55	,	,	PUNCT
fnp-4692	59	56	and	and	CCONJ
fnp-4692	59	57	more	more	ADJ
fnp-4692	59	58	than	than	ADP
fnp-4692	59	59	30	30	NUM
fnp-4692	59	60	%	%	NOUN
fnp-4692	59	61	are	be	AUX
fnp-4692	59	62	strongly	strongly	ADV
fnp-4692	59	63	positive	positive	ADJ
fnp-4692	59	64	,	,	PUNCT
fnp-4692	59	65	however	however	ADV
fnp-4692	59	66	,	,	PUNCT
fnp-4692	59	67	still	still	ADV
fnp-4692	59	68	showing	show	VERB
fnp-4692	59	69	unstained	unstained	ADJ
fnp-4692	59	70	spaces	space	NOUN
fnp-4692	59	71	between	between	ADP
fnp-4692	59	72	the	the	DET
fnp-4692	59	73	tumor	tumor	NOUN
fnp-4692	59	74	cells	cell	NOUN
fnp-4692	59	75	.	.	PUNCT
fnp-4692	60	1	the	the	DET
fnp-4692	60	2	score	score	NOUN
fnp-4692	60	3	h2	h2	PROPN
fnp-4692	60	4	is	be	AUX
fnp-4692	60	5	also	also	ADV
fnp-4692	60	6	given	give	VERB
fnp-4692	60	7	if	if	SCONJ
fnp-4692	60	8	the	the	DET
fnp-4692	60	9	tumor	tumor	NOUN
fnp-4692	60	10	was	be	AUX
fnp-4692	60	11	only	only	ADV
fnp-4692	60	12	moderately	moderately	ADV
fnp-4692	60	13	positive	positive	ADJ
fnp-4692	60	14	,	,	PUNCT
fnp-4692	60	15	however	however	ADV
fnp-4692	60	16	,	,	PUNCT
fnp-4692	60	17	approximately	approximately	ADV
fnp-4692	60	18	100	100	NUM
fnp-4692	60	19	%	%	NOUN
fnp-4692	60	20	of	of	ADP
fnp-4692	60	21	the	the	DET
fnp-4692	60	22	cells	cell	NOUN
fnp-4692	60	23	showed	show	VERB
fnp-4692	60	24	moderate	moderate	ADJ
fnp-4692	60	25	immunoreactivity	immunoreactivity	NOUN
fnp-4692	60	26	in	in	ADP
fnp-4692	60	27	a	a	DET
fnp-4692	60	28	densely	densely	ADV
fnp-4692	60	29	packed	pack	VERB
fnp-4692	60	30	manner	manner	NOUN
fnp-4692	60	31	;	;	PUNCT
fnp-4692	60	32	h3	h3	NOUN
fnp-4692	60	33	:	:	PUNCT
fnp-4692	60	34	approximately	approximately	ADV
fnp-4692	60	35	100	100	NUM
fnp-4692	60	36	%	%	NOUN
fnp-4692	60	37	of	of	ADP
fnp-4692	60	38	the	the	DET
fnp-4692	60	39	tumor	tumor	NOUN
fnp-4692	60	40	cells	cell	NOUN
fnp-4692	60	41	are	be	AUX
fnp-4692	60	42	strongly	strongly	ADV
fnp-4692	60	43	positive	positive	ADJ
fnp-4692	60	44	in	in	ADP
fnp-4692	60	45	a	a	DET
fnp-4692	60	46	diffuse	diffuse	NOUN
fnp-4692	60	47	and	and	CCONJ
fnp-4692	60	48	densely	densely	ADV
fnp-4692	60	49	packed	pack	VERB
fnp-4692	60	50	manner	manner	NOUN
fnp-4692	60	51	,	,	PUNCT
fnp-4692	60	52	with	with	ADP
fnp-4692	60	53	only	only	ADJ
fnp-4692	60	54	blood	blood	NOUN
fnp-4692	60	55	vessels	vessel	NOUN
fnp-4692	60	56	being	be	AUX
fnp-4692	60	57	spared	spare	VERB
fnp-4692	60	58	.	.	PUNCT
fnp-4692	61	1	for	for	ADP
fnp-4692	61	2	the	the	DET
fnp-4692	61	3	assessment	assessment	NOUN
fnp-4692	61	4	of	of	ADP
fnp-4692	61	5	vimentin	vimentin	NOUN
fnp-4692	61	6	(	(	PUNCT
fnp-4692	61	7	scores	score	NOUN
fnp-4692	61	8	v0	v0	PROPN
fnp-4692	61	9	to	to	ADP
fnp-4692	61	10	v3	v3	PROPN
fnp-4692	61	11	were	be	AUX
fnp-4692	61	12	given	give	VERB
fnp-4692	61	13	)	)	PUNCT
fnp-4692	61	14	,	,	PUNCT
fnp-4692	61	15	staining	stain	VERB
fnp-4692	61	16	of	of	ADP
fnp-4692	61	17	blood	blood	NOUN
fnp-4692	61	18	vessels	vessel	NOUN
fnp-4692	61	19	was	be	AUX
fnp-4692	61	20	excluded	exclude	VERB
fnp-4692	61	21	,	,	PUNCT
fnp-4692	61	22	however	however	ADV
fnp-4692	61	23	,	,	PUNCT
fnp-4692	61	24	no	no	DET
fnp-4692	61	25	distinction	distinction	NOUN
fnp-4692	61	26	could	could	AUX
fnp-4692	61	27	be	be	AUX
fnp-4692	61	28	made	make	VERB
fnp-4692	61	29	between	between	ADP
fnp-4692	61	30	reactive	reactive	ADJ
fnp-4692	61	31	and	and	CCONJ
fnp-4692	61	32	neoplastic	neoplastic	ADJ
fnp-4692	61	33	glial	glial	ADJ
fnp-4692	61	34	cells	cell	NOUN
fnp-4692	61	35	.	.	PUNCT
fnp-4692	62	1	v0	v0	NOUN
fnp-4692	62	2	:	:	PUNCT
fnp-4692	62	3	less	less	ADJ
fnp-4692	62	4	than	than	ADP
fnp-4692	62	5	10	10	NUM
fnp-4692	62	6	%	%	NOUN
fnp-4692	62	7	of	of	ADP
fnp-4692	62	8	tumor	tumor	NOUN
fnp-4692	62	9	cells	cell	NOUN
fnp-4692	62	10	are	be	AUX
fnp-4692	62	11	positive	positive	ADJ
fnp-4692	62	12	(	(	PUNCT
fnp-4692	62	13	however	however	ADV
fnp-4692	62	14	,	,	PUNCT
fnp-4692	62	15	blood	blood	NOUN
fnp-4692	62	16	vessels	vessel	NOUN
fnp-4692	62	17	and	and	CCONJ
fnp-4692	62	18	reactive	reactive	ADJ
fnp-4692	62	19	astrocytes	astrocyte	NOUN
fnp-4692	62	20	could	could	AUX
fnp-4692	62	21	be	be	AUX
fnp-4692	62	22	positive	positive	ADJ
fnp-4692	62	23	)	)	PUNCT
fnp-4692	62	24	;	;	PUNCT
fnp-4692	62	25	v1	v1	NOUN
fnp-4692	62	26	:	:	PUNCT
fnp-4692	62	27	10%-20	10%-20	NUM
fnp-4692	62	28	%	%	NOUN
fnp-4692	62	29	of	of	ADP
fnp-4692	62	30	tumor	tumor	NOUN
fnp-4692	62	31	cells	cell	NOUN
fnp-4692	62	32	or	or	CCONJ
fnp-4692	62	33	tumor	tumor	NOUN
fnp-4692	62	34	cell	cell	NOUN
fnp-4692	62	35	processes	process	NOUN
fnp-4692	62	36	are	be	AUX
fnp-4692	62	37	positive	positive	ADJ
fnp-4692	62	38	;	;	PUNCT
fnp-4692	62	39	v2	v2	NOUN
fnp-4692	62	40	:	:	PUNCT
fnp-4692	62	41	20%-70	20%-70	NUM
fnp-4692	62	42	%	%	NOUN
fnp-4692	62	43	of	of	ADP
fnp-4692	62	44	the	the	DET
fnp-4692	62	45	tumor	tumor	NOUN
fnp-4692	62	46	cells	cell	NOUN
fnp-4692	62	47	with	with	ADP
fnp-4692	62	48	many	many	ADJ
fnp-4692	62	49	tumor	tumor	NOUN
fnp-4692	62	50	cell	cell	NOUN
fnp-4692	62	51	processes	process	NOUN
fnp-4692	62	52	are	be	AUX
fnp-4692	62	53	positively	positively	ADV
fnp-4692	62	54	labeled	label	VERB
fnp-4692	62	55	,	,	PUNCT
fnp-4692	62	56	however	however	ADV
fnp-4692	62	57	still	still	ADV
fnp-4692	62	58	30	30	NUM
fnp-4692	62	59	%	%	NOUN
fnp-4692	62	60	or	or	CCONJ
fnp-4692	62	61	more	more	ADJ
fnp-4692	62	62	of	of	ADP
fnp-4692	62	63	the	the	DET
fnp-4692	62	64	tumor	tumor	NOUN
fnp-4692	62	65	cells	cell	NOUN
fnp-4692	62	66	are	be	AUX
fnp-4692	62	67	negative	negative	ADJ
fnp-4692	62	68	;	;	PUNCT
fnp-4692	62	69	v3	v3	PROPN
fnp-4692	62	70	:	:	PUNCT
fnp-4692	62	71	more	more	ADJ
fnp-4692	62	72	than	than	ADP
fnp-4692	62	73	70	70	NUM
fnp-4692	62	74	%	%	NOUN
fnp-4692	62	75	of	of	ADP
fnp-4692	62	76	the	the	DET
fnp-4692	62	77	tumor	tumor	NOUN
fnp-4692	62	78	cells	cell	NOUN
fnp-4692	62	79	are	be	AUX
fnp-4692	62	80	strongly	strongly	ADV
fnp-4692	62	81	positive	positive	ADJ
fnp-4692	62	82	,	,	PUNCT
fnp-4692	62	83	thereby	thereby	ADV
fnp-4692	62	84	the	the	DET
fnp-4692	62	85	tumors	tumor	NOUN
fnp-4692	62	86	exhibit	exhibit	VERB
fnp-4692	62	87	a	a	DET
fnp-4692	62	88	strong	strong	ADJ
fnp-4692	62	89	diffuse	diffuse	ADJ
fnp-4692	62	90	staining	stain	VERB
fnp-4692	62	91	pattern	pattern	NOUN
fnp-4692	62	92	.	.	PUNCT
fnp-4692	63	1	after	after	ADP
fnp-4692	63	2	this	this	DET
fnp-4692	63	3	individual	individual	ADJ
fnp-4692	63	4	assessment	assessment	NOUN
fnp-4692	63	5	,	,	PUNCT
fnp-4692	63	6	the	the	DET
fnp-4692	63	7	comparison	comparison	NOUN
fnp-4692	63	8	between	between	ADP
fnp-4692	63	9	hip1r	hip1r	PROPN
fnp-4692	63	10	and	and	CCONJ
fnp-4692	63	11	vimentin	vimentin	ADV
fnp-4692	63	12	staining	stain	VERB
fnp-4692	63	13	was	be	AUX
fnp-4692	63	14	done	do	VERB
fnp-4692	63	15	as	as	SCONJ
fnp-4692	63	16	shown	show	VERB
fnp-4692	63	17	in	in	ADP
fnp-4692	63	18	figure	figure	NOUN
fnp-4692	63	19	1	1	NUM
fnp-4692	63	20	.	.	NOUN
fnp-4692	64	1	3	3	NUM
fnp-4692	64	2	.	.	X
fnp-4692	64	3	prediction	prediction	NOUN
fnp-4692	64	4	of	of	ADP
fnp-4692	64	5	molecular	molecular	ADJ
fnp-4692	64	6	tumor	tumor	NOUN
fnp-4692	64	7	features	feature	VERB
fnp-4692	64	8	from	from	ADP
fnp-4692	64	9	histology	histology	NOUN
fnp-4692	64	10	by	by	ADP
fnp-4692	64	11	machine	machine	NOUN
fnp-4692	64	12	learning	learn	VERB
fnp-4692	65	1	[	[	X
fnp-4692	65	2	5	5	NUM
fnp-4692	65	3	]	]	PUNCT
fnp-4692	65	4	while	while	SCONJ
fnp-4692	65	5	molecular	molecular	ADJ
fnp-4692	65	6	analyses	analysis	NOUN
fnp-4692	65	7	in	in	ADP
fnp-4692	65	8	neuropathology	neuropathology	NOUN
fnp-4692	65	9	are	be	AUX
fnp-4692	65	10	rapidly	rapidly	ADV
fnp-4692	65	11	progressing	progress	VERB
fnp-4692	65	12	with	with	ADP
fnp-4692	65	13	regard	regard	NOUN
fnp-4692	65	14	to	to	ADP
fnp-4692	65	15	speed	speed	NOUN
fnp-4692	65	16	of	of	ADP
fnp-4692	65	17	analysis	analysis	NOUN
fnp-4692	65	18	and	and	CCONJ
fnp-4692	65	19	precision	precision	NOUN
fnp-4692	65	20	of	of	ADP
fnp-4692	65	21	unbiased	unbiased	ADJ
fnp-4692	65	22	diagnosis	diagnosis	NOUN
fnp-4692	65	23	,	,	PUNCT
fnp-4692	65	24	being	be	AUX
fnp-4692	65	25	always	always	ADV
fnp-4692	65	26	up	up	ADP
fnp-4692	65	27	to	to	ADP
fnp-4692	65	28	a	a	DET
fnp-4692	65	29	perfect	perfect	ADJ
fnp-4692	65	30	state	state	NOUN
fnp-4692	65	31	-	-	PUNCT
fnp-4692	65	32	of	of	ADP
fnp-4692	65	33	-	-	PUNCT
fnp-4692	65	34	the	the	DET
fnp-4692	65	35	-	-	PUNCT
fnp-4692	65	36	art	art	NOUN
fnp-4692	65	37	level	level	NOUN
fnp-4692	65	38	can	can	AUX
fnp-4692	65	39	not	not	PART
fnp-4692	65	40	currently	currently	ADV
fnp-4692	65	41	be	be	AUX
fnp-4692	65	42	guaranteed	guarantee	VERB
fnp-4692	65	43	worldwide	worldwide	ADV
fnp-4692	65	44	.	.	PUNCT
fnp-4692	66	1	therefore	therefore	ADV
fnp-4692	66	2	,	,	PUNCT
fnp-4692	66	3	machine	machine	NOUN
fnp-4692	66	4	-	-	PUNCT
fnp-4692	66	5	learning	learning	NOUN
fnp-4692	66	6	-	-	PUNCT
fnp-4692	66	7	based	base	VERB
fnp-4692	66	8	analyses	analysis	NOUN
fnp-4692	66	9	requiring	require	VERB
fnp-4692	66	10	a	a	DET
fnp-4692	66	11	good	good	ADJ
fnp-4692	66	12	microscopic	microscopic	ADJ
fnp-4692	66	13	detection	detection	NOUN
fnp-4692	66	14	system	system	NOUN
fnp-4692	66	15	together	together	ADV
fnp-4692	66	16	with	with	ADP
fnp-4692	66	17	powerful	powerful	ADJ
fnp-4692	66	18	computers	computer	NOUN
fnp-4692	66	19	could	could	AUX
fnp-4692	66	20	be	be	AUX
fnp-4692	66	21	an	an	DET
fnp-4692	66	22	alternative	alternative	NOUN
fnp-4692	66	23	if	if	SCONJ
fnp-4692	66	24	prediction	prediction	NOUN
fnp-4692	66	25	would	would	AUX
fnp-4692	66	26	be	be	AUX
fnp-4692	66	27	highly	highly	ADV
fnp-4692	66	28	precise	precise	ADJ
fnp-4692	66	29	.	.	PUNCT
fnp-4692	67	1	the	the	DET
fnp-4692	67	2	search	search	NOUN
fnp-4692	67	3	for	for	ADP
fnp-4692	67	4	good	good	ADJ
fnp-4692	67	5	prediction	prediction	NOUN
fnp-4692	67	6	of	of	ADP
fnp-4692	67	7	molecular	molecular	ADJ
fnp-4692	67	8	properties	property	NOUN
fnp-4692	67	9	of	of	ADP
fnp-4692	67	10	tumors	tumor	NOUN
fnp-4692	67	11	from	from	ADP
fnp-4692	67	12	histological	histological	ADJ
fnp-4692	67	13	images	image	NOUN
fnp-4692	67	14	is	be	AUX
fnp-4692	67	15	currently	currently	ADV
fnp-4692	67	16	a	a	DET
fnp-4692	67	17	rapidly	rapidly	ADV
fnp-4692	67	18	progressing	progress	VERB
fnp-4692	67	19	research	research	NOUN
fnp-4692	67	20	field	field	NOUN
fnp-4692	67	21	.	.	PUNCT
fnp-4692	68	1	liechty	liechty	AUX
fnp-4692	68	2	et	et	PROPN
fnp-4692	68	3	al	al	PROPN
fnp-4692	68	4	.	.	PROPN
fnp-4692	68	5	aimed	aim	VERB
fnp-4692	68	6	for	for	ADP
fnp-4692	68	7	predicting	predict	VERB
fnp-4692	68	8	idh	idh	NOUN
fnp-4692	68	9	mutation	mutation	NOUN
fnp-4692	68	10	from	from	ADP
fnp-4692	68	11	histological	histological	ADJ
fnp-4692	68	12	slides	slide	NOUN
fnp-4692	68	13	[	[	X
fnp-4692	68	14	5	5	NUM
fnp-4692	68	15	]	]	PUNCT
fnp-4692	68	16	.	.	PUNCT
fnp-4692	69	1	the	the	DET
fnp-4692	69	2	authors	author	NOUN
fnp-4692	69	3	compared	compare	VERB
fnp-4692	69	4	the	the	DET
fnp-4692	69	5	prediction	prediction	NOUN
fnp-4692	69	6	of	of	ADP
fnp-4692	69	7	a	a	DET
fnp-4692	69	8	machine	machine	NOUN
fnp-4692	69	9	learning	learning	NOUN
fnp-4692	69	10	(	(	PUNCT
fnp-4692	69	11	ml	ml	NOUN
fnp-4692	69	12	)	)	PUNCT
fnp-4692	69	13	system	system	NOUN
fnp-4692	69	14	with	with	ADP
fnp-4692	69	15	the	the	DET
fnp-4692	69	16	prediction	prediction	NOUN
fnp-4692	69	17	of	of	ADP
fnp-4692	69	18	expert	expert	NOUN
fnp-4692	69	19	neuropathologists	neuropathologist	NOUN
fnp-4692	69	20	’	'	PUNCT
fnp-4692	69	21	examination	examination	NOUN
fnp-4692	69	22	,	,	PUNCT
fnp-4692	69	23	however	however	ADV
fnp-4692	69	24	,	,	PUNCT
fnp-4692	69	25	also	also	ADV
fnp-4692	69	26	analyzed	analyze	VERB
fnp-4692	69	27	if	if	SCONJ
fnp-4692	69	28	a	a	DET
fnp-4692	69	29	synergistic	synergistic	ADJ
fnp-4692	69	30	approach	approach	NOUN
fnp-4692	69	31	of	of	ADP
fnp-4692	69	32	ml	ml	NOUN
fnp-4692	69	33	together	together	ADV
fnp-4692	69	34	with	with	ADP
fnp-4692	69	35	the	the	DET
fnp-4692	69	36	neuropathological	neuropathological	ADJ
fnp-4692	69	37	assessment	assessment	NOUN
fnp-4692	69	38	could	could	AUX
fnp-4692	69	39	further	far	ADV
fnp-4692	69	40	enhance	enhance	VERB
fnp-4692	69	41	the	the	DET
fnp-4692	69	42	predictive	predictive	ADJ
fnp-4692	69	43	power	power	NOUN
fnp-4692	69	44	.	.	PUNCT
fnp-4692	70	1	for	for	ADP
fnp-4692	70	2	this	this	DET
fnp-4692	70	3	purpose	purpose	NOUN
fnp-4692	70	4	,	,	PUNCT
fnp-4692	70	5	they	they	PRON
fnp-4692	70	6	used	use	VERB
fnp-4692	70	7	801	801	NUM
fnp-4692	70	8	idh	idh	NOUN
fnp-4692	70	9	mutant	mutant	NOUN
fnp-4692	70	10	and	and	CCONJ
fnp-4692	70	11	wildtype	wildtype	NOUN
fnp-4692	70	12	gliomas	glioma	NOUN
fnp-4692	70	13	from	from	ADP
fnp-4692	70	14	the	the	DET
fnp-4692	70	15	tcga	tcga	PROPN
fnp-4692	70	16	database	database	NOUN
fnp-4692	70	17	,	,	PUNCT
fnp-4692	70	18	which	which	PRON
fnp-4692	70	19	were	be	AUX
fnp-4692	70	20	split	split	VERB
fnp-4692	70	21	into	into	ADP
fnp-4692	70	22	a	a	DET
fnp-4692	70	23	training	training	NOUN
fnp-4692	70	24	and	and	CCONJ
fnp-4692	70	25	a	a	DET
fnp-4692	70	26	validation	validation	NOUN
fnp-4692	70	27	set	set	NOUN
fnp-4692	70	28	(	(	PUNCT
fnp-4692	70	29	tcga	tcga	PROPN
fnp-4692	70	30	research	research	NOUN
fnp-4692	70	31	network	network	NOUN
fnp-4692	70	32	:	:	PUNCT
fnp-4692	70	33	https://www.cancer.gov/tcga	https://www.cancer.gov/tcga	PROPN
fnp-4692	70	34	)	)	PUNCT
fnp-4692	70	35	.	.	PUNCT
fnp-4692	71	1	afterwards	afterwards	ADV
fnp-4692	71	2	,	,	PUNCT
fnp-4692	71	3	an	an	DET
fnp-4692	71	4	institutional	institutional	ADJ
fnp-4692	71	5	cohort	cohort	NOUN
fnp-4692	71	6	of	of	ADP
fnp-4692	71	7	174	174	NUM
fnp-4692	71	8	idh	idh	NOUN
fnp-4692	71	9	mutant	mutant	NOUN
fnp-4692	71	10	and	and	CCONJ
fnp-4692	71	11	wildtype	wildtype	NOUN
fnp-4692	71	12	gliomas	glioma	NOUN
fnp-4692	71	13	was	be	AUX
fnp-4692	71	14	assessed	assess	VERB
fnp-4692	71	15	.	.	PUNCT
fnp-4692	72	1	the	the	DET
fnp-4692	72	2	neuropathologists	neuropathologist	NOUN
fnp-4692	72	3	were	be	AUX
fnp-4692	72	4	allowed	allow	VERB
fnp-4692	72	5	to	to	PART
fnp-4692	72	6	provide	provide	VERB
fnp-4692	72	7	a	a	DET
fnp-4692	72	8	semiquantitative	semiquantitative	ADJ
fnp-4692	72	9	score	score	NOUN
fnp-4692	72	10	between	between	ADP
fnp-4692	72	11	0	0	NUM
fnp-4692	72	12	and	and	CCONJ
fnp-4692	72	13	1	1	NUM
fnp-4692	72	14	(	(	PUNCT
fnp-4692	72	15	with	with	ADP
fnp-4692	72	16	0.5	0.5	NUM
fnp-4692	72	17	for	for	ADP
fnp-4692	72	18	lowest	low	ADJ
fnp-4692	72	19	certainty	certainty	NOUN
fnp-4692	72	20	of	of	ADP
fnp-4692	72	21	tumor	tumor	NOUN
fnp-4692	72	22	being	be	AUX
fnp-4692	72	23	either	either	CCONJ
fnp-4692	72	24	idh	idh	NOUN
fnp-4692	72	25	mutant	mutant	NOUN
fnp-4692	72	26	or	or	CCONJ
fnp-4692	72	27	wildtype	wildtype	NOUN
fnp-4692	72	28	)	)	PUNCT
fnp-4692	72	29	,	,	PUNCT
fnp-4692	72	30	while	while	SCONJ
fnp-4692	72	31	convolutional	convolutional	ADJ
fnp-4692	72	32	neural	neural	ADJ
fnp-4692	72	33	network	network	NOUN
fnp-4692	72	34	(	(	PUNCT
fnp-4692	72	35	cnn	cnn	PROPN
fnp-4692	72	36	)	)	PUNCT
fnp-4692	72	37	analyses	analysis	NOUN
fnp-4692	72	38	were	be	AUX
fnp-4692	72	39	applied	apply	VERB
fnp-4692	72	40	in	in	ADP
fnp-4692	72	41	ml	ml	ADP
fnp-4692	72	42	assessments	assessment	NOUN
fnp-4692	72	43	.	.	PUNCT
fnp-4692	73	1	no	no	DET
fnp-4692	73	2	ml	ml	NOUN
fnp-4692	73	3	approach	approach	NOUN
fnp-4692	73	4	performed	perform	VERB
fnp-4692	73	5	better	well	ADV
fnp-4692	73	6	than	than	ADP
fnp-4692	73	7	the	the	DET
fnp-4692	73	8	neuropathologists	neuropathologist	NOUN
fnp-4692	73	9	in	in	ADP
fnp-4692	73	10	this	this	DET
fnp-4692	73	11	task	task	NOUN
fnp-4692	73	12	,	,	PUNCT
fnp-4692	73	13	however	however	ADV
fnp-4692	73	14	,	,	PUNCT
fnp-4692	73	15	reached	reach	VERB
fnp-4692	73	16	similarly	similarly	ADV
fnp-4692	73	17	good	good	ADJ
fnp-4692	73	18	results	result	NOUN
fnp-4692	73	19	.	.	PUNCT
fnp-4692	74	1	creating	create	VERB
fnp-4692	74	2	an	an	DET
fnp-4692	74	3	average	average	ADJ
fnp-4692	74	4	score	score	NOUN
fnp-4692	74	5	of	of	ADP
fnp-4692	74	6	the	the	DET
fnp-4692	74	7	assessment	assessment	NOUN
fnp-4692	74	8	of	of	ADP
fnp-4692	74	9	two	two	NUM
fnp-4692	74	10	neuropathologists	neuropathologist	NOUN
fnp-4692	74	11	was	be	AUX
fnp-4692	74	12	superior	superior	ADJ
fnp-4692	74	13	than	than	ADP
fnp-4692	74	14	the	the	DET
fnp-4692	74	15	prediction	prediction	NOUN
fnp-4692	74	16	of	of	ADP
fnp-4692	74	17	each	each	DET
fnp-4692	74	18	individual	individual	ADJ
fnp-4692	74	19	neuropathologist	neuropathologist	NOUN
fnp-4692	74	20	alone	alone	ADV
fnp-4692	74	21	.	.	PUNCT
fnp-4692	75	1	the	the	DET
fnp-4692	75	2	combination	combination	NOUN
fnp-4692	75	3	of	of	ADP
fnp-4692	75	4	the	the	DET
fnp-4692	75	5	prediction	prediction	NOUN
fnp-4692	75	6	of	of	ADP
fnp-4692	75	7	one	one	NUM
fnp-4692	75	8	neuropathologist	neuropathologist	NOUN
fnp-4692	75	9	together	together	ADV
fnp-4692	75	10	with	with	ADP
fnp-4692	75	11	the	the	DET
fnp-4692	75	12	ml	ml	PROPN
fnp-4692	75	13	assessment	assessment	NOUN
fnp-4692	75	14	further	far	ADV
fnp-4692	75	15	increased	increase	VERB
fnp-4692	75	16	correct	correct	ADJ
fnp-4692	75	17	prediction	prediction	NOUN
fnp-4692	75	18	as	as	SCONJ
fnp-4692	75	19	compared	compare	VERB
fnp-4692	75	20	to	to	ADP
fnp-4692	75	21	ml	ml	ADP
fnp-4692	75	22	or	or	CCONJ
fnp-4692	75	23	a	a	DET
fnp-4692	75	24	neuropathologist	neuropathologist	NOUN
fnp-4692	75	25	alone	alone	ADV
fnp-4692	75	26	.	.	PUNCT
fnp-4692	76	1	of	of	ADP
fnp-4692	76	2	note	note	NOUN
fnp-4692	76	3	,	,	PUNCT
fnp-4692	76	4	the	the	DET
fnp-4692	76	5	hybrid	hybrid	ADJ
fnp-4692	76	6	model	model	NOUN
fnp-4692	76	7	of	of	ADP
fnp-4692	76	8	ml	ml	INTJ
fnp-4692	76	9	and	and	CCONJ
fnp-4692	76	10	one	one	NUM
fnp-4692	76	11	neuropathologist	neuropathologist	NOUN
fnp-4692	76	12	was	be	AUX
fnp-4692	76	13	similarly	similarly	ADV
fnp-4692	76	14	precise	precise	ADJ
fnp-4692	76	15	as	as	SCONJ
fnp-4692	76	16	compared	compare	VERB
fnp-4692	76	17	to	to	ADP
fnp-4692	76	18	the	the	DET
fnp-4692	76	19	combined	combine	VERB
fnp-4692	76	20	score	score	NOUN
fnp-4692	76	21	derived	derive	VERB
fnp-4692	76	22	from	from	ADP
fnp-4692	76	23	two	two	NUM
fnp-4692	76	24	neuropathologists	neuropathologist	NOUN
fnp-4692	76	25	.	.	PUNCT
fnp-4692	77	1	within	within	ADP
fnp-4692	77	2	this	this	DET
fnp-4692	77	3	relatively	relatively	ADV
fnp-4692	77	4	restricted	restricted	ADJ
fnp-4692	77	5	cohort	cohort	NOUN
fnp-4692	77	6	of	of	ADP
fnp-4692	77	7	gliomas	glioma	NOUN
fnp-4692	77	8	,	,	PUNCT
fnp-4692	77	9	ml	ml	ADP
fnp-4692	77	10	approaches	approach	NOUN
fnp-4692	77	11	were	be	AUX
fnp-4692	77	12	able	able	ADJ
fnp-4692	77	13	to	to	PART
fnp-4692	77	14	perform	perform	VERB
fnp-4692	77	15	similarly	similarly	ADV
fnp-4692	77	16	well	well	ADV
fnp-4692	77	17	as	as	ADP
fnp-4692	77	18	trained	train	VERB
fnp-4692	77	19	neuropathologists	neuropathologist	NOUN
fnp-4692	77	20	.	.	PUNCT
fnp-4692	78	1	taking	take	VERB
fnp-4692	78	2	into	into	ADP
fnp-4692	78	3	account	account	NOUN
fnp-4692	78	4	that	that	SCONJ
fnp-4692	78	5	the	the	DET
fnp-4692	78	6	training	training	NOUN
fnp-4692	78	7	of	of	ADP
fnp-4692	78	8	a	a	DET
fnp-4692	78	9	neuropathologist	neuropathologist	NOUN
fnp-4692	78	10	takes	take	VERB
fnp-4692	78	11	several	several	ADJ
fnp-4692	78	12	years	year	NOUN
fnp-4692	78	13	while	while	SCONJ
fnp-4692	78	14	ml	ml	NOUN
fnp-4692	78	15	-	-	PUNCT
fnp-4692	78	16	based	base	VERB
fnp-4692	78	17	analyses	analysis	NOUN
fnp-4692	78	18	only	only	ADV
fnp-4692	78	19	took	take	VERB
fnp-4692	78	20	a	a	DET
fnp-4692	78	21	very	very	ADV
fnp-4692	78	22	short	short	ADJ
fnp-4692	78	23	time	time	NOUN
fnp-4692	78	24	to	to	PART
fnp-4692	78	25	train	train	VERB
fnp-4692	78	26	;	;	PUNCT
fnp-4692	78	27	these	these	DET
fnp-4692	78	28	findings	finding	NOUN
fnp-4692	78	29	reflect	reflect	VERB
fnp-4692	78	30	the	the	DET
fnp-4692	78	31	high	high	ADJ
fnp-4692	78	32	potential	potential	NOUN
fnp-4692	78	33	of	of	ADP
fnp-4692	78	34	ml	ml	ADP
fnp-4692	78	35	approaches	approach	NOUN
fnp-4692	78	36	in	in	ADP
fnp-4692	78	37	diagnostic	diagnostic	ADJ
fnp-4692	78	38	pathology	pathology	NOUN
fnp-4692	78	39	including	include	VERB
fnp-4692	78	40	neuropathology	neuropathology	NOUN
fnp-4692	78	41	.	.	PUNCT
fnp-4692	79	1	this	this	PRON
fnp-4692	79	2	is	be	AUX
fnp-4692	79	3	all	all	DET
fnp-4692	79	4	the	the	DET
fnp-4692	79	5	more	more	ADV
fnp-4692	79	6	promising	promising	ADJ
fnp-4692	79	7	as	as	ADP
fnp-4692	79	8	initial	initial	ADJ
fnp-4692	79	9	ml	ml	NOUN
fnp-4692	79	10	training	training	NOUN
fnp-4692	79	11	and	and	CCONJ
fnp-4692	79	12	validation	validation	NOUN
fnp-4692	79	13	has	have	AUX
fnp-4692	79	14	been	be	AUX
fnp-4692	79	15	performed	perform	VERB
fnp-4692	79	16	on	on	ADP
fnp-4692	79	17	an	an	DET
fnp-4692	79	18	external	external	ADJ
fnp-4692	79	19	image	image	NOUN
fnp-4692	79	20	set	set	VERB
fnp-4692	79	21	in	in	ADP
fnp-4692	79	22	which	which	PRON
fnp-4692	79	23	potential	potential	ADJ
fnp-4692	79	24	differences	difference	NOUN
fnp-4692	79	25	with	with	ADP
fnp-4692	79	26	regard	regard	NOUN
fnp-4692	79	27	to	to	ADP
fnp-4692	79	28	histology	histology	NOUN
fnp-4692	79	29	,	,	PUNCT
fnp-4692	79	30	for	for	ADP
fnp-4692	79	31	example	example	NOUN
fnp-4692	79	32	in	in	ADP
fnp-4692	79	33	slide	slide	NOUN
fnp-4692	79	34	thickness	thickness	NOUN
fnp-4692	79	35	or	or	CCONJ
fnp-4692	79	36	staining	stain	VERB
fnp-4692	79	37	intensities	intensity	NOUN
fnp-4692	79	38	,	,	PUNCT
fnp-4692	79	39	could	could	AUX
fnp-4692	79	40	have	have	AUX
fnp-4692	79	41	led	lead	VERB
fnp-4692	79	42	to	to	ADP
fnp-4692	79	43	improper	improper	ADJ
fnp-4692	79	44	recognition	recognition	NOUN
fnp-4692	79	45	of	of	ADP
fnp-4692	79	46	histomorphological	histomorphological	ADJ
fnp-4692	79	47	features	feature	NOUN
fnp-4692	79	48	.	.	PUNCT
fnp-4692	80	1	therefore	therefore	ADV
fnp-4692	80	2	,	,	PUNCT
fnp-4692	80	3	computer	computer	NOUN
fnp-4692	80	4	-	-	PUNCT
fnp-4692	80	5	assisted	assist	VERB
fnp-4692	80	6	diagnostic	diagnostic	ADJ
fnp-4692	80	7	procedures	procedure	NOUN
fnp-4692	80	8	could	could	AUX
fnp-4692	80	9	be	be	AUX
fnp-4692	80	10	a	a	DET
fnp-4692	80	11	way	way	NOUN
fnp-4692	80	12	to	to	PART
fnp-4692	80	13	improve	improve	VERB
fnp-4692	80	14	diagnostic	diagnostic	ADJ
fnp-4692	80	15	precision	precision	NOUN
fnp-4692	80	16	,	,	PUNCT
fnp-4692	80	17	especially	especially	ADV
fnp-4692	80	18	for	for	ADP
fnp-4692	80	19	smaller	small	ADJ
fnp-4692	80	20	hospitals	hospital	NOUN
fnp-4692	80	21	or	or	CCONJ
fnp-4692	80	22	pathological	pathological	ADJ
fnp-4692	80	23	institutes	institute	NOUN
fnp-4692	80	24	where	where	SCONJ
fnp-4692	80	25	review	review	NOUN
fnp-4692	80	26	by	by	ADP
fnp-4692	80	27	two	two	NUM
fnp-4692	80	28	neuropathologists	neuropathologist	NOUN
fnp-4692	80	29	may	may	AUX
fnp-4692	80	30	not	not	PART
fnp-4692	80	31	be	be	AUX
fnp-4692	80	32	feasible	feasible	ADJ
fnp-4692	80	33	.	.	PUNCT
fnp-4692	81	1	one	one	PRON
fnp-4692	81	2	should	should	AUX
fnp-4692	81	3	still	still	ADV
fnp-4692	81	4	consider	consider	VERB
fnp-4692	81	5	the	the	DET
fnp-4692	81	6	current	current	ADJ
fnp-4692	81	7	result	result	NOUN
fnp-4692	81	8	with	with	ADP
fnp-4692	81	9	caution	caution	NOUN
fnp-4692	81	10	,	,	PUNCT
fnp-4692	81	11	however	however	ADV
fnp-4692	81	12	,	,	PUNCT
fnp-4692	81	13	as	as	SCONJ
fnp-4692	81	14	still	still	ADV
fnp-4692	81	15	both	both	DET
fnp-4692	81	16	ml	ml	NOUN
fnp-4692	81	17	and	and	CCONJ
fnp-4692	81	18	neuropathologists	neuropathologist	NOUN
fnp-4692	81	19	mixed	mix	VERB
fnp-4692	81	20	up	up	ADP
fnp-4692	81	21	idh	idh	PROPN
fnp-4692	81	22	wildtype	wildtype	NOUN
fnp-4692	81	23	and	and	CCONJ
fnp-4692	81	24	mutant	mutant	ADJ
fnp-4692	81	25	glioma	glioma	NOUN
fnp-4692	81	26	to	to	ADP
fnp-4692	81	27	a	a	DET
fnp-4692	81	28	similar	similar	ADJ
fnp-4692	81	29	extent	extent	NOUN
fnp-4692	81	30	,	,	PUNCT
fnp-4692	81	31	clearly	clearly	ADV
fnp-4692	81	32	indicating	indicate	VERB
fnp-4692	81	33	limits	limit	NOUN
fnp-4692	81	34	of	of	ADP
fnp-4692	81	35	predicting	predict	VERB
fnp-4692	81	36	molecular	molecular	ADJ
fnp-4692	81	37	features	feature	NOUN
fnp-4692	81	38	by	by	ADP
fnp-4692	81	39	means	mean	NOUN
fnp-4692	81	40	of	of	ADP
fnp-4692	81	41	histological	histological	ADJ
fnp-4692	81	42	analyses	analysis	NOUN
fnp-4692	81	43	only	only	ADV
fnp-4692	81	44	.	.	PUNCT
fnp-4692	82	1	this	this	DET
fnp-4692	82	2	task	task	NOUN
fnp-4692	82	3	may	may	AUX
fnp-4692	82	4	even	even	ADV
fnp-4692	82	5	be	be	AUX
fnp-4692	82	6	more	more	ADV
fnp-4692	82	7	challenging	challenging	ADJ
fnp-4692	82	8	in	in	ADP
fnp-4692	82	9	small	small	ADJ
fnp-4692	82	10	round	round	ADJ
fnp-4692	82	11	blue	blue	ADJ
fnp-4692	82	12	cell	cell	NOUN
fnp-4692	82	13	tumors	tumor	NOUN
fnp-4692	82	14	or	or	CCONJ
fnp-4692	82	15	sarcomas	sarcoma	NOUN
fnp-4692	82	16	,	,	PUNCT
fnp-4692	82	17	tumor	tumor	NOUN
fnp-4692	82	18	types	type	NOUN
fnp-4692	82	19	in	in	ADP
fnp-4692	82	20	which	which	PRON
fnp-4692	82	21	morphological	morphological	ADJ
fnp-4692	82	22	features	feature	NOUN
fnp-4692	82	23	often	often	ADV
fnp-4692	82	24	correlate	correlate	VERB
fnp-4692	82	25	even	even	ADV
fnp-4692	82	26	less	less	ADJ
fnp-4692	82	27	with	with	ADP
fnp-4692	82	28	the	the	DET
fnp-4692	82	29	final	final	ADJ
fnp-4692	82	30	integrated	integrate	VERB
fnp-4692	82	31	molecular	molecular	ADJ
fnp-4692	82	32	diagnoses	diagnosis	NOUN
fnp-4692	82	33	.	.	PUNCT
fnp-4692	83	1	4	4	X
fnp-4692	83	2	.	.	X
fnp-4692	83	3	histomolecular	histomolecular	ADJ
fnp-4692	83	4	grading	grading	NOUN
fnp-4692	83	5	for	for	ADP
fnp-4692	83	6	meningioma	meningioma	NOUN
fnp-4692	83	7	[	[	X
fnp-4692	83	8	6	6	NUM
fnp-4692	83	9	]	]	PUNCT
fnp-4692	83	10	besides	besides	SCONJ
fnp-4692	83	11	the	the	DET
fnp-4692	83	12	classic	classic	ADJ
fnp-4692	83	13	grading	grading	NOUN
fnp-4692	83	14	of	of	ADP
fnp-4692	83	15	brain	brain	NOUN
fnp-4692	83	16	tumors	tumor	NOUN
fnp-4692	83	17	according	accord	VERB
fnp-4692	83	18	to	to	ADP
fnp-4692	83	19	the	the	DET
fnp-4692	83	20	who	who	PRON
fnp-4692	83	21	classification	classification	NOUN
fnp-4692	83	22	of	of	ADP
fnp-4692	83	23	central	central	ADJ
fnp-4692	83	24	nervous	nervous	ADJ
fnp-4692	83	25	system	system	NOUN
fnp-4692	83	26	(	(	PUNCT
fnp-4692	83	27	cns	cns	NOUN
fnp-4692	83	28	)	)	PUNCT
fnp-4692	83	29	tumors	tumor	NOUN
fnp-4692	83	30	,	,	PUNCT
fnp-4692	83	31	several	several	ADJ
fnp-4692	83	32	multicentric	multicentric	ADJ
fnp-4692	83	33	studies	study	NOUN
fnp-4692	83	34	aimed	aim	VERB
fnp-4692	83	35	to	to	ADP
fnp-4692	83	36	more	more	ADV
fnp-4692	83	37	precisely	precisely	ADV
fnp-4692	83	38	stratify	stratify	VERB
fnp-4692	83	39	brain	brain	NOUN
fnp-4692	83	40	tumor	tumor	NOUN
fnp-4692	83	41	patients	patient	NOUN
fnp-4692	83	42	with	with	ADP
fnp-4692	83	43	regard	regard	NOUN
fnp-4692	83	44	to	to	ADP
fnp-4692	83	45	their	their	PRON
fnp-4692	83	46	risk	risk	NOUN
fnp-4692	83	47	of	of	ADP
fnp-4692	83	48	recurrence	recurrence	NOUN
fnp-4692	83	49	.	.	PUNCT
fnp-4692	84	1	in	in	ADP
fnp-4692	84	2	a	a	DET
fnp-4692	84	3	previous	previous	ADJ
fnp-4692	84	4	study	study	NOUN
fnp-4692	84	5	,	,	PUNCT
fnp-4692	84	6	it	it	PRON
fnp-4692	84	7	was	be	AUX
fnp-4692	84	8	shown	show	VERB
fnp-4692	84	9	that	that	SCONJ
fnp-4692	84	10	combining	combine	VERB
fnp-4692	84	11	histomorphological	histomorphological	ADJ
fnp-4692	84	12	assessment	assessment	NOUN
fnp-4692	84	13	of	of	ADP
fnp-4692	84	14	meningioma	meningioma	NOUN
fnp-4692	84	15	with	with	ADP
fnp-4692	84	16	methylation	methylation	NOUN
fnp-4692	84	17	analyses	analysis	NOUN
fnp-4692	84	18	led	lead	VERB
fnp-4692	84	19	to	to	ADP
fnp-4692	84	20	inverted	inverted	ADJ
fnp-4692	84	21	recurrence	recurrence	NOUN
fnp-4692	84	22	risk	risk	NOUN
fnp-4692	84	23	in	in	ADP
fnp-4692	84	24	some	some	DET
fnp-4692	84	25	cases	case	NOUN
fnp-4692	84	26	,	,	PUNCT
fnp-4692	84	27	namely	namely	ADV
fnp-4692	84	28	that	that	SCONJ
fnp-4692	84	29	some	some	DET
fnp-4692	84	30	meningiomas	meningioma	NOUN
fnp-4692	84	31	classified	classify	VERB
fnp-4692	84	32	as	as	ADP
fnp-4692	84	33	who	who	PRON
fnp-4692	84	34	grade	grade	VERB
fnp-4692	84	35	i	i	PRON
fnp-4692	84	36	(	(	PUNCT
fnp-4692	84	37	now	now	ADV
fnp-4692	84	38	cns	cns	X
fnp-4692	84	39	who	who	PRON
fnp-4692	84	40	grade	grade	NOUN
fnp-4692	84	41	1	1	NUM
fnp-4692	84	42	)	)	PUNCT
fnp-4692	84	43	displayed	display	VERB
fnp-4692	84	44	a	a	DET
fnp-4692	84	45	higher	high	ADJ
fnp-4692	84	46	recurrence	recurrence	NOUN
fnp-4692	84	47	risk	risk	NOUN
fnp-4692	84	48	when	when	SCONJ
fnp-4692	84	49	applying	apply	VERB
fnp-4692	84	50	the	the	DET
fnp-4692	84	51	meningioma	meningioma	NOUN
fnp-4692	84	52	methylation	methylation	NOUN
fnp-4692	84	53	classifier	classifier	NOUN
fnp-4692	84	54	,	,	PUNCT
fnp-4692	84	55	as	as	SCONJ
fnp-4692	84	56	compared	compare	VERB
fnp-4692	84	57	to	to	ADP
fnp-4692	84	58	cases	case	NOUN
fnp-4692	84	59	initially	initially	ADV
fnp-4692	84	60	diagnosed	diagnose	VERB
fnp-4692	84	61	as	as	ADP
fnp-4692	84	62	who	who	PRON
fnp-4692	84	63	grade	grade	NOUN
fnp-4692	84	64	2	2	NUM
fnp-4692	84	65	tumors	tumor	NOUN
fnp-4692	84	66	according	accord	VERB
fnp-4692	84	67	to	to	ADP
fnp-4692	84	68	histomorphological	histomorphological	ADJ
fnp-4692	84	69	criteria	criterion	NOUN
fnp-4692	84	70	[	[	X
fnp-4692	84	71	17	17	NUM
fnp-4692	84	72	]	]	PUNCT
fnp-4692	84	73	.	.	PUNCT
fnp-4692	85	1	along	along	ADP
fnp-4692	85	2	this	this	DET
fnp-4692	85	3	line	line	NOUN
fnp-4692	85	4	,	,	PUNCT
fnp-4692	85	5	driver	driver	NOUN
fnp-4692	85	6	et	et	PROPN
fnp-4692	85	7	al	al	PROPN
fnp-4692	85	8	.	.	PROPN
fnp-4692	85	9	aimed	aim	VERB
fnp-4692	85	10	at	at	ADP
fnp-4692	85	11	providing	provide	VERB
fnp-4692	85	12	a	a	DET
fnp-4692	85	13	model	model	NOUN
fnp-4692	85	14	for	for	ADP
fnp-4692	85	15	more	more	ADV
fnp-4692	85	16	precise	precise	ADJ
fnp-4692	85	17	prediction	prediction	NOUN
fnp-4692	85	18	of	of	ADP
fnp-4692	85	19	the	the	DET
fnp-4692	85	20	clinical	clinical	ADJ
fnp-4692	85	21	behavior	behavior	NOUN
fnp-4692	85	22	of	of	ADP
fnp-4692	85	23	meningiomas	meningioma	NOUN
fnp-4692	85	24	going	go	VERB
fnp-4692	85	25	beyond	beyond	ADP
fnp-4692	85	26	the	the	DET
fnp-4692	85	27	classic	classic	ADJ
fnp-4692	85	28	histological	histological	ADJ
fnp-4692	85	29	grading	grade	VERB
fnp-4692	85	30	system	system	NOUN
fnp-4692	85	31	[	[	X
fnp-4692	85	32	6	6	NUM
fnp-4692	85	33	]	]	PUNCT
fnp-4692	85	34	.	.	PUNCT
fnp-4692	86	1	this	this	DET
fnp-4692	86	2	paper	paper	NOUN
fnp-4692	86	3	has	have	AUX
fnp-4692	86	4	already	already	ADV
fnp-4692	86	5	been	be	AUX
fnp-4692	86	6	briefly	briefly	ADV
fnp-4692	86	7	presented	present	VERB
fnp-4692	86	8	in	in	ADP
fnp-4692	86	9	the	the	DET
fnp-4692	86	10	“	"	PUNCT
fnp-4692	86	11	neurooncology	neurooncology	NOUN
fnp-4692	86	12	:	:	PUNCT
fnp-4692	86	13	2022	2022	NUM
fnp-4692	86	14	update	update	NOUN
fnp-4692	86	15	”	"	PUNCT
fnp-4692	86	16	series	series	NOUN
fnp-4692	86	17	,	,	PUNCT
fnp-4692	86	18	however	however	ADV
fnp-4692	86	19	,	,	PUNCT
fnp-4692	86	20	given	give	VERB
fnp-4692	86	21	the	the	DET
fnp-4692	86	22	importance	importance	NOUN
fnp-4692	86	23	of	of	ADP
fnp-4692	86	24	the	the	DET
fnp-4692	86	25	study	study	NOUN
fnp-4692	86	26	and	and	CCONJ
fnp-4692	86	27	the	the	DET
fnp-4692	86	28	urgent	urgent	ADJ
fnp-4692	86	29	need	need	NOUN
fnp-4692	86	30	for	for	ADP
fnp-4692	86	31	an	an	DET
fnp-4692	86	32	alignment	alignment	NOUN
fnp-4692	86	33	between	between	ADP
fnp-4692	86	34	different	different	ADJ
fnp-4692	86	35	grading	grade	VERB
fnp-4692	86	36	schemes	scheme	NOUN
fnp-4692	86	37	,	,	PUNCT
fnp-4692	86	38	the	the	DET
fnp-4692	86	39	author	author	NOUN
fnp-4692	86	40	of	of	ADP
fnp-4692	86	41	this	this	DET
fnp-4692	86	42	year	year	NOUN
fnp-4692	86	43	’s	’s	PART
fnp-4692	86	44	edition	edition	NOUN
fnp-4692	86	45	would	would	AUX
fnp-4692	86	46	like	like	VERB
fnp-4692	86	47	to	to	PART
fnp-4692	86	48	stress	stress	VERB
fnp-4692	86	49	the	the	DET
fnp-4692	86	50	study	study	NOUN
fnp-4692	86	51	in	in	ADP
fnp-4692	86	52	more	more	ADJ
fnp-4692	86	53	detail	detail	NOUN
fnp-4692	86	54	again	again	ADV
fnp-4692	86	55	[	[	X
fnp-4692	86	56	18	18	NUM
fnp-4692	86	57	]	]	PUNCT
fnp-4692	86	58	.	.	PUNCT
fnp-4692	87	1	the	the	DET
fnp-4692	87	2	authors	author	NOUN
fnp-4692	87	3	analyzed	analyze	VERB
fnp-4692	87	4	a	a	DET
fnp-4692	87	5	large	large	ADJ
fnp-4692	87	6	variety	variety	NOUN
fnp-4692	87	7	of	of	ADP
fnp-4692	87	8	clinical	clinical	ADJ
fnp-4692	87	9	(	(	PUNCT
fnp-4692	87	10	gross	gross	ADJ
fnp-4692	87	11	total	total	ADJ
fnp-4692	87	12	or	or	CCONJ
fnp-4692	87	13	subtotal	subtotal	ADJ
fnp-4692	87	14	resection	resection	NOUN
fnp-4692	87	15	assessed	assess	VERB
fnp-4692	87	16	by	by	ADP
fnp-4692	87	17	mri	mri	NOUN
fnp-4692	87	18	analyses	analysis	NOUN
fnp-4692	87	19	,	,	PUNCT
fnp-4692	87	20	progression	progression	NOUN
fnp-4692	87	21	-	-	PUNCT
fnp-4692	87	22	free	free	ADJ
fnp-4692	87	23	survival	survival	NOUN
fnp-4692	87	24	)	)	PUNCT
fnp-4692	87	25	,	,	PUNCT
fnp-4692	87	26	histomorphological	histomorphological	NOUN
fnp-4692	87	27	(	(	PUNCT
fnp-4692	87	28	including	include	VERB
fnp-4692	87	29	who	who	PRON
fnp-4692	87	30	grade	grade	NOUN
fnp-4692	87	31	,	,	PUNCT
fnp-4692	87	32	features	feature	NOUN
fnp-4692	87	33	of	of	ADP
fnp-4692	87	34	atypia	atypia	PROPN
fnp-4692	87	35	,	,	PUNCT
fnp-4692	87	36	proliferation	proliferation	NOUN
fnp-4692	87	37	and	and	CCONJ
fnp-4692	87	38	mitotic	mitotic	ADJ
fnp-4692	87	39	index	index	NOUN
fnp-4692	87	40	)	)	PUNCT
fnp-4692	87	41	and	and	CCONJ
fnp-4692	87	42	molecular	molecular	ADJ
fnp-4692	87	43	features	feature	NOUN
fnp-4692	87	44	(	(	PUNCT
fnp-4692	87	45	copy	copy	NOUN
fnp-4692	87	46	number	number	NOUN
fnp-4692	87	47	variation	variation	NOUN
fnp-4692	87	48	,	,	PUNCT
fnp-4692	87	49	as	as	ADV
fnp-4692	87	50	well	well	ADV
fnp-4692	87	51	as	as	ADP
fnp-4692	87	52	partially	partially	ADV
fnp-4692	87	53	targeted	target	VERB
fnp-4692	87	54	mutational	mutational	ADJ
fnp-4692	87	55	profiling	profiling	NOUN
fnp-4692	87	56	and	and	CCONJ
fnp-4692	87	57	methylation	methylation	NOUN
fnp-4692	87	58	analyses	analysis	NOUN
fnp-4692	87	59	)	)	PUNCT
fnp-4692	87	60	.	.	PUNCT
fnp-4692	88	1	by	by	ADP
fnp-4692	88	2	correlating	correlate	VERB
fnp-4692	88	3	all	all	DET
fnp-4692	88	4	those	those	DET
fnp-4692	88	5	features	feature	NOUN
fnp-4692	88	6	with	with	ADP
fnp-4692	88	7	progression	progression	NOUN
fnp-4692	88	8	-	-	PUNCT
fnp-4692	88	9	free	free	ADJ
fnp-4692	88	10	survival	survival	NOUN
fnp-4692	88	11	of	of	ADP
fnp-4692	88	12	meningioma	meningioma	NOUN
fnp-4692	88	13	patients	patient	NOUN
fnp-4692	88	14	,	,	PUNCT
fnp-4692	88	15	the	the	DET
fnp-4692	88	16	authors	author	NOUN
fnp-4692	88	17	finally	finally	ADV
fnp-4692	88	18	proposed	propose	VERB
fnp-4692	88	19	a	a	DET
fnp-4692	88	20	new	new	ADJ
fnp-4692	88	21	3	3	NUM
fnp-4692	88	22	-	-	PUNCT
fnp-4692	88	23	tiered	tiere	VERB
fnp-4692	88	24	grading	grading	NOUN
fnp-4692	88	25	scheme	scheme	NOUN
fnp-4692	88	26	taking	taking	NOUN
fnp-4692	88	27	into	into	ADP
fnp-4692	88	28	account	account	NOUN
fnp-4692	88	29	the	the	DET
fnp-4692	88	30	mitotic	mitotic	ADJ
fnp-4692	88	31	count	count	NOUN
fnp-4692	88	32	,	,	PUNCT
fnp-4692	88	33	loss	loss	NOUN
fnp-4692	88	34	of	of	ADP
fnp-4692	88	35	distinct	distinct	ADJ
fnp-4692	88	36	chromosomal	chromosomal	ADJ
fnp-4692	88	37	arms	arm	NOUN
fnp-4692	88	38	or	or	CCONJ
fnp-4692	88	39	entire	entire	ADJ
fnp-4692	88	40	chromosomes	chromosome	NOUN
fnp-4692	88	41	,	,	PUNCT
fnp-4692	88	42	or	or	CCONJ
fnp-4692	88	43	loss	loss	NOUN
fnp-4692	88	44	of	of	ADP
fnp-4692	88	45	cdkn2a	cdkn2a	PROPN
fnp-4692	88	46	/	/	SYM
fnp-4692	88	47	b.	b.	PROPN
fnp-4692	88	48	a	a	DET
fnp-4692	88	49	maximum	maximum	NOUN
fnp-4692	88	50	of	of	ADP
fnp-4692	88	51	11	11	NUM
fnp-4692	88	52	points	point	NOUN
fnp-4692	88	53	could	could	AUX
fnp-4692	88	54	be	be	AUX
fnp-4692	88	55	obtained	obtain	VERB
fnp-4692	88	56	(	(	PUNCT
fnp-4692	88	57	9	9	NUM
fnp-4692	88	58	for	for	ADP
fnp-4692	88	59	high	high	ADJ
fnp-4692	88	60	-	-	PUNCT
fnp-4692	88	61	molecular	molecular	ADJ
fnp-4692	88	62	risk	risk	NOUN
fnp-4692	88	63	alterations	alteration	NOUN
fnp-4692	88	64	and	and	CCONJ
fnp-4692	88	65	2	2	NUM
fnp-4692	88	66	for	for	ADP
fnp-4692	88	67	mitotic	mitotic	ADJ
fnp-4692	88	68	count	count	NOUN
fnp-4692	88	69	)	)	PUNCT
fnp-4692	88	70	,	,	PUNCT
fnp-4692	88	71	leading	lead	VERB
fnp-4692	88	72	to	to	ADP
fnp-4692	88	73	a	a	DET
fnp-4692	88	74	)	)	PUNCT
fnp-4692	88	75	grade	grade	NOUN
fnp-4692	88	76	1	1	NUM
fnp-4692	88	77	for	for	ADP
fnp-4692	88	78	0	0	NUM
fnp-4692	88	79	-	-	SYM
fnp-4692	88	80	1	1	NUM
fnp-4692	88	81	point	point	NOUN
fnp-4692	88	82	,	,	PUNCT
fnp-4692	88	83	b	b	NOUN
fnp-4692	88	84	)	)	PUNCT
fnp-4692	88	85	grade	grade	NOUN
fnp-4692	88	86	2	2	NUM
fnp-4692	88	87	for	for	ADP
fnp-4692	88	88	2	2	NUM
fnp-4692	88	89	-	-	SYM
fnp-4692	88	90	3	3	NUM
fnp-4692	88	91	points	point	NOUN
fnp-4692	88	92	and	and	CCONJ
fnp-4692	88	93	c	c	NOUN
fnp-4692	88	94	)	)	PUNCT
fnp-4692	88	95	grade	grade	NOUN
fnp-4692	88	96	3	3	NUM
fnp-4692	88	97	if	if	SCONJ
fnp-4692	88	98	4	4	NUM
fnp-4692	88	99	or	or	CCONJ
fnp-4692	88	100	more	more	ADJ
fnp-4692	88	101	points	point	NOUN
fnp-4692	88	102	were	be	AUX
fnp-4692	88	103	obtained	obtain	VERB
fnp-4692	88	104	(	(	PUNCT
fnp-4692	88	105	figure	figure	NOUN
fnp-4692	88	106	2	2	NUM
fnp-4692	88	107	)	)	PUNCT
fnp-4692	88	108	.	.	PUNCT
fnp-4692	89	1	with	with	ADP
fnp-4692	89	2	this	this	DET
fnp-4692	89	3	approach	approach	NOUN
fnp-4692	89	4	,	,	PUNCT
fnp-4692	89	5	more	more	ADJ
fnp-4692	89	6	than	than	ADP
fnp-4692	89	7	30	30	NUM
fnp-4692	89	8	%	%	NOUN
fnp-4692	89	9	of	of	ADP
fnp-4692	89	10	tumors	tumor	NOUN
fnp-4692	89	11	were	be	AUX
fnp-4692	89	12	reclassified	reclassify	VERB
fnp-4692	89	13	as	as	ADP
fnp-4692	89	14	compared	compare	VERB
fnp-4692	89	15	to	to	ADP
fnp-4692	89	16	the	the	DET
fnp-4692	89	17	previously	previously	ADV
fnp-4692	89	18	applied	apply	VERB
fnp-4692	89	19	who	who	PRON
fnp-4692	89	20	grade	grade	NOUN
fnp-4692	89	21	.	.	PUNCT
fnp-4692	90	1	of	of	ADP
fnp-4692	90	2	note	note	NOUN
fnp-4692	90	3	,	,	PUNCT
fnp-4692	90	4	in	in	ADP
fnp-4692	90	5	meningiomas	meningioma	NOUN
fnp-4692	90	6	with	with	ADP
fnp-4692	90	7	an	an	DET
fnp-4692	90	8	integrated	integrated	ADJ
fnp-4692	90	9	tumor	tumor	NOUN
fnp-4692	90	10	score	score	NOUN
fnp-4692	90	11	of	of	ADP
fnp-4692	90	12	3	3	NUM
fnp-4692	90	13	,	,	PUNCT
fnp-4692	90	14	recurrences	recurrence	NOUN
fnp-4692	90	15	could	could	AUX
fnp-4692	90	16	not	not	PART
fnp-4692	90	17	even	even	ADV
fnp-4692	90	18	be	be	AUX
fnp-4692	90	19	significantly	significantly	ADV
fnp-4692	90	20	delayed	delay	VERB
fnp-4692	90	21	by	by	ADP
fnp-4692	90	22	a	a	DET
fnp-4692	90	23	gross	gross	ADJ
fnp-4692	90	24	total	total	ADJ
fnp-4692	90	25	resection	resection	NOUN
fnp-4692	90	26	,	,	PUNCT
fnp-4692	90	27	which	which	PRON
fnp-4692	90	28	is	be	AUX
fnp-4692	90	29	otherwise	otherwise	ADV
fnp-4692	90	30	a	a	DET
fnp-4692	90	31	positive	positive	ADJ
fnp-4692	90	32	factor	factor	NOUN
fnp-4692	90	33	for	for	ADP
fnp-4692	90	34	longer	long	ADJ
fnp-4692	90	35	progression	progression	NOUN
fnp-4692	90	36	free	free	ADJ
fnp-4692	90	37	survival	survival	NOUN
fnp-4692	90	38	intervals	interval	NOUN
fnp-4692	90	39	.	.	PUNCT
fnp-4692	91	1	to	to	PART
fnp-4692	91	2	avoid	avoid	VERB
fnp-4692	91	3	confusion	confusion	NOUN
fnp-4692	91	4	between	between	ADP
fnp-4692	91	5	different	different	ADJ
fnp-4692	91	6	institutional	institutional	ADJ
fnp-4692	91	7	grading	grade	VERB
fnp-4692	91	8	schemes	scheme	NOUN
fnp-4692	91	9	in	in	ADP
fnp-4692	91	10	the	the	DET
fnp-4692	91	11	future	future	NOUN
fnp-4692	91	12	[	[	AUX
fnp-4692	91	13	see	see	VERB
fnp-4692	91	14	also	also	ADV
fnp-4692	91	15	a	a	DET
fnp-4692	91	16	competing	compete	VERB
fnp-4692	91	17	approach	approach	NOUN
fnp-4692	91	18	here	here	ADV
fnp-4692	91	19	:	:	PUNCT
fnp-4692	91	20	19	19	NUM
fnp-4692	91	21	]	]	PUNCT
fnp-4692	91	22	,	,	PUNCT
fnp-4692	91	23	the	the	PRON
fnp-4692	91	24	who	who	PRON
fnp-4692	91	25	should	should	AUX
fnp-4692	91	26	bring	bring	VERB
fnp-4692	91	27	different	different	ADJ
fnp-4692	91	28	multicenter	multicenter	ADJ
fnp-4692	91	29	study	study	NOUN
fnp-4692	91	30	groups	group	NOUN
fnp-4692	91	31	together	together	ADV
fnp-4692	91	32	and	and	CCONJ
fnp-4692	91	33	refine	refine	VERB
fnp-4692	91	34	the	the	DET
fnp-4692	91	35	current	current	ADJ
fnp-4692	91	36	grading	grade	VERB
fnp-4692	91	37	schemes	scheme	NOUN
fnp-4692	91	38	,	,	PUNCT
fnp-4692	91	39	as	as	SCONJ
fnp-4692	91	40	the	the	DET
fnp-4692	91	41	high	high	ADJ
fnp-4692	91	42	discrepancies	discrepancy	NOUN
fnp-4692	91	43	between	between	ADP
fnp-4692	91	44	histomorphological	histomorphological	ADJ
fnp-4692	91	45	assessment	assessment	NOUN
fnp-4692	91	46	and	and	CCONJ
fnp-4692	91	47	different	different	ADJ
fnp-4692	91	48	integrated	integrated	ADJ
fnp-4692	91	49	scores	score	NOUN
fnp-4692	91	50	with	with	ADP
fnp-4692	91	51	regard	regard	NOUN
fnp-4692	91	52	to	to	ADP
fnp-4692	91	53	patient	patient	ADJ
fnp-4692	91	54	prognosis	prognosis	NOUN
fnp-4692	91	55	has	have	VERB
fnp-4692	91	56	the	the	DET
fnp-4692	91	57	potential	potential	NOUN
fnp-4692	91	58	to	to	PART
fnp-4692	91	59	have	have	AUX
fnp-4692	91	60	a	a	DET
fnp-4692	91	61	considerably	considerably	ADV
fnp-4692	91	62	negative	negative	ADJ
fnp-4692	91	63	impact	impact	NOUN
fnp-4692	91	64	on	on	ADP
fnp-4692	91	65	patient	patient	ADJ
fnp-4692	91	66	care	care	NOUN
fnp-4692	91	67	.	.	PUNCT
fnp-4692	92	1	this	this	PRON
fnp-4692	92	2	seems	seem	VERB
fnp-4692	92	3	to	to	PART
fnp-4692	92	4	be	be	AUX
fnp-4692	92	5	all	all	DET
fnp-4692	92	6	the	the	PRON
fnp-4692	92	7	more	more	ADV
fnp-4692	92	8	important	important	ADJ
fnp-4692	92	9	as	as	ADP
fnp-4692	92	10	–	–	PUNCT
fnp-4692	92	11	in	in	ADP
fnp-4692	92	12	contrast	contrast	NOUN
fnp-4692	92	13	to	to	ADP
fnp-4692	92	14	other	other	ADJ
fnp-4692	92	15	chapters	chapter	NOUN
fnp-4692	92	16	in	in	ADP
fnp-4692	92	17	the	the	DET
fnp-4692	92	18	current	current	NOUN
fnp-4692	92	19	who	who	PRON
fnp-4692	92	20	classification	classification	VERB
fnp-4692	92	21	–	–	PUNCT
fnp-4692	92	22	the	the	DET
fnp-4692	92	23	meningioma	meningioma	NOUN
fnp-4692	92	24	chapter	chapter	NOUN
fnp-4692	92	25	is	be	AUX
fnp-4692	92	26	still	still	ADV
fnp-4692	92	27	relatively	relatively	ADV
fnp-4692	92	28	defensive	defensive	ADJ
fnp-4692	92	29	with	with	ADP
fnp-4692	92	30	regard	regard	NOUN
fnp-4692	92	31	to	to	ADP
fnp-4692	92	32	molecular	molecular	ADJ
fnp-4692	92	33	markers	marker	NOUN
fnp-4692	92	34	impacting	impact	VERB
fnp-4692	92	35	patient	patient	ADJ
fnp-4692	92	36	prognosis	prognosis	NOUN
fnp-4692	92	37	.	.	PUNCT
fnp-4692	93	1	figure	figure	NOUN
fnp-4692	93	2	2	2	NUM
fnp-4692	93	3	:	:	PUNCT
fnp-4692	93	4	algorithm	algorithm	NOUN
fnp-4692	93	5	for	for	ADP
fnp-4692	93	6	integrated	integrate	VERB
fnp-4692	93	7	grading	grading	NOUN
fnp-4692	93	8	for	for	ADP
fnp-4692	93	9	recurrence	recurrence	NOUN
fnp-4692	93	10	risk	risk	NOUN
fnp-4692	93	11	prediction	prediction	NOUN
fnp-4692	93	12	in	in	ADP
fnp-4692	93	13	meningioma	meningioma	NOUN
fnp-4692	93	14	(	(	PUNCT
fnp-4692	93	15	mitotic	mitotic	ADJ
fnp-4692	93	16	index	index	NOUN
fnp-4692	93	17	defined	define	VERB
fnp-4692	93	18	as	as	ADP
fnp-4692	93	19	mitoses	mitose	NOUN
fnp-4692	93	20	per	per	ADP
fnp-4692	93	21	10	10	NUM
fnp-4692	93	22	high	high	ADJ
fnp-4692	93	23	-	-	PUNCT
fnp-4692	93	24	power	power	NOUN
fnp-4692	93	25	fields	field	NOUN
fnp-4692	93	26	)	)	PUNCT
fnp-4692	93	27	.	.	PUNCT
fnp-4692	94	1	5	5	X
fnp-4692	94	2	.	.	X
fnp-4692	94	3	molecular	molecular	ADJ
fnp-4692	94	4	profiling	profiling	NOUN
fnp-4692	94	5	of	of	ADP
fnp-4692	94	6	cns	cns	PROPN
fnp-4692	94	7	lymphoma	lymphoma	NOUN
fnp-4692	94	8	[	[	X
fnp-4692	94	9	7	7	X
fnp-4692	94	10	]	]	X
fnp-4692	94	11	primary	primary	ADJ
fnp-4692	94	12	diffuse	diffuse	NOUN
fnp-4692	94	13	large	large	ADJ
fnp-4692	94	14	b	b	NOUN
fnp-4692	94	15	-	-	PUNCT
fnp-4692	94	16	cell	cell	NOUN
fnp-4692	94	17	lymphomas	lymphoma	NOUN
fnp-4692	94	18	of	of	ADP
fnp-4692	94	19	the	the	DET
fnp-4692	94	20	cns	cns	PROPN
fnp-4692	94	21	(	(	PUNCT
fnp-4692	94	22	cns	cns	NOUN
fnp-4692	94	23	-	-	PUNCT
fnp-4692	94	24	dlbcl	dlbcl	NOUN
fnp-4692	94	25	)	)	PUNCT
fnp-4692	94	26	are	be	AUX
fnp-4692	94	27	the	the	DET
fnp-4692	94	28	most	most	ADV
fnp-4692	94	29	frequent	frequent	ADJ
fnp-4692	94	30	primary	primary	ADJ
fnp-4692	94	31	cns	cns	NOUN
fnp-4692	94	32	tumors	tumor	NOUN
fnp-4692	94	33	of	of	ADP
fnp-4692	94	34	haematolymphoid	haematolymphoid	ADJ
fnp-4692	94	35	origin	origin	NOUN
fnp-4692	94	36	sharing	share	VERB
fnp-4692	94	37	multiple	multiple	ADJ
fnp-4692	94	38	morphological	morphological	ADJ
fnp-4692	94	39	and	and	CCONJ
fnp-4692	94	40	molecular	molecular	ADJ
fnp-4692	94	41	features	feature	NOUN
fnp-4692	94	42	with	with	ADP
fnp-4692	94	43	both	both	CCONJ
fnp-4692	94	44	its	its	PRON
fnp-4692	94	45	systemic	systemic	ADJ
fnp-4692	94	46	non	non	ADJ
fnp-4692	94	47	-	-	ADJ
fnp-4692	94	48	cns	cns	ADJ
fnp-4692	94	49	and/or	and/or	CCONJ
fnp-4692	94	50	secondary	secondary	ADJ
fnp-4692	94	51	cns	cns	PROPN
fnp-4692	94	52	counterparts	counterpart	NOUN
fnp-4692	94	53	[	[	X
fnp-4692	94	54	20	20	NUM
fnp-4692	94	55	]	]	PUNCT
fnp-4692	94	56	.	.	PUNCT
fnp-4692	95	1	as	as	SCONJ
fnp-4692	95	2	the	the	DET
fnp-4692	95	3	origin	origin	NOUN
fnp-4692	95	4	of	of	ADP
fnp-4692	95	5	cns	cns	NOUN
fnp-4692	95	6	-	-	PUNCT
fnp-4692	95	7	dlbcl	dlbcl	NOUN
fnp-4692	95	8	is	be	AUX
fnp-4692	95	9	still	still	ADV
fnp-4692	95	10	not	not	PART
fnp-4692	95	11	entirely	entirely	ADV
fnp-4692	95	12	clear	clear	ADJ
fnp-4692	95	13	and	and	CCONJ
fnp-4692	95	14	also	also	ADV
fnp-4692	95	15	some	some	PRON
fnp-4692	95	16	of	of	ADP
fnp-4692	95	17	the	the	DET
fnp-4692	95	18	very	very	ADV
fnp-4692	95	19	recent	recent	ADJ
fnp-4692	95	20	,	,	PUNCT
fnp-4692	95	21	promising	promise	VERB
fnp-4692	95	22	molecular	molecular	ADJ
fnp-4692	95	23	tools	tool	NOUN
fnp-4692	95	24	such	such	ADJ
fnp-4692	95	25	as	as	ADP
fnp-4692	95	26	dna	dna	PROPN
fnp-4692	95	27	methylation	methylation	NOUN
fnp-4692	95	28	-	-	PUNCT
fnp-4692	95	29	based	base	VERB
fnp-4692	95	30	analyses	analysis	NOUN
fnp-4692	95	31	could	could	AUX
fnp-4692	95	32	not	not	PART
fnp-4692	95	33	fully	fully	ADV
fnp-4692	95	34	distinguish	distinguish	VERB
fnp-4692	95	35	cns	cns	NOUN
fnp-4692	95	36	-	-	PUNCT
fnp-4692	95	37	dlbcl	dlbcl	NOUN
fnp-4692	95	38	from	from	ADP
fnp-4692	95	39	its	its	PRON
fnp-4692	95	40	non	non	ADJ
fnp-4692	95	41	-	-	ADJ
fnp-4692	95	42	cns	cns	ADJ
fnp-4692	95	43	counterpart	counterpart	NOUN
fnp-4692	95	44	,	,	PUNCT
fnp-4692	95	45	a	a	DET
fnp-4692	95	46	deeper	deep	ADJ
fnp-4692	95	47	understanding	understanding	NOUN
fnp-4692	95	48	of	of	ADP
fnp-4692	95	49	the	the	DET
fnp-4692	95	50	molecular	molecular	ADJ
fnp-4692	95	51	pedigree	pedigree	NOUN
fnp-4692	95	52	of	of	ADP
fnp-4692	95	53	cns	cns	NOUN
fnp-4692	95	54	-	-	PUNCT
fnp-4692	95	55	dlbcl	dlbcl	NOUN
fnp-4692	95	56	is	be	AUX
fnp-4692	95	57	urgently	urgently	ADV
fnp-4692	95	58	needed	need	VERB
fnp-4692	95	59	.	.	PUNCT
fnp-4692	96	1	radke	radke	AUX
fnp-4692	96	2	et	et	PROPN
fnp-4692	96	3	al	al	PROPN
fnp-4692	96	4	.	.	PROPN
fnp-4692	96	5	attended	attend	VERB
fnp-4692	96	6	to	to	ADP
fnp-4692	96	7	this	this	DET
fnp-4692	96	8	challenge	challenge	NOUN
fnp-4692	96	9	by	by	ADP
fnp-4692	96	10	studying	study	VERB
fnp-4692	96	11	51	51	NUM
fnp-4692	96	12	cns	cns	NOUN
fnp-4692	96	13	-	-	PUNCT
fnp-4692	96	14	dlbcl	dlbcl	NOUN
fnp-4692	96	15	using	use	VERB
fnp-4692	96	16	transcriptomic	transcriptomic	ADJ
fnp-4692	96	17	and	and	CCONJ
fnp-4692	96	18	whole	whole	ADJ
fnp-4692	96	19	genomic	genomic	NOUN
fnp-4692	96	20	analyses	analysis	NOUN
fnp-4692	96	21	and	and	CCONJ
fnp-4692	96	22	comparing	compare	VERB
fnp-4692	96	23	this	this	DET
fnp-4692	96	24	data	datum	NOUN
fnp-4692	96	25	set	set	VERB
fnp-4692	96	26	to	to	ADP
fnp-4692	96	27	one	one	NUM
fnp-4692	96	28	derived	derive	VERB
fnp-4692	96	29	from	from	ADP
fnp-4692	96	30	75	75	NUM
fnp-4692	96	31	lymphomas	lymphoma	NOUN
fnp-4692	96	32	originating	originate	VERB
fnp-4692	96	33	from	from	ADP
fnp-4692	96	34	outside	outside	ADP
fnp-4692	96	35	the	the	DET
fnp-4692	96	36	cns	cns	NOUN
fnp-4692	96	37	,	,	PUNCT
fnp-4692	96	38	the	the	DET
fnp-4692	96	39	latter	latter	ADJ
fnp-4692	96	40	including	include	VERB
fnp-4692	96	41	both	both	CCONJ
fnp-4692	96	42	follicular	follicular	ADJ
fnp-4692	96	43	and	and	CCONJ
fnp-4692	96	44	dlbc	dlbc	VERB
fnp-4692	96	45	lymphomas	lymphoma	NOUN
fnp-4692	96	46	[	[	X
fnp-4692	96	47	7	7	NUM
fnp-4692	96	48	]	]	PUNCT
fnp-4692	96	49	.	.	PUNCT
fnp-4692	97	1	the	the	DET
fnp-4692	97	2	study	study	NOUN
fnp-4692	97	3	could	could	AUX
fnp-4692	97	4	confirm	confirm	VERB
fnp-4692	97	5	myd88	myd88	PROPN
fnp-4692	97	6	(	(	PUNCT
fnp-4692	97	7	l265p	l265p	PROPN
fnp-4692	97	8	)	)	PUNCT
fnp-4692	97	9	and	and	CCONJ
fnp-4692	97	10	cd79b	cd79b	NOUN
fnp-4692	97	11	mutations	mutation	NOUN
fnp-4692	97	12	,	,	PUNCT
fnp-4692	97	13	as	as	ADV
fnp-4692	97	14	well	well	ADV
fnp-4692	97	15	as	as	ADP
fnp-4692	97	16	frequently	frequently	ADV
fnp-4692	97	17	biallelic	biallelic	ADJ
fnp-4692	97	18	cdkn2a	cdkn2a	ADJ
fnp-4692	97	19	loss	loss	NOUN
fnp-4692	97	20	as	as	ADP
fnp-4692	97	21	very	very	ADV
fnp-4692	97	22	early	early	ADJ
fnp-4692	97	23	tumor	tumor	NOUN
fnp-4692	97	24	drivers	driver	NOUN
fnp-4692	97	25	in	in	ADP
fnp-4692	97	26	cns	cns	NOUN
fnp-4692	97	27	-	-	PUNCT
fnp-4692	97	28	dlbcl	dlbcl	NOUN
fnp-4692	97	29	.	.	PUNCT
fnp-4692	98	1	other	other	ADJ
fnp-4692	98	2	frequently	frequently	ADV
fnp-4692	98	3	encountered	encounter	VERB
fnp-4692	98	4	alterations	alteration	NOUN
fnp-4692	98	5	comprised	comprise	VERB
fnp-4692	98	6	activating	activate	VERB
fnp-4692	98	7	mutations	mutation	NOUN
fnp-4692	98	8	of	of	ADP
fnp-4692	98	9	bcr	bcr	NOUN
fnp-4692	98	10	signaling	signaling	ADJ
fnp-4692	98	11	and	and	CCONJ
fnp-4692	98	12	structural	structural	ADJ
fnp-4692	98	13	variants	variant	NOUN
fnp-4692	98	14	of	of	ADP
fnp-4692	98	15	igh	igh	PROPN
fnp-4692	98	16	,	,	PUNCT
fnp-4692	98	17	igl	igl	NOUN
fnp-4692	98	18	and	and	CCONJ
fnp-4692	98	19	igk	igk	NOUN
fnp-4692	98	20	as	as	ADV
fnp-4692	98	21	well	well	ADV
fnp-4692	98	22	as	as	ADP
fnp-4692	98	23	losses	loss	NOUN
fnp-4692	98	24	of	of	ADP
fnp-4692	98	25	chromosome	chromosome	NOUN
fnp-4692	98	26	6p	6p	NUM
fnp-4692	98	27	.	.	PUNCT
fnp-4692	99	1	notably	notably	ADV
fnp-4692	99	2	the	the	DET
fnp-4692	99	3	alteration	alteration	NOUN
fnp-4692	99	4	of	of	ADP
fnp-4692	99	5	chromosome	chromosome	NOUN
fnp-4692	99	6	6p	6p	NUM
fnp-4692	99	7	where	where	SCONJ
fnp-4692	99	8	the	the	DET
fnp-4692	99	9	human	human	ADJ
fnp-4692	99	10	leukocyte	leukocyte	NOUN
fnp-4692	99	11	antigen	antigen	NOUN
fnp-4692	99	12	(	(	PUNCT
fnp-4692	99	13	hla	hla	NOUN
fnp-4692	99	14	)	)	PUNCT
fnp-4692	99	15	complex	complex	NOUN
fnp-4692	99	16	is	be	AUX
fnp-4692	99	17	located	locate	VERB
fnp-4692	99	18	may	may	AUX
fnp-4692	99	19	lead	lead	VERB
fnp-4692	99	20	to	to	ADP
fnp-4692	99	21	an	an	DET
fnp-4692	99	22	immune	immune	ADJ
fnp-4692	99	23	escape	escape	NOUN
fnp-4692	99	24	from	from	ADP
fnp-4692	99	25	cytotoxic	cytotoxic	ADJ
fnp-4692	99	26	t	t	NOUN
fnp-4692	99	27	cells	cell	NOUN
fnp-4692	99	28	due	due	ADJ
fnp-4692	99	29	to	to	ADP
fnp-4692	99	30	limited	limited	ADJ
fnp-4692	99	31	neoantigen	neoantigen	PROPN
fnp-4692	99	32	presentation	presentation	NOUN
fnp-4692	99	33	[	[	X
fnp-4692	99	34	21	21	NUM
fnp-4692	99	35	]	]	PUNCT
fnp-4692	99	36	.	.	PUNCT
fnp-4692	100	1	in	in	ADP
fnp-4692	100	2	addition	addition	NOUN
fnp-4692	100	3	to	to	ADP
fnp-4692	100	4	their	their	PRON
fnp-4692	100	5	findings	finding	NOUN
fnp-4692	100	6	on	on	ADP
fnp-4692	100	7	dna	dna	PROPN
fnp-4692	100	8	level	level	NOUN
fnp-4692	100	9	,	,	PUNCT
fnp-4692	100	10	radke	radke	PROPN
fnp-4692	100	11	et	et	PROPN
fnp-4692	100	12	al	al	PROPN
fnp-4692	100	13	.	.	PROPN
fnp-4692	100	14	could	could	AUX
fnp-4692	100	15	also	also	ADV
fnp-4692	100	16	provide	provide	VERB
fnp-4692	100	17	a	a	DET
fnp-4692	100	18	robust	robust	ADJ
fnp-4692	100	19	transcriptional	transcriptional	NOUN
fnp-4692	100	20	signature	signature	NOUN
fnp-4692	100	21	obtained	obtain	VERB
fnp-4692	100	22	by	by	ADP
fnp-4692	100	23	rna	rna	NOUN
fnp-4692	100	24	sequencing	sequencing	NOUN
fnp-4692	100	25	that	that	PRON
fnp-4692	100	26	was	be	AUX
fnp-4692	100	27	able	able	ADJ
fnp-4692	100	28	to	to	PART
fnp-4692	100	29	distinguish	distinguish	VERB
fnp-4692	100	30	cns	cns	NOUN
fnp-4692	100	31	-	-	PUNCT
fnp-4692	100	32	dlbcl	dlbcl	NOUN
fnp-4692	100	33	from	from	ADP
fnp-4692	100	34	its	its	PRON
fnp-4692	100	35	non	non	ADJ
fnp-4692	100	36	-	-	ADJ
fnp-4692	100	37	cns	cns	ADJ
fnp-4692	100	38	counterparts	counterpart	NOUN
fnp-4692	100	39	.	.	PUNCT
fnp-4692	101	1	they	they	PRON
fnp-4692	101	2	detected	detect	VERB
fnp-4692	101	3	higher	high	ADJ
fnp-4692	101	4	rna	rna	NOUN
fnp-4692	101	5	expression	expression	NOUN
fnp-4692	101	6	levels	level	NOUN
fnp-4692	101	7	of	of	ADP
fnp-4692	101	8	loci	locus	NOUN
fnp-4692	101	9	associated	associate	VERB
fnp-4692	101	10	with	with	ADP
fnp-4692	101	11	aberrant	aberrant	ADJ
fnp-4692	101	12	somatic	somatic	ADJ
fnp-4692	101	13	hypermutation	hypermutation	NOUN
fnp-4692	101	14	phenotypes	phenotype	NOUN
fnp-4692	101	15	,	,	PUNCT
fnp-4692	101	16	although	although	SCONJ
fnp-4692	101	17	it	it	PRON
fnp-4692	101	18	still	still	ADV
fnp-4692	101	19	remains	remain	VERB
fnp-4692	101	20	to	to	PART
fnp-4692	101	21	be	be	AUX
fnp-4692	101	22	determined	determine	VERB
fnp-4692	101	23	what	what	PRON
fnp-4692	101	24	is	be	AUX
fnp-4692	101	25	chicken	chicken	VERB
fnp-4692	101	26	and	and	CCONJ
fnp-4692	101	27	what	what	PRON
fnp-4692	101	28	is	be	AUX
fnp-4692	101	29	egg	egg	NOUN
fnp-4692	101	30	in	in	ADP
fnp-4692	101	31	this	this	DET
fnp-4692	101	32	association	association	NOUN
fnp-4692	101	33	.	.	PUNCT
fnp-4692	102	1	the	the	DET
fnp-4692	102	2	cns	cns	NOUN
fnp-4692	102	3	-	-	PUNCT
fnp-4692	102	4	dlbcl	dlbcl	NOUN
fnp-4692	102	5	group	group	NOUN
fnp-4692	102	6	also	also	ADV
fnp-4692	102	7	displayed	display	VERB
fnp-4692	102	8	a	a	DET
fnp-4692	102	9	higher	high	ADJ
fnp-4692	102	10	tert	tert	NOUN
fnp-4692	102	11	expression	expression	NOUN
fnp-4692	102	12	as	as	SCONJ
fnp-4692	102	13	compared	compare	VERB
fnp-4692	102	14	to	to	ADP
fnp-4692	102	15	the	the	DET
fnp-4692	102	16	group	group	NOUN
fnp-4692	102	17	of	of	ADP
fnp-4692	102	18	non	non	ADJ
fnp-4692	102	19	-	-	ADJ
fnp-4692	102	20	cns	cns	ADJ
fnp-4692	102	21	lymphomas	lymphoma	NOUN
fnp-4692	102	22	,	,	PUNCT
fnp-4692	102	23	however	however	ADV
fnp-4692	102	24	,	,	PUNCT
fnp-4692	102	25	without	without	ADP
fnp-4692	102	26	being	be	AUX
fnp-4692	102	27	associated	associate	VERB
fnp-4692	102	28	with	with	ADP
fnp-4692	102	29	increased	increase	VERB
fnp-4692	102	30	telomere	telomere	NOUN
fnp-4692	102	31	content	content	PROPN
fnp-4692	102	32	.	.	PUNCT
fnp-4692	103	1	of	of	ADP
fnp-4692	103	2	note	note	NOUN
fnp-4692	103	3	,	,	PUNCT
fnp-4692	103	4	ebv	ebv	NOUN
fnp-4692	103	5	-	-	PUNCT
fnp-4692	103	6	positive	positive	ADJ
fnp-4692	103	7	cns	cns	NOUN
fnp-4692	103	8	-	-	PUNCT
fnp-4692	103	9	dlbcl	dlbcl	NOUN
fnp-4692	103	10	did	do	AUX
fnp-4692	103	11	not	not	PART
fnp-4692	103	12	share	share	VERB
fnp-4692	103	13	many	many	ADJ
fnp-4692	103	14	of	of	ADP
fnp-4692	103	15	the	the	DET
fnp-4692	103	16	classic	classic	ADJ
fnp-4692	103	17	mutational	mutational	ADJ
fnp-4692	103	18	hotspots	hotspot	NOUN
fnp-4692	103	19	apart	apart	ADV
fnp-4692	103	20	from	from	ADP
fnp-4692	103	21	igh	igh	PROPN
fnp-4692	103	22	and	and	CCONJ
fnp-4692	103	23	hla	hla	PROPN
fnp-4692	103	24	-	-	PUNCT
fnp-4692	103	25	drb	drb	NOUN
fnp-4692	103	26	locus	locus	NOUN
fnp-4692	103	27	.	.	PUNCT
fnp-4692	104	1	it	it	PRON
fnp-4692	104	2	remains	remain	VERB
fnp-4692	104	3	to	to	PART
fnp-4692	104	4	be	be	AUX
fnp-4692	104	5	determined	determine	VERB
fnp-4692	104	6	how	how	SCONJ
fnp-4692	104	7	this	this	DET
fnp-4692	104	8	important	important	ADJ
fnp-4692	104	9	data	datum	NOUN
fnp-4692	104	10	can	can	AUX
fnp-4692	104	11	be	be	AUX
fnp-4692	104	12	transferred	transfer	VERB
fnp-4692	104	13	into	into	ADP
fnp-4692	104	14	the	the	DET
fnp-4692	104	15	daily	daily	ADJ
fnp-4692	104	16	diagnostic	diagnostic	ADJ
fnp-4692	104	17	routine	routine	NOUN
fnp-4692	104	18	for	for	ADP
fnp-4692	104	19	a	a	DET
fnp-4692	104	20	fast	fast	ADJ
fnp-4692	104	21	and	and	CCONJ
fnp-4692	104	22	precise	precise	ADJ
fnp-4692	104	23	differentiation	differentiation	NOUN
fnp-4692	104	24	between	between	ADP
fnp-4692	104	25	a	a	DET
fnp-4692	104	26	primary	primary	ADJ
fnp-4692	104	27	cns	cns	NOUN
fnp-4692	104	28	-	-	PUNCT
fnp-4692	104	29	dlbcl	dlbcl	NOUN
fnp-4692	104	30	,	,	PUNCT
fnp-4692	104	31	a	a	DET
fnp-4692	104	32	secondary	secondary	ADJ
fnp-4692	104	33	dlbcl	dlbcl	NOUN
fnp-4692	104	34	of	of	ADP
fnp-4692	104	35	the	the	DET
fnp-4692	104	36	cns	cns	NOUN
fnp-4692	104	37	,	,	PUNCT
fnp-4692	104	38	or	or	CCONJ
fnp-4692	104	39	primary	primary	ADJ
fnp-4692	104	40	non	non	ADJ
fnp-4692	104	41	-	-	ADJ
fnp-4692	104	42	cns	cns	ADJ
fnp-4692	104	43	dlbcl	dlbcl	NOUN
fnp-4692	104	44	.	.	PUNCT
fnp-4692	105	1	this	this	PRON
fnp-4692	105	2	would	would	AUX
fnp-4692	105	3	be	be	AUX
fnp-4692	105	4	all	all	DET
fnp-4692	105	5	the	the	DET
fnp-4692	105	6	more	more	ADV
fnp-4692	105	7	important	important	ADJ
fnp-4692	105	8	as	as	ADP
fnp-4692	105	9	depending	depend	VERB
fnp-4692	105	10	on	on	ADP
fnp-4692	105	11	the	the	DET
fnp-4692	105	12	method	method	NOUN
fnp-4692	105	13	–	–	PUNCT
fnp-4692	105	14	if	if	SCONJ
fnp-4692	105	15	immunohistochemical	immunohistochemical	ADJ
fnp-4692	105	16	phenotyping	phenotyping	NOUN
fnp-4692	105	17	or	or	CCONJ
fnp-4692	105	18	gene	gene	NOUN
fnp-4692	105	19	expressing	express	VERB
fnp-4692	105	20	profiling	profiling	NOUN
fnp-4692	105	21	is	be	AUX
fnp-4692	105	22	applied	apply	VERB
fnp-4692	105	23	–	–	PUNCT
fnp-4692	105	24	cns	cns	NOUN
fnp-4692	105	25	-	-	PUNCT
fnp-4692	105	26	dlbcl	dlbcl	NOUN
fnp-4692	105	27	may	may	AUX
fnp-4692	105	28	either	either	CCONJ
fnp-4692	105	29	be	be	AUX
fnp-4692	105	30	classified	classify	VERB
fnp-4692	105	31	as	as	ADP
fnp-4692	105	32	of	of	ADP
fnp-4692	105	33	non	non	ADJ
fnp-4692	105	34	-	-	ADJ
fnp-4692	105	35	germinal	germinal	ADJ
fnp-4692	105	36	center	center	NOUN
fnp-4692	105	37	b	b	X
fnp-4692	105	38	-	-	PUNCT
fnp-4692	105	39	cell	cell	NOUN
fnp-4692	105	40	like	like	ADP
fnp-4692	105	41	(	(	PUNCT
fnp-4692	105	42	non	non	ADJ
fnp-4692	105	43	-	-	ADJ
fnp-4692	105	44	gcb	gcb	ADJ
fnp-4692	105	45	)	)	PUNCT
fnp-4692	105	46	or	or	CCONJ
fnp-4692	105	47	late	late	ADJ
fnp-4692	105	48	germinal	germinal	ADJ
fnp-4692	105	49	-	-	PUNCT
fnp-4692	105	50	center	center	NOUN
fnp-4692	105	51	exit	exit	NOUN
fnp-4692	105	52	b	b	NOUN
fnp-4692	105	53	-	-	PUNCT
fnp-4692	105	54	cell	cell	NOUN
fnp-4692	105	55	origin	origin	NOUN
fnp-4692	105	56	.	.	PUNCT
fnp-4692	106	1	table	table	NOUN
fnp-4692	106	2	2	2	NUM
fnp-4692	106	3	:	:	PUNCT
fnp-4692	106	4	molecular	molecular	ADJ
fnp-4692	106	5	differences	difference	NOUN
fnp-4692	106	6	between	between	ADP
fnp-4692	106	7	cns	cns	PROPN
fnp-4692	106	8	diffuse	diffuse	PROPN
fnp-4692	106	9	large	large	ADJ
fnp-4692	106	10	b	b	NOUN
fnp-4692	106	11	-	-	PUNCT
fnp-4692	106	12	cell	cell	NOUN
fnp-4692	106	13	lymphoma	lymphoma	NOUN
fnp-4692	106	14	(	(	PUNCT
fnp-4692	106	15	dlbcl	dlbcl	NOUN
fnp-4692	106	16	)	)	PUNCT
fnp-4692	106	17	and	and	CCONJ
fnp-4692	106	18	its	its	PRON
fnp-4692	106	19	non	non	ADJ
fnp-4692	106	20	-	-	ADJ
fnp-4692	106	21	cns	cns	ADJ
fnp-4692	106	22	counterpart	counterpart	NOUN
fnp-4692	106	23	.	.	PUNCT
fnp-4692	107	1	molecular	molecular	ADJ
fnp-4692	107	2	feature	feature	NOUN
fnp-4692	107	3	non	non	ADJ
fnp-4692	107	4	-	-	ADJ
fnp-4692	107	5	cns	cns	ADJ
fnp-4692	107	6	dlbcl	dlbcl	NOUN
fnp-4692	107	7	primary	primary	ADJ
fnp-4692	107	8	cns	cns	NOUN
fnp-4692	107	9	dlbcl	dlbcl	NOUN
fnp-4692	107	10	myd88	myd88	PROPN
fnp-4692	107	11	(	(	PUNCT
fnp-4692	107	12	l265p	l265p	PROPN
fnp-4692	107	13	)	)	PUNCT
fnp-4692	107	14	mutation	mutation	NOUN
fnp-4692	107	15	rare	rare	ADJ
fnp-4692	107	16	frequent	frequent	ADJ
fnp-4692	107	17	cd79b	cd79b	NOUN
fnp-4692	107	18	mutation	mutation	NOUN
fnp-4692	107	19	rare	rare	ADJ
fnp-4692	107	20	frequent	frequent	ADJ
fnp-4692	107	21	biallelic	biallelic	ADJ
fnp-4692	107	22	loss	loss	NOUN
fnp-4692	107	23	of	of	ADP
fnp-4692	107	24	cdkn2a	cdkn2a	ADJ
fnp-4692	107	25	rare	rare	ADJ
fnp-4692	107	26	frequent	frequent	ADJ
fnp-4692	107	27	number	number	NOUN
fnp-4692	107	28	of	of	ADP
fnp-4692	107	29	single	single	ADJ
fnp-4692	107	30	nucleotide	nucleotide	ADJ
fnp-4692	107	31	variants	variant	NOUN
fnp-4692	107	32	(	(	PUNCT
fnp-4692	107	33	snv	snv	PROPN
fnp-4692	107	34	)	)	PUNCT
fnp-4692	107	35	lower	low	ADJ
fnp-4692	107	36	higher	high	ADJ
fnp-4692	107	37	number	number	NOUN
fnp-4692	107	38	of	of	ADP
fnp-4692	107	39	insertions	insertion	NOUN
fnp-4692	107	40	or	or	CCONJ
fnp-4692	107	41	deletions	deletion	NOUN
fnp-4692	107	42	(	(	PUNCT
fnp-4692	107	43	indel	indel	NOUN
fnp-4692	107	44	)	)	PUNCT
fnp-4692	107	45	lower	low	ADJ
fnp-4692	107	46	higher	high	ADJ
fnp-4692	107	47	expression	expression	NOUN
fnp-4692	107	48	of	of	ADP
fnp-4692	107	49	ig	ig	PROPN
fnp-4692	107	50	constant	constant	ADJ
fnp-4692	107	51	genes	gene	NOUN
fnp-4692	107	52	higher	higher	ADV
fnp-4692	107	53	lower	low	ADJ
fnp-4692	107	54	expression	expression	NOUN
fnp-4692	107	55	of	of	ADP
fnp-4692	107	56	ighm	ighm	PROPN
fnp-4692	107	57	lower	low	ADJ
fnp-4692	107	58	higher	high	ADJ
fnp-4692	107	59	tert	tert	NOUN
fnp-4692	107	60	expression	expression	NOUN
fnp-4692	107	61	lower	lower	ADV
fnp-4692	107	62	higher	high	ADJ
fnp-4692	107	63	6	6	NUM
fnp-4692	107	64	.	.	PUNCT
fnp-4692	108	1	proteomic	proteomic	ADJ
fnp-4692	108	2	landscape	landscape	NOUN
fnp-4692	108	3	of	of	ADP
fnp-4692	108	4	primary	primary	ADJ
fnp-4692	108	5	and	and	CCONJ
fnp-4692	108	6	recurrent	recurrent	ADJ
fnp-4692	108	7	glioblastoma	glioblastoma	NOUN
fnp-4692	108	8	[	[	X
fnp-4692	108	9	8	8	NUM
fnp-4692	108	10	]	]	PUNCT
fnp-4692	108	11	while	while	SCONJ
fnp-4692	108	12	many	many	ADJ
fnp-4692	108	13	current	current	ADJ
fnp-4692	108	14	brain	brain	NOUN
fnp-4692	108	15	tumor	tumor	NOUN
fnp-4692	108	16	studies	study	NOUN
fnp-4692	108	17	analyze	analyze	VERB
fnp-4692	108	18	molecular	molecular	ADJ
fnp-4692	108	19	changes	change	NOUN
fnp-4692	108	20	at	at	ADP
fnp-4692	108	21	genomic	genomic	ADJ
fnp-4692	108	22	,	,	PUNCT
fnp-4692	108	23	epigenomic	epigenomic	ADJ
fnp-4692	108	24	or	or	CCONJ
fnp-4692	108	25	transcriptomic	transcriptomic	ADJ
fnp-4692	108	26	levels	level	NOUN
fnp-4692	108	27	,	,	PUNCT
fnp-4692	108	28	large	large	ADJ
fnp-4692	108	29	-	-	PUNCT
fnp-4692	108	30	scale	scale	NOUN
fnp-4692	108	31	proteomic	proteomic	NOUN
fnp-4692	108	32	approaches	approach	NOUN
fnp-4692	108	33	are	be	AUX
fnp-4692	108	34	largely	largely	ADV
fnp-4692	108	35	underrepresented	underrepresented	ADJ
fnp-4692	108	36	.	.	PUNCT
fnp-4692	109	1	as	as	SCONJ
fnp-4692	109	2	malignant	malignant	ADJ
fnp-4692	109	3	primary	primary	ADJ
fnp-4692	109	4	and	and	CCONJ
fnp-4692	109	5	secondary	secondary	ADJ
fnp-4692	109	6	brain	brain	NOUN
fnp-4692	109	7	tumors	tumor	NOUN
fnp-4692	109	8	display	display	VERB
fnp-4692	109	9	a	a	DET
fnp-4692	109	10	detrimental	detrimental	ADJ
fnp-4692	109	11	prognosis	prognosis	NOUN
fnp-4692	109	12	despite	despite	SCONJ
fnp-4692	109	13	maximum	maximum	ADJ
fnp-4692	109	14	treatment	treatment	NOUN
fnp-4692	109	15	,	,	PUNCT
fnp-4692	109	16	detection	detection	NOUN
fnp-4692	109	17	of	of	ADP
fnp-4692	109	18	potential	potential	ADJ
fnp-4692	109	19	treatment	treatment	NOUN
fnp-4692	109	20	targets	target	NOUN
fnp-4692	109	21	at	at	ADP
fnp-4692	109	22	protein	protein	NOUN
fnp-4692	109	23	level	level	NOUN
fnp-4692	109	24	is	be	AUX
fnp-4692	109	25	key	key	ADJ
fnp-4692	109	26	for	for	ADP
fnp-4692	109	27	innovative	innovative	ADJ
fnp-4692	109	28	future	future	ADJ
fnp-4692	109	29	treatment	treatment	NOUN
fnp-4692	109	30	approaches	approach	NOUN
fnp-4692	109	31	.	.	PUNCT
fnp-4692	110	1	this	this	PRON
fnp-4692	110	2	is	be	AUX
fnp-4692	110	3	especially	especially	ADV
fnp-4692	110	4	important	important	ADJ
fnp-4692	110	5	for	for	ADP
fnp-4692	110	6	clinical	clinical	ADJ
fnp-4692	110	7	situations	situation	NOUN
fnp-4692	110	8	in	in	ADP
fnp-4692	110	9	which	which	PRON
fnp-4692	110	10	patients	patient	NOUN
fnp-4692	110	11	suffer	suffer	VERB
fnp-4692	110	12	from	from	ADP
fnp-4692	110	13	recurrent	recurrent	ADJ
fnp-4692	110	14	tumors	tumor	NOUN
fnp-4692	110	15	with	with	ADP
fnp-4692	110	16	potentially	potentially	ADV
fnp-4692	110	17	new	new	ADJ
fnp-4692	110	18	tumor	tumor	NOUN
fnp-4692	110	19	-	-	PUNCT
fnp-4692	110	20	related	relate	VERB
fnp-4692	110	21	pathways	pathway	NOUN
fnp-4692	110	22	that	that	PRON
fnp-4692	110	23	might	might	AUX
fnp-4692	110	24	be	be	AUX
fnp-4692	110	25	newly	newly	ADV
fnp-4692	110	26	activated	activate	VERB
fnp-4692	110	27	in	in	ADP
fnp-4692	110	28	the	the	DET
fnp-4692	110	29	context	context	NOUN
fnp-4692	110	30	of	of	ADP
fnp-4692	110	31	treatment	treatment	NOUN
fnp-4692	110	32	resistance	resistance	NOUN
fnp-4692	110	33	.	.	PUNCT
fnp-4692	111	1	buehler	buehler	PROPN
fnp-4692	111	2	et	et	PROPN
fnp-4692	111	3	al	al	PROPN
fnp-4692	111	4	.	.	PROPN
fnp-4692	111	5	address	address	NOUN
fnp-4692	111	6	this	this	DET
fnp-4692	111	7	topic	topic	NOUN
fnp-4692	111	8	by	by	ADP
fnp-4692	111	9	performing	perform	VERB
fnp-4692	111	10	proteomic	proteomic	ADJ
fnp-4692	111	11	profiling	profiling	NOUN
fnp-4692	111	12	of	of	ADP
fnp-4692	111	13	primary	primary	ADJ
fnp-4692	111	14	and	and	CCONJ
fnp-4692	111	15	recurrent	recurrent	ADJ
fnp-4692	111	16	glioblastomas	glioblastoma	NOUN
fnp-4692	111	17	deriving	derive	VERB
fnp-4692	111	18	from	from	ADP
fnp-4692	111	19	42	42	NUM
fnp-4692	111	20	patients	patient	NOUN
fnp-4692	111	21	of	of	ADP
fnp-4692	111	22	two	two	NUM
fnp-4692	111	23	different	different	ADJ
fnp-4692	111	24	clinical	clinical	ADJ
fnp-4692	111	25	cohorts	cohort	NOUN
fnp-4692	111	26	[	[	X
fnp-4692	111	27	8	8	NUM
fnp-4692	111	28	]	]	PUNCT
fnp-4692	111	29	.	.	PUNCT
fnp-4692	112	1	of	of	ADP
fnp-4692	112	2	note	note	NOUN
fnp-4692	112	3	,	,	PUNCT
fnp-4692	112	4	the	the	DET
fnp-4692	112	5	applied	apply	VERB
fnp-4692	112	6	proteomic	proteomic	ADJ
fnp-4692	112	7	analysis	analysis	NOUN
fnp-4692	112	8	is	be	AUX
fnp-4692	112	9	equally	equally	ADV
fnp-4692	112	10	suitable	suitable	ADJ
fnp-4692	112	11	for	for	ADP
fnp-4692	112	12	frozen	frozen	ADJ
fnp-4692	112	13	and	and	CCONJ
fnp-4692	112	14	formalin	formalin	NOUN
fnp-4692	112	15	-	-	PUNCT
fnp-4692	112	16	fixed	fix	VERB
fnp-4692	112	17	,	,	PUNCT
fnp-4692	112	18	paraffin	paraffin	NOUN
fnp-4692	112	19	-	-	PUNCT
fnp-4692	112	20	embedded	embed	VERB
fnp-4692	112	21	(	(	PUNCT
fnp-4692	112	22	ffpe	ffpe	NOUN
fnp-4692	112	23	)	)	PUNCT
fnp-4692	112	24	tissues	tissue	NOUN
fnp-4692	112	25	,	,	PUNCT
fnp-4692	112	26	the	the	DET
fnp-4692	112	27	latter	latter	ADJ
fnp-4692	112	28	facilitating	facilitate	VERB
fnp-4692	112	29	its	its	PRON
fnp-4692	112	30	applicability	applicability	NOUN
fnp-4692	112	31	in	in	ADP
fnp-4692	112	32	diagnostic	diagnostic	ADJ
fnp-4692	112	33	pathology	pathology	NOUN
fnp-4692	112	34	[	[	X
fnp-4692	112	35	22	22	NUM
fnp-4692	112	36	]	]	PUNCT
fnp-4692	112	37	.	.	PUNCT
fnp-4692	113	1	in	in	ADP
fnp-4692	113	2	general	general	ADJ
fnp-4692	113	3	,	,	PUNCT
fnp-4692	113	4	the	the	DET
fnp-4692	113	5	proteomes	proteome	NOUN
fnp-4692	113	6	of	of	ADP
fnp-4692	113	7	the	the	DET
fnp-4692	113	8	initial	initial	ADJ
fnp-4692	113	9	glioblastomas	glioblastoma	NOUN
fnp-4692	113	10	as	as	ADP
fnp-4692	113	11	compared	compare	VERB
fnp-4692	113	12	to	to	ADP
fnp-4692	113	13	their	their	PRON
fnp-4692	113	14	recurrent	recurrent	ADJ
fnp-4692	113	15	counterparts	counterpart	NOUN
fnp-4692	113	16	were	be	AUX
fnp-4692	113	17	highly	highly	ADV
fnp-4692	113	18	similar	similar	ADJ
fnp-4692	113	19	,	,	PUNCT
fnp-4692	113	20	however	however	ADV
fnp-4692	113	21	,	,	PUNCT
fnp-4692	113	22	several	several	ADJ
fnp-4692	113	23	proteins	protein	NOUN
fnp-4692	113	24	were	be	AUX
fnp-4692	113	25	significantly	significantly	ADV
fnp-4692	113	26	enriched	enrich	VERB
fnp-4692	113	27	in	in	ADP
fnp-4692	113	28	recurrences	recurrence	NOUN
fnp-4692	113	29	,	,	PUNCT
fnp-4692	113	30	including	include	VERB
fnp-4692	113	31	,	,	PUNCT
fnp-4692	113	32	among	among	ADP
fnp-4692	113	33	others	other	NOUN
fnp-4692	113	34	,	,	PUNCT
fnp-4692	113	35	brain	brain	NOUN
fnp-4692	113	36	enriched	enrich	VERB
fnp-4692	113	37	myelin	myelin	NOUN
fnp-4692	113	38	associated	associate	VERB
fnp-4692	113	39	protein	protein	NOUN
fnp-4692	113	40	1	1	NUM
fnp-4692	113	41	(	(	PUNCT
fnp-4692	113	42	bcas1	bcas1	NOUN
fnp-4692	113	43	)	)	PUNCT
fnp-4692	113	44	,	,	PUNCT
fnp-4692	113	45	inverted	invert	VERB
fnp-4692	113	46	formin	formin	NOUN
fnp-4692	113	47	2	2	NUM
fnp-4692	113	48	(	(	PUNCT
fnp-4692	113	49	inf2	inf2	PROPN
fnp-4692	113	50	)	)	PUNCT
fnp-4692	113	51	,	,	PUNCT
fnp-4692	113	52	calcium	calcium	NOUN
fnp-4692	113	53	-	-	PUNCT
fnp-4692	113	54	calmodulin	calmodulin	NOUN
fnp-4692	113	55	-	-	PUNCT
fnp-4692	113	56	dependent	dependent	ADJ
fnp-4692	113	57	protein	protein	NOUN
fnp-4692	113	58	kinase	kinase	NOUN
fnp-4692	113	59	2	2	NUM
fnp-4692	113	60	(	(	PUNCT
fnp-4692	113	61	camk2	camk2	PROPN
fnp-4692	113	62	)	)	PUNCT
fnp-4692	113	63	,	,	PUNCT
fnp-4692	113	64	phosphoribosyl	phosphoribosyl	ADJ
fnp-4692	113	65	pyrophosphate	pyrophosphate	NOUN
fnp-4692	113	66	synthetase	synthetase	NOUN
fnp-4692	113	67	2	2	NUM
fnp-4692	113	68	(	(	PUNCT
fnp-4692	113	69	prps2	prps2	X
fnp-4692	113	70	)	)	PUNCT
fnp-4692	113	71	and	and	CCONJ
fnp-4692	113	72	f	f	X
fnp-4692	113	73	-	-	PUNCT
fnp-4692	113	74	box	box	NOUN
fnp-4692	113	75	only	only	ADV
fnp-4692	113	76	protein	protein	NOUN
fnp-4692	113	77	2	2	NUM
fnp-4692	113	78	(	(	PUNCT
fnp-4692	113	79	fbxo2	fbxo2	NOUN
fnp-4692	113	80	)	)	PUNCT
fnp-4692	113	81	.	.	PUNCT
fnp-4692	114	1	these	these	DET
fnp-4692	114	2	results	result	NOUN
fnp-4692	114	3	show	show	VERB
fnp-4692	114	4	that	that	SCONJ
fnp-4692	114	5	the	the	DET
fnp-4692	114	6	method	method	NOUN
fnp-4692	114	7	is	be	AUX
fnp-4692	114	8	able	able	ADJ
fnp-4692	114	9	to	to	PART
fnp-4692	114	10	detect	detect	VERB
fnp-4692	114	11	tumor	tumor	NOUN
fnp-4692	114	12	progression	progression	NOUN
fnp-4692	114	13	-	-	PUNCT
fnp-4692	114	14	associated	associate	VERB
fnp-4692	114	15	changes	change	NOUN
fnp-4692	114	16	in	in	ADP
fnp-4692	114	17	ffpe	ffpe	ADJ
fnp-4692	114	18	tissue	tissue	NOUN
fnp-4692	114	19	.	.	PUNCT
fnp-4692	115	1	the	the	DET
fnp-4692	115	2	authors	author	NOUN
fnp-4692	115	3	proceeded	proceed	VERB
fnp-4692	115	4	in	in	ADP
fnp-4692	115	5	validating	validate	VERB
fnp-4692	115	6	an	an	DET
fnp-4692	115	7	overexpression	overexpression	NOUN
fnp-4692	115	8	for	for	ADP
fnp-4692	115	9	bcas2	bcas2	PROPN
fnp-4692	115	10	,	,	PUNCT
fnp-4692	115	11	inf2	inf2	ADJ
fnp-4692	115	12	and	and	CCONJ
fnp-4692	115	13	fbxo2	fbxo2	NOUN
fnp-4692	115	14	in	in	ADP
fnp-4692	115	15	recurrent	recurrent	ADJ
fnp-4692	115	16	glioblastoma	glioblastoma	NOUN
fnp-4692	115	17	by	by	ADP
fnp-4692	115	18	means	mean	NOUN
fnp-4692	115	19	of	of	ADP
fnp-4692	115	20	immunohistochemistry	immunohistochemistry	NOUN
fnp-4692	115	21	and	and	CCONJ
fnp-4692	115	22	rna	rna	NOUN
fnp-4692	115	23	sequencing	sequencing	NOUN
fnp-4692	115	24	.	.	PUNCT
fnp-4692	116	1	regarding	regard	VERB
fnp-4692	116	2	the	the	DET
fnp-4692	116	3	clinical	clinical	ADJ
fnp-4692	116	4	impact	impact	NOUN
fnp-4692	116	5	of	of	ADP
fnp-4692	116	6	those	those	DET
fnp-4692	116	7	findings	finding	NOUN
fnp-4692	116	8	,	,	PUNCT
fnp-4692	116	9	significantly	significantly	ADV
fnp-4692	116	10	lower	low	ADJ
fnp-4692	116	11	expression	expression	NOUN
fnp-4692	116	12	levels	level	NOUN
fnp-4692	116	13	for	for	ADP
fnp-4692	116	14	inf2	inf2	PROPN
fnp-4692	116	15	and	and	CCONJ
fnp-4692	116	16	fbxo2	fbxo2	NOUN
fnp-4692	116	17	were	be	AUX
fnp-4692	116	18	found	find	VERB
fnp-4692	116	19	in	in	ADP
fnp-4692	116	20	glioblastoma	glioblastoma	NOUN
fnp-4692	116	21	patients	patient	NOUN
fnp-4692	116	22	with	with	ADP
fnp-4692	116	23	longer	long	ADJ
fnp-4692	116	24	survival	survival	NOUN
fnp-4692	116	25	rates	rate	NOUN
fnp-4692	116	26	,	,	PUNCT
fnp-4692	116	27	therefore	therefore	ADV
fnp-4692	116	28	indicating	indicate	VERB
fnp-4692	116	29	that	that	SCONJ
fnp-4692	116	30	both	both	DET
fnp-4692	116	31	factors	factor	NOUN
fnp-4692	116	32	might	might	AUX
fnp-4692	116	33	be	be	AUX
fnp-4692	116	34	implicated	implicate	VERB
fnp-4692	116	35	in	in	ADP
fnp-4692	116	36	tumor	tumor	NOUN
fnp-4692	116	37	progression	progression	NOUN
fnp-4692	116	38	or	or	CCONJ
fnp-4692	116	39	treatment	treatment	NOUN
fnp-4692	116	40	-	-	PUNCT
fnp-4692	116	41	resistance	resistance	NOUN
fnp-4692	116	42	mechanisms	mechanism	NOUN
fnp-4692	116	43	.	.	PUNCT
fnp-4692	117	1	using	use	VERB
fnp-4692	117	2	a	a	DET
fnp-4692	117	3	murine	murine	ADJ
fnp-4692	117	4	approach	approach	NOUN
fnp-4692	117	5	,	,	PUNCT
fnp-4692	117	6	the	the	DET
fnp-4692	117	7	authors	author	NOUN
fnp-4692	117	8	could	could	AUX
fnp-4692	117	9	validate	validate	VERB
fnp-4692	117	10	the	the	DET
fnp-4692	117	11	survival	survival	NOUN
fnp-4692	117	12	benefit	benefit	NOUN
fnp-4692	117	13	in	in	ADP
fnp-4692	117	14	fbxo2	fbxo2	ADJ
fnp-4692	117	15	knockout	knockout	NOUN
fnp-4692	117	16	conditions	condition	NOUN
fnp-4692	117	17	,	,	PUNCT
fnp-4692	117	18	as	as	ADV
fnp-4692	117	19	well	well	ADV
fnp-4692	117	20	as	as	ADP
fnp-4692	117	21	showing	show	VERB
fnp-4692	117	22	a	a	DET
fnp-4692	117	23	reduced	reduce	VERB
fnp-4692	117	24	tumor	tumor	NOUN
fnp-4692	117	25	cell	cell	NOUN
fnp-4692	117	26	growth	growth	NOUN
fnp-4692	117	27	and	and	CCONJ
fnp-4692	117	28	invasive	invasive	ADJ
fnp-4692	117	29	behavior	behavior	NOUN
fnp-4692	117	30	in	in	ADP
fnp-4692	117	31	organotypic	organotypic	ADJ
fnp-4692	117	32	brain	brain	NOUN
fnp-4692	117	33	tumor	tumor	NOUN
fnp-4692	117	34	slice	slice	NOUN
fnp-4692	117	35	cultures	culture	NOUN
fnp-4692	117	36	.	.	PUNCT
fnp-4692	118	1	while	while	SCONJ
fnp-4692	118	2	the	the	DET
fnp-4692	118	3	authors	author	NOUN
fnp-4692	118	4	focus	focus	VERB
fnp-4692	118	5	more	more	ADV
fnp-4692	118	6	on	on	ADP
fnp-4692	118	7	addressing	address	VERB
fnp-4692	118	8	the	the	DET
fnp-4692	118	9	role	role	NOUN
fnp-4692	118	10	of	of	ADP
fnp-4692	118	11	fbxo2	fbxo2	ADJ
fnp-4692	118	12	activation	activation	NOUN
fnp-4692	118	13	as	as	ADP
fnp-4692	118	14	a	a	DET
fnp-4692	118	15	driver	driver	NOUN
fnp-4692	118	16	for	for	ADP
fnp-4692	118	17	glioblastoma	glioblastoma	NOUN
fnp-4692	118	18	progression	progression	NOUN
fnp-4692	118	19	and	and	CCONJ
fnp-4692	118	20	recurrence	recurrence	NOUN
fnp-4692	118	21	at	at	ADP
fnp-4692	118	22	the	the	DET
fnp-4692	118	23	end	end	NOUN
fnp-4692	118	24	of	of	ADP
fnp-4692	118	25	their	their	PRON
fnp-4692	118	26	paper	paper	NOUN
fnp-4692	118	27	,	,	PUNCT
fnp-4692	118	28	i	i	PRON
fnp-4692	118	29	would	would	AUX
fnp-4692	118	30	rather	rather	ADV
fnp-4692	118	31	stress	stress	VERB
fnp-4692	118	32	the	the	DET
fnp-4692	118	33	potential	potential	NOUN
fnp-4692	118	34	of	of	ADP
fnp-4692	118	35	the	the	DET
fnp-4692	118	36	method	method	NOUN
fnp-4692	118	37	for	for	ADP
fnp-4692	118	38	personalized	personalized	ADJ
fnp-4692	118	39	medicine	medicine	NOUN
fnp-4692	118	40	approaches	approach	NOUN
fnp-4692	118	41	in	in	ADP
fnp-4692	118	42	the	the	DET
fnp-4692	118	43	future	future	NOUN
fnp-4692	118	44	.	.	PUNCT
fnp-4692	119	1	taking	take	VERB
fnp-4692	119	2	into	into	ADP
fnp-4692	119	3	account	account	NOUN
fnp-4692	119	4	a	a	X
fnp-4692	119	5	)	)	PUNCT
fnp-4692	119	6	the	the	DET
fnp-4692	119	7	horrible	horrible	ADJ
fnp-4692	119	8	clinical	clinical	ADJ
fnp-4692	119	9	prognosis	prognosis	NOUN
fnp-4692	119	10	of	of	ADP
fnp-4692	119	11	glioblastoma	glioblastoma	NOUN
fnp-4692	119	12	patients	patient	NOUN
fnp-4692	119	13	,	,	PUNCT
fnp-4692	119	14	b	b	X
fnp-4692	119	15	)	)	PUNCT
fnp-4692	119	16	the	the	DET
fnp-4692	119	17	poor	poor	ADJ
fnp-4692	119	18	treatment	treatment	NOUN
fnp-4692	119	19	options	option	NOUN
fnp-4692	119	20	at	at	ADP
fnp-4692	119	21	the	the	DET
fnp-4692	119	22	time	time	NOUN
fnp-4692	119	23	of	of	ADP
fnp-4692	119	24	glioblastoma	glioblastoma	NOUN
fnp-4692	119	25	recurrence	recurrence	NOUN
fnp-4692	119	26	and	and	CCONJ
fnp-4692	119	27	c	c	NOUN
fnp-4692	119	28	)	)	PUNCT
fnp-4692	119	29	that	that	PRON
fnp-4692	119	30	data	datum	NOUN
fnp-4692	119	31	derived	derive	VERB
fnp-4692	119	32	from	from	ADP
fnp-4692	119	33	large	large	ADJ
fnp-4692	119	34	-	-	PUNCT
fnp-4692	119	35	scale	scale	NOUN
fnp-4692	119	36	dna	dna	NOUN
fnp-4692	119	37	or	or	CCONJ
fnp-4692	119	38	rna	rna	NOUN
fnp-4692	119	39	analyses	analysis	NOUN
fnp-4692	119	40	do	do	AUX
fnp-4692	119	41	not	not	PART
fnp-4692	119	42	unequivocally	unequivocally	ADV
fnp-4692	119	43	predict	predict	VERB
fnp-4692	119	44	the	the	DET
fnp-4692	119	45	functional	functional	ADJ
fnp-4692	119	46	proteomic	proteomic	ADJ
fnp-4692	119	47	landscape	landscape	NOUN
fnp-4692	119	48	,	,	PUNCT
fnp-4692	119	49	deciphering	decipher	VERB
fnp-4692	119	50	active	active	ADJ
fnp-4692	119	51	tumor	tumor	NOUN
fnp-4692	119	52	-	-	PUNCT
fnp-4692	119	53	related	relate	VERB
fnp-4692	119	54	pathways	pathway	NOUN
fnp-4692	119	55	by	by	ADP
fnp-4692	119	56	proteomic	proteomic	ADJ
fnp-4692	119	57	approaches	approach	NOUN
fnp-4692	119	58	in	in	ADP
fnp-4692	119	59	a	a	DET
fnp-4692	119	60	close	close	NOUN
fnp-4692	119	61	to	to	PART
fnp-4692	119	62	routine	routine	ADJ
fnp-4692	119	63	pathological	pathological	ADJ
fnp-4692	119	64	setting	setting	NOUN
fnp-4692	119	65	could	could	AUX
fnp-4692	119	66	be	be	AUX
fnp-4692	119	67	a	a	DET
fnp-4692	119	68	great	great	ADJ
fnp-4692	119	69	asset	asset	NOUN
fnp-4692	119	70	especially	especially	ADV
fnp-4692	119	71	for	for	ADP
fnp-4692	119	72	recurrent	recurrent	ADJ
fnp-4692	119	73	tumors	tumor	NOUN
fnp-4692	119	74	as	as	SCONJ
fnp-4692	119	75	compared	compare	VERB
fnp-4692	119	76	to	to	ADP
fnp-4692	119	77	their	their	PRON
fnp-4692	119	78	primary	primary	ADJ
fnp-4692	119	79	counterparts	counterpart	NOUN
fnp-4692	119	80	.	.	PUNCT
fnp-4692	120	1	it	it	PRON
fnp-4692	120	2	would	would	AUX
fnp-4692	120	3	be	be	AUX
fnp-4692	120	4	of	of	ADP
fnp-4692	120	5	interest	interest	NOUN
fnp-4692	120	6	to	to	PART
fnp-4692	120	7	run	run	VERB
fnp-4692	120	8	proteomic	proteomic	ADJ
fnp-4692	120	9	analyses	analysis	NOUN
fnp-4692	120	10	much	much	ADV
fnp-4692	120	11	more	more	ADV
fnp-4692	120	12	frequently	frequently	ADV
fnp-4692	120	13	in	in	ADP
fnp-4692	120	14	parallel	parallel	NOUN
fnp-4692	120	15	to	to	ADP
fnp-4692	120	16	large	large	ADJ
fnp-4692	120	17	-	-	PUNCT
fnp-4692	120	18	scale	scale	NOUN
fnp-4692	120	19	genetic	genetic	ADJ
fnp-4692	120	20	screenings	screening	NOUN
fnp-4692	120	21	,	,	PUNCT
fnp-4692	120	22	which	which	PRON
fnp-4692	120	23	could	could	AUX
fnp-4692	120	24	help	help	VERB
fnp-4692	120	25	to	to	PART
fnp-4692	120	26	support	support	VERB
fnp-4692	120	27	decision	decision	NOUN
fnp-4692	120	28	making	making	NOUN
fnp-4692	120	29	in	in	ADP
fnp-4692	120	30	molecular	molecular	ADJ
fnp-4692	120	31	tumor	tumor	NOUN
fnp-4692	120	32	boards	board	NOUN
fnp-4692	120	33	.	.	PUNCT
fnp-4692	121	1	7	7	X
fnp-4692	121	2	.	.	X
fnp-4692	121	3	methylome	methylome	ADV
fnp-4692	121	4	-	-	PUNCT
fnp-4692	121	5	based	base	VERB
fnp-4692	121	6	brain	brain	NOUN
fnp-4692	121	7	tumor	tumor	NOUN
fnp-4692	121	8	diagnostics	diagnostic	NOUN
fnp-4692	121	9	in	in	ADP
fnp-4692	121	10	csf	csf	ADJ
fnp-4692	121	11	liquid	liquid	ADJ
fnp-4692	121	12	biopsies	biopsy	NOUN
fnp-4692	121	13	[	[	X
fnp-4692	121	14	9	9	NUM
fnp-4692	121	15	]	]	PUNCT
fnp-4692	121	16	since	since	SCONJ
fnp-4692	121	17	neurosurgical	neurosurgical	ADJ
fnp-4692	121	18	interventions	intervention	NOUN
fnp-4692	121	19	are	be	AUX
fnp-4692	121	20	among	among	ADP
fnp-4692	121	21	the	the	DET
fnp-4692	121	22	most	most	ADV
fnp-4692	121	23	invasive	invasive	ADJ
fnp-4692	121	24	medical	medical	ADJ
fnp-4692	121	25	procedures	procedure	NOUN
fnp-4692	121	26	,	,	PUNCT
fnp-4692	121	27	the	the	DET
fnp-4692	121	28	threshold	threshold	NOUN
fnp-4692	121	29	to	to	PART
fnp-4692	121	30	perform	perform	VERB
fnp-4692	121	31	a	a	DET
fnp-4692	121	32	brain	brain	NOUN
fnp-4692	121	33	biopsy	biopsy	NOUN
fnp-4692	121	34	is	be	AUX
fnp-4692	121	35	high	high	ADJ
fnp-4692	121	36	.	.	PUNCT
fnp-4692	122	1	avoiding	avoid	VERB
fnp-4692	122	2	biopsies	biopsy	NOUN
fnp-4692	122	3	for	for	ADP
fnp-4692	122	4	brain	brain	NOUN
fnp-4692	122	5	tumor	tumor	NOUN
fnp-4692	122	6	types	type	NOUN
fnp-4692	122	7	in	in	ADP
fnp-4692	122	8	which	which	PRON
fnp-4692	122	9	no	no	DET
fnp-4692	122	10	subsequent	subsequent	ADJ
fnp-4692	122	11	resection	resection	NOUN
fnp-4692	122	12	would	would	AUX
fnp-4692	122	13	be	be	AUX
fnp-4692	122	14	performed	perform	VERB
fnp-4692	122	15	(	(	PUNCT
fnp-4692	122	16	e.g.	e.g.	ADV
fnp-4692	122	17	lymphomas	lymphoma	NOUN
fnp-4692	122	18	)	)	PUNCT
fnp-4692	122	19	or	or	CCONJ
fnp-4692	122	20	that	that	PRON
fnp-4692	122	21	would	would	AUX
fnp-4692	122	22	significantly	significantly	ADV
fnp-4692	122	23	benefit	benefit	VERB
fnp-4692	122	24	from	from	ADP
fnp-4692	122	25	maximum	maximum	ADJ
fnp-4692	122	26	resection	resection	NOUN
fnp-4692	122	27	would	would	AUX
fnp-4692	122	28	be	be	AUX
fnp-4692	122	29	highly	highly	ADV
fnp-4692	122	30	desirable	desirable	ADJ
fnp-4692	122	31	.	.	PUNCT
fnp-4692	123	1	with	with	SCONJ
fnp-4692	123	2	their	their	PRON
fnp-4692	123	3	approach	approach	NOUN
fnp-4692	123	4	to	to	AUX
fnp-4692	123	5	diagnose	diagnose	NOUN
fnp-4692	123	6	brain	brain	NOUN
fnp-4692	123	7	tumors	tumor	NOUN
fnp-4692	123	8	by	by	ADP
fnp-4692	123	9	methylation	methylation	NOUN
fnp-4692	123	10	analyses	analysis	NOUN
fnp-4692	123	11	from	from	ADP
fnp-4692	123	12	cerebrospinal	cerebrospinal	ADJ
fnp-4692	123	13	fluid	fluid	NOUN
fnp-4692	123	14	(	(	PUNCT
fnp-4692	123	15	csf	csf	NOUN
fnp-4692	123	16	)	)	PUNCT
fnp-4692	123	17	samples	sample	NOUN
fnp-4692	123	18	,	,	PUNCT
fnp-4692	123	19	zuccato	zuccato	NUM
fnp-4692	123	20	et	et	PROPN
fnp-4692	123	21	al	al	PROPN
fnp-4692	123	22	.	.	PROPN
fnp-4692	123	23	pave	pave	VERB
fnp-4692	123	24	the	the	DET
fnp-4692	123	25	way	way	NOUN
fnp-4692	123	26	for	for	ADP
fnp-4692	123	27	a	a	DET
fnp-4692	123	28	less	less	ADV
fnp-4692	123	29	invasive	invasive	ADJ
fnp-4692	123	30	,	,	PUNCT
fnp-4692	123	31	still	still	ADV
fnp-4692	123	32	highly	highly	ADV
fnp-4692	123	33	reliable	reliable	ADJ
fnp-4692	123	34	liquid	liquid	NOUN
fnp-4692	123	35	-	-	PUNCT
fnp-4692	123	36	based	base	VERB
fnp-4692	123	37	brain	brain	NOUN
fnp-4692	123	38	tumor	tumor	NOUN
fnp-4692	123	39	classification	classification	NOUN
fnp-4692	123	40	[	[	X
fnp-4692	123	41	9	9	NUM
fnp-4692	123	42	]	]	PUNCT
fnp-4692	123	43	.	.	PUNCT
fnp-4692	124	1	in	in	ADP
fnp-4692	124	2	this	this	DET
fnp-4692	124	3	pioneering	pioneer	VERB
fnp-4692	124	4	approach	approach	NOUN
fnp-4692	124	5	necessitating	necessitate	VERB
fnp-4692	124	6	only	only	ADV
fnp-4692	124	7	very	very	ADV
fnp-4692	124	8	small	small	ADJ
fnp-4692	124	9	amounts	amount	NOUN
fnp-4692	124	10	of	of	ADP
fnp-4692	124	11	csf	csf	PROPN
fnp-4692	124	12	,	,	PUNCT
fnp-4692	124	13	the	the	DET
fnp-4692	124	14	authors	author	NOUN
fnp-4692	124	15	analyzed	analyze	VERB
fnp-4692	124	16	57	57	NUM
fnp-4692	124	17	brain	brain	NOUN
fnp-4692	124	18	metastases	metastasis	NOUN
fnp-4692	124	19	,	,	PUNCT
fnp-4692	124	20	glioblastomas	glioblastoma	NOUN
fnp-4692	124	21	and	and	CCONJ
fnp-4692	124	22	central	central	ADJ
fnp-4692	124	23	nervous	nervous	ADJ
fnp-4692	124	24	system	system	NOUN
fnp-4692	124	25	lymphomas	lymphoma	NOUN
fnp-4692	124	26	.	.	PUNCT
fnp-4692	125	1	a	a	DET
fnp-4692	125	2	largely	largely	ADV
fnp-4692	125	3	similar	similar	ADJ
fnp-4692	125	4	amount	amount	NOUN
fnp-4692	125	5	of	of	ADP
fnp-4692	125	6	cell	cell	NOUN
fnp-4692	125	7	-	-	PUNCT
fnp-4692	125	8	free	free	ADJ
fnp-4692	125	9	dna	dna	PROPN
fnp-4692	125	10	was	be	AUX
fnp-4692	125	11	obtained	obtain	VERB
fnp-4692	125	12	from	from	ADP
fnp-4692	125	13	csf	csf	ADJ
fnp-4692	125	14	samples	sample	NOUN
fnp-4692	125	15	of	of	ADP
fnp-4692	125	16	all	all	DET
fnp-4692	125	17	3	3	NUM
fnp-4692	125	18	tumor	tumor	NOUN
fnp-4692	125	19	classes	class	NOUN
fnp-4692	125	20	.	.	PUNCT
fnp-4692	126	1	the	the	DET
fnp-4692	126	2	methylation	methylation	NOUN
fnp-4692	126	3	profile	profile	NOUN
fnp-4692	126	4	significantly	significantly	ADV
fnp-4692	126	5	correlated	correlate	VERB
fnp-4692	126	6	between	between	ADP
fnp-4692	126	7	csf	csf	ADJ
fnp-4692	126	8	and	and	CCONJ
fnp-4692	126	9	tumor	tumor	NOUN
fnp-4692	126	10	samples	sample	NOUN
fnp-4692	126	11	in	in	ADP
fnp-4692	126	12	all	all	DET
fnp-4692	126	13	3	3	NUM
fnp-4692	126	14	tumor	tumor	NOUN
fnp-4692	126	15	entities	entity	NOUN
fnp-4692	126	16	.	.	PUNCT
fnp-4692	127	1	furthermore	furthermore	ADV
fnp-4692	127	2	,	,	PUNCT
fnp-4692	127	3	the	the	DET
fnp-4692	127	4	methylation	methylation	NOUN
fnp-4692	127	5	analyses	analysis	NOUN
fnp-4692	127	6	could	could	AUX
fnp-4692	127	7	convincingly	convincingly	ADV
fnp-4692	127	8	distinguish	distinguish	VERB
fnp-4692	127	9	between	between	ADP
fnp-4692	127	10	brain	brain	NOUN
fnp-4692	127	11	metastases	metastasis	NOUN
fnp-4692	127	12	,	,	PUNCT
fnp-4692	127	13	glioblastoma	glioblastoma	NOUN
fnp-4692	127	14	and	and	CCONJ
fnp-4692	127	15	cns	cns	NOUN
fnp-4692	127	16	lymphoma	lymphoma	NOUN
fnp-4692	127	17	.	.	PUNCT
fnp-4692	128	1	the	the	DET
fnp-4692	128	2	methylation	methylation	NOUN
fnp-4692	128	3	profiles	profile	NOUN
fnp-4692	128	4	of	of	ADP
fnp-4692	128	5	cns	cns	NOUN
fnp-4692	128	6	lymphomas	lymphoma	NOUN
fnp-4692	128	7	were	be	AUX
fnp-4692	128	8	highly	highly	ADV
fnp-4692	128	9	discriminatory	discriminatory	ADJ
fnp-4692	128	10	.	.	PUNCT
fnp-4692	129	1	therefore	therefore	ADV
fnp-4692	129	2	,	,	PUNCT
fnp-4692	129	3	perioperative	perioperative	ADJ
fnp-4692	129	4	morbidity	morbidity	NOUN
fnp-4692	129	5	and	and	CCONJ
fnp-4692	129	6	mortality	mortality	NOUN
fnp-4692	129	7	could	could	AUX
fnp-4692	129	8	be	be	AUX
fnp-4692	129	9	considerably	considerably	ADV
fnp-4692	129	10	reduced	reduce	VERB
fnp-4692	129	11	in	in	ADP
fnp-4692	129	12	the	the	DET
fnp-4692	129	13	future	future	NOUN
fnp-4692	129	14	if	if	SCONJ
fnp-4692	129	15	such	such	DET
fnp-4692	129	16	a	a	DET
fnp-4692	129	17	csf	csf	ADJ
fnp-4692	129	18	based	base	VERB
fnp-4692	129	19	methylation	methylation	NOUN
fnp-4692	129	20	approach	approach	NOUN
fnp-4692	129	21	would	would	AUX
fnp-4692	129	22	be	be	AUX
fnp-4692	129	23	implemented	implement	VERB
fnp-4692	129	24	in	in	ADP
fnp-4692	129	25	the	the	DET
fnp-4692	129	26	routine	routine	ADJ
fnp-4692	129	27	diagnostic	diagnostic	ADJ
fnp-4692	129	28	set	set	NOUN
fnp-4692	129	29	-	-	PUNCT
fnp-4692	129	30	up	up	NOUN
fnp-4692	129	31	before	before	SCONJ
fnp-4692	129	32	the	the	DET
fnp-4692	129	33	final	final	ADJ
fnp-4692	129	34	decision	decision	NOUN
fnp-4692	129	35	to	to	PART
fnp-4692	129	36	perform	perform	VERB
fnp-4692	129	37	gross	gross	ADJ
fnp-4692	129	38	resection	resection	NOUN
fnp-4692	129	39	is	be	AUX
fnp-4692	129	40	made	make	VERB
fnp-4692	129	41	.	.	PUNCT
fnp-4692	130	1	the	the	DET
fnp-4692	130	2	prediction	prediction	NOUN
fnp-4692	130	3	from	from	ADP
fnp-4692	130	4	methylation	methylation	NOUN
fnp-4692	130	5	data	datum	NOUN
fnp-4692	130	6	in	in	ADP
fnp-4692	130	7	the	the	DET
fnp-4692	130	8	present	present	ADJ
fnp-4692	130	9	study	study	NOUN
fnp-4692	130	10	was	be	AUX
fnp-4692	130	11	superior	superior	ADJ
fnp-4692	130	12	as	as	SCONJ
fnp-4692	130	13	compared	compare	VERB
fnp-4692	130	14	to	to	ADP
fnp-4692	130	15	previously	previously	ADV
fnp-4692	130	16	published	publish	VERB
fnp-4692	130	17	data	datum	NOUN
fnp-4692	130	18	using	use	VERB
fnp-4692	130	19	plasma	plasma	NOUN
fnp-4692	130	20	samples	sample	NOUN
fnp-4692	130	21	,	,	PUNCT
fnp-4692	130	22	which	which	PRON
fnp-4692	130	23	could	could	AUX
fnp-4692	130	24	be	be	AUX
fnp-4692	130	25	related	relate	VERB
fnp-4692	130	26	to	to	ADP
fnp-4692	130	27	the	the	DET
fnp-4692	130	28	closer	close	ADJ
fnp-4692	130	29	proximity	proximity	NOUN
fnp-4692	130	30	of	of	ADP
fnp-4692	130	31	brain	brain	NOUN
fnp-4692	130	32	tumors	tumor	NOUN
fnp-4692	130	33	to	to	ADP
fnp-4692	130	34	the	the	DET
fnp-4692	130	35	sampled	sample	VERB
fnp-4692	130	36	csf	csf	NOUN
fnp-4692	130	37	and	and	CCONJ
fnp-4692	130	38	the	the	DET
fnp-4692	130	39	distribution	distribution	NOUN
fnp-4692	130	40	of	of	ADP
fnp-4692	130	41	cell	cell	NOUN
fnp-4692	130	42	-	-	PUNCT
fnp-4692	130	43	free	free	ADJ
fnp-4692	130	44	dna	dna	NOUN
fnp-4692	130	45	in	in	ADP
fnp-4692	130	46	less	less	ADJ
fnp-4692	130	47	volume	volume	NOUN
fnp-4692	130	48	with	with	ADP
fnp-4692	130	49	less	less	ADJ
fnp-4692	130	50	liquid	liquid	ADJ
fnp-4692	130	51	turnover	turnover	NOUN
fnp-4692	130	52	as	as	SCONJ
fnp-4692	130	53	compared	compare	VERB
fnp-4692	130	54	to	to	ADP
fnp-4692	130	55	plasma	plasma	NOUN
fnp-4692	130	56	samples	sample	NOUN
fnp-4692	130	57	[	[	X
fnp-4692	130	58	23	23	NUM
fnp-4692	130	59	,	,	PUNCT
fnp-4692	130	60	24	24	NUM
fnp-4692	130	61	]	]	PUNCT
fnp-4692	130	62	.	.	PUNCT
fnp-4692	131	1	in	in	ADP
fnp-4692	131	2	addition	addition	NOUN
fnp-4692	131	3	to	to	ADP
fnp-4692	131	4	the	the	DET
fnp-4692	131	5	very	very	ADV
fnp-4692	131	6	promising	promising	ADJ
fnp-4692	131	7	findings	finding	NOUN
fnp-4692	131	8	regarding	regard	VERB
fnp-4692	131	9	initial	initial	ADJ
fnp-4692	131	10	diagnostics	diagnostic	NOUN
fnp-4692	131	11	of	of	ADP
fnp-4692	131	12	a	a	DET
fnp-4692	131	13	primary	primary	ADJ
fnp-4692	131	14	tumor	tumor	NOUN
fnp-4692	131	15	,	,	PUNCT
fnp-4692	131	16	this	this	DET
fnp-4692	131	17	approach	approach	NOUN
fnp-4692	131	18	has	have	VERB
fnp-4692	131	19	also	also	ADV
fnp-4692	131	20	a	a	DET
fnp-4692	131	21	high	high	ADJ
fnp-4692	131	22	potential	potential	NOUN
fnp-4692	131	23	to	to	PART
fnp-4692	131	24	track	track	VERB
fnp-4692	131	25	treatment	treatment	NOUN
fnp-4692	131	26	responses	response	NOUN
fnp-4692	131	27	or	or	CCONJ
fnp-4692	131	28	detect	detect	VERB
fnp-4692	131	29	recurrent	recurrent	ADJ
fnp-4692	131	30	tumor	tumor	NOUN
fnp-4692	131	31	cell	cell	NOUN
fnp-4692	131	32	growth	growth	NOUN
fnp-4692	131	33	.	.	PUNCT
fnp-4692	132	1	the	the	DET
fnp-4692	132	2	strong	strong	ADJ
fnp-4692	132	3	correlation	correlation	NOUN
fnp-4692	132	4	between	between	ADP
fnp-4692	132	5	primary	primary	ADJ
fnp-4692	132	6	tumors	tumor	NOUN
fnp-4692	132	7	and	and	CCONJ
fnp-4692	132	8	csf	csf	ADJ
fnp-4692	132	9	samples	sample	NOUN
fnp-4692	132	10	might	might	AUX
fnp-4692	132	11	also	also	ADV
fnp-4692	132	12	be	be	AUX
fnp-4692	132	13	useful	useful	ADJ
fnp-4692	132	14	to	to	PART
fnp-4692	132	15	differentiate	differentiate	VERB
fnp-4692	132	16	a	a	DET
fnp-4692	132	17	primary	primary	ADJ
fnp-4692	132	18	brain	brain	NOUN
fnp-4692	132	19	tumor	tumor	NOUN
fnp-4692	132	20	from	from	ADP
fnp-4692	132	21	metastasis	metastasis	NOUN
fnp-4692	132	22	in	in	ADP
fnp-4692	132	23	patients	patient	NOUN
fnp-4692	132	24	suffering	suffer	VERB
fnp-4692	132	25	from	from	ADP
fnp-4692	132	26	different	different	ADJ
fnp-4692	132	27	cancer	cancer	NOUN
fnp-4692	132	28	entities	entity	NOUN
fnp-4692	132	29	at	at	ADP
fnp-4692	132	30	the	the	DET
fnp-4692	132	31	same	same	ADJ
fnp-4692	132	32	time	time	NOUN
fnp-4692	132	33	.	.	PUNCT
fnp-4692	133	1	8	8	X
fnp-4692	133	2	.	.	X
fnp-4692	133	3	intraoperative	intraoperative	ADJ
fnp-4692	133	4	diagnostics	diagnostic	NOUN
fnp-4692	133	5	for	for	ADP
fnp-4692	133	6	brain	brain	NOUN
fnp-4692	133	7	tumors	tumor	NOUN
fnp-4692	133	8	based	base	VERB
fnp-4692	133	9	on	on	ADP
fnp-4692	133	10	raman	raman	ADJ
fnp-4692	133	11	effect	effect	NOUN
fnp-4692	133	12	[	[	X
fnp-4692	133	13	10	10	NUM
fnp-4692	133	14	,	,	PUNCT
fnp-4692	133	15	11	11	NUM
fnp-4692	133	16	]	]	SYM
fnp-4692	133	17	intraoperative	intraoperative	ADJ
fnp-4692	133	18	brain	brain	NOUN
fnp-4692	133	19	tumor	tumor	NOUN
fnp-4692	133	20	diagnostics	diagnostic	NOUN
fnp-4692	133	21	necessitate	necessitate	ADJ
fnp-4692	133	22	an	an	DET
fnp-4692	133	23	availability	availability	NOUN
fnp-4692	133	24	of	of	ADP
fnp-4692	133	25	experienced	experienced	ADJ
fnp-4692	133	26	neuropathologists	neuropathologist	NOUN
fnp-4692	133	27	,	,	PUNCT
fnp-4692	133	28	however	however	ADV
fnp-4692	133	29	,	,	PUNCT
fnp-4692	133	30	multiple	multiple	ADJ
fnp-4692	133	31	smaller	small	ADJ
fnp-4692	133	32	centers	center	NOUN
fnp-4692	133	33	have	have	VERB
fnp-4692	133	34	only	only	ADV
fnp-4692	133	35	one	one	NUM
fnp-4692	133	36	or	or	CCONJ
fnp-4692	133	37	none	none	NOUN
fnp-4692	133	38	of	of	ADP
fnp-4692	133	39	this	this	DET
fnp-4692	133	40	rather	rather	ADV
fnp-4692	133	41	rare	rare	ADJ
fnp-4692	133	42	“	"	PUNCT
fnp-4692	133	43	species	specie	NOUN
fnp-4692	133	44	”	"	PUNCT
fnp-4692	133	45	.	.	PUNCT
fnp-4692	134	1	furthermore	furthermore	ADV
fnp-4692	134	2	,	,	PUNCT
fnp-4692	134	3	diagnostic	diagnostic	ADJ
fnp-4692	134	4	quality	quality	NOUN
fnp-4692	134	5	and	and	CCONJ
fnp-4692	134	6	precision	precision	NOUN
fnp-4692	134	7	may	may	AUX
fnp-4692	134	8	be	be	AUX
fnp-4692	134	9	suboptimal	suboptimal	ADJ
fnp-4692	134	10	and	and	CCONJ
fnp-4692	134	11	frequently	frequently	ADV
fnp-4692	134	12	show	show	VERB
fnp-4692	134	13	less	less	ADJ
fnp-4692	134	14	than	than	ADP
fnp-4692	134	15	70	70	NUM
fnp-4692	134	16	%	%	NOUN
fnp-4692	134	17	complete	complete	ADJ
fnp-4692	134	18	concordance	concordance	NOUN
fnp-4692	134	19	with	with	ADP
fnp-4692	134	20	final	final	ADJ
fnp-4692	134	21	neuropathological	neuropathological	ADJ
fnp-4692	134	22	diagnoses	diagnosis	NOUN
fnp-4692	134	23	[	[	X
fnp-4692	134	24	25	25	NUM
fnp-4692	134	25	]	]	PUNCT
fnp-4692	134	26	.	.	PUNCT
fnp-4692	135	1	therefore	therefore	ADV
fnp-4692	135	2	,	,	PUNCT
fnp-4692	135	3	the	the	DET
fnp-4692	135	4	central	central	ADJ
fnp-4692	135	5	intraoperative	intraoperative	ADJ
fnp-4692	135	6	questions	question	NOUN
fnp-4692	135	7	are	be	AUX
fnp-4692	135	8	rather	rather	ADV
fnp-4692	135	9	if	if	SCONJ
fnp-4692	135	10	the	the	DET
fnp-4692	135	11	neurosurgeon	neurosurgeon	NOUN
fnp-4692	135	12	correctly	correctly	ADV
fnp-4692	135	13	hit	hit	VERB
fnp-4692	135	14	the	the	DET
fnp-4692	135	15	lesion	lesion	NOUN
fnp-4692	135	16	or	or	CCONJ
fnp-4692	135	17	if	if	SCONJ
fnp-4692	135	18	enough	enough	ADJ
fnp-4692	135	19	material	material	NOUN
fnp-4692	135	20	was	be	AUX
fnp-4692	135	21	obtained	obtain	VERB
fnp-4692	135	22	for	for	ADP
fnp-4692	135	23	further	further	ADJ
fnp-4692	135	24	microscopic	microscopic	ADJ
fnp-4692	135	25	and	and	CCONJ
fnp-4692	135	26	molecular	molecular	ADJ
fnp-4692	135	27	diagnostics	diagnostic	NOUN
fnp-4692	135	28	.	.	PUNCT
fnp-4692	136	1	taking	take	VERB
fnp-4692	136	2	all	all	DET
fnp-4692	136	3	those	those	DET
fnp-4692	136	4	arguments	argument	NOUN
fnp-4692	136	5	into	into	ADP
fnp-4692	136	6	account	account	NOUN
fnp-4692	136	7	,	,	PUNCT
fnp-4692	136	8	there	there	PRON
fnp-4692	136	9	is	be	VERB
fnp-4692	136	10	an	an	DET
fnp-4692	136	11	obvious	obvious	ADJ
fnp-4692	136	12	need	need	NOUN
fnp-4692	136	13	for	for	ADP
fnp-4692	136	14	faster	fast	ADJ
fnp-4692	136	15	,	,	PUNCT
fnp-4692	136	16	more	more	ADV
fnp-4692	136	17	unbiased	unbiased	ADJ
fnp-4692	136	18	,	,	PUNCT
fnp-4692	136	19	less	less	ADJ
fnp-4692	136	20	work	work	NOUN
fnp-4692	136	21	intensive	intensive	ADJ
fnp-4692	136	22	and	and	CCONJ
fnp-4692	136	23	,	,	PUNCT
fnp-4692	136	24	ideally	ideally	ADV
fnp-4692	136	25	,	,	PUNCT
fnp-4692	136	26	automated	automate	VERB
fnp-4692	136	27	intraoperative	intraoperative	ADJ
fnp-4692	136	28	diagnostic	diagnostic	ADJ
fnp-4692	136	29	procedures	procedure	NOUN
fnp-4692	136	30	.	.	PUNCT
fnp-4692	137	1	it	it	PRON
fnp-4692	137	2	was	be	AUX
fnp-4692	137	3	shown	show	VERB
fnp-4692	137	4	that	that	SCONJ
fnp-4692	137	5	label	label	NOUN
fnp-4692	137	6	-	-	PUNCT
fnp-4692	137	7	free	free	ADJ
fnp-4692	137	8	,	,	PUNCT
fnp-4692	137	9	stimulated	stimulated	ADJ
fnp-4692	137	10	raman	raman	NOUN
fnp-4692	137	11	based	base	VERB
fnp-4692	137	12	histology	histology	NOUN
fnp-4692	137	13	(	(	PUNCT
fnp-4692	137	14	srh	srh	PROPN
fnp-4692	137	15	)	)	PUNCT
fnp-4692	137	16	assessed	assess	VERB
fnp-4692	137	17	by	by	ADP
fnp-4692	137	18	machine	machine	NOUN
fnp-4692	137	19	learning	learn	VERB
fnp-4692	137	20	algorithms	algorithm	NOUN
fnp-4692	137	21	was	be	AUX
fnp-4692	137	22	able	able	ADJ
fnp-4692	137	23	to	to	PART
fnp-4692	137	24	provide	provide	VERB
fnp-4692	137	25	an	an	DET
fnp-4692	137	26	intraoperative	intraoperative	ADJ
fnp-4692	137	27	diagnosis	diagnosis	NOUN
fnp-4692	137	28	almost	almost	ADV
fnp-4692	137	29	in	in	ADP
fnp-4692	137	30	real	real	ADJ
fnp-4692	137	31	-	-	PUNCT
fnp-4692	137	32	time	time	NOUN
fnp-4692	137	33	without	without	ADP
fnp-4692	137	34	showing	show	VERB
fnp-4692	137	35	less	less	ADJ
fnp-4692	137	36	diagnostic	diagnostic	ADJ
fnp-4692	137	37	precision	precision	NOUN
fnp-4692	137	38	as	as	SCONJ
fnp-4692	137	39	compared	compare	VERB
fnp-4692	137	40	to	to	ADP
fnp-4692	137	41	experienced	experienced	ADJ
fnp-4692	137	42	pathologists	pathologist	NOUN
fnp-4692	137	43	[	[	X
fnp-4692	137	44	26	26	NUM
fnp-4692	137	45	]	]	PUNCT
fnp-4692	137	46	.	.	PUNCT
fnp-4692	138	1	this	this	DET
fnp-4692	138	2	method	method	NOUN
fnp-4692	138	3	is	be	AUX
fnp-4692	138	4	based	base	VERB
fnp-4692	138	5	on	on	ADP
fnp-4692	138	6	the	the	DET
fnp-4692	138	7	raman	raman	NOUN
fnp-4692	138	8	scattering	scatter	VERB
fnp-4692	138	9	effect	effect	NOUN
fnp-4692	138	10	,	,	PUNCT
fnp-4692	138	11	namely	namely	ADV
fnp-4692	138	12	,	,	PUNCT
fnp-4692	138	13	that	that	SCONJ
fnp-4692	138	14	the	the	DET
fnp-4692	138	15	energy	energy	NOUN
fnp-4692	138	16	level	level	NOUN
fnp-4692	138	17	of	of	ADP
fnp-4692	138	18	light	light	NOUN
fnp-4692	138	19	can	can	AUX
fnp-4692	138	20	be	be	AUX
fnp-4692	138	21	altered	alter	VERB
fnp-4692	138	22	upon	upon	SCONJ
fnp-4692	138	23	interaction	interaction	NOUN
fnp-4692	138	24	with	with	ADP
fnp-4692	138	25	molecular	molecular	ADJ
fnp-4692	138	26	bonds	bond	NOUN
fnp-4692	138	27	,	,	PUNCT
fnp-4692	138	28	changes	change	NOUN
fnp-4692	138	29	that	that	PRON
fnp-4692	138	30	can	can	AUX
fnp-4692	138	31	be	be	AUX
fnp-4692	138	32	visualized	visualize	VERB
fnp-4692	138	33	spectrophotometrically	spectrophotometrically	ADV
fnp-4692	139	1	only	only	ADV
fnp-4692	139	2	[	[	X
fnp-4692	139	3	for	for	ADP
fnp-4692	139	4	comprehensive	comprehensive	ADJ
fnp-4692	139	5	overview	overview	NOUN
fnp-4692	139	6	,	,	PUNCT
fnp-4692	139	7	please	please	INTJ
fnp-4692	139	8	see	see	VERB
fnp-4692	139	9	27	27	NUM
fnp-4692	139	10	]	]	PUNCT
fnp-4692	139	11	.	.	PUNCT
fnp-4692	140	1	when	when	SCONJ
fnp-4692	140	2	this	this	DET
fnp-4692	140	3	method	method	NOUN
fnp-4692	140	4	iscombined	iscombine	VERB
fnp-4692	140	5	with	with	ADP
fnp-4692	140	6	a	a	DET
fnp-4692	140	7	microscopic	microscopic	ADJ
fnp-4692	140	8	device	device	NOUN
fnp-4692	140	9	,	,	PUNCT
fnp-4692	140	10	a	a	DET
fnp-4692	140	11	spatial	spatial	ADJ
fnp-4692	140	12	resolution	resolution	NOUN
fnp-4692	140	13	between	between	ADP
fnp-4692	140	14	0.5	0.5	NUM
fnp-4692	140	15	and	and	CCONJ
fnp-4692	140	16	1	1	NUM
fnp-4692	140	17	µm	µm	NOUN
fnp-4692	140	18	is	be	AUX
fnp-4692	140	19	achieved	achieve	VERB
fnp-4692	140	20	.	.	PUNCT
fnp-4692	141	1	reinecke	reinecke	VERB
fnp-4692	141	2	et	et	PROPN
fnp-4692	141	3	al	al	PROPN
fnp-4692	141	4	.	.	PROPN
fnp-4692	141	5	applied	apply	VERB
fnp-4692	141	6	srh	srh	NOUN
fnp-4692	141	7	on	on	ADP
fnp-4692	141	8	a	a	DET
fnp-4692	141	9	larger	large	ADJ
fnp-4692	141	10	series	series	NOUN
fnp-4692	141	11	of	of	ADP
fnp-4692	141	12	intraoperative	intraoperative	ADJ
fnp-4692	141	13	neuro	neuro	NOUN
fnp-4692	141	14	-	-	PUNCT
fnp-4692	141	15	oncological	oncological	ADJ
fnp-4692	141	16	cases	case	NOUN
fnp-4692	141	17	and	and	CCONJ
fnp-4692	141	18	created	create	VERB
fnp-4692	141	19	an	an	DET
fnp-4692	141	20	automated	automate	VERB
fnp-4692	141	21	diagnostic	diagnostic	ADJ
fnp-4692	141	22	pipeline	pipeline	NOUN
fnp-4692	141	23	based	base	VERB
fnp-4692	141	24	on	on	ADP
fnp-4692	141	25	convolutional	convolutional	ADJ
fnp-4692	141	26	neural	neural	ADJ
fnp-4692	141	27	network	network	NOUN
fnp-4692	141	28	analyses	analysis	NOUN
fnp-4692	141	29	,	,	PUNCT
fnp-4692	141	30	revealing	reveal	VERB
fnp-4692	141	31	a	a	DET
fnp-4692	141	32	high	high	ADJ
fnp-4692	141	33	diagnostic	diagnostic	ADJ
fnp-4692	141	34	accuracy	accuracy	NOUN
fnp-4692	141	35	as	as	ADP
fnp-4692	141	36	compared	compare	VERB
fnp-4692	141	37	to	to	ADP
fnp-4692	141	38	an	an	DET
fnp-4692	141	39	independently	independently	ADV
fnp-4692	141	40	performed	perform	VERB
fnp-4692	141	41	neuropathological	neuropathological	ADJ
fnp-4692	141	42	assessment	assessment	NOUN
fnp-4692	141	43	[	[	X
fnp-4692	141	44	11	11	NUM
fnp-4692	141	45	]	]	PUNCT
fnp-4692	141	46	.	.	PUNCT
fnp-4692	142	1	furthermore	furthermore	ADV
fnp-4692	142	2	,	,	PUNCT
fnp-4692	142	3	a	a	DET
fnp-4692	142	4	high	high	ADJ
fnp-4692	142	5	consistency	consistency	NOUN
fnp-4692	142	6	between	between	ADP
fnp-4692	142	7	randomly	randomly	ADV
fnp-4692	142	8	chosen	choose	VERB
fnp-4692	142	9	areas	area	NOUN
fnp-4692	142	10	on	on	ADP
fnp-4692	142	11	tumor	tumor	NOUN
fnp-4692	142	12	samples	sample	NOUN
fnp-4692	142	13	was	be	AUX
fnp-4692	142	14	observed	observe	VERB
fnp-4692	142	15	.	.	PUNCT
fnp-4692	143	1	taking	take	VERB
fnp-4692	143	2	into	into	ADP
fnp-4692	143	3	account	account	NOUN
fnp-4692	143	4	that	that	DET
fnp-4692	143	5	decision	decision	NOUN
fnp-4692	143	6	from	from	ADP
fnp-4692	143	7	this	this	DET
fnp-4692	143	8	automated	automate	VERB
fnp-4692	143	9	diagnostic	diagnostic	ADJ
fnp-4692	143	10	pipeline	pipeline	NOUN
fnp-4692	143	11	took	take	VERB
fnp-4692	143	12	less	less	ADJ
fnp-4692	143	13	than	than	ADP
fnp-4692	143	14	5	5	NUM
fnp-4692	143	15	minutes	minute	NOUN
fnp-4692	143	16	in	in	ADP
fnp-4692	143	17	total	total	NOUN
fnp-4692	143	18	,	,	PUNCT
fnp-4692	143	19	this	this	DET
fnp-4692	143	20	approach	approach	NOUN
fnp-4692	143	21	seems	seem	VERB
fnp-4692	143	22	to	to	PART
fnp-4692	143	23	be	be	AUX
fnp-4692	143	24	highly	highly	ADV
fnp-4692	143	25	promising	promising	ADJ
fnp-4692	143	26	to	to	PART
fnp-4692	143	27	replace	replace	VERB
fnp-4692	143	28	intraoperative	intraoperative	ADJ
fnp-4692	143	29	neuropathological	neuropathological	ADJ
fnp-4692	143	30	intervention	intervention	NOUN
fnp-4692	143	31	in	in	ADP
fnp-4692	143	32	the	the	DET
fnp-4692	143	33	medium	medium	ADJ
fnp-4692	143	34	term	term	NOUN
fnp-4692	143	35	.	.	PUNCT
fnp-4692	144	1	as	as	SCONJ
fnp-4692	144	2	especially	especially	ADV
fnp-4692	144	3	pediatric	pediatric	ADJ
fnp-4692	144	4	brain	brain	NOUN
fnp-4692	144	5	tumors	tumor	NOUN
fnp-4692	144	6	are	be	AUX
fnp-4692	144	7	nowadays	nowadays	ADV
fnp-4692	144	8	much	much	ADV
fnp-4692	144	9	more	more	ADV
fnp-4692	144	10	specifically	specifically	ADV
fnp-4692	144	11	classified	classified	ADJ
fnp-4692	144	12	according	accord	VERB
fnp-4692	144	13	to	to	ADP
fnp-4692	144	14	molecular	molecular	ADJ
fnp-4692	144	15	pathological	pathological	ADJ
fnp-4692	144	16	markers	marker	NOUN
fnp-4692	144	17	,	,	PUNCT
fnp-4692	144	18	microscopic	microscopic	ADJ
fnp-4692	144	19	diagnostics	diagnostic	NOUN
fnp-4692	144	20	during	during	ADP
fnp-4692	144	21	surgery	surgery	NOUN
fnp-4692	144	22	is	be	AUX
fnp-4692	144	23	frequently	frequently	ADV
fnp-4692	144	24	of	of	ADP
fnp-4692	144	25	limited	limited	ADJ
fnp-4692	144	26	value	value	NOUN
fnp-4692	144	27	if	if	SCONJ
fnp-4692	144	28	intraoperative	intraoperative	ADJ
fnp-4692	144	29	statement	statement	NOUN
fnp-4692	144	30	is	be	AUX
fnp-4692	144	31	,	,	PUNCT
fnp-4692	144	32	for	for	ADP
fnp-4692	144	33	example	example	NOUN
fnp-4692	144	34	,	,	PUNCT
fnp-4692	144	35	“	"	PUNCT
fnp-4692	144	36	small	small	ADJ
fnp-4692	144	37	round	round	ADJ
fnp-4692	144	38	blue	blue	ADJ
fnp-4692	144	39	cell	cell	NOUN
fnp-4692	144	40	tumor	tumor	NOUN
fnp-4692	144	41	”	"	PUNCT
fnp-4692	144	42	or	or	CCONJ
fnp-4692	144	43	“	"	PUNCT
fnp-4692	144	44	suspicion	suspicion	NOUN
fnp-4692	144	45	of	of	ADP
fnp-4692	144	46	low	low	ADJ
fnp-4692	144	47	-	-	PUNCT
fnp-4692	144	48	grade	grade	NOUN
fnp-4692	144	49	glioma	glioma	NOUN
fnp-4692	144	50	”	"	PUNCT
fnp-4692	144	51	.	.	PUNCT
fnp-4692	145	1	if	if	SCONJ
fnp-4692	145	2	a	a	DET
fnp-4692	145	3	fast	fast	ADJ
fnp-4692	145	4	unbiased	unbiased	ADJ
fnp-4692	145	5	intraoperative	intraoperative	ADJ
fnp-4692	145	6	method	method	NOUN
fnp-4692	145	7	would	would	AUX
fnp-4692	145	8	be	be	AUX
fnp-4692	145	9	able	able	ADJ
fnp-4692	145	10	to	to	PART
fnp-4692	145	11	distinguish	distinguish	VERB
fnp-4692	145	12	normal	normal	ADJ
fnp-4692	145	13	from	from	ADP
fnp-4692	145	14	tumor	tumor	NOUN
fnp-4692	145	15	tissue	tissue	NOUN
fnp-4692	145	16	and	and	CCONJ
fnp-4692	145	17	high	high	ADJ
fnp-4692	145	18	from	from	ADP
fnp-4692	145	19	lower	low	ADJ
fnp-4692	145	20	grade	grade	NOUN
fnp-4692	145	21	brain	brain	NOUN
fnp-4692	145	22	tumors	tumor	NOUN
fnp-4692	145	23	in	in	ADP
fnp-4692	145	24	addition	addition	NOUN
fnp-4692	145	25	to	to	ADP
fnp-4692	145	26	a	a	DET
fnp-4692	145	27	good	good	ADJ
fnp-4692	145	28	estimation	estimation	NOUN
fnp-4692	145	29	of	of	ADP
fnp-4692	145	30	the	the	DET
fnp-4692	145	31	tumor	tumor	NOUN
fnp-4692	145	32	cell	cell	NOUN
fnp-4692	145	33	content	content	NOUN
fnp-4692	145	34	,	,	PUNCT
fnp-4692	145	35	this	this	PRON
fnp-4692	145	36	would	would	AUX
fnp-4692	145	37	considerably	considerably	ADV
fnp-4692	145	38	decrease	decrease	VERB
fnp-4692	145	39	the	the	DET
fnp-4692	145	40	need	need	NOUN
fnp-4692	145	41	for	for	ADP
fnp-4692	145	42	neuropathology	neuropathology	NOUN
fnp-4692	145	43	expertise	expertise	NOUN
fnp-4692	145	44	during	during	ADP
fnp-4692	145	45	the	the	DET
fnp-4692	145	46	surgical	surgical	ADJ
fnp-4692	145	47	procedure	procedure	NOUN
fnp-4692	145	48	.	.	PUNCT
fnp-4692	146	1	in	in	ADP
fnp-4692	146	2	particular	particular	ADJ
fnp-4692	146	3	,	,	PUNCT
fnp-4692	146	4	the	the	DET
fnp-4692	146	5	presence	presence	NOUN
fnp-4692	146	6	or	or	CCONJ
fnp-4692	146	7	absence	absence	NOUN
fnp-4692	146	8	of	of	ADP
fnp-4692	146	9	tumoris	tumoris	NOUN
fnp-4692	146	10	strongly	strongly	ADV
fnp-4692	146	11	needed	need	VERB
fnp-4692	146	12	information	information	NOUN
fnp-4692	146	13	during	during	ADP
fnp-4692	146	14	the	the	DET
fnp-4692	146	15	surgical	surgical	ADJ
fnp-4692	146	16	procedure	procedure	NOUN
fnp-4692	146	17	,	,	PUNCT
fnp-4692	146	18	as	as	SCONJ
fnp-4692	146	19	the	the	DET
fnp-4692	146	20	extent	extent	NOUN
fnp-4692	146	21	of	of	ADP
fnp-4692	146	22	resection	resection	NOUN
fnp-4692	146	23	is	be	AUX
fnp-4692	146	24	one	one	NUM
fnp-4692	146	25	the	the	DET
fnp-4692	146	26	most	most	ADV
fnp-4692	146	27	important	important	ADJ
fnp-4692	146	28	predictors	predictor	NOUN
fnp-4692	146	29	for	for	ADP
fnp-4692	146	30	progression	progression	NOUN
fnp-4692	146	31	free	free	ADJ
fnp-4692	146	32	survival	survival	NOUN
fnp-4692	146	33	in	in	ADP
fnp-4692	146	34	pediatric	pediatric	ADJ
fnp-4692	146	35	brain	brain	NOUN
fnp-4692	146	36	tumors	tumor	NOUN
fnp-4692	147	1	[	[	X
fnp-4692	147	2	28	28	NUM
fnp-4692	147	3	]	]	X
fnp-4692	147	4	jabarkheel	jabarkheel	PROPN
fnp-4692	147	5	et	et	PROPN
fnp-4692	147	6	al	al	PROPN
fnp-4692	147	7	.	.	PROPN
fnp-4692	147	8	investigated	investigate	VERB
fnp-4692	147	9	the	the	DET
fnp-4692	147	10	suitability	suitability	NOUN
fnp-4692	147	11	of	of	ADP
fnp-4692	147	12	raman	raman	NOUN
fnp-4692	147	13	spectroscopy	spectroscopy	NOUN
fnp-4692	147	14	for	for	ADP
fnp-4692	147	15	pediatric	pediatric	ADJ
fnp-4692	147	16	brain	brain	NOUN
fnp-4692	147	17	tumor	tumor	NOUN
fnp-4692	147	18	cases	case	NOUN
fnp-4692	147	19	[	[	X
fnp-4692	147	20	10	10	NUM
fnp-4692	147	21	]	]	PUNCT
fnp-4692	147	22	.	.	PUNCT
fnp-4692	148	1	with	with	ADP
fnp-4692	148	2	their	their	PRON
fnp-4692	148	3	approach	approach	NOUN
fnp-4692	148	4	,	,	PUNCT
fnp-4692	148	5	jabarkheel	jabarkheel	PROPN
fnp-4692	148	6	et	et	PROPN
fnp-4692	148	7	al	al	PROPN
fnp-4692	148	8	.	.	PROPN
fnp-4692	148	9	were	be	AUX
fnp-4692	148	10	able	able	ADJ
fnp-4692	148	11	to	to	PART
fnp-4692	148	12	correctly	correctly	ADV
fnp-4692	148	13	distinguish	distinguish	VERB
fnp-4692	148	14	tumor	tumor	NOUN
fnp-4692	148	15	tissue	tissue	NOUN
fnp-4692	148	16	from	from	ADP
fnp-4692	148	17	normal	normal	ADJ
fnp-4692	148	18	tissue	tissue	NOUN
fnp-4692	148	19	in	in	ADP
fnp-4692	148	20	89.9	89.9	NUM
fnp-4692	148	21	%	%	NOUN
fnp-4692	148	22	;	;	PUNCT
fnp-4692	148	23	furthermore	furthermore	ADV
fnp-4692	148	24	,	,	PUNCT
fnp-4692	148	25	the	the	DET
fnp-4692	148	26	more	more	ADV
fnp-4692	148	27	complicated	complicated	ADJ
fnp-4692	148	28	task	task	NOUN
fnp-4692	148	29	of	of	ADP
fnp-4692	148	30	differentiating	differentiate	VERB
fnp-4692	148	31	low	low	ADJ
fnp-4692	148	32	-	-	PUNCT
fnp-4692	148	33	grade	grade	NOUN
fnp-4692	148	34	tumors	tumor	NOUN
fnp-4692	148	35	from	from	ADP
fnp-4692	148	36	normal	normal	ADJ
fnp-4692	148	37	brain	brain	NOUN
fnp-4692	148	38	tissue	tissue	NOUN
fnp-4692	148	39	was	be	AUX
fnp-4692	148	40	mastered	master	VERB
fnp-4692	148	41	in	in	ADP
fnp-4692	148	42	86.2	86.2	NUM
fnp-4692	148	43	%	%	NOUN
fnp-4692	148	44	.	.	PUNCT
fnp-4692	149	1	although	although	SCONJ
fnp-4692	149	2	this	this	DET
fnp-4692	149	3	development	development	NOUN
fnp-4692	149	4	may	may	AUX
fnp-4692	149	5	impact	impact	VERB
fnp-4692	149	6	neuropathology	neuropathology	NOUN
fnp-4692	149	7	as	as	ADP
fnp-4692	149	8	a	a	DET
fnp-4692	149	9	gold	gold	NOUN
fnp-4692	149	10	standard	standard	NOUN
fnp-4692	149	11	in	in	ADP
fnp-4692	149	12	intraoperative	intraoperative	ADJ
fnp-4692	149	13	brain	brain	NOUN
fnp-4692	149	14	tumor	tumor	NOUN
fnp-4692	149	15	diagnostics	diagnostic	NOUN
fnp-4692	149	16	(	(	PUNCT
fnp-4692	149	17	figure	figure	NOUN
fnp-4692	149	18	3	3	NUM
fnp-4692	149	19	)	)	PUNCT
fnp-4692	149	20	,	,	PUNCT
fnp-4692	149	21	neuropathologists	neuropathologist	NOUN
fnp-4692	149	22	are	be	AUX
fnp-4692	149	23	still	still	ADV
fnp-4692	149	24	key	key	ADJ
fnp-4692	149	25	for	for	SCONJ
fnp-4692	149	26	the	the	DET
fnp-4692	149	27	further	further	ADJ
fnp-4692	149	28	development	development	NOUN
fnp-4692	149	29	of	of	ADP
fnp-4692	149	30	these	these	DET
fnp-4692	149	31	approaches	approach	NOUN
fnp-4692	149	32	as	as	SCONJ
fnp-4692	149	33	well	well	ADV
fnp-4692	149	34	-	-	PUNCT
fnp-4692	149	35	functioning	function	VERB
fnp-4692	149	36	machine	machine	NOUN
fnp-4692	149	37	learning	learn	VERB
fnp-4692	149	38	pipelines	pipeline	NOUN
fnp-4692	149	39	need	need	VERB
fnp-4692	149	40	an	an	DET
fnp-4692	149	41	excellent	excellent	ADJ
fnp-4692	149	42	prior	prior	ADJ
fnp-4692	149	43	histological	histological	ADJ
fnp-4692	149	44	and	and	CCONJ
fnp-4692	149	45	molecular	molecular	ADJ
fnp-4692	149	46	annotation	annotation	NOUN
fnp-4692	149	47	.	.	PUNCT
fnp-4692	150	1	figure	figure	NOUN
fnp-4692	150	2	3	3	NUM
fnp-4692	150	3	:	:	PUNCT
fnp-4692	150	4	potential	potential	ADJ
fnp-4692	150	5	intraoperative	intraoperative	ADJ
fnp-4692	150	6	applications	application	NOUN
fnp-4692	150	7	of	of	ADP
fnp-4692	150	8	raman	raman	ADJ
fnp-4692	150	9	effect	effect	NOUN
fnp-4692	150	10	-	-	PUNCT
fnp-4692	150	11	based	base	VERB
fnp-4692	150	12	techniques	technique	NOUN
fnp-4692	150	13	combined	combine	VERB
fnp-4692	150	14	with	with	ADP
fnp-4692	150	15	machine	machine	NOUN
fnp-4692	150	16	learning	learning	NOUN
fnp-4692	150	17	tools	tool	NOUN
fnp-4692	150	18	.	.	PUNCT
fnp-4692	151	1	raman	raman	NOUN
fnp-4692	151	2	spectroscopy	spectroscopy	NOUN
fnp-4692	151	3	is	be	AUX
fnp-4692	151	4	a	a	DET
fnp-4692	151	5	label	label	NOUN
fnp-4692	151	6	-	-	PUNCT
fnp-4692	151	7	free	free	ADJ
fnp-4692	151	8	,	,	PUNCT
fnp-4692	151	9	non	non	ADJ
fnp-4692	151	10	-	-	ADJ
fnp-4692	151	11	disruptive	disruptive	ADJ
fnp-4692	151	12	method	method	NOUN
fnp-4692	151	13	based	base	VERB
fnp-4692	151	14	on	on	ADP
fnp-4692	151	15	an	an	DET
fnp-4692	151	16	inelastic	inelastic	ADJ
fnp-4692	151	17	scattering	scatter	VERB
fnp-4692	151	18	effect	effect	NOUN
fnp-4692	151	19	of	of	ADP
fnp-4692	151	20	photons	photon	NOUN
fnp-4692	151	21	allowing	allow	VERB
fnp-4692	151	22	for	for	ADP
fnp-4692	151	23	the	the	DET
fnp-4692	151	24	quantitative	quantitative	ADJ
fnp-4692	151	25	molecular	molecular	ADJ
fnp-4692	151	26	assessment	assessment	NOUN
fnp-4692	151	27	of	of	ADP
fnp-4692	151	28	biological	biological	ADJ
fnp-4692	151	29	samples	sample	NOUN
fnp-4692	151	30	resulting	result	VERB
fnp-4692	151	31	in	in	ADP
fnp-4692	151	32	different	different	ADJ
fnp-4692	151	33	spectra	spectra	PROPN
fnp-4692	151	34	.	.	PROPN
fnp-4692	151	35	stimulated	stimulate	VERB
fnp-4692	151	36	raman	raman	NOUN
fnp-4692	151	37	histology	histology	NOUN
fnp-4692	151	38	(	(	PUNCT
fnp-4692	151	39	srh	srh	PROPN
fnp-4692	151	40	)	)	PUNCT
fnp-4692	151	41	is	be	AUX
fnp-4692	151	42	a	a	DET
fnp-4692	151	43	variant	variant	NOUN
fnp-4692	151	44	of	of	ADP
fnp-4692	151	45	raman	raman	NOUN
fnp-4692	151	46	spectroscopy	spectroscopy	NOUN
fnp-4692	151	47	allowing	allow	VERB
fnp-4692	151	48	for	for	ADP
fnp-4692	151	49	the	the	DET
fnp-4692	151	50	creation	creation	NOUN
fnp-4692	151	51	of	of	ADP
fnp-4692	151	52	hematoxylin	hematoxylin	NOUN
fnp-4692	151	53	and	and	CCONJ
fnp-4692	151	54	eosin	eosin	NOUN
fnp-4692	151	55	(	(	PUNCT
fnp-4692	151	56	he	he	PRON
fnp-4692	151	57	)	)	PUNCT
fnp-4692	151	58	slide	slide	NOUN
fnp-4692	151	59	mimics	mimic	NOUN
fnp-4692	151	60	based	base	VERB
fnp-4692	151	61	on	on	ADP
fnp-4692	151	62	quantification	quantification	NOUN
fnp-4692	151	63	of	of	ADP
fnp-4692	151	64	distinct	distinct	ADJ
fnp-4692	151	65	molecules	molecule	NOUN
fnp-4692	151	66	(	(	PUNCT
fnp-4692	151	67	mainly	mainly	ADV
fnp-4692	151	68	lipids	lipids	ADJ
fnp-4692	151	69	,	,	PUNCT
fnp-4692	151	70	proteins	protein	NOUN
fnp-4692	151	71	and	and	CCONJ
fnp-4692	151	72	nucleic	nucleic	ADJ
fnp-4692	151	73	acids	acid	NOUN
fnp-4692	151	74	)	)	PUNCT
fnp-4692	151	75	.	.	PUNCT
fnp-4692	152	1	9	9	X
fnp-4692	152	2	.	.	X
fnp-4692	152	3	intraoperative	intraoperative	ADJ
fnp-4692	152	4	molecular	molecular	ADJ
fnp-4692	152	5	tumor	tumor	NOUN
fnp-4692	152	6	profiling	profiling	NOUN
fnp-4692	152	7	[	[	X
fnp-4692	152	8	12	12	NUM
fnp-4692	152	9	,	,	PUNCT
fnp-4692	152	10	13	13	NUM
fnp-4692	152	11	]	]	X
fnp-4692	152	12	molecular	molecular	ADJ
fnp-4692	152	13	diagnostics	diagnostic	NOUN
fnp-4692	152	14	becomes	become	VERB
fnp-4692	152	15	more	more	ADV
fnp-4692	152	16	and	and	CCONJ
fnp-4692	152	17	more	more	ADV
fnp-4692	152	18	important	important	ADJ
fnp-4692	152	19	not	not	PART
fnp-4692	152	20	only	only	ADV
fnp-4692	152	21	for	for	ADP
fnp-4692	152	22	precise	precise	ADJ
fnp-4692	152	23	patient	patient	ADJ
fnp-4692	152	24	stratification	stratification	NOUN
fnp-4692	152	25	but	but	CCONJ
fnp-4692	152	26	also	also	ADV
fnp-4692	152	27	for	for	ADP
fnp-4692	152	28	targeted	target	VERB
fnp-4692	152	29	therapy	therapy	NOUN
fnp-4692	152	30	strategies	strategy	NOUN
fnp-4692	152	31	[	[	X
fnp-4692	152	32	29	29	NUM
fnp-4692	152	33	]	]	PUNCT
fnp-4692	152	34	.	.	PUNCT
fnp-4692	153	1	especially	especially	ADV
fnp-4692	153	2	in	in	ADP
fnp-4692	153	3	the	the	DET
fnp-4692	153	4	field	field	NOUN
fnp-4692	153	5	of	of	ADP
fnp-4692	153	6	cns	cns	NOUN
fnp-4692	153	7	neoplasms	neoplasm	NOUN
fnp-4692	153	8	,	,	PUNCT
fnp-4692	153	9	some	some	DET
fnp-4692	153	10	entities	entity	NOUN
fnp-4692	153	11	can	can	AUX
fnp-4692	153	12	nowadays	nowadays	ADV
fnp-4692	153	13	only	only	ADV
fnp-4692	153	14	be	be	AUX
fnp-4692	153	15	unequivocally	unequivocally	ADV
fnp-4692	153	16	diagnosed	diagnose	VERB
fnp-4692	153	17	by	by	ADP
fnp-4692	153	18	methylation	methylation	NOUN
fnp-4692	153	19	profiling	profiling	NOUN
fnp-4692	153	20	[	[	X
fnp-4692	153	21	20	20	NUM
fnp-4692	153	22	]	]	PUNCT
fnp-4692	153	23	.	.	PUNCT
fnp-4692	154	1	along	along	ADP
fnp-4692	154	2	this	this	DET
fnp-4692	154	3	line	line	NOUN
fnp-4692	154	4	,	,	PUNCT
fnp-4692	154	5	technical	technical	ADJ
fnp-4692	154	6	developments	development	NOUN
fnp-4692	154	7	and	and	CCONJ
fnp-4692	154	8	applications	application	NOUN
fnp-4692	154	9	related	relate	VERB
fnp-4692	154	10	to	to	ADP
fnp-4692	154	11	molecular	molecular	ADJ
fnp-4692	154	12	tumor	tumor	NOUN
fnp-4692	154	13	testing	testing	NOUN
fnp-4692	154	14	need	need	VERB
fnp-4692	154	15	to	to	PART
fnp-4692	154	16	take	take	VERB
fnp-4692	154	17	into	into	ADP
fnp-4692	154	18	account	account	NOUN
fnp-4692	154	19	diagnostic	diagnostic	ADJ
fnp-4692	154	20	precision	precision	NOUN
fnp-4692	154	21	,	,	PUNCT
fnp-4692	154	22	speed	speed	NOUN
fnp-4692	154	23	and	and	CCONJ
fnp-4692	154	24	costs	cost	NOUN
fnp-4692	154	25	.	.	PUNCT
fnp-4692	155	1	as	as	ADP
fnp-4692	155	2	the	the	DET
fnp-4692	155	3	method	method	NOUN
fnp-4692	155	4	of	of	ADP
fnp-4692	155	5	the	the	DET
fnp-4692	155	6	year	year	NOUN
fnp-4692	155	7	2022	2022	NUM
fnp-4692	155	8	,	,	PUNCT
fnp-4692	155	9	nature	nature	NOUN
fnp-4692	155	10	methods	method	NOUN
fnp-4692	155	11	has	have	AUX
fnp-4692	155	12	chosen	choose	VERB
fnp-4692	155	13	long	long	ADV
fnp-4692	155	14	-	-	PUNCT
fnp-4692	155	15	read	read	NOUN
fnp-4692	155	16	sequencing	sequencing	NOUN
fnp-4692	155	17	,	,	PUNCT
fnp-4692	155	18	with	with	ADP
fnp-4692	155	19	single	single	ADJ
fnp-4692	155	20	molecule	molecule	NOUN
fnp-4692	155	21	real	real	ADJ
fnp-4692	155	22	-	-	PUNCT
fnp-4692	155	23	time	time	NOUN
fnp-4692	155	24	(	(	PUNCT
fnp-4692	155	25	smrt	smrt	NOUN
fnp-4692	155	26	)	)	PUNCT
fnp-4692	155	27	from	from	ADP
fnp-4692	155	28	pacific	pacific	ADJ
fnp-4692	155	29	biosciences	bioscience	NOUN
fnp-4692	155	30	and	and	CCONJ
fnp-4692	155	31	nanopore	nanopore	ADV
fnp-4692	155	32	sequencing	sequence	VERB
fnp-4692	155	33	(	(	PUNCT
fnp-4692	155	34	nps	nps	PROPN
fnp-4692	155	35	)	)	PUNCT
fnp-4692	155	36	from	from	ADP
fnp-4692	155	37	oxford	oxford	PROPN
fnp-4692	155	38	nanopore	nanopore	ADJ
fnp-4692	155	39	technologies	technology	NOUN
fnp-4692	155	40	being	be	AUX
fnp-4692	155	41	the	the	DET
fnp-4692	155	42	most	most	ADV
fnp-4692	155	43	frequently	frequently	ADV
fnp-4692	155	44	used	use	VERB
fnp-4692	155	45	commercially	commercially	ADV
fnp-4692	155	46	available	available	ADJ
fnp-4692	155	47	applications	application	NOUN
fnp-4692	155	48	[	[	X
fnp-4692	155	49	30	30	NUM
fnp-4692	155	50	]	]	PUNCT
fnp-4692	155	51	.	.	PUNCT
fnp-4692	156	1	while	while	SCONJ
fnp-4692	156	2	accuracy	accuracy	NOUN
fnp-4692	156	3	seems	seem	VERB
fnp-4692	156	4	to	to	PART
fnp-4692	156	5	be	be	AUX
fnp-4692	156	6	only	only	ADV
fnp-4692	156	7	slightly	slightly	ADV
fnp-4692	156	8	superior	superior	ADJ
fnp-4692	156	9	in	in	ADP
fnp-4692	156	10	smrt	smrt	NOUN
fnp-4692	156	11	as	as	SCONJ
fnp-4692	156	12	compared	compare	VERB
fnp-4692	156	13	to	to	ADP
fnp-4692	156	14	nps	nps	PROPN
fnp-4692	156	15	,	,	PUNCT
fnp-4692	156	16	the	the	DET
fnp-4692	156	17	latter	latter	ADJ
fnp-4692	156	18	allows	allow	VERB
fnp-4692	156	19	for	for	ADP
fnp-4692	156	20	longer	long	ADJ
fnp-4692	156	21	average	average	ADJ
fnp-4692	156	22	read	read	NOUN
fnp-4692	156	23	lengths	length	NOUN
fnp-4692	156	24	(	(	PUNCT
fnp-4692	156	25	approximately	approximately	ADV
fnp-4692	156	26	100	100	NUM
fnp-4692	156	27	kb	kb	NOUN
fnp-4692	156	28	for	for	ADP
fnp-4692	156	29	ultra	ultra	ADJ
fnp-4692	156	30	-	-	ADJ
fnp-4692	156	31	long	long	ADJ
fnp-4692	156	32	reads	read	NOUN
fnp-4692	156	33	)	)	PUNCT
fnp-4692	156	34	as	as	SCONJ
fnp-4692	156	35	compared	compare	VERB
fnp-4692	156	36	to	to	ADP
fnp-4692	156	37	smrt	smrt	NOUN
fnp-4692	156	38	.	.	PUNCT
fnp-4692	157	1	it	it	PRON
fnp-4692	157	2	is	be	AUX
fnp-4692	157	3	therefore	therefore	ADV
fnp-4692	157	4	no	no	DET
fnp-4692	157	5	surprise	surprise	NOUN
fnp-4692	157	6	that	that	SCONJ
fnp-4692	157	7	those	those	DET
fnp-4692	157	8	techniques	technique	NOUN
fnp-4692	157	9	could	could	AUX
fnp-4692	157	10	also	also	ADV
fnp-4692	157	11	have	have	VERB
fnp-4692	157	12	an	an	DET
fnp-4692	157	13	impact	impact	NOUN
fnp-4692	157	14	on	on	ADP
fnp-4692	157	15	diagnostic	diagnostic	ADJ
fnp-4692	157	16	strategies	strategy	NOUN
fnp-4692	157	17	in	in	ADP
fnp-4692	157	18	neuropathological	neuropathological	ADJ
fnp-4692	157	19	tumor	tumor	NOUN
fnp-4692	157	20	diagnostics	diagnostic	NOUN
fnp-4692	157	21	.	.	PUNCT
fnp-4692	158	1	using	use	VERB
fnp-4692	158	2	nanopore	nanopore	ADJ
fnp-4692	158	3	sequencing	sequence	VERB
fnp-4692	158	4	techniques	technique	NOUN
fnp-4692	158	5	,	,	PUNCT
fnp-4692	158	6	patel	patel	PROPN
fnp-4692	158	7	et	et	PROPN
fnp-4692	158	8	al	al	PROPN
fnp-4692	158	9	.	.	PROPN
fnp-4692	158	10	introduce	introduce	VERB
fnp-4692	158	11	a	a	DET
fnp-4692	158	12	diagnostic	diagnostic	ADJ
fnp-4692	158	13	pipeline	pipeline	NOUN
fnp-4692	158	14	entitled	entitle	VERB
fnp-4692	158	15	rapid	rapid	ADJ
fnp-4692	158	16	-	-	PUNCT
fnp-4692	158	17	cns2	cns2	NOUN
fnp-4692	158	18	allowing	allowing	NOUN
fnp-4692	158	19	for	for	ADP
fnp-4692	158	20	testing	testing	NOUN
fnp-4692	158	21	copy	copy	NOUN
fnp-4692	158	22	-	-	PUNCT
fnp-4692	158	23	number	number	NOUN
fnp-4692	158	24	,	,	PUNCT
fnp-4692	158	25	mutational	mutational	ADJ
fnp-4692	158	26	and	and	CCONJ
fnp-4692	158	27	methylation	methylation	NOUN
fnp-4692	158	28	profiling	profiling	NOUN
fnp-4692	158	29	in	in	ADP
fnp-4692	158	30	parallel	parallel	NOUN
fnp-4692	158	31	[	[	X
fnp-4692	158	32	13	13	NUM
fnp-4692	158	33	]	]	PUNCT
fnp-4692	158	34	.	.	PUNCT
fnp-4692	159	1	with	with	ADP
fnp-4692	159	2	this	this	DET
fnp-4692	159	3	approach	approach	NOUN
fnp-4692	159	4	,	,	PUNCT
fnp-4692	159	5	considerably	considerably	ADV
fnp-4692	159	6	simplified	simplified	ADJ
fnp-4692	159	7	library	library	ADJ
fnp-4692	159	8	preparations	preparation	NOUN
fnp-4692	159	9	at	at	ADP
fnp-4692	159	10	lower	low	ADJ
fnp-4692	159	11	costs	cost	NOUN
fnp-4692	159	12	are	be	AUX
fnp-4692	159	13	possible	possible	ADJ
fnp-4692	159	14	with	with	ADP
fnp-4692	159	15	highly	highly	ADV
fnp-4692	159	16	similar	similar	ADJ
fnp-4692	159	17	diagnostic	diagnostic	ADJ
fnp-4692	159	18	precision	precision	NOUN
fnp-4692	159	19	as	as	SCONJ
fnp-4692	159	20	compared	compare	VERB
fnp-4692	159	21	to	to	ADP
fnp-4692	159	22	standard	standard	ADJ
fnp-4692	159	23	methods	method	NOUN
fnp-4692	159	24	(	(	PUNCT
fnp-4692	159	25	figure	figure	NOUN
fnp-4692	159	26	4	4	NUM
fnp-4692	159	27	)	)	PUNCT
fnp-4692	159	28	.	.	PUNCT
fnp-4692	160	1	discrepancies	discrepancy	NOUN
fnp-4692	160	2	in	in	ADP
fnp-4692	160	3	isolated	isolated	ADJ
fnp-4692	160	4	cases	case	NOUN
fnp-4692	160	5	were	be	AUX
fnp-4692	160	6	related	relate	VERB
fnp-4692	160	7	to	to	ADP
fnp-4692	160	8	a	a	DET
fnp-4692	160	9	low	low	ADJ
fnp-4692	160	10	tumor	tumor	NOUN
fnp-4692	160	11	cell	cell	NOUN
fnp-4692	160	12	content	content	NOUN
fnp-4692	160	13	,	,	PUNCT
fnp-4692	160	14	therefore	therefore	ADV
fnp-4692	160	15	,	,	PUNCT
fnp-4692	160	16	a	a	DET
fnp-4692	160	17	careful	careful	ADJ
fnp-4692	160	18	standard	standard	ADJ
fnp-4692	160	19	microscopic	microscopic	ADJ
fnp-4692	160	20	neuropathological	neuropathological	ADJ
fnp-4692	160	21	assessment	assessment	NOUN
fnp-4692	160	22	is	be	AUX
fnp-4692	160	23	mandatory	mandatory	ADJ
fnp-4692	160	24	during	during	ADP
fnp-4692	160	25	the	the	DET
fnp-4692	160	26	workflow	workflow	NOUN
fnp-4692	160	27	.	.	PUNCT
fnp-4692	161	1	a	a	DET
fnp-4692	161	2	pure	pure	ADJ
fnp-4692	161	3	sequencing	sequencing	NOUN
fnp-4692	161	4	time	time	NOUN
fnp-4692	161	5	of	of	ADP
fnp-4692	161	6	24	24	NUM
fnp-4692	161	7	hours	hour	NOUN
fnp-4692	161	8	was	be	AUX
fnp-4692	161	9	sufficient	sufficient	ADJ
fnp-4692	161	10	to	to	PART
fnp-4692	161	11	conclude	conclude	VERB
fnp-4692	161	12	cases	case	NOUN
fnp-4692	161	13	with	with	ADP
fnp-4692	161	14	a	a	DET
fnp-4692	161	15	comprehensive	comprehensive	ADJ
fnp-4692	161	16	neuropathological	neuropathological	ADJ
fnp-4692	161	17	diagnosis	diagnosis	NOUN
fnp-4692	161	18	,	,	PUNCT
fnp-4692	161	19	however	however	ADV
fnp-4692	161	20	,	,	PUNCT
fnp-4692	161	21	this	this	DET
fnp-4692	161	22	pipeline	pipeline	NOUN
fnp-4692	161	23	is	be	AUX
fnp-4692	161	24	currently	currently	ADV
fnp-4692	161	25	restricted	restrict	VERB
fnp-4692	161	26	in	in	ADP
fnp-4692	161	27	use	use	NOUN
fnp-4692	161	28	for	for	ADP
fnp-4692	161	29	cryo	cryo	NOUN
fnp-4692	161	30	-	-	PUNCT
fnp-4692	161	31	preserved	preserve	VERB
fnp-4692	161	32	tissue	tissue	NOUN
fnp-4692	161	33	only	only	ADV
fnp-4692	161	34	.	.	PUNCT
fnp-4692	162	1	in	in	ADP
fnp-4692	162	2	a	a	DET
fnp-4692	162	3	similar	similar	ADJ
fnp-4692	162	4	nanopore	nanopore	ADJ
fnp-4692	162	5	sequencing	sequence	VERB
fnp-4692	162	6	approach	approach	NOUN
fnp-4692	162	7	,	,	PUNCT
fnp-4692	162	8	however	however	ADV
fnp-4692	162	9	,	,	PUNCT
fnp-4692	162	10	focusing	focus	VERB
fnp-4692	162	11	on	on	ADP
fnp-4692	162	12	methylation	methylation	NOUN
fnp-4692	162	13	profiling	profiling	NOUN
fnp-4692	162	14	without	without	ADP
fnp-4692	162	15	having	have	VERB
fnp-4692	162	16	the	the	DET
fnp-4692	162	17	full	full	ADJ
fnp-4692	162	18	molecular	molecular	ADJ
fnp-4692	162	19	profile	profile	NOUN
fnp-4692	162	20	for	for	ADP
fnp-4692	162	21	important	important	ADJ
fnp-4692	162	22	selected	select	VERB
fnp-4692	162	23	mutations	mutation	NOUN
fnp-4692	162	24	,	,	PUNCT
fnp-4692	162	25	kuschel	kuschel	PROPN
fnp-4692	162	26	et	et	PROPN
fnp-4692	162	27	al	al	PROPN
fnp-4692	162	28	.	.	PROPN
fnp-4692	162	29	performed	perform	VERB
fnp-4692	162	30	a	a	DET
fnp-4692	162	31	combined	combine	VERB
fnp-4692	162	32	retroand	retroand	NOUN
fnp-4692	162	33	prospective	prospective	ADJ
fnp-4692	162	34	study	study	NOUN
fnp-4692	162	35	arriving	arrive	VERB
fnp-4692	162	36	at	at	ADP
fnp-4692	162	37	a	a	DET
fnp-4692	162	38	total	total	ADJ
fnp-4692	162	39	turnaround	turnaround	NOUN
fnp-4692	162	40	time	time	NOUN
fnp-4692	162	41	of	of	ADP
fnp-4692	162	42	only	only	ADV
fnp-4692	162	43	21	21	NUM
fnp-4692	162	44	hours	hour	NOUN
fnp-4692	162	45	from	from	ADP
fnp-4692	162	46	sample	sample	NOUN
fnp-4692	162	47	reception	reception	NOUN
fnp-4692	162	48	to	to	PART
fnp-4692	162	49	report	report	VERB
fnp-4692	162	50	of	of	ADP
fnp-4692	162	51	the	the	DET
fnp-4692	162	52	diagnoses	diagnosis	NOUN
fnp-4692	162	53	[	[	X
fnp-4692	162	54	12	12	NUM
fnp-4692	162	55	]	]	PUNCT
fnp-4692	162	56	.	.	PUNCT
fnp-4692	163	1	of	of	ADP
fnp-4692	163	2	note	note	NOUN
fnp-4692	163	3	,	,	PUNCT
fnp-4692	163	4	as	as	ADV
fnp-4692	163	5	few	few	ADJ
fnp-4692	163	6	as	as	ADP
fnp-4692	163	7	1000	1000	NUM
fnp-4692	163	8	randomly	randomly	ADV
fnp-4692	163	9	analyzed	analyze	VERB
fnp-4692	163	10	cpgs	cpgs	NOUN
fnp-4692	163	11	were	be	AUX
fnp-4692	163	12	sufficient	sufficient	ADJ
fnp-4692	163	13	for	for	ADP
fnp-4692	163	14	highly	highly	ADV
fnp-4692	163	15	meaningful	meaningful	ADJ
fnp-4692	163	16	methylation	methylation	NOUN
fnp-4692	163	17	classification	classification	NOUN
fnp-4692	163	18	.	.	PUNCT
fnp-4692	164	1	multiple	multiple	ADJ
fnp-4692	164	2	initiatives	initiative	NOUN
fnp-4692	164	3	are	be	AUX
fnp-4692	164	4	ongoing	ongoing	ADJ
fnp-4692	164	5	,	,	PUNCT
fnp-4692	164	6	pushing	push	VERB
fnp-4692	164	7	even	even	ADV
fnp-4692	164	8	further	far	ADV
fnp-4692	164	9	towards	towards	ADP
fnp-4692	164	10	direct	direct	ADJ
fnp-4692	164	11	intraoperative	intraoperative	ADJ
fnp-4692	164	12	molecular	molecular	ADJ
fnp-4692	164	13	tumor	tumor	NOUN
fnp-4692	164	14	profiling	profiling	NOUN
fnp-4692	164	15	[	[	X
fnp-4692	164	16	31	31	NUM
fnp-4692	164	17	]	]	PUNCT
fnp-4692	164	18	.	.	PUNCT
fnp-4692	165	1	as	as	ADP
fnp-4692	165	2	final	final	ADJ
fnp-4692	165	3	treatment	treatment	NOUN
fnp-4692	165	4	decisions	decision	NOUN
fnp-4692	165	5	according	accord	VERB
fnp-4692	165	6	to	to	ADP
fnp-4692	165	7	standard	standard	ADJ
fnp-4692	165	8	treatment	treatment	NOUN
fnp-4692	165	9	guidelines	guideline	NOUN
fnp-4692	165	10	are	be	AUX
fnp-4692	165	11	often	often	ADV
fnp-4692	165	12	made	make	VERB
fnp-4692	165	13	only	only	ADV
fnp-4692	165	14	several	several	ADJ
fnp-4692	165	15	days	day	NOUN
fnp-4692	165	16	after	after	ADP
fnp-4692	165	17	the	the	DET
fnp-4692	165	18	operation	operation	NOUN
fnp-4692	165	19	in	in	ADP
fnp-4692	165	20	multidisciplinary	multidisciplinary	ADJ
fnp-4692	165	21	tumor	tumor	NOUN
fnp-4692	165	22	boards	board	NOUN
fnp-4692	165	23	,	,	PUNCT
fnp-4692	165	24	one	one	PRON
fnp-4692	165	25	could	could	AUX
fnp-4692	165	26	question	question	VERB
fnp-4692	165	27	the	the	DET
fnp-4692	165	28	necessity	necessity	NOUN
fnp-4692	165	29	of	of	ADP
fnp-4692	165	30	speeding	speed	VERB
fnp-4692	165	31	up	up	ADP
fnp-4692	165	32	intraoperative	intraoperative	ADJ
fnp-4692	165	33	diagnostic	diagnostic	ADJ
fnp-4692	165	34	assessments	assessment	NOUN
fnp-4692	165	35	.	.	PUNCT
fnp-4692	166	1	however	however	ADV
fnp-4692	166	2	,	,	PUNCT
fnp-4692	166	3	as	as	ADP
fnp-4692	166	4	multiple	multiple	ADJ
fnp-4692	166	5	innovative	innovative	ADJ
fnp-4692	166	6	,	,	PUNCT
fnp-4692	166	7	targeted	target	VERB
fnp-4692	166	8	anti	anti	ADJ
fnp-4692	166	9	-	-	ADJ
fnp-4692	166	10	tumor	tumor	ADJ
fnp-4692	166	11	treatment	treatment	NOUN
fnp-4692	166	12	approaches	approach	NOUN
fnp-4692	166	13	such	such	ADJ
fnp-4692	166	14	as	as	ADP
fnp-4692	166	15	the	the	DET
fnp-4692	166	16	application	application	NOUN
fnp-4692	166	17	of	of	ADP
fnp-4692	166	18	t	t	PROPN
fnp-4692	166	19	cells	cell	NOUN
fnp-4692	166	20	harboring	harbor	VERB
fnp-4692	166	21	chimeric	chimeric	ADJ
fnp-4692	166	22	antigen	antigen	ADJ
fnp-4692	166	23	receptors	receptor	NOUN
fnp-4692	166	24	(	(	PUNCT
fnp-4692	166	25	car	car	NOUN
fnp-4692	166	26	-	-	PUNCT
fnp-4692	166	27	t	t	NOUN
fnp-4692	166	28	cells	cell	NOUN
fnp-4692	166	29	)	)	PUNCT
fnp-4692	166	30	or	or	CCONJ
fnp-4692	166	31	oncolytic	oncolytic	ADJ
fnp-4692	166	32	viruses	virus	NOUN
fnp-4692	166	33	would	would	AUX
fnp-4692	166	34	necessitate	necessitate	VERB
fnp-4692	166	35	a	a	DET
fnp-4692	166	36	follow	follow	VERB
fnp-4692	166	37	-	-	PUNCT
fnp-4692	166	38	up	up	ADP
fnp-4692	166	39	neurosurgical	neurosurgical	ADJ
fnp-4692	166	40	intervention	intervention	NOUN
fnp-4692	166	41	,	,	PUNCT
fnp-4692	166	42	e.g.	e.g.	ADV
fnp-4692	166	43	for	for	ADP
fnp-4692	166	44	the	the	DET
fnp-4692	166	45	placement	placement	NOUN
fnp-4692	166	46	of	of	ADP
fnp-4692	166	47	a	a	DET
fnp-4692	166	48	catheter	catheter	NOUN
fnp-4692	166	49	after	after	ADP
fnp-4692	166	50	the	the	DET
fnp-4692	166	51	exact	exact	ADJ
fnp-4692	166	52	molecular	molecular	ADJ
fnp-4692	166	53	definition	definition	NOUN
fnp-4692	166	54	of	of	ADP
fnp-4692	166	55	potential	potential	ADJ
fnp-4692	166	56	targets	target	NOUN
fnp-4692	166	57	,	,	PUNCT
fnp-4692	166	58	intraoperative	intraoperative	ADJ
fnp-4692	166	59	tumor	tumor	NOUN
fnp-4692	166	60	diagnostics	diagnostic	NOUN
fnp-4692	166	61	could	could	AUX
fnp-4692	166	62	overcome	overcome	VERB
fnp-4692	166	63	those	those	DET
fnp-4692	166	64	obstacles	obstacle	NOUN
fnp-4692	166	65	.	.	PUNCT
fnp-4692	167	1	figure	figure	VERB
fnp-4692	167	2	4	4	NUM
fnp-4692	167	3	:	:	PUNCT
fnp-4692	167	4	scheme	scheme	NOUN
fnp-4692	167	5	for	for	ADP
fnp-4692	167	6	fast	fast	ADJ
fnp-4692	167	7	,	,	PUNCT
fnp-4692	167	8	precise	precise	ADJ
fnp-4692	167	9	and	and	CCONJ
fnp-4692	167	10	unbiased	unbiased	ADJ
fnp-4692	167	11	molecular	molecular	ADJ
fnp-4692	167	12	diagnostics	diagnostic	NOUN
fnp-4692	167	13	using	use	VERB
fnp-4692	167	14	nanopore	nanopore	ADJ
fnp-4692	167	15	sequencing	sequence	VERB
fnp-4692	167	16	,	,	PUNCT
fnp-4692	167	17	suitable	suitable	ADJ
fnp-4692	167	18	for	for	ADP
fnp-4692	167	19	mutational	mutational	ADJ
fnp-4692	167	20	,	,	PUNCT
fnp-4692	167	21	transcriptome	transcriptome	ADJ
fnp-4692	167	22	and	and	CCONJ
fnp-4692	167	23	methylome	methylome	ADJ
fnp-4692	167	24	analyses	analysis	NOUN
fnp-4692	167	25	.	.	PUNCT
fnp-4692	168	1	10	10	NUM
fnp-4692	168	2	.	.	PUNCT
fnp-4692	168	3	drug	drug	NOUN
fnp-4692	168	4	screening	screen	VERB
fnp-4692	168	5	platform	platform	NOUN
fnp-4692	168	6	for	for	ADP
fnp-4692	168	7	brain	brain	NOUN
fnp-4692	168	8	metastasis	metastasis	NOUN
fnp-4692	168	9	[	[	X
fnp-4692	168	10	14	14	NUM
fnp-4692	168	11	]	]	PUNCT
fnp-4692	168	12	brain	brain	NOUN
fnp-4692	168	13	metastases	metastasis	NOUN
fnp-4692	168	14	constitute	constitute	VERB
fnp-4692	168	15	the	the	DET
fnp-4692	168	16	group	group	NOUN
fnp-4692	168	17	of	of	ADP
fnp-4692	168	18	the	the	DET
fnp-4692	168	19	most	most	ADV
fnp-4692	168	20	frequent	frequent	ADJ
fnp-4692	168	21	and	and	CCONJ
fnp-4692	168	22	malignant	malignant	ADJ
fnp-4692	168	23	brain	brain	NOUN
fnp-4692	168	24	tumors	tumor	NOUN
fnp-4692	168	25	that	that	PRON
fnp-4692	168	26	may	may	AUX
fnp-4692	168	27	affect	affect	VERB
fnp-4692	168	28	around	around	ADV
fnp-4692	168	29	20	20	NUM
fnp-4692	168	30	-	-	SYM
fnp-4692	168	31	25	25	NUM
fnp-4692	168	32	%	%	NOUN
fnp-4692	168	33	of	of	ADP
fnp-4692	168	34	all	all	DET
fnp-4692	168	35	cancer	cancer	NOUN
fnp-4692	168	36	patients	patient	NOUN
fnp-4692	168	37	and	and	CCONJ
fnp-4692	168	38	are	be	AUX
fnp-4692	168	39	usually	usually	ADV
fnp-4692	168	40	associated	associate	VERB
fnp-4692	168	41	with	with	ADP
fnp-4692	168	42	a	a	DET
fnp-4692	168	43	very	very	ADV
fnp-4692	168	44	poor	poor	ADJ
fnp-4692	168	45	prognosis	prognosis	NOUN
fnp-4692	168	46	[	[	X
fnp-4692	168	47	32	32	NUM
fnp-4692	168	48	,	,	PUNCT
fnp-4692	168	49	33	33	NUM
fnp-4692	168	50	]	]	PUNCT
fnp-4692	168	51	.	.	PUNCT
fnp-4692	169	1	although	although	SCONJ
fnp-4692	169	2	brain	brain	NOUN
fnp-4692	169	3	metastases	metastasis	NOUN
fnp-4692	169	4	comprise	comprise	VERB
fnp-4692	169	5	a	a	DET
fnp-4692	169	6	very	very	ADV
fnp-4692	169	7	heterogenous	heterogenous	ADJ
fnp-4692	169	8	group	group	NOUN
fnp-4692	169	9	regarding	regard	VERB
fnp-4692	169	10	their	their	PRON
fnp-4692	169	11	cellular	cellular	ADJ
fnp-4692	169	12	origin	origin	NOUN
fnp-4692	169	13	,	,	PUNCT
fnp-4692	169	14	the	the	DET
fnp-4692	169	15	site	site	NOUN
fnp-4692	169	16	of	of	ADP
fnp-4692	169	17	metastasis	metastasis	PRON
fnp-4692	169	18	as	as	ADV
fnp-4692	169	19	well	well	ADV
fnp-4692	169	20	as	as	ADP
fnp-4692	169	21	the	the	DET
fnp-4692	169	22	number	number	NOUN
fnp-4692	169	23	of	of	ADP
fnp-4692	169	24	metastatic	metastatic	ADJ
fnp-4692	169	25	spots	spot	NOUN
fnp-4692	169	26	,	,	PUNCT
fnp-4692	169	27	in	in	ADP
fnp-4692	169	28	many	many	ADJ
fnp-4692	169	29	clinical	clinical	ADJ
fnp-4692	169	30	conditions	condition	NOUN
fnp-4692	169	31	no	no	DET
fnp-4692	169	32	entityor	entityor	ADJ
fnp-4692	169	33	target	target	NOUN
fnp-4692	169	34	-	-	PUNCT
fnp-4692	169	35	specific	specific	ADJ
fnp-4692	169	36	treatment	treatment	NOUN
fnp-4692	169	37	is	be	AUX
fnp-4692	169	38	available	available	ADJ
fnp-4692	169	39	.	.	PUNCT
fnp-4692	170	1	furthermore	furthermore	ADV
fnp-4692	170	2	,	,	PUNCT
fnp-4692	170	3	even	even	ADV
fnp-4692	170	4	though	though	SCONJ
fnp-4692	170	5	both	both	CCONJ
fnp-4692	170	6	primary	primary	ADJ
fnp-4692	170	7	and	and	CCONJ
fnp-4692	170	8	secondary	secondary	ADJ
fnp-4692	170	9	tumors	tumor	NOUN
fnp-4692	170	10	are	be	AUX
fnp-4692	170	11	more	more	ADV
fnp-4692	170	12	and	and	CCONJ
fnp-4692	170	13	more	more	ADV
fnp-4692	170	14	profiled	profile	VERB
fnp-4692	170	15	by	by	ADP
fnp-4692	170	16	means	mean	NOUN
fnp-4692	170	17	of	of	ADP
fnp-4692	170	18	molecular	molecular	ADJ
fnp-4692	170	19	diagnostics	diagnostic	NOUN
fnp-4692	170	20	,	,	PUNCT
fnp-4692	170	21	potential	potential	ADJ
fnp-4692	170	22	molecular	molecular	ADJ
fnp-4692	170	23	targets	target	NOUN
fnp-4692	170	24	might	might	AUX
fnp-4692	170	25	be	be	AUX
fnp-4692	170	26	no	no	ADV
fnp-4692	170	27	longer	long	ADV
fnp-4692	170	28	successfully	successfully	ADV
fnp-4692	170	29	druggable	druggable	ADJ
fnp-4692	170	30	as	as	SCONJ
fnp-4692	170	31	the	the	DET
fnp-4692	170	32	development	development	NOUN
fnp-4692	170	33	of	of	ADP
fnp-4692	170	34	resistance	resistance	NOUN
fnp-4692	170	35	mechanisms	mechanism	NOUN
fnp-4692	170	36	may	may	AUX
fnp-4692	170	37	negatively	negatively	ADV
fnp-4692	170	38	impact	impact	VERB
fnp-4692	170	39	targeted	target	VERB
fnp-4692	170	40	treatment	treatment	NOUN
fnp-4692	170	41	.	.	PUNCT
fnp-4692	171	1	to	to	PART
fnp-4692	171	2	overcome	overcome	VERB
fnp-4692	171	3	these	these	DET
fnp-4692	171	4	drawbacks	drawback	NOUN
fnp-4692	171	5	,	,	PUNCT
fnp-4692	171	6	drug	drug	NOUN
fnp-4692	171	7	screening	screening	NOUN
fnp-4692	171	8	platforms	platform	NOUN
fnp-4692	171	9	are	be	AUX
fnp-4692	171	10	emerging	emerge	VERB
fnp-4692	171	11	that	that	PRON
fnp-4692	171	12	may	may	AUX
fnp-4692	171	13	allow	allow	VERB
fnp-4692	171	14	for	for	ADP
fnp-4692	171	15	deciphering	decipher	VERB
fnp-4692	171	16	the	the	DET
fnp-4692	171	17	best	good	ADJ
fnp-4692	171	18	drugs	drug	NOUN
fnp-4692	171	19	specifically	specifically	ADV
fnp-4692	171	20	applicable	applicable	ADJ
fnp-4692	171	21	for	for	ADP
fnp-4692	171	22	individual	individual	ADJ
fnp-4692	171	23	brain	brain	NOUN
fnp-4692	171	24	metastasis	metastasis	NOUN
fnp-4692	171	25	in	in	ADP
fnp-4692	171	26	a	a	DET
fnp-4692	171	27	preclinical	preclinical	ADJ
fnp-4692	171	28	or	or	CCONJ
fnp-4692	171	29	clinical	clinical	ADJ
fnp-4692	171	30	setting	setting	NOUN
fnp-4692	171	31	(	(	PUNCT
fnp-4692	171	32	figure	figure	NOUN
fnp-4692	171	33	5	5	NUM
fnp-4692	171	34	)	)	PUNCT
fnp-4692	171	35	.	.	PUNCT
fnp-4692	172	1	zhu	zhu	PROPN
fnp-4692	172	2	et	et	PROPN
fnp-4692	172	3	al	al	PROPN
fnp-4692	172	4	.	.	PROPN
fnp-4692	172	5	developed	develop	VERB
fnp-4692	172	6	a	a	DET
fnp-4692	172	7	murine	murine	ADJ
fnp-4692	172	8	model	model	NOUN
fnp-4692	172	9	giving	give	VERB
fnp-4692	172	10	rise	rise	NOUN
fnp-4692	172	11	to	to	ADP
fnp-4692	172	12	brain	brain	NOUN
fnp-4692	172	13	metastasis	metastasis	NOUN
fnp-4692	172	14	upon	upon	SCONJ
fnp-4692	172	15	tumor	tumor	NOUN
fnp-4692	172	16	cell	cell	NOUN
fnp-4692	172	17	injection	injection	NOUN
fnp-4692	172	18	in	in	ADP
fnp-4692	172	19	the	the	DET
fnp-4692	172	20	left	left	ADJ
fnp-4692	172	21	heart	heart	NOUN
fnp-4692	172	22	ventricle	ventricle	NOUN
fnp-4692	173	1	[	[	X
fnp-4692	173	2	14	14	NUM
fnp-4692	173	3	]	]	PUNCT
fnp-4692	173	4	.	.	PUNCT
fnp-4692	174	1	from	from	ADP
fnp-4692	174	2	those	those	DET
fnp-4692	174	3	animals	animal	NOUN
fnp-4692	174	4	,	,	PUNCT
fnp-4692	174	5	organotypic	organotypic	ADJ
fnp-4692	174	6	slice	slice	NOUN
fnp-4692	174	7	cultures	culture	NOUN
fnp-4692	174	8	of	of	ADP
fnp-4692	174	9	brain	brain	NOUN
fnp-4692	174	10	metastases	metastasis	NOUN
fnp-4692	174	11	were	be	AUX
fnp-4692	174	12	performed	perform	VERB
fnp-4692	174	13	and	and	CCONJ
fnp-4692	174	14	treated	treat	VERB
fnp-4692	174	15	with	with	ADP
fnp-4692	174	16	a	a	DET
fnp-4692	174	17	drug	drug	NOUN
fnp-4692	174	18	-	-	PUNCT
fnp-4692	174	19	library	library	NOUN
fnp-4692	174	20	consisting	consist	VERB
fnp-4692	174	21	of	of	ADP
fnp-4692	174	22	114	114	NUM
fnp-4692	174	23	drugs	drug	NOUN
fnp-4692	174	24	,	,	PUNCT
fnp-4692	174	25	that	that	PRON
fnp-4692	174	26	were	be	AUX
fnp-4692	174	27	either	either	CCONJ
fnp-4692	174	28	fda	fda	PROPN
fnp-4692	174	29	-	-	PUNCT
fnp-4692	174	30	approved	approve	VERB
fnp-4692	174	31	or	or	CCONJ
fnp-4692	174	32	are	be	AUX
fnp-4692	174	33	currently	currently	ADV
fnp-4692	174	34	in	in	ADP
fnp-4692	174	35	use	use	NOUN
fnp-4692	174	36	in	in	ADP
fnp-4692	174	37	clinical	clinical	ADJ
fnp-4692	174	38	trials	trial	NOUN
fnp-4692	174	39	.	.	PUNCT
fnp-4692	175	1	the	the	DET
fnp-4692	175	2	use	use	NOUN
fnp-4692	175	3	of	of	ADP
fnp-4692	175	4	slice	slice	NOUN
fnp-4692	175	5	culture	culture	NOUN
fnp-4692	175	6	has	have	VERB
fnp-4692	175	7	the	the	DET
fnp-4692	175	8	advantage	advantage	NOUN
fnp-4692	175	9	that	that	SCONJ
fnp-4692	175	10	tumor	tumor	NOUN
fnp-4692	175	11	cells	cell	NOUN
fnp-4692	175	12	can	can	AUX
fnp-4692	175	13	grow	grow	VERB
fnp-4692	175	14	in	in	ADP
fnp-4692	175	15	their	their	PRON
fnp-4692	175	16	associated	associate	VERB
fnp-4692	175	17	microenvironment	microenvironment	NOUN
fnp-4692	175	18	which	which	PRON
fnp-4692	175	19	is	be	AUX
fnp-4692	175	20	key	key	ADJ
fnp-4692	175	21	for	for	ADP
fnp-4692	175	22	both	both	CCONJ
fnp-4692	175	23	the	the	DET
fnp-4692	175	24	metastasizing	metastasizing	ADJ
fnp-4692	175	25	process	process	NOUN
fnp-4692	175	26	,	,	PUNCT
fnp-4692	175	27	but	but	CCONJ
fnp-4692	175	28	may	may	AUX
fnp-4692	175	29	also	also	ADV
fnp-4692	175	30	play	play	VERB
fnp-4692	175	31	an	an	DET
fnp-4692	175	32	important	important	ADJ
fnp-4692	175	33	role	role	NOUN
fnp-4692	175	34	in	in	ADP
fnp-4692	175	35	treatment	treatment	NOUN
fnp-4692	175	36	resistance	resistance	NOUN
fnp-4692	175	37	.	.	PUNCT
fnp-4692	176	1	with	with	ADP
fnp-4692	176	2	this	this	DET
fnp-4692	176	3	so	so	ADV
fnp-4692	176	4	-	-	PUNCT
fnp-4692	176	5	called	call	VERB
fnp-4692	176	6	medium	medium	ADJ
fnp-4692	176	7	-	-	PUNCT
fnp-4692	176	8	throughput	throughput	NOUN
fnp-4692	176	9	drug	drug	NOUN
fnp-4692	176	10	-	-	PUNCT
fnp-4692	176	11	screening	screen	VERB
fnp-4692	176	12	platform	platform	NOUN
fnp-4692	176	13	(	(	PUNCT
fnp-4692	176	14	metplatform	metplatform	NOUN
fnp-4692	176	15	)	)	PUNCT
fnp-4692	176	16	,	,	PUNCT
fnp-4692	176	17	they	they	PRON
fnp-4692	176	18	were	be	AUX
fnp-4692	176	19	able	able	ADJ
fnp-4692	176	20	to	to	PART
fnp-4692	176	21	identify	identify	VERB
fnp-4692	176	22	a	a	DET
fnp-4692	176	23	blood	blood	NOUN
fnp-4692	176	24	-	-	PUNCT
fnp-4692	176	25	barrier	barrier	NOUN
fnp-4692	176	26	permeable	permeable	ADJ
fnp-4692	176	27	hsp90	hsp90	ADJ
fnp-4692	176	28	inhibitor	inhibitor	NOUN
fnp-4692	176	29	as	as	ADP
fnp-4692	176	30	a	a	DET
fnp-4692	176	31	promising	promising	ADJ
fnp-4692	176	32	drug	drug	NOUN
fnp-4692	176	33	for	for	ADP
fnp-4692	176	34	the	the	DET
fnp-4692	176	35	treatment	treatment	NOUN
fnp-4692	176	36	of	of	ADP
fnp-4692	176	37	brain	brain	NOUN
fnp-4692	176	38	metastases	metastasis	NOUN
fnp-4692	176	39	.	.	PUNCT
fnp-4692	177	1	in	in	ADP
fnp-4692	177	2	a	a	DET
fnp-4692	177	3	follow	follow	VERB
fnp-4692	177	4	-	-	PUNCT
fnp-4692	177	5	up	up	ADP
fnp-4692	177	6	experiment	experiment	NOUN
fnp-4692	177	7	,	,	PUNCT
fnp-4692	177	8	the	the	DET
fnp-4692	177	9	authors	author	NOUN
fnp-4692	177	10	successfully	successfully	ADV
fnp-4692	177	11	treated	treat	VERB
fnp-4692	177	12	patient	patient	NOUN
fnp-4692	177	13	-	-	PUNCT
fnp-4692	177	14	derived	derive	VERB
fnp-4692	177	15	organotypic	organotypic	ADJ
fnp-4692	177	16	cultures	culture	NOUN
fnp-4692	177	17	deriving	derive	VERB
fnp-4692	177	18	from	from	ADP
fnp-4692	177	19	various	various	ADJ
fnp-4692	177	20	different	different	ADJ
fnp-4692	177	21	cancer	cancer	NOUN
fnp-4692	177	22	types	type	NOUN
fnp-4692	177	23	.	.	PUNCT
fnp-4692	178	1	while	while	SCONJ
fnp-4692	178	2	the	the	DET
fnp-4692	178	3	paper	paper	NOUN
fnp-4692	178	4	was	be	AUX
fnp-4692	178	5	focusing	focus	VERB
fnp-4692	178	6	more	more	ADV
fnp-4692	178	7	on	on	ADP
fnp-4692	178	8	elucidating	elucidate	VERB
fnp-4692	178	9	the	the	DET
fnp-4692	178	10	underlying	underlying	ADJ
fnp-4692	178	11	mechanisms	mechanism	NOUN
fnp-4692	178	12	of	of	ADP
fnp-4692	178	13	hsp90	hsp90	ADJ
fnp-4692	178	14	inhibition	inhibition	NOUN
fnp-4692	178	15	in	in	ADP
fnp-4692	178	16	brain	brain	NOUN
fnp-4692	178	17	metastasis	metastasis	NOUN
fnp-4692	178	18	treatment	treatment	NOUN
fnp-4692	178	19	,	,	PUNCT
fnp-4692	178	20	targeting	target	VERB
fnp-4692	178	21	hsp90	hsp90	PROPN
fnp-4692	178	22	will	will	AUX
fnp-4692	178	23	certainly	certainly	ADV
fnp-4692	178	24	once	once	ADV
fnp-4692	178	25	again	again	ADV
fnp-4692	178	26	not	not	PART
fnp-4692	178	27	be	be	AUX
fnp-4692	178	28	suitable	suitable	ADJ
fnp-4692	178	29	as	as	SCONJ
fnp-4692	178	30	a	a	DET
fnp-4692	178	31	“	"	PUNCT
fnp-4692	178	32	one	one	NOUN
fnp-4692	178	33	fits	fit	VERB
fnp-4692	178	34	all	all	PRON
fnp-4692	178	35	”	"	PUNCT
fnp-4692	178	36	in	in	ADP
fnp-4692	178	37	future	future	ADJ
fnp-4692	178	38	brain	brain	NOUN
fnp-4692	178	39	metastasis	metastasis	NOUN
fnp-4692	178	40	treatment	treatment	NOUN
fnp-4692	178	41	.	.	PUNCT
fnp-4692	179	1	what	what	PRON
fnp-4692	179	2	could	could	AUX
fnp-4692	179	3	be	be	AUX
fnp-4692	179	4	much	much	ADV
fnp-4692	179	5	more	more	ADV
fnp-4692	179	6	important	important	ADJ
fnp-4692	179	7	in	in	ADP
fnp-4692	179	8	the	the	DET
fnp-4692	179	9	future	future	NOUN
fnp-4692	179	10	,	,	PUNCT
fnp-4692	179	11	is	be	AUX
fnp-4692	179	12	to	to	PART
fnp-4692	179	13	make	make	VERB
fnp-4692	179	14	use	use	NOUN
fnp-4692	179	15	of	of	ADP
fnp-4692	179	16	metplatform	metplatform	NOUN
fnp-4692	179	17	or	or	CCONJ
fnp-4692	179	18	other	other	ADJ
fnp-4692	179	19	similar	similar	ADJ
fnp-4692	179	20	drug	drug	NOUN
fnp-4692	179	21	-	-	PUNCT
fnp-4692	179	22	testing	testing	NOUN
fnp-4692	179	23	pipelines	pipeline	NOUN
fnp-4692	179	24	as	as	ADP
fnp-4692	179	25	a	a	DET
fnp-4692	179	26	clinical	clinical	ADJ
fnp-4692	179	27	“	"	PUNCT
fnp-4692	179	28	avatar	avatar	NOUN
fnp-4692	179	29	”	"	PUNCT
fnp-4692	179	30	,	,	PUNCT
fnp-4692	179	31	as	as	SCONJ
fnp-4692	179	32	the	the	DET
fnp-4692	179	33	authors	author	NOUN
fnp-4692	179	34	called	call	VERB
fnp-4692	179	35	their	their	PRON
fnp-4692	179	36	approach	approach	NOUN
fnp-4692	179	37	.	.	PUNCT
fnp-4692	180	1	with	with	ADP
fnp-4692	180	2	this	this	PRON
fnp-4692	180	3	,	,	PUNCT
fnp-4692	180	4	medium	medium	ADJ
fnp-4692	180	5	or	or	CCONJ
fnp-4692	180	6	even	even	ADV
fnp-4692	180	7	high	high	ADJ
fnp-4692	180	8	-	-	PUNCT
fnp-4692	180	9	throughput	throughput	NOUN
fnp-4692	180	10	drug	drug	NOUN
fnp-4692	180	11	libraries	library	NOUN
fnp-4692	180	12	could	could	AUX
fnp-4692	180	13	be	be	AUX
fnp-4692	180	14	applied	apply	VERB
fnp-4692	180	15	on	on	ADP
fnp-4692	180	16	either	either	CCONJ
fnp-4692	180	17	primary	primary	ADJ
fnp-4692	180	18	tumor	tumor	NOUN
fnp-4692	180	19	slices	slice	NOUN
fnp-4692	180	20	or	or	CCONJ
fnp-4692	180	21	tumor	tumor	NOUN
fnp-4692	180	22	-	-	PUNCT
fnp-4692	180	23	derived	derive	VERB
fnp-4692	180	24	organoids	organoid	NOUN
fnp-4692	180	25	with	with	ADP
fnp-4692	180	26	the	the	DET
fnp-4692	180	27	goal	goal	NOUN
fnp-4692	180	28	to	to	AUX
fnp-4692	180	29	individually	individually	ADV
fnp-4692	180	30	decipher	decipher	ADV
fnp-4692	180	31	the	the	DET
fnp-4692	180	32	most	most	ADV
fnp-4692	180	33	promising	promising	ADJ
fnp-4692	180	34	treatment	treatment	NOUN
fnp-4692	180	35	strategies	strategy	NOUN
fnp-4692	180	36	for	for	ADP
fnp-4692	180	37	this	this	DET
fnp-4692	180	38	most	most	ADV
fnp-4692	180	39	detrimental	detrimental	ADJ
fnp-4692	180	40	clinical	clinical	ADJ
fnp-4692	180	41	situation	situation	NOUN
fnp-4692	180	42	.	.	PUNCT
fnp-4692	181	1	although	although	SCONJ
fnp-4692	181	2	slice	slice	NOUN
fnp-4692	181	3	culture	culture	NOUN
fnp-4692	181	4	-	-	PUNCT
fnp-4692	181	5	based	base	VERB
fnp-4692	181	6	approaches	approach	NOUN
fnp-4692	181	7	seem	seem	VERB
fnp-4692	181	8	to	to	PART
fnp-4692	181	9	excellently	excellently	ADV
fnp-4692	181	10	reflect	reflect	VERB
fnp-4692	181	11	the	the	DET
fnp-4692	181	12	microenvironmental	microenvironmental	ADJ
fnp-4692	181	13	composition	composition	NOUN
fnp-4692	181	14	of	of	ADP
fnp-4692	181	15	the	the	DET
fnp-4692	181	16	tumor	tumor	NOUN
fnp-4692	181	17	in	in	ADP
fnp-4692	181	18	situ	situ	NOUN
fnp-4692	181	19	,	,	PUNCT
fnp-4692	181	20	the	the	DET
fnp-4692	181	21	high	high	ADJ
fnp-4692	181	22	variability	variability	NOUN
fnp-4692	181	23	between	between	ADP
fnp-4692	181	24	slices	slice	NOUN
fnp-4692	181	25	as	as	ADV
fnp-4692	181	26	well	well	ADV
fnp-4692	181	27	as	as	ADP
fnp-4692	181	28	the	the	DET
fnp-4692	181	29	potentially	potentially	ADV
fnp-4692	181	30	limited	limited	ADJ
fnp-4692	181	31	availability	availability	NOUN
fnp-4692	181	32	of	of	ADP
fnp-4692	181	33	consecutive	consecutive	ADJ
fnp-4692	181	34	slices	slice	NOUN
fnp-4692	181	35	may	may	AUX
fnp-4692	181	36	negatively	negatively	ADV
fnp-4692	181	37	impact	impact	VERB
fnp-4692	181	38	a	a	DET
fnp-4692	181	39	homogenous	homogenous	ADJ
fnp-4692	181	40	readout	readout	NOUN
fnp-4692	181	41	when	when	SCONJ
fnp-4692	181	42	using	use	VERB
fnp-4692	181	43	larger	large	ADJ
fnp-4692	181	44	drug	drug	NOUN
fnp-4692	181	45	libraries	library	NOUN
fnp-4692	181	46	.	.	PUNCT
fnp-4692	182	1	this	this	DET
fnp-4692	182	2	potential	potential	ADJ
fnp-4692	182	3	drawback	drawback	NOUN
fnp-4692	182	4	could	could	AUX
fnp-4692	182	5	be	be	AUX
fnp-4692	182	6	potentially	potentially	ADV
fnp-4692	182	7	overcome	overcome	VERB
fnp-4692	182	8	by	by	ADP
fnp-4692	182	9	creating	create	VERB
fnp-4692	182	10	ex	ex	ADJ
fnp-4692	182	11	-	-	ADJ
fnp-4692	182	12	vivo	vivo	ADJ
fnp-4692	182	13	spheroids	spheroid	NOUN
fnp-4692	182	14	as	as	ADP
fnp-4692	182	15	an	an	DET
fnp-4692	182	16	alternative	alternative	ADJ
fnp-4692	182	17	“	"	PUNCT
fnp-4692	182	18	avatar	avatar	NOUN
fnp-4692	182	19	”	"	PUNCT
fnp-4692	182	20	,	,	PUNCT
fnp-4692	182	21	that	that	PRON
fnp-4692	182	22	have	have	AUX
fnp-4692	182	23	already	already	ADV
fnp-4692	182	24	shown	show	VERB
fnp-4692	182	25	their	their	PRON
fnp-4692	182	26	clinical	clinical	ADJ
fnp-4692	182	27	suitability	suitability	NOUN
fnp-4692	182	28	in	in	ADP
fnp-4692	182	29	single	single	ADJ
fnp-4692	182	30	patients	patient	NOUN
fnp-4692	182	31	with	with	ADP
fnp-4692	182	32	metastatic	metastatic	ADJ
fnp-4692	182	33	tumors	tumor	NOUN
fnp-4692	183	1	[	[	X
fnp-4692	183	2	34	34	NUM
fnp-4692	183	3	]	]	PUNCT
fnp-4692	183	4	.	.	PUNCT
fnp-4692	184	1	figure	figure	NOUN
fnp-4692	184	2	5	5	NUM
fnp-4692	184	3	:	:	PUNCT
fnp-4692	184	4	potential	potential	ADJ
fnp-4692	184	5	implementation	implementation	NOUN
fnp-4692	184	6	of	of	ADP
fnp-4692	184	7	personalized	personalized	ADJ
fnp-4692	184	8	drug	drug	NOUN
fnp-4692	184	9	-	-	PUNCT
fnp-4692	184	10	screening	screen	VERB
fnp-4692	184	11	approaches	approach	NOUN
fnp-4692	184	12	in	in	ADP
fnp-4692	184	13	the	the	DET
fnp-4692	184	14	clinical	clinical	ADJ
fnp-4692	184	15	setting	setting	NOUN
fnp-4692	184	16	.	.	PUNCT
fnp-4692	185	1	discussion	discussion	NOUN
fnp-4692	185	2	this	this	DET
fnp-4692	185	3	overview	overview	NOUN
fnp-4692	185	4	regarding	regard	VERB
fnp-4692	185	5	key	key	ADJ
fnp-4692	185	6	developments	development	NOUN
fnp-4692	185	7	of	of	ADP
fnp-4692	185	8	the	the	DET
fnp-4692	185	9	year	year	NOUN
fnp-4692	185	10	2022	2022	NUM
fnp-4692	185	11	in	in	ADP
fnp-4692	185	12	the	the	DET
fnp-4692	185	13	field	field	NOUN
fnp-4692	185	14	of	of	ADP
fnp-4692	185	15	neuro	neuro	NOUN
fnp-4692	185	16	-	-	PUNCT
fnp-4692	185	17	oncology	oncology	NOUN
fnp-4692	185	18	(	(	PUNCT
fnp-4692	185	19	with	with	ADP
fnp-4692	185	20	a	a	DET
fnp-4692	185	21	link	link	NOUN
fnp-4692	185	22	to	to	ADP
fnp-4692	185	23	neuropathology	neuropathology	NOUN
fnp-4692	185	24	)	)	PUNCT
fnp-4692	185	25	clearly	clearly	ADV
fnp-4692	185	26	shows	show	VERB
fnp-4692	185	27	that	that	SCONJ
fnp-4692	185	28	scientific	scientific	ADJ
fnp-4692	185	29	findings	finding	NOUN
fnp-4692	185	30	are	be	AUX
fnp-4692	185	31	very	very	ADV
fnp-4692	185	32	closely	closely	ADV
fnp-4692	185	33	linked	link	VERB
fnp-4692	185	34	to	to	ADP
fnp-4692	185	35	technical	technical	ADJ
fnp-4692	185	36	developments	development	NOUN
fnp-4692	185	37	.	.	PUNCT
fnp-4692	186	1	nanopore	nanopore	ADJ
fnp-4692	186	2	sequencing	sequencing	NOUN
fnp-4692	186	3	has	have	AUX
fnp-4692	186	4	been	be	AUX
fnp-4692	186	5	proposed	propose	VERB
fnp-4692	186	6	as	as	ADP
fnp-4692	186	7	one	one	NUM
fnp-4692	186	8	of	of	ADP
fnp-4692	186	9	the	the	DET
fnp-4692	186	10	methods	method	NOUN
fnp-4692	186	11	of	of	ADP
fnp-4692	186	12	the	the	DET
fnp-4692	186	13	year	year	NOUN
fnp-4692	186	14	2022	2022	NUM
fnp-4692	187	1	[	[	X
fnp-4692	187	2	30	30	NUM
fnp-4692	187	3	]	]	PUNCT
fnp-4692	187	4	by	by	ADP
fnp-4692	187	5	nature	nature	NOUN
fnp-4692	187	6	methods	method	NOUN
fnp-4692	187	7	as	as	SCONJ
fnp-4692	187	8	it	it	PRON
fnp-4692	187	9	allows	allow	VERB
fnp-4692	187	10	for	for	ADP
fnp-4692	187	11	faster	fast	ADJ
fnp-4692	187	12	,	,	PUNCT
fnp-4692	187	13	unbiased	unbiased	ADJ
fnp-4692	187	14	,	,	PUNCT
fnp-4692	187	15	precise	precise	ADJ
fnp-4692	187	16	diagnostics	diagnostic	NOUN
fnp-4692	187	17	having	have	VERB
fnp-4692	187	18	the	the	DET
fnp-4692	187	19	advantage	advantage	NOUN
fnp-4692	187	20	of	of	ADP
fnp-4692	187	21	assessing	assess	VERB
fnp-4692	187	22	mutations	mutation	NOUN
fnp-4692	187	23	,	,	PUNCT
fnp-4692	187	24	transcriptome	transcriptome	NOUN
fnp-4692	187	25	and	and	CCONJ
fnp-4692	187	26	methylome	methylome	ADJ
fnp-4692	187	27	by	by	ADP
fnp-4692	187	28	using	use	VERB
fnp-4692	187	29	only	only	ADV
fnp-4692	187	30	one	one	NUM
fnp-4692	187	31	device	device	NOUN
fnp-4692	187	32	at	at	ADP
fnp-4692	187	33	relatively	relatively	ADV
fnp-4692	187	34	low	low	ADJ
fnp-4692	187	35	costs	cost	NOUN
fnp-4692	187	36	.	.	PUNCT
fnp-4692	188	1	it	it	PRON
fnp-4692	188	2	is	be	AUX
fnp-4692	188	3	,	,	PUNCT
fnp-4692	188	4	therefore	therefore	ADV
fnp-4692	188	5	,	,	PUNCT
fnp-4692	188	6	no	no	DET
fnp-4692	188	7	wonder	wonder	NOUN
fnp-4692	188	8	that	that	SCONJ
fnp-4692	188	9	multiple	multiple	ADJ
fnp-4692	188	10	initiatives	initiative	NOUN
fnp-4692	188	11	have	have	AUX
fnp-4692	188	12	started	start	VERB
fnp-4692	188	13	to	to	PART
fnp-4692	188	14	apply	apply	VERB
fnp-4692	188	15	such	such	ADJ
fnp-4692	188	16	techniques	technique	NOUN
fnp-4692	188	17	seeing	see	VERB
fnp-4692	188	18	a	a	DET
fnp-4692	188	19	potential	potential	NOUN
fnp-4692	188	20	to	to	PART
fnp-4692	188	21	provide	provide	VERB
fnp-4692	188	22	intraoperative	intraoperative	ADJ
fnp-4692	188	23	molecular	molecular	ADJ
fnp-4692	188	24	diagnostics	diagnostic	NOUN
fnp-4692	188	25	[	[	X
fnp-4692	188	26	12	12	NUM
fnp-4692	188	27	,	,	PUNCT
fnp-4692	188	28	13	13	NUM
fnp-4692	188	29	]	]	PUNCT
fnp-4692	188	30	.	.	PUNCT
fnp-4692	189	1	in	in	ADP
fnp-4692	189	2	some	some	DET
fnp-4692	189	3	clinical	clinical	ADJ
fnp-4692	189	4	disciplines	discipline	NOUN
fnp-4692	189	5	such	such	ADJ
fnp-4692	189	6	as	as	ADP
fnp-4692	189	7	gynecological	gynecological	ADJ
fnp-4692	189	8	oncology	oncology	NOUN
fnp-4692	189	9	[	[	X
fnp-4692	189	10	35	35	NUM
fnp-4692	189	11	]	]	X
fnp-4692	189	12	,	,	PUNCT
fnp-4692	189	13	more	more	ADJ
fnp-4692	189	14	and	and	CCONJ
fnp-4692	189	15	more	more	ADV
fnp-4692	189	16	molecular	molecular	ADJ
fnp-4692	189	17	tests	test	NOUN
fnp-4692	189	18	are	be	AUX
fnp-4692	189	19	commercialized	commercialize	VERB
fnp-4692	189	20	in	in	ADP
fnp-4692	189	21	a	a	DET
fnp-4692	189	22	highly	highly	ADV
fnp-4692	189	23	protected	protect	VERB
fnp-4692	189	24	manner	manner	NOUN
fnp-4692	189	25	,	,	PUNCT
fnp-4692	189	26	especially	especially	ADV
fnp-4692	189	27	if	if	SCONJ
fnp-4692	189	28	it	it	PRON
fnp-4692	189	29	comes	come	VERB
fnp-4692	189	30	to	to	ADP
fnp-4692	189	31	prognostic	prognostic	ADJ
fnp-4692	189	32	prediction	prediction	NOUN
fnp-4692	189	33	for	for	ADP
fnp-4692	189	34	distinct	distinct	ADJ
fnp-4692	189	35	treatment	treatment	NOUN
fnp-4692	189	36	regimens	regimen	NOUN
fnp-4692	189	37	.	.	PUNCT
fnp-4692	190	1	in	in	ADP
fnp-4692	190	2	contrast	contrast	NOUN
fnp-4692	190	3	,	,	PUNCT
fnp-4692	190	4	the	the	DET
fnp-4692	190	5	neuropathology	neuropathology	NOUN
fnp-4692	190	6	community	community	NOUN
fnp-4692	190	7	–	–	PUNCT
fnp-4692	190	8	at	at	ADP
fnp-4692	190	9	least	least	ADJ
fnp-4692	190	10	until	until	ADP
fnp-4692	190	11	now	now	ADV
fnp-4692	190	12	–	–	PUNCT
fnp-4692	190	13	has	have	AUX
fnp-4692	190	14	managed	manage	VERB
fnp-4692	190	15	to	to	PART
fnp-4692	190	16	keep	keep	VERB
fnp-4692	190	17	complex	complex	ADJ
fnp-4692	190	18	diagnostic	diagnostic	ADJ
fnp-4692	190	19	tests	test	NOUN
fnp-4692	190	20	running	run	VERB
fnp-4692	190	21	within	within	ADP
fnp-4692	190	22	the	the	DET
fnp-4692	190	23	scientific	scientific	ADJ
fnp-4692	190	24	community	community	NOUN
fnp-4692	190	25	for	for	ADP
fnp-4692	190	26	a	a	DET
fnp-4692	190	27	long	long	ADJ
fnp-4692	190	28	time	time	NOUN
fnp-4692	190	29	without	without	ADP
fnp-4692	190	30	commercialization	commercialization	NOUN
fnp-4692	190	31	[	[	X
fnp-4692	190	32	15	15	NUM
fnp-4692	190	33	]	]	PUNCT
fnp-4692	190	34	.	.	PUNCT
fnp-4692	191	1	those	those	DET
fnp-4692	191	2	initiatives	initiative	NOUN
fnp-4692	191	3	,	,	PUNCT
fnp-4692	191	4	mainly	mainly	ADV
fnp-4692	191	5	based	base	VERB
fnp-4692	191	6	on	on	ADP
fnp-4692	191	7	excellent	excellent	ADJ
fnp-4692	191	8	clinical	clinical	ADJ
fnp-4692	191	9	data	datum	NOUN
fnp-4692	191	10	,	,	PUNCT
fnp-4692	191	11	neuropathological	neuropathological	ADJ
fnp-4692	191	12	annotations	annotation	NOUN
fnp-4692	191	13	and	and	CCONJ
fnp-4692	191	14	research	research	NOUN
fnp-4692	191	15	-	-	PUNCT
fnp-4692	191	16	driven	drive	VERB
fnp-4692	191	17	modeling	modeling	NOUN
fnp-4692	191	18	and	and	CCONJ
fnp-4692	191	19	machine	machine	NOUN
fnp-4692	191	20	learning	learning	NOUN
fnp-4692	191	21	,	,	PUNCT
fnp-4692	191	22	were	be	AUX
fnp-4692	191	23	mostly	mostly	ADV
fnp-4692	191	24	financed	finance	VERB
fnp-4692	191	25	by	by	ADP
fnp-4692	191	26	governmental	governmental	ADJ
fnp-4692	191	27	support	support	NOUN
fnp-4692	191	28	or	or	CCONJ
fnp-4692	191	29	funding	funding	NOUN
fnp-4692	191	30	organizations	organization	NOUN
fnp-4692	191	31	and	and	CCONJ
fnp-4692	191	32	have	have	AUX
fnp-4692	191	33	frequently	frequently	ADV
fnp-4692	191	34	proven	prove	VERB
fnp-4692	191	35	their	their	PRON
fnp-4692	191	36	high	high	ADJ
fnp-4692	191	37	value	value	NOUN
fnp-4692	191	38	for	for	ADP
fnp-4692	191	39	the	the	DET
fnp-4692	191	40	healthcare	healthcare	NOUN
fnp-4692	191	41	system	system	NOUN
fnp-4692	191	42	,	,	PUNCT
fnp-4692	191	43	e.g.	e.g.	ADV
fnp-4692	191	44	by	by	ADP
fnp-4692	191	45	dramatically	dramatically	ADV
fnp-4692	191	46	changing	change	VERB
fnp-4692	191	47	the	the	DET
fnp-4692	191	48	most	most	ADV
fnp-4692	191	49	recent	recent	ADJ
fnp-4692	191	50	who	who	PRON
fnp-4692	191	51	classification	classification	VERB
fnp-4692	191	52	[	[	X
fnp-4692	191	53	20	20	NUM
fnp-4692	191	54	]	]	PUNCT
fnp-4692	191	55	.	.	PUNCT
fnp-4692	192	1	it	it	PRON
fnp-4692	192	2	remains	remain	VERB
fnp-4692	192	3	to	to	PART
fnp-4692	192	4	be	be	AUX
fnp-4692	192	5	determined	determine	VERB
fnp-4692	192	6	how	how	SCONJ
fnp-4692	192	7	those	those	DET
fnp-4692	192	8	approaches	approach	NOUN
fnp-4692	192	9	can	can	AUX
fnp-4692	192	10	sustainably	sustainably	ADV
fnp-4692	192	11	be	be	AUX
fnp-4692	192	12	kept	keep	VERB
fnp-4692	192	13	running	run	VERB
fnp-4692	192	14	,	,	PUNCT
fnp-4692	192	15	for	for	ADP
fnp-4692	192	16	example	example	NOUN
fnp-4692	192	17	by	by	ADP
fnp-4692	192	18	hosting	host	VERB
fnp-4692	192	19	joint	joint	ADJ
fnp-4692	192	20	platforms	platform	NOUN
fnp-4692	192	21	openly	openly	ADV
fnp-4692	192	22	accessible	accessible	ADJ
fnp-4692	192	23	on	on	ADP
fnp-4692	192	24	university	university	NOUN
fnp-4692	192	25	servers	server	NOUN
fnp-4692	192	26	.	.	PUNCT
fnp-4692	193	1	another	another	DET
fnp-4692	193	2	potential	potential	ADJ
fnp-4692	193	3	risk	risk	NOUN
fnp-4692	193	4	is	be	AUX
fnp-4692	193	5	the	the	DET
fnp-4692	193	6	fact	fact	NOUN
fnp-4692	193	7	that	that	SCONJ
fnp-4692	193	8	several	several	ADJ
fnp-4692	193	9	machine	machine	NOUN
fnp-4692	193	10	learning	learning	NOUN
fnp-4692	193	11	approaches	approach	NOUN
fnp-4692	193	12	are	be	AUX
fnp-4692	193	13	based	base	VERB
fnp-4692	193	14	on	on	ADP
fnp-4692	193	15	data	datum	NOUN
fnp-4692	193	16	mainly	mainly	ADV
fnp-4692	193	17	deriving	derive	VERB
fnp-4692	193	18	from	from	ADP
fnp-4692	193	19	a	a	DET
fnp-4692	193	20	specific	specific	ADJ
fnp-4692	193	21	platform	platform	NOUN
fnp-4692	193	22	(	(	PUNCT
fnp-4692	193	23	e.g.	e.g.	ADV
fnp-4692	193	24	illumina	illumina	PROPN
fnp-4692	193	25	infinium	infinium	PROPN
fnp-4692	193	26	methylationepic	methylationepic	PROPN
fnp-4692	193	27	array	array	PROPN
fnp-4692	193	28	®	®	PROPN
fnp-4692	193	29	)	)	PUNCT
fnp-4692	193	30	and	and	CCONJ
fnp-4692	193	31	would	would	AUX
fnp-4692	193	32	need	need	VERB
fnp-4692	193	33	new	new	ADJ
fnp-4692	193	34	validation	validation	NOUN
fnp-4692	193	35	when	when	SCONJ
fnp-4692	193	36	new	new	ADJ
fnp-4692	193	37	techniques	technique	NOUN
fnp-4692	193	38	for	for	ADP
fnp-4692	193	39	the	the	DET
fnp-4692	193	40	same	same	ADJ
fnp-4692	193	41	application	application	NOUN
fnp-4692	193	42	are	be	AUX
fnp-4692	193	43	coming	come	VERB
fnp-4692	193	44	on	on	ADP
fnp-4692	193	45	the	the	DET
fnp-4692	193	46	market	market	NOUN
fnp-4692	193	47	(	(	PUNCT
fnp-4692	193	48	e.g.	e.g.	ADV
fnp-4692	193	49	changing	change	VERB
fnp-4692	193	50	from	from	ADP
fnp-4692	193	51	array	array	NOUN
fnp-4692	193	52	-	-	PUNCT
fnp-4692	193	53	based	base	VERB
fnp-4692	193	54	methylome	methylome	NOUN
fnp-4692	193	55	to	to	ADP
fnp-4692	193	56	nanopore	nanopore	ADJ
fnp-4692	193	57	sequencing	sequencing	NOUN
fnp-4692	193	58	)	)	PUNCT
fnp-4692	193	59	.	.	PUNCT
fnp-4692	194	1	this	this	PRON
fnp-4692	194	2	could	could	AUX
fnp-4692	194	3	even	even	ADV
fnp-4692	194	4	affect	affect	VERB
fnp-4692	194	5	the	the	DET
fnp-4692	194	6	who	who	PRON
fnp-4692	194	7	classification	classification	VERB
fnp-4692	194	8	as	as	SCONJ
fnp-4692	194	9	several	several	ADJ
fnp-4692	194	10	tumor	tumor	NOUN
fnp-4692	194	11	entities	entity	NOUN
fnp-4692	194	12	are	be	AUX
fnp-4692	194	13	currently	currently	ADV
fnp-4692	194	14	essentially	essentially	ADV
fnp-4692	194	15	defined	define	VERB
fnp-4692	194	16	by	by	ADP
fnp-4692	194	17	their	their	PRON
fnp-4692	194	18	methylation	methylation	NOUN
fnp-4692	194	19	profile	profile	NOUN
fnp-4692	194	20	,	,	PUNCT
fnp-4692	194	21	such	such	ADJ
fnp-4692	194	22	as	as	ADP
fnp-4692	194	23	high	high	ADJ
fnp-4692	194	24	-	-	PUNCT
fnp-4692	194	25	grade	grade	NOUN
fnp-4692	194	26	astrocytoma	astrocytoma	NOUN
fnp-4692	194	27	with	with	ADP
fnp-4692	194	28	piloid	piloid	PROPN
fnp-4692	194	29	features	feature	NOUN
fnp-4692	194	30	,	,	PUNCT
fnp-4692	194	31	astroblastoma	astroblastoma	NOUN
fnp-4692	194	32	with	with	ADP
fnp-4692	194	33	mn1	mn1	PROPN
fnp-4692	194	34	alteration	alteration	NOUN
fnp-4692	194	35	,	,	PUNCT
fnp-4692	194	36	diffuse	diffuse	VERB
fnp-4692	194	37	glioneuronal	glioneuronal	ADJ
fnp-4692	194	38	tumour	tumour	NOUN
fnp-4692	194	39	with	with	ADP
fnp-4692	194	40	oligodendroglioma	oligodendroglioma	ADJ
fnp-4692	194	41	-	-	PUNCT
fnp-4692	194	42	like	like	ADJ
fnp-4692	194	43	features	feature	NOUN
fnp-4692	194	44	and	and	CCONJ
fnp-4692	194	45	nuclear	nuclear	ADJ
fnp-4692	194	46	clusters	cluster	NOUN
fnp-4692	194	47	(	(	PUNCT
fnp-4692	194	48	dgonc	dgonc	PROPN
fnp-4692	194	49	)	)	PUNCT
fnp-4692	194	50	or	or	CCONJ
fnp-4692	194	51	papillary	papillary	ADJ
fnp-4692	194	52	glioneuronal	glioneuronal	ADJ
fnp-4692	194	53	tumor	tumor	NOUN
fnp-4692	194	54	,	,	PUNCT
fnp-4692	194	55	while	while	SCONJ
fnp-4692	194	56	for	for	ADP
fnp-4692	194	57	many	many	ADJ
fnp-4692	194	58	others	other	NOUN
fnp-4692	194	59	the	the	DET
fnp-4692	194	60	methylation	methylation	NOUN
fnp-4692	194	61	profile	profile	NOUN
fnp-4692	194	62	is	be	AUX
fnp-4692	194	63	included	include	VERB
fnp-4692	194	64	as	as	ADP
fnp-4692	194	65	a	a	DET
fnp-4692	194	66	desirable	desirable	ADJ
fnp-4692	194	67	diagnostic	diagnostic	ADJ
fnp-4692	194	68	criterion	criterion	NOUN
fnp-4692	194	69	[	[	X
fnp-4692	194	70	20	20	NUM
fnp-4692	194	71	]	]	PUNCT
fnp-4692	194	72	.	.	PUNCT
fnp-4692	195	1	the	the	DET
fnp-4692	195	2	use	use	NOUN
fnp-4692	195	3	of	of	ADP
fnp-4692	195	4	joint	joint	ADJ
fnp-4692	195	5	worldwide	worldwide	ADJ
fnp-4692	195	6	platforms	platform	NOUN
fnp-4692	195	7	also	also	ADV
fnp-4692	195	8	has	have	VERB
fnp-4692	195	9	the	the	DET
fnp-4692	195	10	advantage	advantage	NOUN
fnp-4692	195	11	to	to	PART
fnp-4692	195	12	discover	discover	VERB
fnp-4692	195	13	much	much	ADV
fnp-4692	195	14	faster	fast	ADV
fnp-4692	195	15	new	new	ADJ
fnp-4692	195	16	,	,	PUNCT
fnp-4692	195	17	rare	rare	ADJ
fnp-4692	195	18	tumor	tumor	NOUN
fnp-4692	195	19	entities	entity	NOUN
fnp-4692	195	20	as	as	SCONJ
fnp-4692	195	21	it	it	PRON
fnp-4692	195	22	has	have	AUX
fnp-4692	195	23	been	be	AUX
fnp-4692	195	24	successfully	successfully	ADV
fnp-4692	195	25	shown	show	VERB
fnp-4692	195	26	in	in	ADP
fnp-4692	195	27	2022	2022	NUM
fnp-4692	195	28	with	with	ADP
fnp-4692	195	29	high	high	ADJ
fnp-4692	195	30	-	-	PUNCT
fnp-4692	195	31	grade	grade	NOUN
fnp-4692	195	32	glioma	glioma	NOUN
fnp-4692	195	33	with	with	ADP
fnp-4692	195	34	pleomorphic	pleomorphic	ADJ
fnp-4692	195	35	and	and	CCONJ
fnp-4692	195	36	pseudopapillary	pseudopapillary	ADJ
fnp-4692	195	37	features	feature	NOUN
fnp-4692	195	38	(	(	PUNCT
fnp-4692	195	39	hpap	hpap	NOUN
fnp-4692	195	40	)	)	PUNCT
fnp-4692	195	41	,	,	PUNCT
fnp-4692	195	42	an	an	DET
fnp-4692	195	43	entity	entity	NOUN
fnp-4692	195	44	that	that	PRON
fnp-4692	195	45	would	would	AUX
fnp-4692	195	46	otherwise	otherwise	ADV
fnp-4692	195	47	have	have	AUX
fnp-4692	195	48	been	be	AUX
fnp-4692	195	49	associated	associate	VERB
fnp-4692	195	50	with	with	ADP
fnp-4692	195	51	a	a	DET
fnp-4692	195	52	wrong	wrong	ADJ
fnp-4692	195	53	prognostic	prognostic	ADJ
fnp-4692	195	54	prediction	prediction	NOUN
fnp-4692	195	55	if	if	SCONJ
fnp-4692	195	56	diagnosis	diagnosis	NOUN
fnp-4692	195	57	would	would	AUX
fnp-4692	195	58	have	have	AUX
fnp-4692	195	59	been	be	AUX
fnp-4692	195	60	based	base	VERB
fnp-4692	195	61	on	on	ADP
fnp-4692	195	62	classic	classic	ADJ
fnp-4692	195	63	microscopic	microscopic	ADJ
fnp-4692	195	64	assessment	assessment	NOUN
fnp-4692	195	65	only	only	ADV
fnp-4692	195	66	[	[	X
fnp-4692	195	67	3	3	NUM
fnp-4692	195	68	]	]	PUNCT
fnp-4692	195	69	.	.	PUNCT
fnp-4692	196	1	along	along	ADP
fnp-4692	196	2	this	this	DET
fnp-4692	196	3	line	line	NOUN
fnp-4692	196	4	,	,	PUNCT
fnp-4692	196	5	the	the	PRON
fnp-4692	196	6	who	who	PRON
fnp-4692	196	7	has	have	VERB
fnp-4692	196	8	an	an	DET
fnp-4692	196	9	important	important	ADJ
fnp-4692	196	10	role	role	NOUN
fnp-4692	196	11	in	in	ADP
fnp-4692	196	12	balancing	balancing	NOUN
fnp-4692	196	13	between	between	ADP
fnp-4692	196	14	the	the	DET
fnp-4692	196	15	clinical	clinical	ADJ
fnp-4692	196	16	needs	need	NOUN
fnp-4692	196	17	in	in	ADP
fnp-4692	196	18	underdeveloped	underdeveloped	ADJ
fnp-4692	196	19	countries	country	NOUN
fnp-4692	196	20	and	and	CCONJ
fnp-4692	196	21	the	the	DET
fnp-4692	196	22	amazing	amazing	ADJ
fnp-4692	196	23	advances	advance	NOUN
fnp-4692	196	24	that	that	PRON
fnp-4692	196	25	especially	especially	ADV
fnp-4692	196	26	come	come	VERB
fnp-4692	196	27	up	up	ADP
fnp-4692	196	28	in	in	ADP
fnp-4692	196	29	first	first	ADJ
fnp-4692	196	30	world	world	NOUN
fnp-4692	196	31	academic	academic	ADJ
fnp-4692	196	32	centers	center	NOUN
fnp-4692	196	33	in	in	ADP
fnp-4692	196	34	the	the	DET
fnp-4692	196	35	field	field	NOUN
fnp-4692	196	36	of	of	ADP
fnp-4692	196	37	molecular	molecular	ADJ
fnp-4692	196	38	tumor	tumor	NOUN
fnp-4692	196	39	profiling	profiling	NOUN
fnp-4692	196	40	.	.	PUNCT
fnp-4692	197	1	it	it	PRON
fnp-4692	197	2	is	be	AUX
fnp-4692	197	3	therefore	therefore	ADV
fnp-4692	197	4	as	as	ADV
fnp-4692	197	5	important	important	ADJ
fnp-4692	197	6	to	to	PART
fnp-4692	197	7	continue	continue	VERB
fnp-4692	197	8	with	with	ADP
fnp-4692	197	9	finding	find	VERB
fnp-4692	197	10	simple	simple	ADJ
fnp-4692	197	11	diagnostic	diagnostic	ADJ
fnp-4692	197	12	tools	tool	NOUN
fnp-4692	197	13	for	for	ADP
fnp-4692	197	14	exact	exact	ADJ
fnp-4692	197	15	prognostic	prognostic	ADJ
fnp-4692	197	16	or	or	CCONJ
fnp-4692	197	17	therapeutic	therapeutic	ADJ
fnp-4692	197	18	prediction	prediction	NOUN
fnp-4692	197	19	as	as	SCONJ
fnp-4692	197	20	presented	present	VERB
fnp-4692	197	21	for	for	ADP
fnp-4692	197	22	the	the	DET
fnp-4692	197	23	prediction	prediction	NOUN
fnp-4692	197	24	of	of	ADP
fnp-4692	197	25	the	the	DET
fnp-4692	197	26	1p/19q	1p/19q	ADJ
fnp-4692	197	27	status	status	NOUN
fnp-4692	197	28	in	in	ADP
fnp-4692	197	29	idh	idh	NOUN
fnp-4692	197	30	-	-	PUNCT
fnp-4692	197	31	mutant	mutant	NOUN
fnp-4692	197	32	glioma	glioma	NOUN
fnp-4692	197	33	by	by	ADP
fnp-4692	197	34	an	an	DET
fnp-4692	197	35	easy	easy	ADJ
fnp-4692	197	36	2	2	NUM
fnp-4692	197	37	-	-	PUNCT
fnp-4692	197	38	step	step	NOUN
fnp-4692	197	39	ihc	ihc	NOUN
fnp-4692	197	40	-	-	PUNCT
fnp-4692	197	41	based	base	VERB
fnp-4692	197	42	approach	approach	NOUN
fnp-4692	197	43	[	[	X
fnp-4692	197	44	4	4	NUM
fnp-4692	197	45	]	]	PUNCT
fnp-4692	197	46	.	.	PUNCT
fnp-4692	198	1	if	if	SCONJ
fnp-4692	198	2	machine	machine	NOUN
fnp-4692	198	3	learning	learn	VERB
fnp-4692	198	4	algorithms	algorithm	NOUN
fnp-4692	198	5	for	for	ADP
fnp-4692	198	6	microscopic	microscopic	ADJ
fnp-4692	198	7	(	(	PUNCT
fnp-4692	198	8	neuro-)pathological	neuro-)pathological	ADJ
fnp-4692	198	9	assessments	assessment	NOUN
fnp-4692	198	10	would	would	AUX
fnp-4692	198	11	be	be	AUX
fnp-4692	198	12	as	as	ADV
fnp-4692	198	13	powerful	powerful	ADJ
fnp-4692	198	14	as	as	SCONJ
fnp-4692	198	15	shown	show	VERB
fnp-4692	198	16	for	for	ADP
fnp-4692	198	17	molecular	molecular	ADJ
fnp-4692	198	18	pathology	pathology	NOUN
fnp-4692	198	19	or	or	CCONJ
fnp-4692	198	20	radiology	radiology	NOUN
fnp-4692	198	21	[	[	X
fnp-4692	198	22	36	36	NUM
fnp-4692	198	23	]	]	PUNCT
fnp-4692	198	24	,	,	PUNCT
fnp-4692	198	25	the	the	DET
fnp-4692	198	26	latter	latter	ADJ
fnp-4692	198	27	now	now	ADV
fnp-4692	198	28	even	even	ADV
fnp-4692	198	29	aiming	aim	VERB
fnp-4692	198	30	for	for	ADP
fnp-4692	198	31	quantitative	quantitative	ADJ
fnp-4692	198	32	analyses	analysis	NOUN
fnp-4692	198	33	,	,	PUNCT
fnp-4692	198	34	new	new	ADJ
fnp-4692	198	35	histology	histology	NOUN
fnp-4692	198	36	-	-	PUNCT
fnp-4692	198	37	based	base	VERB
fnp-4692	198	38	classification	classification	NOUN
fnp-4692	198	39	algorithms	algorithm	NOUN
fnp-4692	198	40	would	would	AUX
fnp-4692	198	41	then	then	ADV
fnp-4692	198	42	allow	allow	VERB
fnp-4692	198	43	for	for	ADP
fnp-4692	198	44	a	a	DET
fnp-4692	198	45	very	very	ADV
fnp-4692	198	46	cheap	cheap	ADJ
fnp-4692	198	47	assessment	assessment	NOUN
fnp-4692	198	48	of	of	ADP
fnp-4692	198	49	he	he	PRON
fnp-4692	198	50	slides	slide	VERB
fnp-4692	198	51	in	in	ADP
fnp-4692	198	52	underdeveloped	underdeveloped	ADJ
fnp-4692	198	53	countries	country	NOUN
fnp-4692	198	54	.	.	PUNCT
fnp-4692	199	1	therefore	therefore	ADV
fnp-4692	199	2	,	,	PUNCT
fnp-4692	199	3	the	the	DET
fnp-4692	199	4	study	study	NOUN
fnp-4692	199	5	of	of	ADP
fnp-4692	199	6	liechty	liechty	PROPN
fnp-4692	199	7	et	et	PROPN
fnp-4692	199	8	al	al	PROPN
fnp-4692	199	9	.	.	PROPN
fnp-4692	199	10	has	have	AUX
fnp-4692	199	11	also	also	ADV
fnp-4692	199	12	been	be	AUX
fnp-4692	199	13	selected	select	VERB
fnp-4692	199	14	as	as	ADP
fnp-4692	199	15	a	a	DET
fnp-4692	199	16	highlight	highlight	NOUN
fnp-4692	199	17	as	as	SCONJ
fnp-4692	199	18	it	it	PRON
fnp-4692	199	19	shows	show	VERB
fnp-4692	199	20	that	that	SCONJ
fnp-4692	199	21	machine	machine	NOUN
fnp-4692	199	22	learning	learning	NOUN
fnp-4692	199	23	-	-	PUNCT
fnp-4692	199	24	based	base	VERB
fnp-4692	199	25	diagnostics	diagnostic	NOUN
fnp-4692	199	26	may	may	AUX
fnp-4692	199	27	be	be	AUX
fnp-4692	199	28	similarly	similarly	ADV
fnp-4692	199	29	powerful	powerful	ADJ
fnp-4692	199	30	as	as	ADP
fnp-4692	199	31	a	a	DET
fnp-4692	199	32	(	(	PUNCT
fnp-4692	199	33	neuro-)pathologist	neuro-)pathologist	NOUN
fnp-4692	199	34	[	[	X
fnp-4692	199	35	5	5	NUM
fnp-4692	199	36	]	]	PUNCT
fnp-4692	199	37	.	.	PUNCT
fnp-4692	200	1	such	such	DET
fnp-4692	200	2	an	an	DET
fnp-4692	200	3	approach	approach	NOUN
fnp-4692	200	4	could	could	AUX
fnp-4692	200	5	be	be	AUX
fnp-4692	200	6	helpful	helpful	ADJ
fnp-4692	200	7	not	not	PART
fnp-4692	200	8	only	only	ADV
fnp-4692	200	9	for	for	ADP
fnp-4692	200	10	countries	country	NOUN
fnp-4692	200	11	where	where	SCONJ
fnp-4692	200	12	no	no	DET
fnp-4692	200	13	neuropathologists	neuropathologist	NOUN
fnp-4692	200	14	are	be	AUX
fnp-4692	200	15	available	available	ADJ
fnp-4692	200	16	,	,	PUNCT
fnp-4692	200	17	but	but	CCONJ
fnp-4692	200	18	also	also	ADV
fnp-4692	200	19	for	for	ADP
fnp-4692	200	20	smaller	small	ADJ
fnp-4692	200	21	health	health	NOUN
fnp-4692	200	22	care	care	NOUN
fnp-4692	200	23	centers	center	NOUN
fnp-4692	200	24	,	,	PUNCT
fnp-4692	200	25	in	in	ADP
fnp-4692	200	26	which	which	PRON
fnp-4692	200	27	a	a	DET
fnp-4692	200	28	4	4	NUM
fnp-4692	200	29	(	(	PUNCT
fnp-4692	200	30	or	or	CCONJ
fnp-4692	200	31	more	more	ADJ
fnp-4692	200	32	)	)	PUNCT
fnp-4692	200	33	eye	eye	NOUN
fnp-4692	200	34	principle	principle	NOUN
fnp-4692	200	35	is	be	AUX
fnp-4692	200	36	not	not	PART
fnp-4692	200	37	possible	possible	ADJ
fnp-4692	200	38	.	.	PUNCT
fnp-4692	201	1	the	the	DET
fnp-4692	201	2	fact	fact	NOUN
fnp-4692	201	3	that	that	SCONJ
fnp-4692	201	4	“	"	PUNCT
fnp-4692	201	5	artificial	artificial	ADJ
fnp-4692	201	6	intelligence	intelligence	NOUN
fnp-4692	201	7	”	"	PUNCT
fnp-4692	201	8	never	never	ADV
fnp-4692	201	9	gets	get	VERB
fnp-4692	201	10	tired	tired	ADJ
fnp-4692	201	11	and	and	CCONJ
fnp-4692	201	12	is	be	AUX
fnp-4692	201	13	able	able	ADJ
fnp-4692	201	14	to	to	PART
fnp-4692	201	15	quickly	quickly	ADV
fnp-4692	201	16	capture	capture	VERB
fnp-4692	201	17	information	information	NOUN
fnp-4692	201	18	from	from	ADP
fnp-4692	201	19	huge	huge	ADJ
fnp-4692	201	20	databases	database	NOUN
fnp-4692	201	21	,	,	PUNCT
fnp-4692	201	22	a	a	DET
fnp-4692	201	23	task	task	NOUN
fnp-4692	201	24	for	for	ADP
fnp-4692	201	25	which	which	PRON
fnp-4692	201	26	an	an	DET
fnp-4692	201	27	experienced	experienced	ADJ
fnp-4692	201	28	pathologist	pathologist	NOUN
fnp-4692	201	29	would	would	AUX
fnp-4692	201	30	need	need	VERB
fnp-4692	201	31	decades	decade	NOUN
fnp-4692	201	32	,	,	PUNCT
fnp-4692	201	33	may	may	AUX
fnp-4692	201	34	be	be	AUX
fnp-4692	201	35	very	very	ADV
fnp-4692	201	36	worrying	worrying	ADJ
fnp-4692	201	37	for	for	ADP
fnp-4692	201	38	classic	classic	ADJ
fnp-4692	201	39	“	"	PUNCT
fnp-4692	201	40	histomorphologists	histomorphologist	NOUN
fnp-4692	201	41	”	"	PUNCT
fnp-4692	201	42	.	.	PUNCT
fnp-4692	202	1	this	this	PRON
fnp-4692	202	2	might	might	AUX
fnp-4692	202	3	be	be	AUX
fnp-4692	202	4	even	even	ADV
fnp-4692	202	5	more	more	ADJ
fnp-4692	202	6	the	the	DET
fnp-4692	202	7	case	case	NOUN
fnp-4692	202	8	when	when	SCONJ
fnp-4692	202	9	machine	machine	NOUN
fnp-4692	202	10	-	-	PUNCT
fnp-4692	202	11	learning	learn	VERB
fnp-4692	202	12	pipelines	pipeline	NOUN
fnp-4692	202	13	will	will	AUX
fnp-4692	202	14	be	be	AUX
fnp-4692	202	15	more	more	ADV
fnp-4692	202	16	directly	directly	ADV
fnp-4692	202	17	fed	feed	VERB
fnp-4692	202	18	with	with	ADP
fnp-4692	202	19	clinical	clinical	ADJ
fnp-4692	202	20	,	,	PUNCT
fnp-4692	202	21	radiological	radiological	ADJ
fnp-4692	202	22	and	and	CCONJ
fnp-4692	202	23	molecular	molecular	ADJ
fnp-4692	202	24	data	datum	NOUN
fnp-4692	202	25	.	.	PUNCT
fnp-4692	203	1	nowadays	nowadays	ADV
fnp-4692	203	2	,	,	PUNCT
fnp-4692	203	3	it	it	PRON
fnp-4692	203	4	is	be	AUX
fnp-4692	203	5	already	already	ADV
fnp-4692	203	6	very	very	ADV
fnp-4692	203	7	clear	clear	ADJ
fnp-4692	203	8	that	that	SCONJ
fnp-4692	203	9	morphological	morphological	ADJ
fnp-4692	203	10	classification	classification	NOUN
fnp-4692	203	11	alone	alone	ADV
fnp-4692	203	12	is	be	AUX
fnp-4692	203	13	significantly	significantly	ADV
fnp-4692	203	14	inferior	inferior	ADJ
fnp-4692	203	15	to	to	ADP
fnp-4692	203	16	approaches	approach	NOUN
fnp-4692	203	17	that	that	PRON
fnp-4692	203	18	also	also	ADV
fnp-4692	203	19	take	take	VERB
fnp-4692	203	20	into	into	ADP
fnp-4692	203	21	account	account	NOUN
fnp-4692	203	22	molecular	molecular	ADJ
fnp-4692	203	23	pathological	pathological	ADJ
fnp-4692	203	24	data	datum	NOUN
fnp-4692	204	1	[	[	X
fnp-4692	204	2	6	6	NUM
fnp-4692	204	3	]	]	PUNCT
fnp-4692	204	4	.	.	PUNCT
fnp-4692	205	1	as	as	SCONJ
fnp-4692	205	2	previously	previously	ADV
fnp-4692	205	3	shown	show	VERB
fnp-4692	205	4	for	for	ADP
fnp-4692	205	5	several	several	ADJ
fnp-4692	205	6	joint	joint	ADJ
fnp-4692	205	7	initiatives	initiative	NOUN
fnp-4692	205	8	in	in	ADP
fnp-4692	205	9	molecular	molecular	ADJ
fnp-4692	205	10	profiling	profiling	NOUN
fnp-4692	205	11	,	,	PUNCT
fnp-4692	205	12	it	it	PRON
fnp-4692	205	13	would	would	AUX
fnp-4692	205	14	be	be	AUX
fnp-4692	205	15	highly	highly	ADV
fnp-4692	205	16	beneficial	beneficial	ADJ
fnp-4692	205	17	if	if	SCONJ
fnp-4692	205	18	prognostic	prognostic	ADJ
fnp-4692	205	19	prediction	prediction	NOUN
fnp-4692	205	20	algorithms	algorithm	NOUN
fnp-4692	205	21	would	would	AUX
fnp-4692	205	22	be	be	AUX
fnp-4692	205	23	cross	cross	ADJ
fnp-4692	205	24	-	-	VERB
fnp-4692	205	25	validated	validated	ADJ
fnp-4692	205	26	with	with	ADP
fnp-4692	205	27	the	the	DET
fnp-4692	205	28	goal	goal	NOUN
fnp-4692	205	29	to	to	PART
fnp-4692	205	30	constantly	constantly	ADV
fnp-4692	205	31	improve	improve	VERB
fnp-4692	205	32	,	,	PUNCT
fnp-4692	205	33	instead	instead	ADV
fnp-4692	205	34	of	of	ADP
fnp-4692	205	35	having	have	VERB
fnp-4692	205	36	several	several	ADJ
fnp-4692	205	37	competing	compete	VERB
fnp-4692	205	38	grading	grade	VERB
fnp-4692	205	39	systems	system	NOUN
fnp-4692	205	40	[	[	X
fnp-4692	205	41	6	6	NUM
fnp-4692	205	42	,	,	PUNCT
fnp-4692	205	43	17	17	NUM
fnp-4692	205	44	]	]	PUNCT
fnp-4692	205	45	.	.	PUNCT
fnp-4692	206	1	similarly	similarly	ADV
fnp-4692	206	2	,	,	PUNCT
fnp-4692	206	3	joint	joint	ADJ
fnp-4692	206	4	efforts	effort	NOUN
fnp-4692	206	5	would	would	AUX
fnp-4692	206	6	of	of	ADP
fnp-4692	206	7	course	course	NOUN
fnp-4692	206	8	be	be	AUX
fnp-4692	206	9	necessary	necessary	ADJ
fnp-4692	206	10	for	for	ADP
fnp-4692	206	11	other	other	ADJ
fnp-4692	206	12	ongoing	ongoing	ADJ
fnp-4692	206	13	initiatives	initiative	NOUN
fnp-4692	206	14	that	that	PRON
fnp-4692	206	15	have	have	AUX
fnp-4692	206	16	been	be	AUX
fnp-4692	206	17	presented	present	VERB
fnp-4692	206	18	in	in	ADP
fnp-4692	206	19	this	this	DET
fnp-4692	206	20	manuscript	manuscript	NOUN
fnp-4692	206	21	,	,	PUNCT
fnp-4692	206	22	such	such	ADJ
fnp-4692	206	23	as	as	ADP
fnp-4692	206	24	methylome	methylome	ADV
fnp-4692	206	25	-	-	PUNCT
fnp-4692	206	26	based	base	VERB
fnp-4692	206	27	brain	brain	NOUN
fnp-4692	206	28	tumor	tumor	NOUN
fnp-4692	206	29	diagnostics	diagnostic	NOUN
fnp-4692	206	30	in	in	ADP
fnp-4692	206	31	csf	csf	ADJ
fnp-4692	206	32	liquid	liquid	ADJ
fnp-4692	206	33	biopsies	biopsy	NOUN
fnp-4692	206	34	[	[	X
fnp-4692	206	35	9	9	NUM
fnp-4692	206	36	]	]	PUNCT
fnp-4692	206	37	,	,	PUNCT
fnp-4692	206	38	molecular	molecular	ADJ
fnp-4692	206	39	profiling	profiling	NOUN
fnp-4692	206	40	for	for	ADP
fnp-4692	206	41	entities	entity	NOUN
fnp-4692	206	42	that	that	PRON
fnp-4692	206	43	are	be	AUX
fnp-4692	206	44	not	not	PART
fnp-4692	206	45	yet	yet	ADV
fnp-4692	206	46	broadly	broadly	ADV
fnp-4692	206	47	covered	cover	VERB
fnp-4692	206	48	in	in	ADP
fnp-4692	206	49	openly	openly	ADV
fnp-4692	206	50	accessible	accessible	ADJ
fnp-4692	206	51	classification	classification	NOUN
fnp-4692	206	52	pipelines	pipeline	NOUN
fnp-4692	206	53	,	,	PUNCT
fnp-4692	206	54	[	[	X
fnp-4692	206	55	7	7	X
fnp-4692	206	56	]	]	PUNCT
fnp-4692	206	57	or	or	CCONJ
fnp-4692	206	58	more	more	ADV
fnp-4692	206	59	recently	recently	ADV
fnp-4692	206	60	upcoming	upcoming	ADJ
fnp-4692	206	61	techniques	technique	NOUN
fnp-4692	206	62	such	such	ADJ
fnp-4692	206	63	as	as	ADP
fnp-4692	206	64	close	close	ADJ
fnp-4692	206	65	to	to	ADP
fnp-4692	206	66	real	real	ADJ
fnp-4692	206	67	-	-	PUNCT
fnp-4692	206	68	time	time	NOUN
fnp-4692	206	69	diagnostic	diagnostic	ADJ
fnp-4692	206	70	approaches	approach	NOUN
fnp-4692	206	71	based	base	VERB
fnp-4692	206	72	on	on	ADP
fnp-4692	206	73	the	the	DET
fnp-4692	206	74	raman	raman	ADJ
fnp-4692	206	75	effect	effect	NOUN
fnp-4692	206	76	[	[	X
fnp-4692	206	77	10	10	NUM
fnp-4692	206	78	,	,	PUNCT
fnp-4692	206	79	11	11	NUM
fnp-4692	206	80	]	]	PUNCT
fnp-4692	206	81	.	.	PUNCT
fnp-4692	207	1	while	while	SCONJ
fnp-4692	207	2	most	most	ADJ
fnp-4692	207	3	profiling	profiling	ADJ
fnp-4692	207	4	studies	study	NOUN
fnp-4692	207	5	published	publish	VERB
fnp-4692	207	6	in	in	ADP
fnp-4692	207	7	2022	2022	NUM
fnp-4692	207	8	rather	rather	ADV
fnp-4692	207	9	focused	focus	VERB
fnp-4692	207	10	on	on	ADP
fnp-4692	207	11	“	"	PUNCT
fnp-4692	207	12	faster	fast	ADJ
fnp-4692	207	13	,	,	PUNCT
fnp-4692	207	14	deeper	deep	ADJ
fnp-4692	207	15	,	,	PUNCT
fnp-4692	207	16	broader	broad	ADJ
fnp-4692	207	17	,	,	PUNCT
fnp-4692	207	18	more	more	ADV
fnp-4692	207	19	precise	precise	ADJ
fnp-4692	207	20	”	"	PUNCT
fnp-4692	207	21	,	,	PUNCT
fnp-4692	207	22	really	really	ADV
fnp-4692	207	23	new	new	ADJ
fnp-4692	207	24	concepts	concept	NOUN
fnp-4692	207	25	were	be	AUX
fnp-4692	207	26	very	very	ADV
fnp-4692	207	27	infrequently	infrequently	ADV
fnp-4692	207	28	encountered	encounter	VERB
fnp-4692	207	29	.	.	PUNCT
fnp-4692	208	1	one	one	NUM
fnp-4692	208	2	very	very	ADV
fnp-4692	208	3	interesting	interesting	ADJ
fnp-4692	208	4	approach	approach	NOUN
fnp-4692	208	5	is	be	AUX
fnp-4692	208	6	based	base	VERB
fnp-4692	208	7	on	on	ADP
fnp-4692	208	8	a	a	DET
fnp-4692	208	9	deciphering	decipher	VERB
fnp-4692	208	10	the	the	DET
fnp-4692	208	11	proteomic	proteomic	ADJ
fnp-4692	208	12	landscape	landscape	NOUN
fnp-4692	208	13	in	in	ADP
fnp-4692	208	14	recurrent	recurrent	ADJ
fnp-4692	208	15	glioblastoma	glioblastoma	NOUN
fnp-4692	208	16	as	as	SCONJ
fnp-4692	208	17	compared	compare	VERB
fnp-4692	208	18	to	to	ADP
fnp-4692	208	19	its	its	PRON
fnp-4692	208	20	primary	primary	ADJ
fnp-4692	208	21	counterpart	counterpart	NOUN
fnp-4692	209	1	[	[	X
fnp-4692	209	2	8	8	NUM
fnp-4692	209	3	]	]	PUNCT
fnp-4692	209	4	.	.	PUNCT
fnp-4692	210	1	this	this	DET
fnp-4692	210	2	method	method	NOUN
fnp-4692	210	3	would	would	AUX
fnp-4692	210	4	allow	allow	VERB
fnp-4692	210	5	for	for	ADP
fnp-4692	210	6	a	a	DET
fnp-4692	210	7	personalized	personalized	ADJ
fnp-4692	210	8	treatment	treatment	NOUN
fnp-4692	210	9	addressing	address	VERB
fnp-4692	210	10	potentially	potentially	ADV
fnp-4692	210	11	newly	newly	ADV
fnp-4692	210	12	activated	activate	VERB
fnp-4692	210	13	tumor	tumor	NOUN
fnp-4692	210	14	pathways	pathway	NOUN
fnp-4692	210	15	emerging	emerge	VERB
fnp-4692	210	16	during	during	ADP
fnp-4692	210	17	treatment	treatment	NOUN
fnp-4692	210	18	resistance	resistance	NOUN
fnp-4692	210	19	and	and	CCONJ
fnp-4692	210	20	recurrence	recurrence	NOUN
fnp-4692	210	21	.	.	PUNCT
fnp-4692	211	1	focusing	focus	VERB
fnp-4692	211	2	on	on	ADP
fnp-4692	211	3	the	the	DET
fnp-4692	211	4	tumor	tumor	NOUN
fnp-4692	211	5	-	-	PUNCT
fnp-4692	211	6	associated	associate	VERB
fnp-4692	211	7	proteome	proteome	NOUN
fnp-4692	211	8	,	,	PUNCT
fnp-4692	211	9	one	one	PRON
fnp-4692	211	10	may	may	AUX
fnp-4692	211	11	get	get	VERB
fnp-4692	211	12	more	more	ADV
fnp-4692	211	13	real	real	ADJ
fnp-4692	211	14	functional	functional	ADJ
fnp-4692	211	15	information	information	NOUN
fnp-4692	211	16	about	about	ADP
fnp-4692	211	17	the	the	DET
fnp-4692	211	18	tumor	tumor	NOUN
fnp-4692	211	19	cells	cell	NOUN
fnp-4692	211	20	as	as	ADP
fnp-4692	211	21	compared	compare	VERB
fnp-4692	211	22	to	to	ADP
fnp-4692	211	23	transcriptome	transcriptome	PROPN
fnp-4692	211	24	,	,	PUNCT
fnp-4692	211	25	methylome	methylome	ADJ
fnp-4692	211	26	or	or	CCONJ
fnp-4692	211	27	mutational	mutational	ADJ
fnp-4692	211	28	analyses	analysis	NOUN
fnp-4692	211	29	.	.	PUNCT
fnp-4692	212	1	finally	finally	ADV
fnp-4692	212	2	,	,	PUNCT
fnp-4692	212	3	it	it	PRON
fnp-4692	212	4	is	be	AUX
fnp-4692	212	5	of	of	ADP
fnp-4692	212	6	high	high	ADJ
fnp-4692	212	7	importance	importance	NOUN
fnp-4692	212	8	to	to	PART
fnp-4692	212	9	come	come	VERB
fnp-4692	212	10	up	up	ADP
fnp-4692	212	11	with	with	ADP
fnp-4692	212	12	new	new	ADJ
fnp-4692	212	13	,	,	PUNCT
fnp-4692	212	14	more	more	ADV
fnp-4692	212	15	personalized	personalized	ADJ
fnp-4692	212	16	treatment	treatment	NOUN
fnp-4692	212	17	approaches	approach	NOUN
fnp-4692	212	18	,	,	PUNCT
fnp-4692	212	19	especially	especially	ADV
fnp-4692	212	20	for	for	ADP
fnp-4692	212	21	patients	patient	NOUN
fnp-4692	212	22	suffering	suffer	VERB
fnp-4692	212	23	from	from	ADP
fnp-4692	212	24	recurrent	recurrent	ADJ
fnp-4692	212	25	malignant	malignant	ADJ
fnp-4692	212	26	brain	brain	NOUN
fnp-4692	212	27	tumors	tumor	NOUN
fnp-4692	212	28	with	with	ADP
fnp-4692	212	29	a	a	DET
fnp-4692	212	30	detrimental	detrimental	ADJ
fnp-4692	212	31	prognosis	prognosis	NOUN
fnp-4692	212	32	for	for	ADP
fnp-4692	212	33	which	which	PRON
fnp-4692	212	34	no	no	DET
fnp-4692	212	35	really	really	ADV
fnp-4692	212	36	helpful	helpful	ADJ
fnp-4692	212	37	established	establish	VERB
fnp-4692	212	38	treatment	treatment	NOUN
fnp-4692	212	39	schemes	scheme	NOUN
fnp-4692	212	40	are	be	AUX
fnp-4692	212	41	available	available	ADJ
fnp-4692	212	42	.	.	PUNCT
fnp-4692	213	1	a	a	DET
fnp-4692	213	2	promising	promising	ADJ
fnp-4692	213	3	approach	approach	NOUN
fnp-4692	213	4	is	be	AUX
fnp-4692	213	5	the	the	DET
fnp-4692	213	6	use	use	NOUN
fnp-4692	213	7	of	of	ADP
fnp-4692	213	8	drug	drug	NOUN
fnp-4692	213	9	screening	screening	NOUN
fnp-4692	213	10	libraries	library	NOUN
fnp-4692	213	11	which	which	PRON
fnp-4692	213	12	may	may	AUX
fnp-4692	213	13	be	be	AUX
fnp-4692	213	14	very	very	ADV
fnp-4692	213	15	useful	useful	ADJ
fnp-4692	213	16	to	to	PART
fnp-4692	213	17	detect	detect	VERB
fnp-4692	213	18	potential	potential	ADJ
fnp-4692	213	19	drugs	drug	NOUN
fnp-4692	213	20	that	that	PRON
fnp-4692	213	21	can	can	AUX
fnp-4692	213	22	not	not	PART
fnp-4692	213	23	easily	easily	ADV
fnp-4692	213	24	be	be	AUX
fnp-4692	213	25	predicted	predict	VERB
fnp-4692	213	26	by	by	ADP
fnp-4692	213	27	deep	deep	ADJ
fnp-4692	213	28	sequencing	sequencing	NOUN
fnp-4692	213	29	analyses	analysis	NOUN
fnp-4692	213	30	[	[	X
fnp-4692	213	31	14	14	NUM
fnp-4692	213	32	]	]	PUNCT
fnp-4692	213	33	.	.	PUNCT
fnp-4692	214	1	as	as	SCONJ
fnp-4692	214	2	the	the	DET
fnp-4692	214	3	author	author	NOUN
fnp-4692	214	4	put	put	VERB
fnp-4692	214	5	the	the	DET
fnp-4692	214	6	brain	brain	NOUN
fnp-4692	214	7	tumor	tumor	NOUN
fnp-4692	214	8	cell(s	cell(s	PROPN
fnp-4692	214	9	)	)	PUNCT
fnp-4692	214	10	in	in	ADP
fnp-4692	214	11	the	the	DET
fnp-4692	214	12	center	center	NOUN
fnp-4692	214	13	of	of	ADP
fnp-4692	214	14	this	this	DET
fnp-4692	214	15	“	"	PUNCT
fnp-4692	214	16	top	top	ADJ
fnp-4692	214	17	ten	ten	NUM
fnp-4692	214	18	”	"	PUNCT
fnp-4692	214	19	series	series	NOUN
fnp-4692	214	20	,	,	PUNCT
fnp-4692	214	21	several	several	ADJ
fnp-4692	214	22	high	high	ADJ
fnp-4692	214	23	impact	impact	NOUN
fnp-4692	214	24	papers	paper	NOUN
fnp-4692	214	25	that	that	PRON
fnp-4692	214	26	focused	focus	VERB
fnp-4692	214	27	on	on	ADP
fnp-4692	214	28	cells	cell	NOUN
fnp-4692	214	29	of	of	ADP
fnp-4692	214	30	or	or	CCONJ
fnp-4692	214	31	interaction	interaction	NOUN
fnp-4692	214	32	mechanisms	mechanism	NOUN
fnp-4692	214	33	within	within	ADP
fnp-4692	214	34	the	the	DET
fnp-4692	214	35	tumor	tumor	NOUN
fnp-4692	214	36	microenvironment	microenvironment	NOUN
fnp-4692	214	37	unfortunately	unfortunately	ADV
fnp-4692	214	38	did	do	AUX
fnp-4692	214	39	not	not	PART
fnp-4692	214	40	make	make	VERB
fnp-4692	214	41	it	it	PRON
fnp-4692	214	42	on	on	ADP
fnp-4692	214	43	this	this	DET
fnp-4692	214	44	list	list	NOUN
fnp-4692	214	45	.	.	PUNCT
fnp-4692	215	1	an	an	DET
fnp-4692	215	2	amazing	amazing	ADJ
fnp-4692	215	3	new	new	ADJ
fnp-4692	215	4	concept	concept	NOUN
fnp-4692	215	5	about	about	ADP
fnp-4692	215	6	how	how	SCONJ
fnp-4692	215	7	glioblastoma	glioblastoma	NOUN
fnp-4692	215	8	cells	cell	NOUN
fnp-4692	215	9	are	be	AUX
fnp-4692	215	10	hijacking	hijack	VERB
fnp-4692	215	11	neuronal	neuronal	ADJ
fnp-4692	215	12	activity	activity	NOUN
fnp-4692	215	13	for	for	ADP
fnp-4692	215	14	invasion	invasion	NOUN
fnp-4692	215	15	has	have	AUX
fnp-4692	215	16	been	be	AUX
fnp-4692	215	17	presented	present	VERB
fnp-4692	215	18	,	,	PUNCT
fnp-4692	215	19	however	however	ADV
fnp-4692	215	20	,	,	PUNCT
fnp-4692	215	21	it	it	PRON
fnp-4692	215	22	remains	remain	VERB
fnp-4692	215	23	to	to	PART
fnp-4692	215	24	be	be	AUX
fnp-4692	215	25	determined	determine	VERB
fnp-4692	215	26	to	to	PART
fnp-4692	215	27	which	which	DET
fnp-4692	215	28	degree	degree	NOUN
fnp-4692	215	29	this	this	PRON
fnp-4692	215	30	is	be	AUX
fnp-4692	215	31	important	important	ADJ
fnp-4692	215	32	in	in	ADP
fnp-4692	215	33	humans	human	NOUN
fnp-4692	215	34	and	and	CCONJ
fnp-4692	215	35	if	if	SCONJ
fnp-4692	215	36	this	this	DET
fnp-4692	215	37	mechanism	mechanism	NOUN
fnp-4692	215	38	may	may	AUX
fnp-4692	215	39	serve	serve	VERB
fnp-4692	215	40	as	as	ADP
fnp-4692	215	41	a	a	DET
fnp-4692	215	42	potential	potential	ADJ
fnp-4692	215	43	future	future	ADJ
fnp-4692	215	44	treatment	treatment	NOUN
fnp-4692	215	45	target	target	NOUN
fnp-4692	215	46	[	[	X
fnp-4692	215	47	37	37	NUM
fnp-4692	215	48	]	]	PUNCT
fnp-4692	215	49	.	.	PUNCT
fnp-4692	216	1	another	another	DET
fnp-4692	216	2	fascinating	fascinating	ADJ
fnp-4692	216	3	study	study	NOUN
fnp-4692	216	4	showed	show	VERB
fnp-4692	216	5	in	in	ADP
fnp-4692	216	6	a	a	DET
fnp-4692	216	7	murine	murine	ADJ
fnp-4692	216	8	model	model	NOUN
fnp-4692	216	9	that	that	SCONJ
fnp-4692	216	10	a	a	DET
fnp-4692	216	11	loss	loss	NOUN
fnp-4692	216	12	of	of	ADP
fnp-4692	216	13	mhc	mhc	PROPN
fnp-4692	216	14	-	-	PUNCT
fnp-4692	216	15	ii	ii	PROPN
fnp-4692	216	16	on	on	ADP
fnp-4692	216	17	blood	blood	NOUN
fnp-4692	216	18	-	-	PUNCT
fnp-4692	216	19	borne	bear	VERB
fnp-4692	216	20	myeloid	myeloid	ADJ
fnp-4692	216	21	cells	cell	NOUN
fnp-4692	216	22	leads	lead	VERB
fnp-4692	216	23	to	to	ADP
fnp-4692	216	24	dysfunctional	dysfunctional	ADJ
fnp-4692	216	25	cd8	cd8	PROPN
fnp-4692	216	26	-	-	ADJ
fnp-4692	216	27	positive	positive	ADJ
fnp-4692	216	28	cytotoxic	cytotoxic	ADJ
fnp-4692	216	29	t	t	NOUN
fnp-4692	216	30	cells	cell	NOUN
fnp-4692	216	31	and	and	CCONJ
fnp-4692	216	32	therefore	therefore	ADV
fnp-4692	216	33	impaired	impaired	ADJ
fnp-4692	216	34	tumor	tumor	NOUN
fnp-4692	216	35	control	control	NOUN
fnp-4692	216	36	while	while	SCONJ
fnp-4692	216	37	functional	functional	ADJ
fnp-4692	216	38	mhc	mhc	PROPN
fnp-4692	216	39	-	-	PUNCT
fnp-4692	216	40	ii	ii	NOUN
fnp-4692	216	41	-	-	PUNCT
fnp-4692	216	42	restricted	restrict	VERB
fnp-4692	216	43	antigen	antigen	ADJ
fnp-4692	216	44	presentation	presentation	NOUN
fnp-4692	216	45	was	be	AUX
fnp-4692	216	46	associated	associate	VERB
fnp-4692	216	47	with	with	ADP
fnp-4692	216	48	improved	improve	VERB
fnp-4692	216	49	tumor	tumor	NOUN
fnp-4692	216	50	control	control	NOUN
fnp-4692	217	1	[	[	X
fnp-4692	217	2	38	38	NUM
fnp-4692	217	3	]	]	PUNCT
fnp-4692	217	4	.	.	PUNCT
fnp-4692	218	1	although	although	SCONJ
fnp-4692	218	2	the	the	DET
fnp-4692	218	3	authors	author	NOUN
fnp-4692	218	4	could	could	AUX
fnp-4692	218	5	show	show	VERB
fnp-4692	218	6	an	an	DET
fnp-4692	218	7	inverse	inverse	NOUN
fnp-4692	218	8	correlation	correlation	NOUN
fnp-4692	218	9	of	of	ADP
fnp-4692	218	10	mhc	mhc	PROPN
fnp-4692	218	11	-	-	PUNCT
fnp-4692	218	12	ii	ii	PROPN
fnp-4692	218	13	expression	expression	NOUN
fnp-4692	218	14	with	with	ADP
fnp-4692	218	15	dysfunctional	dysfunctional	ADJ
fnp-4692	218	16	cd8	cd8	PROPN
fnp-4692	218	17	-	-	ADJ
fnp-4692	218	18	positive	positive	ADJ
fnp-4692	218	19	t	t	NOUN
fnp-4692	218	20	cell	cell	NOUN
fnp-4692	218	21	phenotypes	phenotype	NOUN
fnp-4692	218	22	,	,	PUNCT
fnp-4692	218	23	this	this	DET
fnp-4692	218	24	finding	finding	NOUN
fnp-4692	218	25	was	be	AUX
fnp-4692	218	26	only	only	ADV
fnp-4692	218	27	provided	provide	VERB
fnp-4692	218	28	in	in	ADP
fnp-4692	218	29	a	a	DET
fnp-4692	218	30	very	very	ADV
fnp-4692	218	31	small	small	ADJ
fnp-4692	218	32	cohort	cohort	NOUN
fnp-4692	218	33	of	of	ADP
fnp-4692	218	34	human	human	ADJ
fnp-4692	218	35	glioblastoma	glioblastoma	NOUN
fnp-4692	218	36	samples	sample	NOUN
fnp-4692	218	37	and	and	CCONJ
fnp-4692	218	38	needs	need	VERB
fnp-4692	218	39	further	further	ADJ
fnp-4692	218	40	corroboration	corroboration	NOUN
fnp-4692	218	41	.	.	PUNCT
fnp-4692	219	1	in	in	ADP
fnp-4692	219	2	conclusion	conclusion	NOUN
fnp-4692	219	3	,	,	PUNCT
fnp-4692	219	4	neurooncological	neurooncological	ADJ
fnp-4692	219	5	research	research	NOUN
fnp-4692	219	6	in	in	ADP
fnp-4692	219	7	2022	2022	NUM
fnp-4692	219	8	provided	provide	VERB
fnp-4692	219	9	a	a	DET
fnp-4692	219	10	huge	huge	ADJ
fnp-4692	219	11	number	number	NOUN
fnp-4692	219	12	of	of	ADP
fnp-4692	219	13	excellent	excellent	ADJ
fnp-4692	219	14	studies	study	NOUN
fnp-4692	219	15	that	that	PRON
fnp-4692	219	16	considerably	considerably	ADV
fnp-4692	219	17	improved	improve	VERB
fnp-4692	219	18	speed	speed	NOUN
fnp-4692	219	19	and	and	CCONJ
fnp-4692	219	20	precision	precision	NOUN
fnp-4692	219	21	in	in	ADP
fnp-4692	219	22	classifying	classify	VERB
fnp-4692	219	23	tumors	tumor	NOUN
fnp-4692	219	24	of	of	ADP
fnp-4692	219	25	the	the	DET
fnp-4692	219	26	central	central	ADJ
fnp-4692	219	27	nervous	nervous	ADJ
fnp-4692	219	28	system	system	NOUN
fnp-4692	219	29	,	,	PUNCT
fnp-4692	219	30	detected	detect	VERB
fnp-4692	219	31	new	new	ADJ
fnp-4692	219	32	tumor	tumor	NOUN
fnp-4692	219	33	entities	entity	NOUN
fnp-4692	219	34	and	and	CCONJ
fnp-4692	219	35	provided	provide	VERB
fnp-4692	219	36	promising	promising	ADJ
fnp-4692	219	37	approaches	approach	NOUN
fnp-4692	219	38	for	for	ADP
fnp-4692	219	39	more	more	ADJ
fnp-4692	219	40	individualized	individualized	ADJ
fnp-4692	219	41	treatment	treatment	NOUN
fnp-4692	219	42	approaches	approach	NOUN
fnp-4692	219	43	.	.	PUNCT
fnp-4692	220	1	there	there	PRON
fnp-4692	220	2	is	be	VERB
fnp-4692	220	3	nothing	nothing	PRON
fnp-4692	220	4	else	else	ADV
fnp-4692	220	5	for	for	ADP
fnp-4692	220	6	it	it	PRON
fnp-4692	220	7	but	but	CCONJ
fnp-4692	220	8	to	to	PART
fnp-4692	220	9	hope	hope	VERB
fnp-4692	220	10	that	that	SCONJ
fnp-4692	220	11	at	at	ADV
fnp-4692	220	12	least	least	ADJ
fnp-4692	220	13	some	some	PRON
fnp-4692	220	14	of	of	ADP
fnp-4692	220	15	those	those	DET
fnp-4692	220	16	approaches	approach	NOUN
fnp-4692	220	17	finally	finally	ADV
fnp-4692	220	18	make	make	VERB
fnp-4692	220	19	it	it	PRON
fnp-4692	220	20	into	into	ADP
fnp-4692	220	21	a	a	DET
fnp-4692	220	22	therapeutic	therapeutic	ADJ
fnp-4692	220	23	application	application	NOUN
fnp-4692	220	24	thereby	thereby	ADV
fnp-4692	220	25	helping	help	VERB
fnp-4692	220	26	to	to	PART
fnp-4692	220	27	improve	improve	VERB
fnp-4692	220	28	the	the	DET
fnp-4692	220	29	still	still	ADV
fnp-4692	220	30	detrimental	detrimental	ADJ
fnp-4692	220	31	prognosis	prognosis	NOUN
fnp-4692	220	32	of	of	ADP
fnp-4692	220	33	patients	patient	NOUN
fnp-4692	220	34	with	with	ADP
fnp-4692	220	35	malignant	malignant	ADJ
fnp-4692	220	36	brain	brain	NOUN
fnp-4692	220	37	tumors	tumor	NOUN
fnp-4692	220	38	.	.	PUNCT
fnp-4692	221	1	acknowledgements	acknowledgement	NOUN
fnp-4692	221	2	mm	mm	PROPN
fnp-4692	221	3	would	would	AUX
fnp-4692	221	4	like	like	VERB
fnp-4692	221	5	to	to	PART
fnp-4692	221	6	thank	thank	VERB
fnp-4692	221	7	the	the	DET
fnp-4692	221	8	luxembourg	luxembourg	PROPN
fnp-4692	221	9	national	national	PROPN
fnp-4692	221	10	research	research	PROPN
fnp-4692	221	11	fond	fond	ADJ
fnp-4692	221	12	(	(	PUNCT
fnp-4692	221	13	fnr	fnr	PROPN
fnp-4692	221	14	)	)	PUNCT
fnp-4692	221	15	for	for	ADP
fnp-4692	221	16	the	the	DET
fnp-4692	221	17	support	support	NOUN
fnp-4692	221	18	(	(	PUNCT
fnp-4692	221	19	fnr	fnr	PROPN
fnp-4692	221	20	pearl	pearl	NOUN
fnp-4692	221	21	p16	p16	PROPN
fnp-4692	221	22	/	/	SYM
fnp-4692	221	23	bm/11192868	bm/11192868	ADJ
fnp-4692	221	24	grant	grant	NOUN
fnp-4692	221	25	)	)	PUNCT
fnp-4692	221	26	.	.	PUNCT
fnp-4692	222	1	the	the	DET
fnp-4692	222	2	figures	figure	NOUN
fnp-4692	222	3	were	be	AUX
fnp-4692	222	4	prepared	prepare	VERB
fnp-4692	222	5	using	use	VERB
fnp-4692	222	6	https://biorender.com	https://biorender.com	X
fnp-4692	222	7	figure	figure	VERB
fnp-4692	222	8	creation	creation	NOUN
fnp-4692	222	9	tool	tool	NOUN
fnp-4692	222	10	.	.	PUNCT
fnp-4692	223	1	single	single	ADJ
fnp-4692	223	2	images	image	NOUN
fnp-4692	223	3	using	use	VERB
fnp-4692	223	4	for	for	ADP
fnp-4692	223	5	the	the	DET
fnp-4692	223	6	figures	figure	NOUN
fnp-4692	223	7	were	be	AUX
fnp-4692	223	8	freely	freely	ADV
fnp-4692	223	9	available	available	ADJ
fnp-4692	223	10	tagged	tag	VERB
fnp-4692	223	11	with	with	ADP
fnp-4692	223	12	creative	creative	ADJ
fnp-4692	223	13	common	common	ADJ
fnp-4692	223	14	license	license	NOUN
fnp-4692	223	15	.	.	PUNCT
fnp-4692	224	1	declaration	declaration	NOUN
fnp-4692	224	2	of	of	ADP
fnp-4692	224	3	interests	interest	NOUN
fnp-4692	224	4	the	the	DET
fnp-4692	224	5	author	author	NOUN
fnp-4692	224	6	declares	declare	VERB
fnp-4692	224	7	to	to	PART
fnp-4692	224	8	not	not	PART
fnp-4692	224	9	have	have	VERB
fnp-4692	224	10	any	any	DET
fnp-4692	224	11	competing	compete	VERB
fnp-4692	224	12	interests	interest	NOUN
fnp-4692	224	13	.	.	PUNCT
fnp-4692	225	1	references	reference	NOUN
fnp-4692	225	2	1	1	NUM
fnp-4692	225	3	.	.	PUNCT
fnp-4692	225	4	falagas	falagas	VERB
fnp-4692	225	5	me	i	PRON
fnp-4692	225	6	,	,	PUNCT
fnp-4692	225	7	pitsouni	pitsouni	PROPN
fnp-4692	225	8	ei	ei	PROPN
fnp-4692	225	9	,	,	PUNCT
fnp-4692	225	10	malietzis	malietzis	PROPN
fnp-4692	225	11	ga	ga	PROPN
fnp-4692	225	12	,	,	PUNCT
fnp-4692	225	13	pappas	pappas	PROPN
fnp-4692	225	14	g.	g.	PROPN
fnp-4692	225	15	comparison	comparison	NOUN
fnp-4692	225	16	of	of	ADP
fnp-4692	225	17	pubmed	pubmed	PROPN
fnp-4692	225	18	,	,	PUNCT
fnp-4692	225	19	scopus	scopus	PROPN
fnp-4692	225	20	,	,	PUNCT
fnp-4692	225	21	web	web	NOUN
fnp-4692	225	22	of	of	ADP
fnp-4692	225	23	science	science	NOUN
fnp-4692	225	24	,	,	PUNCT
fnp-4692	225	25	and	and	CCONJ
fnp-4692	225	26	google	google	PROPN
fnp-4692	225	27	scholar	scholar	NOUN
fnp-4692	225	28	:	:	PUNCT
fnp-4692	225	29	strengths	strength	NOUN
fnp-4692	225	30	and	and	CCONJ
fnp-4692	225	31	weaknesses	weakness	NOUN
fnp-4692	225	32	.	.	PUNCT
fnp-4692	226	1	faseb	faseb	PROPN
fnp-4692	226	2	j.	j.	PROPN
fnp-4692	226	3	2008	2008	NUM
fnp-4692	226	4	feb;22(2):338	feb;22(2):338	PROPN
fnp-4692	226	5	-	-	PUNCT
fnp-4692	226	6	42	42	NUM
fnp-4692	226	7	.	.	PUNCT
fnp-4692	226	8	https://doi.org/10.1096/fj.07-9492lsf	https://doi.org/10.1096/fj.07-9492lsf	NOUN
fnp-4692	226	9	.	.	PUNCT
fnp-4692	227	1	epub	epub	NOUN
fnp-4692	227	2	2007	2007	NUM
fnp-4692	227	3	sep	sep	PROPN
fnp-4692	227	4	20	20	NUM
fnp-4692	227	5	.	.	PUNCT
fnp-4692	228	1	pmid	pmid	NOUN
fnp-4692	228	2	:	:	PUNCT
fnp-4692	228	3	17884971	17884971	NUM
fnp-4692	228	4	.	.	PUNCT
fnp-4692	229	1	2	2	X
fnp-4692	229	2	.	.	X
fnp-4692	229	3	shariff	shariff	PROPN
fnp-4692	229	4	sz	sz	PROPN
fnp-4692	229	5	,	,	PUNCT
fnp-4692	229	6	bejaimal	bejaimal	PROPN
fnp-4692	229	7	sa	sa	PROPN
fnp-4692	229	8	,	,	PUNCT
fnp-4692	229	9	sontrop	sontrop	VERB
fnp-4692	229	10	jm	jm	PROPN
fnp-4692	229	11	,	,	PUNCT
fnp-4692	229	12	iansavichus	iansavichus	PROPN
fnp-4692	229	13	av	av	PROPN
fnp-4692	229	14	,	,	PUNCT
fnp-4692	229	15	haynes	haynes	PROPN
fnp-4692	229	16	rb	rb	PROPN
fnp-4692	229	17	,	,	PUNCT
fnp-4692	229	18	weir	weir	PROPN
fnp-4692	229	19	ma	ma	PROPN
fnp-4692	229	20	,	,	PUNCT
fnp-4692	229	21	garg	garg	NOUN
fnp-4692	229	22	ax	ax	NOUN
fnp-4692	229	23	.	.	PUNCT
fnp-4692	230	1	retrieving	retrieve	VERB
fnp-4692	230	2	clinical	clinical	ADJ
fnp-4692	230	3	evidence	evidence	NOUN
fnp-4692	230	4	:	:	PUNCT
fnp-4692	230	5	a	a	DET
fnp-4692	230	6	comparison	comparison	NOUN
fnp-4692	230	7	of	of	ADP
fnp-4692	230	8	pubmed	pubmed	PROPN
fnp-4692	230	9	and	and	CCONJ
fnp-4692	230	10	google	google	PROPN
fnp-4692	230	11	scholar	scholar	NOUN
fnp-4692	230	12	for	for	ADP
fnp-4692	230	13	quick	quick	ADJ
fnp-4692	230	14	clinical	clinical	ADJ
fnp-4692	230	15	searches	search	NOUN
fnp-4692	230	16	.	.	PUNCT
fnp-4692	231	1	j	j	PROPN
fnp-4692	231	2	med	med	PROPN
fnp-4692	231	3	internet	internet	NOUN
fnp-4692	231	4	res	re	NOUN
fnp-4692	231	5	.	.	PUNCT
fnp-4692	232	1	2013	2013	NUM
fnp-4692	232	2	aug	aug	PROPN
fnp-4692	232	3	15;15(8):e164	15;15(8):e164	NUM
fnp-4692	232	4	.	.	PUNCT
fnp-4692	233	1	https://doi.org/10.2196/jmir.2624	https://doi.org/10.2196/jmir.2624	PROPN
fnp-4692	233	2	.	.	PUNCT
fnp-4692	234	1	pmid	pmid	NOUN
fnp-4692	234	2	:	:	PUNCT
fnp-4692	234	3	23948488	23948488	NUM
fnp-4692	234	4	.	.	PUNCT
fnp-4692	235	1	3	3	X
fnp-4692	235	2	.	.	X
fnp-4692	235	3	pratt	pratt	PROPN
fnp-4692	235	4	d	d	PROPN
fnp-4692	235	5	,	,	PUNCT
fnp-4692	235	6	abdullaev	abdullaev	PROPN
fnp-4692	235	7	z	z	PROPN
fnp-4692	235	8	,	,	PUNCT
fnp-4692	235	9	papanicolau	papanicolau	NOUN
fnp-4692	235	10	-	-	PUNCT
fnp-4692	235	11	sengos	sengo	NOUN
fnp-4692	235	12	a	a	PRON
fnp-4692	235	13	,	,	PUNCT
fnp-4692	235	14	ketchum	ketchum	PROPN
fnp-4692	235	15	c	c	PROPN
fnp-4692	235	16	,	,	PUNCT
fnp-4692	235	17	panneer	panneer	NOUN
fnp-4692	235	18	selvam	selvam	PROPN
fnp-4692	235	19	p	p	X
fnp-4692	235	20	,	,	PUNCT
fnp-4692	235	21	chung	chung	PROPN
fnp-4692	235	22	hj	hj	PROPN
fnp-4692	235	23	,	,	PUNCT
fnp-4692	235	24	lee	lee	PROPN
fnp-4692	235	25	i	i	PROPN
fnp-4692	235	26	,	,	PUNCT
fnp-4692	235	27	raffeld	raffeld	PROPN
fnp-4692	235	28	m	m	PROPN
fnp-4692	235	29	,	,	PUNCT
fnp-4692	235	30	gilbert	gilbert	PROPN
fnp-4692	235	31	mr	mr	PROPN
fnp-4692	235	32	,	,	PUNCT
fnp-4692	235	33	armstrong	armstrong	PROPN
fnp-4692	235	34	ts	ts	PROPN
fnp-4692	235	35	,	,	PUNCT
fnp-4692	235	36	pytel	pytel	NOUN
fnp-4692	235	37	p	p	NOUN
fnp-4692	235	38	,	,	PUNCT
fnp-4692	235	39	borys	borys	NOUN
fnp-4692	235	40	e	e	NOUN
fnp-4692	235	41	,	,	PUNCT
fnp-4692	235	42	klonoski	klonoski	PROPN
fnp-4692	235	43	jm	jm	PROPN
fnp-4692	235	44	,	,	PUNCT
fnp-4692	235	45	mccord	mccord	PROPN
fnp-4692	235	46	m	m	PROPN
fnp-4692	235	47	,	,	PUNCT
fnp-4692	235	48	horbinski	horbinski	PROPN
fnp-4692	235	49	c	c	NOUN
fnp-4692	235	50	,	,	PUNCT
fnp-4692	235	51	brat	brat	NOUN
fnp-4692	235	52	d	d	PROPN
fnp-4692	235	53	,	,	PUNCT
fnp-4692	235	54	perry	perry	PROPN
fnp-4692	235	55	a	a	PROPN
fnp-4692	235	56	,	,	PUNCT
fnp-4692	235	57	solomon	solomon	PROPN
fnp-4692	235	58	d	d	PROPN
fnp-4692	235	59	,	,	PUNCT
fnp-4692	235	60	eberhart	eberhart	NOUN
fnp-4692	235	61	c	c	NOUN
fnp-4692	235	62	,	,	PUNCT
fnp-4692	235	63	giannini	giannini	PROPN
fnp-4692	235	64	c	c	NOUN
fnp-4692	235	65	,	,	PUNCT
fnp-4692	235	66	quezado	quezado	PROPN
fnp-4692	235	67	m	m	PROPN
fnp-4692	235	68	,	,	PUNCT
fnp-4692	235	69	aldape	aldape	PROPN
fnp-4692	235	70	k.	k.	PROPN
fnp-4692	235	71	high	high	ADJ
fnp-4692	235	72	-	-	PUNCT
fnp-4692	235	73	grade	grade	NOUN
fnp-4692	235	74	glioma	glioma	NOUN
fnp-4692	235	75	with	with	ADP
fnp-4692	235	76	pleomorphic	pleomorphic	ADJ
fnp-4692	235	77	and	and	CCONJ
fnp-4692	235	78	pseudopapillary	pseudopapillary	ADJ
fnp-4692	235	79	features	feature	NOUN
fnp-4692	235	80	(	(	PUNCT
fnp-4692	235	81	hpap	hpap	NOUN
fnp-4692	235	82	):	):	PUNCT
fnp-4692	235	83	a	a	DET
fnp-4692	235	84	proposed	propose	VERB
fnp-4692	235	85	type	type	NOUN
fnp-4692	235	86	of	of	ADP
fnp-4692	235	87	circumscribed	circumscribed	ADJ
fnp-4692	235	88	glioma	glioma	NOUN
fnp-4692	235	89	in	in	ADP
fnp-4692	235	90	adults	adult	NOUN
fnp-4692	235	91	harboring	harbor	VERB
fnp-4692	235	92	frequent	frequent	ADJ
fnp-4692	235	93	tp53	tp53	PROPN
fnp-4692	235	94	mutations	mutation	NOUN
fnp-4692	235	95	and	and	CCONJ
fnp-4692	235	96	recurrent	recurrent	ADJ
fnp-4692	235	97	monosomy	monosomy	NOUN
fnp-4692	235	98	13	13	NUM
fnp-4692	235	99	.	.	PUNCT
fnp-4692	236	1	acta	acta	PROPN
fnp-4692	236	2	neuropathol	neuropathol	PROPN
fnp-4692	236	3	.	.	PUNCT
fnp-4692	237	1	2022	2022	NUM
fnp-4692	237	2	mar;143(3):403	mar;143(3):403	NOUN
fnp-4692	237	3	-	-	PUNCT
fnp-4692	237	4	414	414	NUM
fnp-4692	237	5	.	.	PUNCT
fnp-4692	238	1	https://doi.org/10.1007/s00401-022-02404-9	https://doi.org/10.1007/s00401-022-02404-9	NUM
fnp-4692	238	2	.	.	PUNCT
fnp-4692	239	1	epub	epub	VERB
fnp-4692	239	2	2022	2022	NUM
fnp-4692	239	3	feb	feb	NOUN
fnp-4692	239	4	1	1	NUM
fnp-4692	239	5	.	.	PUNCT
fnp-4692	240	1	pmid	pmid	NOUN
fnp-4692	240	2	:	:	PUNCT
fnp-4692	240	3	35103816	35103816	NUM
fnp-4692	240	4	.	.	PUNCT
fnp-4692	241	1	4	4	X
fnp-4692	241	2	.	.	X
fnp-4692	241	3	felix	felix	PROPN
fnp-4692	241	4	m	m	PROPN
fnp-4692	241	5	,	,	PUNCT
fnp-4692	241	6	friedel	friedel	PROPN
fnp-4692	241	7	d	d	PROPN
fnp-4692	241	8	,	,	PUNCT
fnp-4692	241	9	jayavelu	jayavelu	PROPN
fnp-4692	241	10	ak	ak	PROPN
fnp-4692	241	11	,	,	PUNCT
fnp-4692	241	12	filipski	filipski	PROPN
fnp-4692	241	13	k	k	PROPN
fnp-4692	241	14	,	,	PUNCT
fnp-4692	241	15	reinhardt	reinhardt	PROPN
fnp-4692	241	16	a	a	PROPN
fnp-4692	241	17	,	,	PUNCT
fnp-4692	241	18	warnken	warnken	ADJ
fnp-4692	241	19	u	u	NOUN
fnp-4692	241	20	,	,	PUNCT
fnp-4692	241	21	stichel	stichel	PROPN
fnp-4692	241	22	d	d	PROPN
fnp-4692	241	23	,	,	PUNCT
fnp-4692	241	24	schrimpf	schrimpf	NOUN
fnp-4692	241	25	d	d	PROPN
fnp-4692	241	26	,	,	PUNCT
fnp-4692	241	27	korshunov	korshunov	PROPN
fnp-4692	241	28	a	a	PROPN
fnp-4692	241	29	,	,	PUNCT
fnp-4692	241	30	wang	wang	PROPN
fnp-4692	241	31	y	y	PROPN
fnp-4692	241	32	,	,	PUNCT
fnp-4692	241	33	kessler	kessler	PROPN
fnp-4692	241	34	t	t	PROPN
fnp-4692	241	35	,	,	PUNCT
fnp-4692	241	36	etminan	etminan	PROPN
fnp-4692	241	37	n	n	CCONJ
fnp-4692	241	38	,	,	PUNCT
fnp-4692	241	39	unterberg	unterberg	PROPN
fnp-4692	241	40	a	a	DET
fnp-4692	241	41	,	,	PUNCT
fnp-4692	241	42	herold	herold	NOUN
fnp-4692	241	43	-	-	PUNCT
fnp-4692	241	44	mende	mende	PROPN
fnp-4692	241	45	c	c	PROPN
fnp-4692	241	46	,	,	PUNCT
fnp-4692	241	47	heikaus	heikaus	PROPN
fnp-4692	241	48	l	l	PROPN
fnp-4692	241	49	,	,	PUNCT
fnp-4692	241	50	sahm	sahm	PROPN
fnp-4692	241	51	f	f	PROPN
fnp-4692	241	52	,	,	PUNCT
fnp-4692	241	53	wick	wick	PROPN
fnp-4692	241	54	w	w	PROPN
fnp-4692	241	55	,	,	PUNCT
fnp-4692	241	56	harter	harter	PROPN
fnp-4692	241	57	pn	pn	PROPN
fnp-4692	241	58	,	,	PUNCT
fnp-4692	241	59	von	von	PROPN
fnp-4692	241	60	deimling	deimle	VERB
fnp-4692	241	61	a	a	PRON
fnp-4692	241	62	,	,	PUNCT
fnp-4692	241	63	reuss	reuss	PROPN
fnp-4692	241	64	de	de	X
fnp-4692	241	65	.	.	PROPN
fnp-4692	241	66	hip1r	hip1r	NUM
fnp-4692	242	1	and	and	CCONJ
fnp-4692	242	2	vimentin	vimentin	ADJ
fnp-4692	242	3	immunohistochemistry	immunohistochemistry	NOUN
fnp-4692	242	4	predict	predict	VERB
fnp-4692	242	5	1p/19q	1p/19q	ADJ
fnp-4692	242	6	status	status	NOUN
fnp-4692	242	7	in	in	ADP
fnp-4692	242	8	idh	idh	NOUN
fnp-4692	242	9	-	-	PUNCT
fnp-4692	242	10	mutant	mutant	NOUN
fnp-4692	242	11	glioma	glioma	NOUN
fnp-4692	242	12	.	.	PUNCT
fnp-4692	243	1	neuro	neuro	PROPN
fnp-4692	243	2	oncol	oncol	PROPN
fnp-4692	243	3	.	.	PUNCT
fnp-4692	244	1	2022	2022	NUM
fnp-4692	244	2	dec	dec	PROPN
fnp-4692	244	3	1;24(12):2121	1;24(12):2121	PROPN
fnp-4692	244	4	-	-	SYM
fnp-4692	244	5	2132	2132	NUM
fnp-4692	244	6	.	.	PUNCT
fnp-4692	245	1	https://doi.org/10.1093/neuonc/noac111	https://doi.org/10.1093/neuonc/noac111	NOUN
fnp-4692	245	2	.	.	PUNCT
fnp-4692	246	1	pmid	pmid	NOUN
fnp-4692	246	2	:	:	PUNCT
fnp-4692	246	3	35511748	35511748	NUM
fnp-4692	246	4	.	.	PUNCT
fnp-4692	247	1	5	5	X
fnp-4692	247	2	.	.	X
fnp-4692	247	3	liechty	liechty	PROPN
fnp-4692	247	4	b	b	PROPN
fnp-4692	247	5	,	,	PUNCT
fnp-4692	247	6	xu	xu	PROPN
fnp-4692	248	1	z	z	PROPN
fnp-4692	248	2	,	,	PUNCT
fnp-4692	248	3	zhang	zhang	PROPN
fnp-4692	248	4	z	z	PROPN
fnp-4692	248	5	,	,	PUNCT
fnp-4692	248	6	slocum	slocum	PROPN
fnp-4692	248	7	c	c	PROPN
fnp-4692	248	8	,	,	PUNCT
fnp-4692	248	9	bahadir	bahadir	PROPN
fnp-4692	248	10	cd	cd	PROPN
fnp-4692	248	11	,	,	PUNCT
fnp-4692	248	12	sabuncu	sabuncu	PROPN
fnp-4692	248	13	mr	mr	PROPN
fnp-4692	248	14	,	,	PUNCT
fnp-4692	248	15	pisapia	pisapia	PROPN
fnp-4692	248	16	dj	dj	PROPN
fnp-4692	248	17	.	.	PUNCT
fnp-4692	248	18	machine	machine	NOUN
fnp-4692	248	19	learning	learning	NOUN
fnp-4692	248	20	can	can	AUX
fnp-4692	248	21	aid	aid	VERB
fnp-4692	248	22	in	in	ADP
fnp-4692	248	23	prediction	prediction	NOUN
fnp-4692	248	24	of	of	ADP
fnp-4692	248	25	idh	idh	NOUN
fnp-4692	248	26	mutation	mutation	NOUN
fnp-4692	248	27	from	from	ADP
fnp-4692	248	28	h&e	h&e	PROPN
fnp-4692	248	29	-	-	PUNCT
fnp-4692	248	30	stained	stain	VERB
fnp-4692	248	31	histology	histology	NOUN
fnp-4692	248	32	slides	slide	VERB
fnp-4692	248	33	in	in	ADP
fnp-4692	248	34	infiltrating	infiltrate	VERB
fnp-4692	248	35	gliomas	glioma	NOUN
fnp-4692	248	36	.	.	PUNCT
fnp-4692	249	1	sci	sci	PROPN
fnp-4692	249	2	rep	rep	PROPN
fnp-4692	249	3	.	.	PROPN
fnp-4692	249	4	2022	2022	NUM
fnp-4692	249	5	dec	dec	PROPN
fnp-4692	249	6	31;12(1):22623	31;12(1):22623	NUM
fnp-4692	249	7	.	.	PUNCT
fnp-4692	250	1	https://doi.org/10.1038/s41598-022-26170-6	https://doi.org/10.1038/s41598-022-26170-6	PROPN
fnp-4692	250	2	.	.	PUNCT
fnp-4692	251	1	pmid	pmid	NOUN
fnp-4692	251	2	:	:	PUNCT
fnp-4692	251	3	36587030	36587030	NUM
fnp-4692	251	4	.	.	PUNCT
fnp-4692	252	1	6	6	NUM
fnp-4692	252	2	.	.	X
fnp-4692	252	3	driver	driver	PROPN
fnp-4692	252	4	j	j	PROPN
fnp-4692	252	5	,	,	PUNCT
fnp-4692	252	6	hoffman	hoffman	PROPN
fnp-4692	252	7	se	se	PROPN
fnp-4692	252	8	,	,	PUNCT
fnp-4692	252	9	tavakol	tavakol	PROPN
fnp-4692	252	10	s	s	PART
fnp-4692	252	11	,	,	PUNCT
fnp-4692	252	12	woodward	woodward	PROPN
fnp-4692	252	13	e	e	PROPN
fnp-4692	252	14	,	,	PUNCT
fnp-4692	252	15	maury	maury	PROPN
fnp-4692	252	16	ea	ea	PROPN
fnp-4692	252	17	,	,	PUNCT
fnp-4692	252	18	bhave	bhave	PROPN
fnp-4692	252	19	v	v	PROPN
fnp-4692	252	20	,	,	PUNCT
fnp-4692	252	21	greenwald	greenwald	PROPN
fnp-4692	252	22	nf	nf	PROPN
fnp-4692	252	23	,	,	PUNCT
fnp-4692	252	24	nassiri	nassiri	NOUN
fnp-4692	252	25	f	f	NOUN
fnp-4692	252	26	,	,	PUNCT
fnp-4692	252	27	aldape	aldape	PROPN
fnp-4692	252	28	k	k	PROPN
fnp-4692	252	29	,	,	PUNCT
fnp-4692	252	30	zadeh	zadeh	PROPN
fnp-4692	252	31	g	g	PROPN
fnp-4692	252	32	,	,	PUNCT
fnp-4692	252	33	choudhury	choudhury	PROPN
fnp-4692	252	34	a	a	PROPN
fnp-4692	252	35	,	,	PUNCT
fnp-4692	252	36	vasudevan	vasudevan	PROPN
fnp-4692	252	37	hn	hn	PROPN
fnp-4692	252	38	,	,	PUNCT
fnp-4692	252	39	magill	magill	PROPN
fnp-4692	252	40	st	st	PROPN
fnp-4692	252	41	,	,	PUNCT
fnp-4692	252	42	raleigh	raleigh	PROPN
fnp-4692	252	43	dr	dr	PROPN
fnp-4692	252	44	,	,	PUNCT
fnp-4692	252	45	abedalthagafi	abedalthagafi	PROPN
fnp-4692	252	46	m	m	PROPN
fnp-4692	252	47	,	,	PUNCT
fnp-4692	252	48	aizer	aizer	NOUN
fnp-4692	252	49	aa	aa	NOUN
fnp-4692	252	50	,	,	PUNCT
fnp-4692	252	51	alexander	alexander	PROPN
fnp-4692	252	52	bm	bm	PROPN
fnp-4692	252	53	,	,	PUNCT
fnp-4692	252	54	ligon	ligon	PROPN
fnp-4692	252	55	kl	kl	PROPN
fnp-4692	252	56	,	,	PUNCT
fnp-4692	252	57	reardon	reardon	PROPN
fnp-4692	252	58	da	da	PROPN
fnp-4692	252	59	,	,	PUNCT
fnp-4692	252	60	wen	wen	PROPN
fnp-4692	252	61	py	py	PROPN
fnp-4692	252	62	,	,	PUNCT
fnp-4692	252	63	al	al	PROPN
fnp-4692	252	64	-	-	PUNCT
fnp-4692	252	65	mefty	mefty	PROPN
fnp-4692	252	66	o	o	NOUN
fnp-4692	252	67	,	,	PUNCT
fnp-4692	252	68	ligon	ligon	PROPN
fnp-4692	252	69	ah	ah	INTJ
fnp-4692	252	70	,	,	PUNCT
fnp-4692	252	71	dubuc	dubuc	ADV
fnp-4692	252	72	am	be	AUX
fnp-4692	252	73	,	,	PUNCT
fnp-4692	252	74	beroukhim	beroukhim	PROPN
fnp-4692	252	75	r	r	NOUN
fnp-4692	252	76	,	,	PUNCT
fnp-4692	252	77	claus	claus	PROPN
fnp-4692	252	78	eb	eb	PROPN
fnp-4692	252	79	,	,	PUNCT
fnp-4692	252	80	dunn	dunn	PROPN
fnp-4692	252	81	if	if	SCONJ
fnp-4692	252	82	,	,	PUNCT
fnp-4692	252	83	santagata	santagata	NOUN
fnp-4692	252	84	s	s	PROPN
fnp-4692	252	85	,	,	PUNCT
fnp-4692	252	86	linda	linda	PROPN
fnp-4692	252	87	bi	bi	PROPN
fnp-4692	252	88	w.	w.	PROPN
fnp-4692	252	89	a	a	DET
fnp-4692	252	90	molecularly	molecularly	ADV
fnp-4692	252	91	integrated	integrate	VERB
fnp-4692	252	92	grade	grade	NOUN
fnp-4692	252	93	for	for	ADP
fnp-4692	252	94	meningioma	meningioma	NOUN
fnp-4692	252	95	.	.	PUNCT
fnp-4692	253	1	neuro	neuro	PROPN
fnp-4692	253	2	oncol	oncol	PROPN
fnp-4692	253	3	.	.	PUNCT
fnp-4692	254	1	2022	2022	NUM
fnp-4692	254	2	may	may	AUX
fnp-4692	254	3	4;24(5):796	4;24(5):796	NUM
fnp-4692	254	4	-	-	SYM
fnp-4692	254	5	808	808	NUM
fnp-4692	254	6	.	.	PUNCT
fnp-4692	255	1	https://doi.org/10.1093/neuonc/noab213	https://doi.org/10.1093/neuonc/noab213	NOUN
fnp-4692	255	2	.	.	PUNCT
fnp-4692	256	1	pmid	pmid	NOUN
fnp-4692	256	2	:	:	PUNCT
fnp-4692	256	3	34508644	34508644	NUM
fnp-4692	256	4	.	.	PUNCT
fnp-4692	257	1	7	7	X
fnp-4692	257	2	.	.	X
fnp-4692	257	3	radke	radke	PROPN
fnp-4692	257	4	j	j	PROPN
fnp-4692	257	5	,	,	PUNCT
fnp-4692	257	6	ishaque	ishaque	ADJ
fnp-4692	257	7	n	n	CCONJ
fnp-4692	257	8	,	,	PUNCT
fnp-4692	257	9	koll	koll	PROPN
fnp-4692	257	10	r	r	PROPN
fnp-4692	257	11	,	,	PUNCT
fnp-4692	257	12	gu	gu	NOUN
fnp-4692	257	13	z	z	PROPN
fnp-4692	257	14	,	,	PUNCT
fnp-4692	257	15	schumann	schumann	PROPN
fnp-4692	257	16	e	e	PROPN
fnp-4692	257	17	,	,	PUNCT
fnp-4692	257	18	sieverling	sieverle	VERB
fnp-4692	257	19	l	l	NOUN
fnp-4692	257	20	,	,	PUNCT
fnp-4692	257	21	uhrig	uhrig	PROPN
fnp-4692	257	22	s	s	PART
fnp-4692	257	23	,	,	PUNCT
fnp-4692	257	24	hübschmann	hübschmann	PROPN
fnp-4692	257	25	d	d	PROPN
fnp-4692	257	26	,	,	PUNCT
fnp-4692	257	27	toprak	toprak	PROPN
fnp-4692	257	28	uh	uh	INTJ
fnp-4692	257	29	,	,	PUNCT
fnp-4692	257	30	lópez	lópez	PROPN
fnp-4692	257	31	c	c	NOUN
fnp-4692	257	32	,	,	PUNCT
fnp-4692	257	33	hostench	hostench	VERB
fnp-4692	257	34	xp	xp	PROPN
fnp-4692	257	35	,	,	PUNCT
fnp-4692	257	36	borgoni	borgoni	PROPN
fnp-4692	257	37	s	s	PROPN
fnp-4692	257	38	,	,	PUNCT
fnp-4692	257	39	juraeva	juraeva	PROPN
fnp-4692	257	40	d	d	PROPN
fnp-4692	257	41	,	,	PUNCT
fnp-4692	257	42	pritsch	pritsch	PROPN
fnp-4692	257	43	f	f	PROPN
fnp-4692	257	44	,	,	PUNCT
fnp-4692	257	45	paramasivam	paramasivam	VERB
fnp-4692	257	46	n	n	CCONJ
fnp-4692	257	47	,	,	PUNCT
fnp-4692	257	48	balasubramanian	balasubramanian	ADJ
fnp-4692	257	49	gp	gp	NOUN
fnp-4692	257	50	,	,	PUNCT
fnp-4692	257	51	schlesner	schlesner	PROPN
fnp-4692	257	52	m	m	PROPN
fnp-4692	257	53	,	,	PUNCT
fnp-4692	257	54	sahay	sahay	PROPN
fnp-4692	257	55	s	s	PROPN
fnp-4692	257	56	,	,	PUNCT
fnp-4692	257	57	weniger	weniger	NOUN
fnp-4692	257	58	m	m	PROPN
fnp-4692	257	59	,	,	PUNCT
fnp-4692	257	60	pehl	pehl	NOUN
fnp-4692	257	61	d	d	NOUN
fnp-4692	257	62	,	,	PUNCT
fnp-4692	257	63	radbruch	radbruch	ADJ
fnp-4692	257	64	h	h	NOUN
fnp-4692	257	65	,	,	PUNCT
fnp-4692	257	66	osterloh	osterloh	ADP
fnp-4692	257	67	a	a	PRON
fnp-4692	257	68	,	,	PUNCT
fnp-4692	257	69	korfel	korfel	NOUN
fnp-4692	257	70	a	a	NOUN
fnp-4692	257	71	,	,	PUNCT
fnp-4692	257	72	misch	misch	PROPN
fnp-4692	257	73	m	m	PROPN
fnp-4692	257	74	,	,	PUNCT
fnp-4692	257	75	onken	onken	ADJ
fnp-4692	257	76	j	j	PROPN
fnp-4692	257	77	,	,	PUNCT
fnp-4692	257	78	faust	faust	PROPN
fnp-4692	257	79	k	k	PROPN
fnp-4692	257	80	,	,	PUNCT
fnp-4692	257	81	vajkoczy	vajkoczy	PROPN
fnp-4692	257	82	p	p	X
fnp-4692	257	83	,	,	PUNCT
fnp-4692	257	84	moskopp	moskopp	PROPN
fnp-4692	257	85	d	d	PROPN
fnp-4692	257	86	,	,	PUNCT
fnp-4692	257	87	wang	wang	PROPN
fnp-4692	257	88	y	y	PROPN
fnp-4692	257	89	,	,	PUNCT
fnp-4692	257	90	jödicke	jödicke	PROPN
fnp-4692	257	91	a	a	NOUN
fnp-4692	257	92	,	,	PUNCT
fnp-4692	257	93	trümper	trümper	NOUN
fnp-4692	257	94	l	l	NOUN
fnp-4692	257	95	,	,	PUNCT
fnp-4692	257	96	anagnostopoulos	anagnostopoulos	PROPN
fnp-4692	257	97	i	i	PROPN
fnp-4692	257	98	,	,	PUNCT
fnp-4692	257	99	lenze	lenze	PROPN
fnp-4692	257	100	d	d	PROPN
fnp-4692	257	101	,	,	PUNCT
fnp-4692	257	102	küppers	küpper	NOUN
fnp-4692	257	103	r	r	NOUN
fnp-4692	257	104	,	,	PUNCT
fnp-4692	257	105	hummel	hummel	PROPN
fnp-4692	257	106	m	m	PROPN
fnp-4692	257	107	,	,	PUNCT
fnp-4692	257	108	schmitt	schmitt	PROPN
fnp-4692	257	109	ca	ca	PROPN
fnp-4692	257	110	,	,	PUNCT
fnp-4692	257	111	wiestler	wiestler	PROPN
fnp-4692	257	112	od	od	PROPN
fnp-4692	257	113	,	,	PUNCT
fnp-4692	257	114	wolf	wolf	PROPN
fnp-4692	257	115	s	s	PROPN
fnp-4692	257	116	,	,	PUNCT
fnp-4692	257	117	unterberg	unterberg	ADV
fnp-4692	257	118	a	a	PRON
fnp-4692	257	119	,	,	PUNCT
fnp-4692	257	120	eils	eil	NOUN
fnp-4692	257	121	r	r	NOUN
fnp-4692	257	122	,	,	PUNCT
fnp-4692	257	123	herold	herold	NOUN
fnp-4692	257	124	-	-	PUNCT
fnp-4692	257	125	mende	mende	PROPN
fnp-4692	257	126	c	c	PROPN
fnp-4692	257	127	,	,	PUNCT
fnp-4692	257	128	brors	brors	PROPN
fnp-4692	257	129	b	b	PROPN
fnp-4692	257	130	;	;	PUNCT
fnp-4692	257	131	icgc	icgc	ADJ
fnp-4692	257	132	mmml	mmml	PROPN
fnp-4692	257	133	-	-	PUNCT
fnp-4692	257	134	seq	seq	NOUN
fnp-4692	257	135	consortium	consortium	NOUN
fnp-4692	257	136	;	;	PUNCT
fnp-4692	257	137	siebert	siebert	PROPN
fnp-4692	257	138	r	r	PROPN
fnp-4692	257	139	,	,	PUNCT
fnp-4692	257	140	wiemann	wiemann	PROPN
fnp-4692	257	141	s	s	PROPN
fnp-4692	257	142	,	,	PUNCT
fnp-4692	257	143	heppner	heppner	PROPN
fnp-4692	257	144	fl	fl	PROPN
fnp-4692	257	145	.	.	PUNCT
fnp-4692	258	1	the	the	DET
fnp-4692	258	2	genomic	genomic	NOUN
fnp-4692	258	3	and	and	CCONJ
fnp-4692	258	4	transcriptional	transcriptional	ADJ
fnp-4692	258	5	landscape	landscape	NOUN
fnp-4692	258	6	of	of	ADP
fnp-4692	258	7	primary	primary	ADJ
fnp-4692	258	8	central	central	ADJ
fnp-4692	258	9	nervous	nervous	ADJ
fnp-4692	258	10	system	system	NOUN
fnp-4692	258	11	lymphoma	lymphoma	NOUN
fnp-4692	258	12	.	.	PUNCT
fnp-4692	259	1	nat	nat	PROPN
fnp-4692	259	2	commun	commun	PROPN
fnp-4692	259	3	.	.	PUNCT
fnp-4692	260	1	2022	2022	NUM
fnp-4692	260	2	may	may	AUX
fnp-4692	260	3	10;13(1):2558	10;13(1):2558	NUM
fnp-4692	260	4	.	.	PUNCT
fnp-4692	261	1	https://doi.org/10.1038/s41467-022-30050-y	https://doi.org/10.1038/s41467-022-30050-y	PROPN
fnp-4692	261	2	.	.	PUNCT
fnp-4692	262	1	pmid	pmid	NOUN
fnp-4692	262	2	:	:	PUNCT
fnp-4692	262	3	35538064	35538064	NUM
fnp-4692	262	4	.	.	PUNCT
fnp-4692	263	1	8	8	NUM
fnp-4692	263	2	.	.	X
fnp-4692	263	3	buehler	buehler	PROPN
fnp-4692	263	4	m	m	PROPN
fnp-4692	263	5	,	,	PUNCT
fnp-4692	263	6	yi	yi	PROPN
fnp-4692	263	7	x	x	PROPN
fnp-4692	263	8	,	,	PUNCT
fnp-4692	263	9	ge	ge	PROPN
fnp-4692	263	10	w	w	PROPN
fnp-4692	263	11	,	,	PUNCT
fnp-4692	263	12	blattmann	blattmann	NOUN
fnp-4692	263	13	p	p	NOUN
fnp-4692	263	14	,	,	PUNCT
fnp-4692	263	15	rushing	rush	VERB
fnp-4692	263	16	e	e	NOUN
fnp-4692	263	17	,	,	PUNCT
fnp-4692	263	18	reifenberger	reifenberger	NOUN
fnp-4692	263	19	g	g	NOUN
fnp-4692	263	20	,	,	PUNCT
fnp-4692	263	21	felsberg	felsberg	PROPN
fnp-4692	263	22	j	j	PROPN
fnp-4692	263	23	,	,	PUNCT
fnp-4692	263	24	yeh	yeh	PROPN
fnp-4692	263	25	c	c	PROPN
fnp-4692	263	26	,	,	PUNCT
fnp-4692	263	27	corn	corn	PROPN
fnp-4692	263	28	je	je	PROPN
fnp-4692	263	29	,	,	PUNCT
fnp-4692	263	30	regli	regli	VERB
fnp-4692	263	31	l	l	PROPN
fnp-4692	263	32	,	,	PUNCT
fnp-4692	263	33	zhang	zhang	PROPN
fnp-4692	263	34	j	j	PROPN
fnp-4692	263	35	,	,	PUNCT
fnp-4692	263	36	cloos	cloo	VERB
fnp-4692	263	37	a	a	PRON
fnp-4692	263	38	,	,	PUNCT
fnp-4692	263	39	ravi	ravi	PROPN
fnp-4692	263	40	vm	vm	PROPN
fnp-4692	263	41	,	,	PUNCT
fnp-4692	263	42	wiestler	wiestler	PROPN
fnp-4692	263	43	b	b	PROPN
fnp-4692	263	44	,	,	PUNCT
fnp-4692	263	45	heiland	heiland	PROPN
fnp-4692	263	46	dh	dh	PROPN
fnp-4692	263	47	,	,	PUNCT
fnp-4692	263	48	aebersold	aebersold	PROPN
fnp-4692	263	49	r	r	PROPN
fnp-4692	263	50	,	,	PUNCT
fnp-4692	263	51	weller	weller	PROPN
fnp-4692	263	52	m	m	PROPN
fnp-4692	263	53	,	,	PUNCT
fnp-4692	263	54	guo	guo	PROPN
fnp-4692	263	55	t	t	PROPN
fnp-4692	263	56	,	,	PUNCT
fnp-4692	263	57	weiss	weiss	PROPN
fnp-4692	263	58	t.	t.	PROPN
fnp-4692	263	59	quantitative	quantitative	ADJ
fnp-4692	263	60	proteomic	proteomic	ADJ
fnp-4692	263	61	landscapes	landscape	NOUN
fnp-4692	263	62	of	of	ADP
fnp-4692	263	63	primary	primary	ADJ
fnp-4692	263	64	and	and	CCONJ
fnp-4692	263	65	recurrent	recurrent	ADJ
fnp-4692	263	66	glioblastoma	glioblastoma	NOUN
fnp-4692	263	67	reveal	reveal	VERB
fnp-4692	263	68	a	a	DET
fnp-4692	263	69	protumorigeneic	protumorigeneic	ADJ
fnp-4692	263	70	role	role	NOUN
fnp-4692	263	71	for	for	ADP
fnp-4692	263	72	fbxo2	fbxo2	ADJ
fnp-4692	263	73	-	-	PUNCT
fnp-4692	263	74	dependent	dependent	ADJ
fnp-4692	263	75	glioma	glioma	NOUN
fnp-4692	263	76	-	-	PUNCT
fnp-4692	263	77	microenvironment	microenvironment	NOUN
fnp-4692	263	78	interactions	interaction	NOUN
fnp-4692	263	79	.	.	PUNCT
fnp-4692	264	1	neuro	neuro	PROPN
fnp-4692	264	2	oncol	oncol	PROPN
fnp-4692	264	3	.	.	PUNCT
fnp-4692	265	1	2023	2023	NUM
fnp-4692	265	2	feb	feb	NOUN
fnp-4692	265	3	14;25(2):290	14;25(2):290	NUM
fnp-4692	265	4	-	-	SYM
fnp-4692	265	5	302	302	NUM
fnp-4692	265	6	.	.	PUNCT
fnp-4692	265	7	https://doi.org/10.1093/neuonc/noac169	https://doi.org/10.1093/neuonc/noac169	PROPN
fnp-4692	265	8	.	.	PUNCT
fnp-4692	266	1	pmid	pmid	NOUN
fnp-4692	266	2	:	:	PUNCT
fnp-4692	266	3	35802605	35802605	NUM
fnp-4692	266	4	.	.	PUNCT
fnp-4692	267	1	9	9	NUM
fnp-4692	267	2	.	.	X
fnp-4692	267	3	zuccato	zuccato	PROPN
fnp-4692	267	4	ja	ja	PROPN
fnp-4692	267	5	,	,	PUNCT
fnp-4692	267	6	patil	patil	PROPN
fnp-4692	267	7	v	v	PROPN
fnp-4692	267	8	,	,	PUNCT
fnp-4692	267	9	mansouri	mansouri	PROPN
fnp-4692	267	10	s	s	PROPN
fnp-4692	267	11	,	,	PUNCT
fnp-4692	267	12	voisin	voisin	PROPN
fnp-4692	267	13	m	m	PROPN
fnp-4692	267	14	,	,	PUNCT
fnp-4692	267	15	chakravarthy	chakravarthy	ADJ
fnp-4692	267	16	a	a	PRON
fnp-4692	267	17	,	,	PUNCT
fnp-4692	267	18	shen	shen	PROPN
fnp-4692	267	19	sy	sy	PROPN
fnp-4692	267	20	,	,	PUNCT
fnp-4692	267	21	nassiri	nassiri	NOUN
fnp-4692	267	22	f	f	NOUN
fnp-4692	267	23	,	,	PUNCT
fnp-4692	267	24	mikolajewicz	mikolajewicz	VERB
fnp-4692	267	25	n	n	CCONJ
fnp-4692	267	26	,	,	PUNCT
fnp-4692	267	27	trifoi	trifoi	PROPN
fnp-4692	267	28	m	m	PROPN
fnp-4692	267	29	,	,	PUNCT
fnp-4692	267	30	skakodub	skakodub	PROPN
fnp-4692	267	31	a	a	PRON
fnp-4692	267	32	,	,	PUNCT
fnp-4692	267	33	zacharia	zacharia	PROPN
fnp-4692	267	34	b	b	NOUN
fnp-4692	267	35	,	,	PUNCT
fnp-4692	267	36	glantz	glantz	PROPN
fnp-4692	267	37	m	m	PROPN
fnp-4692	267	38	,	,	PUNCT
fnp-4692	267	39	de	de	PROPN
fnp-4692	267	40	carvalho	carvalho	PROPN
fnp-4692	267	41	dd	dd	PROPN
fnp-4692	267	42	,	,	PUNCT
fnp-4692	267	43	mansouri	mansouri	PROPN
fnp-4692	267	44	a	a	PROPN
fnp-4692	267	45	,	,	PUNCT
fnp-4692	267	46	zadeh	zadeh	PROPN
fnp-4692	267	47	g.	g.	PROPN
fnp-4692	267	48	cerebrospinal	cerebrospinal	ADJ
fnp-4692	267	49	fluid	fluid	NOUN
fnp-4692	267	50	methylome	methylome	ADV
fnp-4692	267	51	-	-	PUNCT
fnp-4692	267	52	based	base	VERB
fnp-4692	267	53	liquid	liquid	ADJ
fnp-4692	267	54	biopsies	biopsy	NOUN
fnp-4692	267	55	for	for	ADP
fnp-4692	267	56	accurate	accurate	ADJ
fnp-4692	267	57	malignant	malignant	ADJ
fnp-4692	267	58	brain	brain	NOUN
fnp-4692	267	59	neoplasm	neoplasm	ADJ
fnp-4692	267	60	classification	classification	NOUN
fnp-4692	267	61	.	.	PUNCT
fnp-4692	268	1	neuro	neuro	PROPN
fnp-4692	268	2	oncol	oncol	PROPN
fnp-4692	268	3	.	.	PUNCT
fnp-4692	269	1	2022	2022	NUM
fnp-4692	269	2	dec	dec	PROPN
fnp-4692	269	3	1	1	NUM
fnp-4692	269	4	:	:	PUNCT
fnp-4692	269	5	noac264	noac264	PROPN
fnp-4692	269	6	.	.	PUNCT
fnp-4692	270	1	https://doi.org/10.1093/neuonc/noac264	https://doi.org/10.1093/neuonc/noac264	NOUN
fnp-4692	270	2	.	.	PUNCT
fnp-4692	271	1	online	online	ADV
fnp-4692	271	2	ahead	ahead	ADV
fnp-4692	271	3	of	of	ADP
fnp-4692	271	4	print	print	NOUN
fnp-4692	271	5	.	.	PUNCT
fnp-4692	272	1	pmid	pmid	NOUN
fnp-4692	272	2	:	:	PUNCT
fnp-4692	272	3	36455236	36455236	NUM
fnp-4692	272	4	.	.	PUNCT
fnp-4692	273	1	10	10	NUM
fnp-4692	273	2	.	.	PUNCT
fnp-4692	273	3	jabarkheel	jabarkheel	PROPN
fnp-4692	273	4	r	r	PROPN
fnp-4692	273	5	,	,	PUNCT
fnp-4692	273	6	ho	ho	PROPN
fnp-4692	273	7	cs	cs	PROPN
fnp-4692	273	8	,	,	PUNCT
fnp-4692	273	9	rodrigues	rodrigues	PROPN
fnp-4692	273	10	aj	aj	PROPN
fnp-4692	273	11	,	,	PUNCT
fnp-4692	273	12	jin	jin	PROPN
fnp-4692	273	13	mc	mc	PROPN
fnp-4692	273	14	,	,	PUNCT
fnp-4692	273	15	parker	parker	PROPN
fnp-4692	273	16	jj	jj	PROPN
fnp-4692	273	17	,	,	PUNCT
fnp-4692	273	18	mensah	mensah	PROPN
fnp-4692	273	19	-	-	PUNCT
fnp-4692	273	20	brown	brown	PROPN
fnp-4692	273	21	k	k	NOUN
fnp-4692	273	22	,	,	PUNCT
fnp-4692	273	23	yecies	yecie	NOUN
fnp-4692	273	24	d	d	PROPN
fnp-4692	273	25	,	,	PUNCT
fnp-4692	273	26	grant	grant	PROPN
fnp-4692	273	27	ga	ga	PROPN
fnp-4692	273	28	.	.	PROPN
fnp-4692	273	29	rapid	rapid	ADJ
fnp-4692	273	30	intraoperative	intraoperative	ADJ
fnp-4692	273	31	diagnosis	diagnosis	NOUN
fnp-4692	273	32	of	of	ADP
fnp-4692	273	33	pediatric	pediatric	ADJ
fnp-4692	273	34	brain	brain	NOUN
fnp-4692	273	35	tumors	tumor	NOUN
fnp-4692	273	36	using	use	VERB
fnp-4692	273	37	raman	raman	NOUN
fnp-4692	273	38	spectroscopy	spectroscopy	NOUN
fnp-4692	273	39	:	:	PUNCT
fnp-4692	273	40	a	a	DET
fnp-4692	273	41	machine	machine	NOUN
fnp-4692	273	42	learning	learning	NOUN
fnp-4692	273	43	approach	approach	NOUN
fnp-4692	273	44	.	.	PUNCT
fnp-4692	274	1	neurooncol	neurooncol	PROPN
fnp-4692	274	2	adv	adv	PROPN
fnp-4692	274	3	.	.	PUNCT
fnp-4692	275	1	2022	2022	NUM
fnp-4692	275	2	jul	jul	PROPN
fnp-4692	275	3	26;4(1):vdac118	26;4(1):vdac118	NUM
fnp-4692	275	4	.	.	PUNCT
fnp-4692	276	1	https://doi.org/10.1093/noajnl/vdac118	https://doi.org/10.1093/noajnl/vdac118	PROPN
fnp-4692	276	2	.	.	PUNCT
fnp-4692	277	1	ecollection	ecollection	NOUN
fnp-4692	277	2	2022	2022	NUM
fnp-4692	277	3	jan	jan	PROPN
fnp-4692	277	4	-	-	PUNCT
fnp-4692	277	5	dec	dec	PROPN
fnp-4692	277	6	.	.	PUNCT
fnp-4692	278	1	pmid	pmid	PROPN
fnp-4692	278	2	:	:	PUNCT
fnp-4692	278	3	35919071	35919071	NUM
fnp-4692	278	4	.	.	PUNCT
fnp-4692	279	1	11	11	NUM
fnp-4692	279	2	.	.	PUNCT
fnp-4692	280	1	reinecke	reinecke	VERB
fnp-4692	280	2	d	d	PROPN
fnp-4692	280	3	,	,	PUNCT
fnp-4692	280	4	von	von	PROPN
fnp-4692	280	5	spreckelsen	spreckelsen	PROPN
fnp-4692	280	6	n	n	PROPN
fnp-4692	280	7	,	,	PUNCT
fnp-4692	280	8	mawrin	mawrin	NOUN
fnp-4692	280	9	c	c	NOUN
fnp-4692	280	10	,	,	PUNCT
fnp-4692	280	11	ion	ion	NOUN
fnp-4692	280	12	-	-	PUNCT
fnp-4692	280	13	margineanu	margineanu	NOUN
fnp-4692	280	14	a	a	NOUN
fnp-4692	280	15	,	,	PUNCT
fnp-4692	280	16	fürtjes	fürtjes	NOUN
fnp-4692	280	17	g	g	NOUN
fnp-4692	280	18	,	,	PUNCT
fnp-4692	280	19	jünger	jünger	PROPN
fnp-4692	280	20	st	st	PROPN
fnp-4692	280	21	,	,	PUNCT
fnp-4692	280	22	khalid	khalid	PROPN
fnp-4692	280	23	f	f	PROPN
fnp-4692	280	24	,	,	PUNCT
fnp-4692	280	25	freudiger	freudiger	PROPN
fnp-4692	280	26	cw	cw	PROPN
fnp-4692	280	27	,	,	PUNCT
fnp-4692	280	28	timmer	timmer	PROPN
fnp-4692	280	29	m	m	PROPN
fnp-4692	280	30	,	,	PUNCT
fnp-4692	280	31	ruge	ruge	PROPN
fnp-4692	280	32	mi	mi	PROPN
fnp-4692	280	33	,	,	PUNCT
fnp-4692	280	34	goldbrunner	goldbrunner	NOUN
fnp-4692	280	35	r	r	NOUN
fnp-4692	280	36	,	,	PUNCT
fnp-4692	280	37	neuschmelting	neuschmelte	VERB
fnp-4692	280	38	v.	v.	ADP
fnp-4692	280	39	novel	novel	ADJ
fnp-4692	280	40	rapid	rapid	ADJ
fnp-4692	280	41	intraoperative	intraoperative	ADJ
fnp-4692	280	42	qualitative	qualitative	ADJ
fnp-4692	280	43	tumor	tumor	NOUN
fnp-4692	280	44	detection	detection	NOUN
fnp-4692	280	45	by	by	ADP
fnp-4692	280	46	a	a	DET
fnp-4692	280	47	residual	residual	ADJ
fnp-4692	280	48	convolutional	convolutional	ADJ
fnp-4692	280	49	neural	neural	ADJ
fnp-4692	280	50	network	network	NOUN
fnp-4692	280	51	using	use	VERB
fnp-4692	280	52	label	label	NOUN
fnp-4692	280	53	-	-	PUNCT
fnp-4692	280	54	free	free	ADJ
fnp-4692	280	55	stimulated	stimulated	ADJ
fnp-4692	280	56	raman	raman	NOUN
fnp-4692	280	57	scattering	scatter	VERB
fnp-4692	280	58	microscopy	microscopy	NOUN
fnp-4692	280	59	.	.	PUNCT
fnp-4692	281	1	acta	acta	PROPN
fnp-4692	281	2	neuropathol	neuropathol	PROPN
fnp-4692	281	3	commun	commun	PROPN
fnp-4692	281	4	.	.	PUNCT
fnp-4692	282	1	2022	2022	NUM
fnp-4692	282	2	aug	aug	PROPN
fnp-4692	282	3	6;10(1):109	6;10(1):109	NUM
fnp-4692	282	4	.	.	PUNCT
fnp-4692	283	1	https://doi.org/10.1186/s40478-022-01411-x	https://doi.org/10.1186/s40478-022-01411-x	PROPN
fnp-4692	283	2	.	.	PUNCT
fnp-4692	284	1	pmid	pmid	NOUN
fnp-4692	284	2	:	:	PUNCT
fnp-4692	284	3	35933416	35933416	NUM
fnp-4692	284	4	.	.	PUNCT
fnp-4692	285	1	12	12	NUM
fnp-4692	285	2	.	.	PUNCT
fnp-4692	286	1	kuschel	kuschel	PROPN
fnp-4692	286	2	lp	lp	PROPN
fnp-4692	286	3	,	,	PUNCT
fnp-4692	286	4	hench	hench	PROPN
fnp-4692	286	5	j	j	PROPN
fnp-4692	286	6	,	,	PUNCT
fnp-4692	286	7	frank	frank	PROPN
fnp-4692	286	8	s	s	PROPN
fnp-4692	286	9	,	,	PUNCT
fnp-4692	286	10	hench	hench	NOUN
fnp-4692	286	11	ib	ib	NOUN
fnp-4692	286	12	,	,	PUNCT
fnp-4692	286	13	girard	girard	PROPN
fnp-4692	286	14	e	e	PROPN
fnp-4692	286	15	,	,	PUNCT
fnp-4692	286	16	blanluet	blanluet	PROPN
fnp-4692	286	17	m	m	PROPN
fnp-4692	286	18	,	,	PUNCT
fnp-4692	286	19	masliah	masliah	PROPN
fnp-4692	286	20	-	-	PUNCT
fnp-4692	286	21	planchon	planchon	PROPN
fnp-4692	286	22	j	j	PROPN
fnp-4692	286	23	,	,	PUNCT
fnp-4692	286	24	misch	misch	PROPN
fnp-4692	286	25	m	m	PROPN
fnp-4692	286	26	,	,	PUNCT
fnp-4692	286	27	onken	onken	ADJ
fnp-4692	286	28	j	j	PROPN
fnp-4692	286	29	,	,	PUNCT
fnp-4692	286	30	czabanka	czabanka	NOUN
fnp-4692	286	31	m	m	PROPN
fnp-4692	286	32	,	,	PUNCT
fnp-4692	286	33	yuan	yuan	PROPN
fnp-4692	286	34	d	d	PROPN
fnp-4692	286	35	,	,	PUNCT
fnp-4692	286	36	lukassen	lukassen	ADJ
fnp-4692	286	37	s	s	PROPN
fnp-4692	286	38	,	,	PUNCT
fnp-4692	286	39	karau	karau	ADJ
fnp-4692	286	40	p	p	X
fnp-4692	286	41	,	,	PUNCT
fnp-4692	286	42	ishaque	ishaque	ADJ
fnp-4692	286	43	n	n	CCONJ
fnp-4692	286	44	,	,	PUNCT
fnp-4692	286	45	hain	hain	PROPN
fnp-4692	286	46	eg	eg	PROPN
fnp-4692	286	47	,	,	PUNCT
fnp-4692	286	48	heppner	heppner	PROPN
fnp-4692	286	49	f	f	PROPN
fnp-4692	286	50	,	,	PUNCT
fnp-4692	286	51	idbaih	idbaih	VERB
fnp-4692	286	52	a	a	DET
fnp-4692	286	53	,	,	PUNCT
fnp-4692	286	54	behr	behr	NOUN
fnp-4692	286	55	n	n	CCONJ
fnp-4692	286	56	,	,	PUNCT
fnp-4692	286	57	harms	harm	VERB
fnp-4692	286	58	c	c	NOUN
fnp-4692	286	59	,	,	PUNCT
fnp-4692	286	60	capper	capper	NOUN
fnp-4692	286	61	d	d	NOUN
fnp-4692	286	62	,	,	PUNCT
fnp-4692	286	63	euskirchen	euskirchen	ADV
fnp-4692	286	64	p.	p.	NOUN
fnp-4692	286	65	robust	robust	ADJ
fnp-4692	286	66	methylation	methylation	NOUN
fnp-4692	286	67	-	-	PUNCT
fnp-4692	286	68	based	base	VERB
fnp-4692	286	69	classification	classification	NOUN
fnp-4692	286	70	of	of	ADP
fnp-4692	286	71	brain	brain	NOUN
fnp-4692	286	72	tumours	tumour	NOUN
fnp-4692	286	73	using	use	VERB
fnp-4692	286	74	nanopore	nanopore	ADJ
fnp-4692	286	75	sequencing	sequencing	NOUN
fnp-4692	286	76	.	.	PUNCT
fnp-4692	287	1	neuropathol	neuropathol	NOUN
fnp-4692	287	2	appl	appl	PROPN
fnp-4692	287	3	neurobiol	neurobiol	PROPN
fnp-4692	287	4	.	.	PUNCT
fnp-4692	288	1	2023	2023	NUM
fnp-4692	288	2	feb;49(1):e12856	feb;49(1):e12856	NOUN
fnp-4692	288	3	.	.	PUNCT
fnp-4692	289	1	https://doi.org/10.1111/nan.12856	https://doi.org/10.1111/nan.12856	PROPN
fnp-4692	289	2	.	.	PUNCT
fnp-4692	290	1	pmid	pmid	PROPN
fnp-4692	290	2	:	:	PUNCT
fnp-4692	290	3	36269599	36269599	NUM
fnp-4692	290	4	.	.	PUNCT
fnp-4692	291	1	13	13	NUM
fnp-4692	291	2	.	.	X
fnp-4692	292	1	patel	patel	PROPN
fnp-4692	292	2	a	a	PROPN
fnp-4692	292	3	,	,	PUNCT
fnp-4692	292	4	dogan	dogan	PROPN
fnp-4692	292	5	h	h	PROPN
fnp-4692	292	6	,	,	PUNCT
fnp-4692	292	7	payne	payne	PROPN
fnp-4692	292	8	a	a	PROPN
fnp-4692	292	9	,	,	PUNCT
fnp-4692	292	10	krause	krause	PROPN
fnp-4692	292	11	e	e	PROPN
fnp-4692	292	12	,	,	PUNCT
fnp-4692	292	13	sievers	sievers	PROPN
fnp-4692	292	14	p	p	NOUN
fnp-4692	292	15	,	,	PUNCT
fnp-4692	292	16	schoebe	schoebe	NOUN
fnp-4692	292	17	n	n	CCONJ
fnp-4692	292	18	,	,	PUNCT
fnp-4692	292	19	schrimpf	schrimpf	NOUN
fnp-4692	292	20	d	d	PROPN
fnp-4692	292	21	,	,	PUNCT
fnp-4692	292	22	blume	blume	PROPN
fnp-4692	292	23	c	c	PROPN
fnp-4692	292	24	,	,	PUNCT
fnp-4692	292	25	stichel	stichel	PROPN
fnp-4692	292	26	d	d	PROPN
fnp-4692	292	27	,	,	PUNCT
fnp-4692	292	28	holmes	holmes	PROPN
fnp-4692	292	29	n	n	PART
fnp-4692	292	30	,	,	PUNCT
fnp-4692	292	31	euskirchen	euskirchen	ADV
fnp-4692	292	32	p	p	NOUN
fnp-4692	292	33	,	,	PUNCT
fnp-4692	292	34	hench	hench	PROPN
fnp-4692	292	35	j	j	PROPN
fnp-4692	292	36	,	,	PUNCT
fnp-4692	292	37	frank	frank	PROPN
fnp-4692	292	38	s	s	PROPN
fnp-4692	292	39	,	,	PUNCT
fnp-4692	292	40	rosenstiel	rosenstiel	NOUN
fnp-4692	292	41	-	-	PUNCT
fnp-4692	292	42	goidts	goidts	ADJ
fnp-4692	292	43	v	v	NOUN
fnp-4692	292	44	,	,	PUNCT
fnp-4692	292	45	ratliff	ratliff	PROPN
fnp-4692	292	46	m	m	PROPN
fnp-4692	292	47	,	,	PUNCT
fnp-4692	292	48	etminan	etminan	PROPN
fnp-4692	292	49	n	n	CCONJ
fnp-4692	292	50	,	,	PUNCT
fnp-4692	292	51	unterberg	unterberg	PROPN
fnp-4692	292	52	a	a	PROPN
fnp-4692	292	53	,	,	PUNCT
fnp-4692	292	54	dieterich	dieterich	PROPN
fnp-4692	292	55	c	c	NOUN
fnp-4692	292	56	,	,	PUNCT
fnp-4692	292	57	herold	herold	PROPN
fnp-4692	292	58	-	-	PUNCT
fnp-4692	292	59	mende	mende	PROPN
fnp-4692	292	60	c	c	PROPN
fnp-4692	292	61	,	,	PUNCT
fnp-4692	292	62	pfister	pfister	PROPN
fnp-4692	292	63	sm	sm	PROPN
fnp-4692	292	64	,	,	PUNCT
fnp-4692	292	65	wick	wick	VERB
fnp-4692	292	66	w	w	PROPN
fnp-4692	292	67	,	,	PUNCT
fnp-4692	292	68	loose	loose	ADJ
fnp-4692	292	69	m	m	PROPN
fnp-4692	292	70	,	,	PUNCT
fnp-4692	292	71	von	von	PROPN
fnp-4692	292	72	deimling	deimle	VERB
fnp-4692	292	73	a	a	PRON
fnp-4692	292	74	,	,	PUNCT
fnp-4692	292	75	sill	sill	NOUN
fnp-4692	292	76	m	m	PROPN
fnp-4692	292	77	,	,	PUNCT
fnp-4692	292	78	jones	jones	PROPN
fnp-4692	292	79	dtw	dtw	PROPN
fnp-4692	292	80	,	,	PUNCT
fnp-4692	292	81	schlesner	schlesner	PROPN
fnp-4692	292	82	m	m	PROPN
fnp-4692	292	83	,	,	PUNCT
fnp-4692	292	84	sahm	sahm	PROPN
fnp-4692	292	85	f.	f.	PROPN
fnp-4692	292	86	rapid	rapid	PROPN
fnp-4692	292	87	-	-	PUNCT
fnp-4692	292	88	cns2	cns2	NOUN
fnp-4692	292	89	:	:	PUNCT
fnp-4692	292	90	rapid	rapid	ADJ
fnp-4692	292	91	comprehensive	comprehensive	ADJ
fnp-4692	292	92	adaptive	adaptive	ADJ
fnp-4692	292	93	nanopore	nanopore	ADV
fnp-4692	292	94	-	-	PUNCT
fnp-4692	292	95	sequencing	sequencing	NOUN
fnp-4692	292	96	of	of	ADP
fnp-4692	292	97	cns	cns	NOUN
fnp-4692	292	98	tumors	tumor	NOUN
fnp-4692	292	99	,	,	PUNCT
fnp-4692	292	100	a	a	DET
fnp-4692	292	101	proof	proof	NOUN
fnp-4692	292	102	-	-	PUNCT
fnp-4692	292	103	of	of	ADP
fnp-4692	292	104	-	-	PUNCT
fnp-4692	292	105	concept	concept	NOUN
fnp-4692	292	106	study	study	NOUN
fnp-4692	292	107	.	.	PUNCT
fnp-4692	293	1	acta	acta	PROPN
fnp-4692	293	2	neuropathol	neuropathol	PROPN
fnp-4692	293	3	.	.	PUNCT
fnp-4692	294	1	2022	2022	NUM
fnp-4692	294	2	may;143(5):609	may;143(5):609	NOUN
fnp-4692	294	3	-	-	PUNCT
fnp-4692	294	4	612	612	NUM
fnp-4692	294	5	.	.	PUNCT
fnp-4692	295	1	https://doi.org/10.1007/s00401-022-02415-6	https://doi.org/10.1007/s00401-022-02415-6	PROPN
fnp-4692	295	2	.	.	PUNCT
fnp-4692	296	1	epub	epub	NOUN
fnp-4692	296	2	2022	2022	NUM
fnp-4692	296	3	mar	mar	PROPN
fnp-4692	296	4	31	31	NUM
fnp-4692	296	5	.	.	PUNCT
fnp-4692	297	1	pmid	pmid	NOUN
fnp-4692	297	2	:	:	PUNCT
fnp-4692	297	3	35357562	35357562	NUM
fnp-4692	297	4	.	.	PUNCT
fnp-4692	298	1	14	14	NUM
fnp-4692	298	2	.	.	PUNCT
fnp-4692	299	1	zhu	zhu	PROPN
fnp-4692	299	2	l	l	PROPN
fnp-4692	299	3	,	,	PUNCT
fnp-4692	299	4	retana	retana	PROPN
fnp-4692	299	5	d	d	PROPN
fnp-4692	299	6	,	,	PUNCT
fnp-4692	299	7	garcía	garcía	ADJ
fnp-4692	299	8	-	-	PUNCT
fnp-4692	299	9	gómez	gómez	NOUN
fnp-4692	299	10	p	p	NOUN
fnp-4692	299	11	,	,	PUNCT
fnp-4692	299	12	álvaro	álvaro	NOUN
fnp-4692	299	13	-	-	PUNCT
fnp-4692	299	14	espinosa	espinosa	PROPN
fnp-4692	299	15	l	l	PROPN
fnp-4692	299	16	,	,	PUNCT
fnp-4692	299	17	priego	priego	ADJ
fnp-4692	299	18	n	n	CCONJ
fnp-4692	299	19	,	,	PUNCT
fnp-4692	299	20	masmudi	masmudi	NOUN
fnp-4692	299	21	-	-	PUNCT
fnp-4692	299	22	martín	martín	NOUN
fnp-4692	299	23	m	m	PROPN
fnp-4692	299	24	,	,	PUNCT
fnp-4692	299	25	yebra	yebra	PROPN
fnp-4692	299	26	n	n	CCONJ
fnp-4692	299	27	,	,	PUNCT
fnp-4692	299	28	miarka	miarka	NOUN
fnp-4692	299	29	l	l	NOUN
fnp-4692	299	30	,	,	PUNCT
fnp-4692	299	31	hernández	hernández	PROPN
fnp-4692	299	32	-	-	PUNCT
fnp-4692	299	33	encinas	encinas	PROPN
fnp-4692	299	34	e	e	NOUN
fnp-4692	299	35	,	,	PUNCT
fnp-4692	299	36	blanco	blanco	PROPN
fnp-4692	299	37	-	-	PUNCT
fnp-4692	299	38	aparicio	aparicio	PROPN
fnp-4692	299	39	c	c	NOUN
fnp-4692	299	40	,	,	PUNCT
fnp-4692	299	41	martínez	martínez	PROPN
fnp-4692	299	42	s	s	PART
fnp-4692	299	43	,	,	PUNCT
fnp-4692	299	44	sobrino	sobrino	PROPN
fnp-4692	299	45	c	c	X
fnp-4692	299	46	,	,	PUNCT
fnp-4692	299	47	ajenjo	ajenjo	VERB
fnp-4692	299	48	n	n	CCONJ
fnp-4692	299	49	,	,	PUNCT
fnp-4692	299	50	artiga	artiga	PROPN
fnp-4692	299	51	mj	mj	PROPN
fnp-4692	299	52	,	,	PUNCT
fnp-4692	299	53	ortega	ortega	PROPN
fnp-4692	299	54	-	-	PROPN
fnp-4692	299	55	paino	paino	PROPN
fnp-4692	299	56	e	e	NOUN
fnp-4692	299	57	,	,	PUNCT
fnp-4692	299	58	torres	torre	NOUN
fnp-4692	299	59	-	-	PUNCT
fnp-4692	299	60	ruiz	ruiz	NOUN
fnp-4692	299	61	r	r	NOUN
fnp-4692	299	62	,	,	PUNCT
fnp-4692	299	63	rodríguez	rodríguez	NOUN
fnp-4692	299	64	-	-	PUNCT
fnp-4692	299	65	perales	perales	PROPN
fnp-4692	299	66	s	s	PART
fnp-4692	299	67	;	;	PUNCT
fnp-4692	299	68	renacer	renacer	NOUN
fnp-4692	299	69	;	;	PUNCT
fnp-4692	299	70	soffietti	soffietti	ADJ
fnp-4692	299	71	r	r	NOUN
fnp-4692	299	72	,	,	PUNCT
fnp-4692	299	73	bertero	bertero	NOUN
fnp-4692	299	74	l	l	NOUN
fnp-4692	299	75	,	,	PUNCT
fnp-4692	299	76	cassoni	cassoni	PROPN
fnp-4692	299	77	p	p	X
fnp-4692	299	78	,	,	PUNCT
fnp-4692	299	79	weiss	weiss	PROPN
fnp-4692	299	80	t	t	PROPN
fnp-4692	299	81	,	,	PUNCT
fnp-4692	299	82	muñoz	muñoz	PROPN
fnp-4692	299	83	j	j	PROPN
fnp-4692	299	84	,	,	PUNCT
fnp-4692	299	85	sepúlveda	sepúlveda	PROPN
fnp-4692	299	86	jm	jm	PROPN
fnp-4692	299	87	,	,	PUNCT
fnp-4692	299	88	gonzález	gonzález	PROPN
fnp-4692	299	89	-	-	PUNCT
fnp-4692	299	90	león	león	PROPN
fnp-4692	299	91	p	p	X
fnp-4692	299	92	,	,	PUNCT
fnp-4692	299	93	jiménez	jiménez	PROPN
fnp-4692	299	94	-	-	PUNCT
fnp-4692	299	95	roldán	roldán	PROPN
fnp-4692	299	96	l	l	PROPN
fnp-4692	299	97	,	,	PUNCT
fnp-4692	299	98	moreno	moreno	PROPN
fnp-4692	299	99	lm	lm	PROPN
fnp-4692	299	100	,	,	PUNCT
fnp-4692	299	101	esteban	esteban	PROPN
fnp-4692	299	102	o	o	NOUN
fnp-4692	299	103	,	,	PUNCT
fnp-4692	299	104	pérez	pérez	NOUN
fnp-4692	299	105	-	-	PUNCT
fnp-4692	299	106	núñez	núñez	PROPN
fnp-4692	299	107	á	á	PROPN
fnp-4692	299	108	,	,	PUNCT
fnp-4692	299	109	hernández	hernández	PROPN
fnp-4692	299	110	-	-	PUNCT
fnp-4692	299	111	laín	laín	PROPN
fnp-4692	299	112	a	a	NOUN
fnp-4692	299	113	,	,	PUNCT
fnp-4692	299	114	toldos	toldo	NOUN
fnp-4692	299	115	o	o	NOUN
fnp-4692	299	116	,	,	PUNCT
fnp-4692	299	117	ruano	ruano	PROPN
fnp-4692	299	118	y	y	PROPN
fnp-4692	299	119	,	,	PUNCT
fnp-4692	299	120	alcázar	alcázar	PROPN
fnp-4692	299	121	l	l	PROPN
fnp-4692	299	122	,	,	PUNCT
fnp-4692	299	123	blasco	blasco	PROPN
fnp-4692	299	124	g	g	PROPN
fnp-4692	299	125	,	,	PUNCT
fnp-4692	299	126	fernández	fernández	PROPN
fnp-4692	299	127	-	-	PUNCT
fnp-4692	299	128	alén	alén	PROPN
fnp-4692	299	129	j	j	PROPN
fnp-4692	299	130	,	,	PUNCT
fnp-4692	299	131	caleiras	caleiras	PROPN
fnp-4692	299	132	e	e	NOUN
fnp-4692	299	133	,	,	PUNCT
fnp-4692	299	134	lafarga	lafarga	PROPN
fnp-4692	299	135	m	m	PROPN
fnp-4692	299	136	,	,	PUNCT
fnp-4692	299	137	megías	megías	PROPN
fnp-4692	299	138	d	d	PROPN
fnp-4692	299	139	,	,	PUNCT
fnp-4692	299	140	graña	graña	ADJ
fnp-4692	299	141	-	-	PUNCT
fnp-4692	299	142	castro	castro	NOUN
fnp-4692	299	143	o	o	NOUN
fnp-4692	299	144	,	,	PUNCT
fnp-4692	299	145	nör	nör	PROPN
fnp-4692	299	146	c	c	PROPN
fnp-4692	299	147	,	,	PUNCT
fnp-4692	299	148	taylor	taylor	PROPN
fnp-4692	299	149	md	md	PROPN
fnp-4692	299	150	,	,	PUNCT
fnp-4692	299	151	young	young	PROPN
fnp-4692	299	152	ls	ls	ADJ
fnp-4692	299	153	,	,	PUNCT
fnp-4692	299	154	varešlija	varešlija	NOUN
fnp-4692	299	155	d	d	PROPN
fnp-4692	299	156	,	,	PUNCT
fnp-4692	299	157	cosgrove	cosgrove	PROPN
fnp-4692	299	158	n	n	PRON
fnp-4692	299	159	,	,	PUNCT
fnp-4692	299	160	couch	couch	NOUN
fnp-4692	299	161	fj	fj	NOUN
fnp-4692	299	162	,	,	PUNCT
fnp-4692	299	163	cussó	cussó	ADV
fnp-4692	299	164	l	l	NOUN
fnp-4692	299	165	,	,	PUNCT
fnp-4692	299	166	desco	desco	PROPN
fnp-4692	299	167	m	m	PROPN
fnp-4692	299	168	,	,	PUNCT
fnp-4692	299	169	mouron	mouron	PROPN
fnp-4692	299	170	s	s	PROPN
fnp-4692	299	171	,	,	PUNCT
fnp-4692	299	172	quintela	quintela	PROPN
fnp-4692	299	173	-	-	PUNCT
fnp-4692	299	174	fandino	fandino	PROPN
fnp-4692	299	175	m	m	PROPN
fnp-4692	299	176	,	,	PUNCT
fnp-4692	299	177	weller	weller	PROPN
fnp-4692	299	178	m	m	PROPN
fnp-4692	299	179	,	,	PUNCT
fnp-4692	299	180	pastor	pastor	PROPN
fnp-4692	299	181	j	j	PROPN
fnp-4692	299	182	,	,	PUNCT
fnp-4692	299	183	valiente	valiente	PROPN
fnp-4692	299	184	m.	m.	PROPN
fnp-4692	299	185	a	a	DET
fnp-4692	299	186	clinically	clinically	ADV
fnp-4692	299	187	compatible	compatible	ADJ
fnp-4692	299	188	drug	drug	NOUN
fnp-4692	299	189	-	-	PUNCT
fnp-4692	299	190	screening	screen	VERB
fnp-4692	299	191	platform	platform	NOUN
fnp-4692	299	192	based	base	VERB
fnp-4692	299	193	on	on	ADP
fnp-4692	299	194	organotypic	organotypic	ADJ
fnp-4692	299	195	cultures	culture	NOUN
fnp-4692	299	196	identifies	identify	VERB
fnp-4692	299	197	vulnerabilities	vulnerability	NOUN
fnp-4692	299	198	to	to	PART
fnp-4692	299	199	prevent	prevent	VERB
fnp-4692	299	200	and	and	CCONJ
fnp-4692	299	201	treat	treat	VERB
fnp-4692	299	202	brain	brain	NOUN
fnp-4692	299	203	metastasis	metastasis	NOUN
fnp-4692	299	204	.	.	PUNCT
fnp-4692	300	1	embo	embo	NOUN
fnp-4692	300	2	mol	mol	ADP
fnp-4692	300	3	med	med	PROPN
fnp-4692	300	4	.	.	PUNCT
fnp-4692	301	1	2022	2022	NUM
fnp-4692	301	2	mar	mar	PROPN
fnp-4692	301	3	7;14(3):e14552	7;14(3):e14552	NUM
fnp-4692	301	4	.	.	PUNCT
fnp-4692	302	1	https://doi.org/10.15252/emmm.202114552	https://doi.org/10.15252/emmm.202114552	NOUN
fnp-4692	302	2	.	.	PUNCT
fnp-4692	303	1	epub	epub	VERB
fnp-4692	303	2	2022	2022	NUM
fnp-4692	303	3	feb	feb	NOUN
fnp-4692	303	4	17	17	NUM
fnp-4692	303	5	.	.	PUNCT
fnp-4692	304	1	pmid	pmid	NOUN
fnp-4692	304	2	:	:	PUNCT
fnp-4692	304	3	35174975	35174975	NUM
fnp-4692	304	4	.	.	PUNCT
fnp-4692	305	1	15	15	NUM
fnp-4692	305	2	.	.	X
fnp-4692	306	1	capper	capper	PROPN
fnp-4692	306	2	d	d	PROPN
fnp-4692	306	3	,	,	PUNCT
fnp-4692	306	4	jones	jones	PROPN
fnp-4692	306	5	dtw	dtw	PROPN
fnp-4692	306	6	,	,	PUNCT
fnp-4692	306	7	sill	sill	NOUN
fnp-4692	306	8	m	m	PROPN
fnp-4692	306	9	,	,	PUNCT
fnp-4692	306	10	hovestadt	hovestadt	ADJ
fnp-4692	306	11	v	v	NOUN
fnp-4692	306	12	,	,	PUNCT
fnp-4692	306	13	schrimpf	schrimpf	NOUN
fnp-4692	306	14	d	d	PROPN
fnp-4692	306	15	,	,	PUNCT
fnp-4692	306	16	sturm	sturm	PROPN
fnp-4692	306	17	d	d	PROPN
fnp-4692	306	18	,	,	PUNCT
fnp-4692	306	19	koelsche	koelsche	PROPN
fnp-4692	306	20	c	c	PROPN
fnp-4692	306	21	,	,	PUNCT
fnp-4692	306	22	sahm	sahm	PROPN
fnp-4692	306	23	f	f	PROPN
fnp-4692	306	24	,	,	PUNCT
fnp-4692	306	25	chavez	chavez	PROPN
fnp-4692	306	26	l	l	PROPN
fnp-4692	306	27	,	,	PUNCT
fnp-4692	306	28	reuss	reuss	PROPN
fnp-4692	306	29	de	de	PROPN
fnp-4692	306	30	,	,	PUNCT
fnp-4692	306	31	kratz	kratz	PROPN
fnp-4692	306	32	a	a	PROPN
fnp-4692	306	33	,	,	PUNCT
fnp-4692	306	34	wefers	wefers	PROPN
fnp-4692	306	35	ak	ak	PROPN
fnp-4692	306	36	,	,	PUNCT
fnp-4692	306	37	huang	huang	PROPN
fnp-4692	306	38	k	k	PROPN
fnp-4692	306	39	,	,	PUNCT
fnp-4692	306	40	pajtler	pajtler	ADJ
fnp-4692	306	41	kw	kw	PROPN
fnp-4692	306	42	,	,	PUNCT
fnp-4692	306	43	schweizer	schweizer	PROPN
fnp-4692	306	44	l	l	PROPN
fnp-4692	306	45	,	,	PUNCT
fnp-4692	306	46	stichel	stichel	PROPN
fnp-4692	306	47	d	d	PROPN
fnp-4692	306	48	,	,	PUNCT
fnp-4692	306	49	olar	olar	ADJ
fnp-4692	306	50	a	a	PRON
fnp-4692	306	51	,	,	PUNCT
fnp-4692	306	52	engel	engel	PROPN
fnp-4692	306	53	nw	nw	PROPN
fnp-4692	306	54	,	,	PUNCT
fnp-4692	306	55	lindenberg	lindenberg	PROPN
fnp-4692	306	56	k	k	PROPN
fnp-4692	306	57	,	,	PUNCT
fnp-4692	306	58	harter	harter	PROPN
fnp-4692	306	59	pn	pn	PROPN
fnp-4692	306	60	,	,	PUNCT
fnp-4692	306	61	braczynski	braczynski	PROPN
fnp-4692	306	62	ak	ak	PROPN
fnp-4692	306	63	,	,	PUNCT
fnp-4692	306	64	plate	plate	NOUN
fnp-4692	306	65	kh	kh	PROPN
fnp-4692	306	66	,	,	PUNCT
fnp-4692	306	67	dohmen	dohmen	PROPN
fnp-4692	306	68	h	h	NOUN
fnp-4692	306	69	,	,	PUNCT
fnp-4692	306	70	garvalov	garvalov	VERB
fnp-4692	306	71	bk	bk	PROPN
fnp-4692	306	72	,	,	PUNCT
fnp-4692	306	73	coras	coras	PROPN
fnp-4692	306	74	r	r	PROPN
fnp-4692	306	75	,	,	PUNCT
fnp-4692	306	76	hölsken	hölsken	VERB
fnp-4692	306	77	a	a	PRON
fnp-4692	306	78	,	,	PUNCT
fnp-4692	306	79	hewer	hewer	PROPN
fnp-4692	306	80	e	e	NOUN
fnp-4692	306	81	,	,	PUNCT
fnp-4692	306	82	bewerunge	bewerunge	NOUN
fnp-4692	306	83	-	-	PUNCT
fnp-4692	306	84	hudler	hudler	PROPN
fnp-4692	306	85	m	m	PROPN
fnp-4692	306	86	,	,	PUNCT
fnp-4692	306	87	schick	schick	PROPN
fnp-4692	306	88	m	m	PROPN
fnp-4692	306	89	,	,	PUNCT
fnp-4692	306	90	fischer	fischer	PROPN
fnp-4692	306	91	r	r	PROPN
fnp-4692	306	92	,	,	PUNCT
fnp-4692	306	93	beschorner	beschorner	NOUN
fnp-4692	306	94	r	r	NOUN
fnp-4692	306	95	,	,	PUNCT
fnp-4692	306	96	schittenhelm	schittenhelm	PROPN
fnp-4692	306	97	j	j	PROPN
fnp-4692	306	98	,	,	PUNCT
fnp-4692	306	99	staszewski	staszewski	PROPN
fnp-4692	306	100	o	o	PROPN
fnp-4692	306	101	,	,	PUNCT
fnp-4692	306	102	wani	wani	PROPN
fnp-4692	306	103	k	k	PROPN
fnp-4692	306	104	,	,	PUNCT
fnp-4692	306	105	varlet	varlet	VERB
fnp-4692	306	106	p	p	PRON
fnp-4692	306	107	,	,	PUNCT
fnp-4692	306	108	pages	page	NOUN
fnp-4692	306	109	m	m	PRON
fnp-4692	306	110	,	,	PUNCT
fnp-4692	306	111	temming	temme	VERB
fnp-4692	306	112	p	p	PRON
fnp-4692	306	113	,	,	PUNCT
fnp-4692	307	1	lohmann	lohmann	PROPN
fnp-4692	307	2	d	d	PROPN
fnp-4692	307	3	,	,	PUNCT
fnp-4692	307	4	selt	selt	PROPN
fnp-4692	307	5	f	f	PROPN
fnp-4692	307	6	,	,	PUNCT
fnp-4692	307	7	witt	witt	PROPN
fnp-4692	307	8	h	h	PROPN
fnp-4692	307	9	,	,	PUNCT
fnp-4692	307	10	milde	milde	PROPN
fnp-4692	307	11	t	t	PROPN
fnp-4692	307	12	,	,	PUNCT
fnp-4692	307	13	witt	witt	PROPN
fnp-4692	307	14	o	o	NOUN
fnp-4692	307	15	,	,	PUNCT
fnp-4692	307	16	aronica	aronica	PROPN
fnp-4692	307	17	e	e	PROPN
fnp-4692	307	18	,	,	PUNCT
fnp-4692	307	19	giangaspero	giangaspero	PROPN
fnp-4692	307	20	f	f	PROPN
fnp-4692	307	21	,	,	PUNCT
fnp-4692	307	22	rushing	rush	VERB
fnp-4692	307	23	e	e	NOUN
fnp-4692	307	24	,	,	PUNCT
fnp-4692	307	25	scheurlen	scheurlen	PROPN
fnp-4692	307	26	w	w	NOUN
fnp-4692	307	27	,	,	PUNCT
fnp-4692	307	28	geisenberger	geisenberger	ADJ
fnp-4692	307	29	c	c	NOUN
fnp-4692	307	30	,	,	PUNCT
fnp-4692	307	31	rodriguez	rodriguez	PROPN
fnp-4692	307	32	fj	fj	PROPN
fnp-4692	307	33	,	,	PUNCT
fnp-4692	307	34	becker	becker	PROPN
fnp-4692	308	1	a	a	PRON
fnp-4692	308	2	,	,	PUNCT
fnp-4692	308	3	preusser	preusser	PROPN
fnp-4692	308	4	m	m	PROPN
fnp-4692	308	5	,	,	PUNCT
fnp-4692	308	6	haberler	haberler	NOUN
fnp-4692	308	7	c	c	NOUN
fnp-4692	308	8	,	,	PUNCT
fnp-4692	308	9	bjerkvig	bjerkvig	NOUN
fnp-4692	308	10	r	r	NOUN
fnp-4692	308	11	,	,	PUNCT
fnp-4692	308	12	cryan	cryan	PROPN
fnp-4692	308	13	j	j	PROPN
fnp-4692	308	14	,	,	PUNCT
fnp-4692	308	15	farrell	farrell	PROPN
fnp-4692	308	16	m	m	PROPN
fnp-4692	308	17	,	,	PUNCT
fnp-4692	308	18	deckert	deckert	PROPN
fnp-4692	308	19	m	m	PRON
fnp-4692	308	20	,	,	PUNCT
fnp-4692	308	21	hench	hench	PROPN
fnp-4692	308	22	j	j	PROPN
fnp-4692	308	23	,	,	PUNCT
fnp-4692	308	24	frank	frank	PROPN
fnp-4692	308	25	s	s	PROPN
fnp-4692	308	26	,	,	PUNCT
fnp-4692	308	27	serrano	serrano	PROPN
fnp-4692	308	28	j	j	PROPN
fnp-4692	308	29	,	,	PUNCT
fnp-4692	308	30	kannan	kannan	PROPN
fnp-4692	308	31	k	k	PROPN
fnp-4692	308	32	,	,	PUNCT
fnp-4692	308	33	tsirigos	tsirigo	NOUN
fnp-4692	308	34	a	a	DET
fnp-4692	308	35	,	,	PUNCT
fnp-4692	308	36	brück	brück	PROPN
fnp-4692	308	37	w	w	PROPN
fnp-4692	308	38	,	,	PUNCT
fnp-4692	308	39	hofer	hofer	PROPN
fnp-4692	308	40	s	s	PROPN
fnp-4692	308	41	,	,	PUNCT
fnp-4692	308	42	brehmer	brehmer	PROPN
fnp-4692	308	43	s	s	PROPN
fnp-4692	308	44	,	,	PUNCT
fnp-4692	308	45	seiz	seiz	PROPN
fnp-4692	308	46	-	-	PUNCT
fnp-4692	308	47	rosenhagen	rosenhagen	PROPN
fnp-4692	308	48	m	m	PROPN
fnp-4692	308	49	,	,	PUNCT
fnp-4692	308	50	hänggi	hänggi	PROPN
fnp-4692	308	51	d	d	PROPN
fnp-4692	308	52	,	,	PUNCT
fnp-4692	308	53	hans	hans	PROPN
fnp-4692	308	54	v	v	PROPN
fnp-4692	308	55	,	,	PUNCT
fnp-4692	308	56	rozsnoki	rozsnoki	NOUN
fnp-4692	308	57	s	s	PROPN
fnp-4692	308	58	,	,	PUNCT
fnp-4692	308	59	hansford	hansford	PROPN
fnp-4692	308	60	jr	jr	PROPN
fnp-4692	308	61	,	,	PUNCT
fnp-4692	308	62	kohlhof	kohlhof	PROPN
fnp-4692	308	63	p	p	PROPN
fnp-4692	308	64	,	,	PUNCT
fnp-4692	308	65	kristensen	kristensen	PROPN
fnp-4692	308	66	bw	bw	PROPN
fnp-4692	308	67	,	,	PUNCT
fnp-4692	308	68	lechner	lechner	PROPN
fnp-4692	308	69	m	m	PROPN
fnp-4692	308	70	,	,	PUNCT
fnp-4692	308	71	lopes	lopes	PROPN
fnp-4692	308	72	b	b	PROPN
fnp-4692	308	73	,	,	PUNCT
fnp-4692	308	74	mawrin	mawrin	NOUN
fnp-4692	308	75	c	c	NOUN
fnp-4692	308	76	,	,	PUNCT
fnp-4692	308	77	ketter	ketter	NOUN
fnp-4692	308	78	r	r	NOUN
fnp-4692	308	79	,	,	PUNCT
fnp-4692	308	80	kulozik	kulozik	NOUN
fnp-4692	308	81	a	a	PRON
fnp-4692	308	82	,	,	PUNCT
fnp-4692	308	83	khatib	khatib	PROPN
fnp-4692	308	84	z	z	PROPN
fnp-4692	308	85	,	,	PUNCT
fnp-4692	308	86	heppner	heppner	PROPN
fnp-4692	308	87	f	f	PROPN
fnp-4692	308	88	,	,	PUNCT
fnp-4692	308	89	koch	koch	PROPN
fnp-4692	308	90	a	a	PRON
fnp-4692	308	91	,	,	PUNCT
fnp-4692	308	92	jouvet	jouvet	NOUN
fnp-4692	308	93	a	a	PRON
fnp-4692	308	94	,	,	PUNCT
fnp-4692	308	95	keohane	keohane	PROPN
fnp-4692	308	96	c	c	NOUN
fnp-4692	308	97	,	,	PUNCT
fnp-4692	308	98	mühleisen	mühleisen	VERB
fnp-4692	308	99	h	h	NOUN
fnp-4692	308	100	,	,	PUNCT
fnp-4692	308	101	mueller	mueller	PROPN
fnp-4692	308	102	w	w	PROPN
fnp-4692	308	103	,	,	PUNCT
fnp-4692	308	104	pohl	pohl	PROPN
fnp-4692	308	105	u	u	PROPN
fnp-4692	308	106	,	,	PUNCT
fnp-4692	308	107	prinz	prinz	PROPN
fnp-4692	308	108	m	m	PROPN
fnp-4692	308	109	,	,	PUNCT
fnp-4692	308	110	benner	benner	PROPN
fnp-4692	308	111	a	a	PROPN
fnp-4692	308	112	,	,	PUNCT
fnp-4692	308	113	zapatka	zapatka	PROPN
fnp-4692	308	114	m	m	PROPN
fnp-4692	308	115	,	,	PUNCT
fnp-4692	308	116	gottardo	gottardo	PROPN
fnp-4692	308	117	ng	ng	PROPN
fnp-4692	308	118	,	,	PUNCT
fnp-4692	308	119	driever	driever	NOUN
fnp-4692	308	120	ph	ph	PROPN
fnp-4692	308	121	,	,	PUNCT
fnp-4692	308	122	kramm	kramm	PROPN
fnp-4692	308	123	cm	cm	PROPN
fnp-4692	308	124	,	,	PUNCT
fnp-4692	308	125	müller	müller	PROPN
fnp-4692	308	126	hl	hl	PROPN
fnp-4692	308	127	,	,	PUNCT
fnp-4692	308	128	rutkowski	rutkowski	PROPN
fnp-4692	308	129	s	s	PROPN
fnp-4692	308	130	,	,	PUNCT
fnp-4692	308	131	von	von	PROPN
fnp-4692	308	132	hoff	hoff	PROPN
fnp-4692	308	133	k	k	PROPN
fnp-4692	308	134	,	,	PUNCT
fnp-4692	308	135	frühwald	frühwald	PROPN
fnp-4692	308	136	mc	mc	PROPN
fnp-4692	308	137	,	,	PUNCT
fnp-4692	308	138	gnekow	gnekow	ADV
fnp-4692	308	139	a	a	DET
fnp-4692	308	140	,	,	PUNCT
fnp-4692	308	141	fleischhack	fleischhack	NOUN
fnp-4692	308	142	g	g	NOUN
fnp-4692	308	143	,	,	PUNCT
fnp-4692	308	144	tippelt	tippelt	NOUN
fnp-4692	308	145	s	s	NOUN
fnp-4692	308	146	,	,	PUNCT
fnp-4692	308	147	calaminus	calaminus	NOUN
fnp-4692	308	148	g	g	NOUN
fnp-4692	308	149	,	,	PUNCT
fnp-4692	308	150	monoranu	monoranu	NOUN
fnp-4692	308	151	cm	cm	PROPN
fnp-4692	308	152	,	,	PUNCT
fnp-4692	308	153	perry	perry	PROPN
fnp-4692	308	154	a	a	PROPN
fnp-4692	308	155	,	,	PUNCT
fnp-4692	308	156	jones	jones	PROPN
fnp-4692	308	157	c	c	PROPN
fnp-4692	308	158	,	,	PUNCT
fnp-4692	308	159	jacques	jacques	PROPN
fnp-4692	308	160	ts	ts	PROPN
fnp-4692	308	161	,	,	PUNCT
fnp-4692	308	162	radlwimmer	radlwimmer	PROPN
fnp-4692	308	163	b	b	PROPN
fnp-4692	308	164	,	,	PUNCT
fnp-4692	308	165	gessi	gessi	PROPN
fnp-4692	308	166	m	m	PROPN
fnp-4692	308	167	,	,	PUNCT
fnp-4692	308	168	pietsch	pietsch	VERB
fnp-4692	308	169	t	t	PROPN
fnp-4692	308	170	,	,	PUNCT
fnp-4692	308	171	schramm	schramm	PROPN
fnp-4692	308	172	j	j	PROPN
fnp-4692	308	173	,	,	PUNCT
fnp-4692	308	174	schackert	schackert	PROPN
fnp-4692	308	175	g	g	PROPN
fnp-4692	308	176	,	,	PUNCT
fnp-4692	308	177	westphal	westphal	PROPN
fnp-4692	308	178	m	m	PROPN
fnp-4692	308	179	,	,	PUNCT
fnp-4692	308	180	reifenberger	reifenberger	VERB
fnp-4692	308	181	g	g	NOUN
fnp-4692	308	182	,	,	PUNCT
fnp-4692	308	183	wesseling	wessele	VERB
fnp-4692	308	184	p	p	PRON
fnp-4692	308	185	,	,	PUNCT
fnp-4692	308	186	weller	weller	PROPN
fnp-4692	308	187	m	m	PROPN
fnp-4692	308	188	,	,	PUNCT
fnp-4692	308	189	collins	collins	PROPN
fnp-4692	308	190	vp	vp	PROPN
fnp-4692	308	191	,	,	PUNCT
fnp-4692	308	192	blümcke	blümcke	PROPN
fnp-4692	308	193	i	i	PROPN
fnp-4692	308	194	,	,	PUNCT
fnp-4692	308	195	bendszus	bendszus	PROPN
fnp-4692	308	196	m	m	PROPN
fnp-4692	308	197	,	,	PUNCT
fnp-4692	308	198	debus	debus	PROPN
fnp-4692	308	199	j	j	PROPN
fnp-4692	308	200	,	,	PUNCT
fnp-4692	308	201	huang	huang	PROPN
fnp-4692	308	202	a	a	PROPN
fnp-4692	308	203	,	,	PUNCT
fnp-4692	308	204	jabado	jabado	ADJ
fnp-4692	308	205	n	n	CCONJ
fnp-4692	308	206	,	,	PUNCT
fnp-4692	308	207	northcott	northcott	PROPN
fnp-4692	308	208	pa	pa	PROPN
fnp-4692	308	209	,	,	PUNCT
fnp-4692	308	210	paulus	paulus	PROPN
fnp-4692	308	211	w	w	PROPN
fnp-4692	308	212	,	,	PUNCT
fnp-4692	308	213	gajjar	gajjar	NOUN
fnp-4692	308	214	a	a	PRON
fnp-4692	308	215	,	,	PUNCT
fnp-4692	308	216	robinson	robinson	PROPN
fnp-4692	308	217	gw	gw	PROPN
fnp-4692	308	218	,	,	PUNCT
fnp-4692	308	219	taylor	taylor	PROPN
fnp-4692	308	220	md	md	PROPN
fnp-4692	308	221	,	,	PUNCT
fnp-4692	308	222	jaunmuktane	jaunmuktane	PROPN
fnp-4692	308	223	z	z	PROPN
fnp-4692	308	224	,	,	PUNCT
fnp-4692	308	225	ryzhova	ryzhova	PROPN
fnp-4692	308	226	m	m	PROPN
fnp-4692	308	227	,	,	PUNCT
fnp-4692	308	228	platten	platten	PROPN
fnp-4692	308	229	m	m	PROPN
fnp-4692	308	230	,	,	PUNCT
fnp-4692	308	231	unterberg	unterberg	PROPN
fnp-4692	308	232	a	a	PRON
fnp-4692	308	233	,	,	PUNCT
fnp-4692	308	234	wick	wick	PROPN
fnp-4692	308	235	w	w	PROPN
fnp-4692	308	236	,	,	PUNCT
fnp-4692	308	237	karajannis	karajannis	PROPN
fnp-4692	308	238	ma	ma	PROPN
fnp-4692	308	239	,	,	PUNCT
fnp-4692	308	240	mittelbronn	mittelbronn	PROPN
fnp-4692	308	241	m	m	PROPN
fnp-4692	308	242	,	,	PUNCT
fnp-4692	308	243	acker	acker	PROPN
fnp-4692	308	244	t	t	PROPN
fnp-4692	308	245	,	,	PUNCT
fnp-4692	308	246	hartmann	hartmann	PROPN
fnp-4692	308	247	c	c	PROPN
fnp-4692	308	248	,	,	PUNCT
fnp-4692	308	249	aldape	aldape	PROPN
fnp-4692	308	250	k	k	PROPN
fnp-4692	308	251	,	,	PUNCT
fnp-4692	308	252	schüller	schüll	ADJ
fnp-4692	308	253	u	u	NOUN
fnp-4692	308	254	,	,	PUNCT
fnp-4692	308	255	buslei	buslei	NOUN
fnp-4692	308	256	r	r	NOUN
fnp-4692	308	257	,	,	PUNCT
fnp-4692	308	258	lichter	lichter	PROPN
fnp-4692	308	259	p	p	PROPN
fnp-4692	308	260	,	,	PUNCT
fnp-4692	308	261	kool	kool	PROPN
fnp-4692	308	262	m	m	PROPN
fnp-4692	308	263	,	,	PUNCT
fnp-4692	308	264	herold	herold	PROPN
fnp-4692	308	265	-	-	PUNCT
fnp-4692	308	266	mende	mende	PROPN
fnp-4692	308	267	c	c	PROPN
fnp-4692	308	268	,	,	PUNCT
fnp-4692	308	269	ellison	ellison	PROPN
fnp-4692	308	270	dw	dw	PROPN
fnp-4692	308	271	,	,	PUNCT
fnp-4692	308	272	hasselblatt	hasselblatt	PROPN
fnp-4692	308	273	m	m	PROPN
fnp-4692	308	274	,	,	PUNCT
fnp-4692	308	275	snuderl	snuderl	PROPN
fnp-4692	308	276	m	m	PROPN
fnp-4692	308	277	,	,	PUNCT
fnp-4692	308	278	brandner	brandner	PROPN
fnp-4692	308	279	s	s	PROPN
fnp-4692	308	280	,	,	PUNCT
fnp-4692	308	281	korshunov	korshunov	PROPN
fnp-4692	308	282	a	a	PROPN
fnp-4692	308	283	,	,	PUNCT
fnp-4692	308	284	von	von	PROPN
fnp-4692	308	285	deimling	deimle	VERB
fnp-4692	308	286	a	a	PRON
fnp-4692	308	287	,	,	PUNCT
fnp-4692	308	288	pfister	pfister	NOUN
fnp-4692	308	289	sm	sm	PROPN
fnp-4692	308	290	.	.	PROPN
fnp-4692	308	291	dna	dna	PROPN
fnp-4692	308	292	methylation	methylation	NOUN
fnp-4692	308	293	-	-	PUNCT
fnp-4692	308	294	based	base	VERB
fnp-4692	308	295	classification	classification	NOUN
fnp-4692	308	296	of	of	ADP
fnp-4692	308	297	central	central	ADJ
fnp-4692	308	298	nervous	nervous	ADJ
fnp-4692	308	299	system	system	NOUN
fnp-4692	308	300	tumours	tumour	VERB
fnp-4692	308	301	.	.	PUNCT
fnp-4692	309	1	nature	nature	NOUN
fnp-4692	309	2	.	.	PUNCT
fnp-4692	310	1	2018	2018	NUM
fnp-4692	310	2	mar	mar	PROPN
fnp-4692	310	3	22;555(7697):469	22;555(7697):469	NUM
fnp-4692	310	4	-	-	SYM
fnp-4692	310	5	474	474	NUM
fnp-4692	310	6	.	.	PUNCT
fnp-4692	311	1	https://doi.org/10.1038/nature26000	https://doi.org/10.1038/nature26000	NOUN
fnp-4692	311	2	.	.	PUNCT
fnp-4692	312	1	epub	epub	PROPN
fnp-4692	312	2	2018	2018	NUM
fnp-4692	312	3	mar	mar	PROPN
fnp-4692	312	4	14	14	NUM
fnp-4692	312	5	.	.	PUNCT
fnp-4692	313	1	pmid	pmid	NOUN
fnp-4692	313	2	:	:	PUNCT
fnp-4692	313	3	29539639	29539639	NUM
fnp-4692	313	4	.	.	PUNCT
fnp-4692	314	1	16	16	NUM
fnp-4692	314	2	.	.	PUNCT
fnp-4692	315	1	raffeld	raffeld	PROPN
fnp-4692	315	2	m	m	PROPN
fnp-4692	315	3	,	,	PUNCT
fnp-4692	315	4	abdullaev	abdullaev	PROPN
fnp-4692	315	5	z	z	PROPN
fnp-4692	315	6	,	,	PUNCT
fnp-4692	315	7	pack	pack	NOUN
fnp-4692	315	8	sd	sd	NOUN
fnp-4692	315	9	,	,	PUNCT
fnp-4692	315	10	xi	xi	PROPN
fnp-4692	315	11	l	l	PROPN
fnp-4692	315	12	,	,	PUNCT
fnp-4692	315	13	nagaraj	nagaraj	PROPN
fnp-4692	315	14	s	s	PROPN
fnp-4692	315	15	,	,	PUNCT
fnp-4692	315	16	briceno	briceno	NOUN
fnp-4692	315	17	n	n	CCONJ
fnp-4692	315	18	,	,	PUNCT
fnp-4692	315	19	vera	vera	NOUN
fnp-4692	315	20	e	e	NOUN
fnp-4692	315	21	,	,	PUNCT
fnp-4692	315	22	pittaluga	pittaluga	PROPN
fnp-4692	315	23	s	s	PROPN
fnp-4692	315	24	,	,	PUNCT
fnp-4692	315	25	lopes	lopes	PROPN
fnp-4692	315	26	abath	abath	ADP
fnp-4692	315	27	neto	neto	PROPN
fnp-4692	315	28	o	o	PROPN
fnp-4692	315	29	,	,	PUNCT
fnp-4692	315	30	quezado	quezado	PROPN
fnp-4692	315	31	m	m	PROPN
fnp-4692	315	32	,	,	PUNCT
fnp-4692	315	33	aldape	aldape	PROPN
fnp-4692	315	34	k	k	PROPN
fnp-4692	315	35	,	,	PUNCT
fnp-4692	315	36	armstrong	armstrong	PROPN
fnp-4692	315	37	ts	ts	PROPN
fnp-4692	315	38	,	,	PUNCT
fnp-4692	315	39	gilbert	gilbert	PROPN
fnp-4692	315	40	mr	mr	PROPN
fnp-4692	315	41	.	.	PROPN
fnp-4692	315	42	high	high	ADJ
fnp-4692	315	43	level	level	NOUN
fnp-4692	315	44	mycn	mycn	NOUN
fnp-4692	315	45	amplification	amplification	NOUN
fnp-4692	315	46	and	and	CCONJ
fnp-4692	315	47	distinct	distinct	ADJ
fnp-4692	315	48	methylation	methylation	NOUN
fnp-4692	315	49	signature	signature	NOUN
fnp-4692	315	50	define	define	VERB
fnp-4692	315	51	an	an	DET
fnp-4692	315	52	aggressive	aggressive	ADJ
fnp-4692	315	53	subtype	subtype	NOUN
fnp-4692	315	54	of	of	ADP
fnp-4692	315	55	spinal	spinal	ADJ
fnp-4692	315	56	cord	cord	NOUN
fnp-4692	315	57	ependymoma	ependymoma	NOUN
fnp-4692	315	58	.	.	PUNCT
fnp-4692	316	1	acta	acta	PROPN
fnp-4692	316	2	neuropathol	neuropathol	PROPN
fnp-4692	316	3	commun	commun	PROPN
fnp-4692	316	4	.	.	PUNCT
fnp-4692	317	1	2020	2020	NUM
fnp-4692	317	2	jul	jul	PROPN
fnp-4692	317	3	8;8(1):101	8;8(1):101	PROPN
fnp-4692	317	4	.	.	PUNCT
fnp-4692	318	1	https://doi.org/10.1186/s40478-020-00973-y	https://doi.org/10.1186/s40478-020-00973-y	PROPN
fnp-4692	318	2	.	.	PUNCT
fnp-4692	319	1	pmid	pmid	NOUN
fnp-4692	319	2	:	:	PUNCT
fnp-4692	319	3	32641156	32641156	NUM
fnp-4692	319	4	.	.	PUNCT
fnp-4692	320	1	17	17	NUM
fnp-4692	320	2	.	.	PUNCT
fnp-4692	321	1	sahm	sahm	PROPN
fnp-4692	321	2	f	f	PROPN
fnp-4692	321	3	,	,	PUNCT
fnp-4692	321	4	schrimpf	schrimpf	NOUN
fnp-4692	321	5	d	d	PROPN
fnp-4692	321	6	,	,	PUNCT
fnp-4692	321	7	stichel	stichel	PROPN
fnp-4692	321	8	d	d	PROPN
fnp-4692	321	9	,	,	PUNCT
fnp-4692	321	10	jones	jones	PROPN
fnp-4692	321	11	dtw	dtw	PROPN
fnp-4692	321	12	,	,	PUNCT
fnp-4692	321	13	hielscher	hielscher	NOUN
fnp-4692	321	14	t	t	PROPN
fnp-4692	321	15	,	,	PUNCT
fnp-4692	321	16	schefzyk	schefzyk	VERB
fnp-4692	321	17	s	s	PROPN
fnp-4692	321	18	,	,	PUNCT
fnp-4692	321	19	okonechnikov	okonechnikov	PROPN
fnp-4692	321	20	k	k	PROPN
fnp-4692	321	21	,	,	PUNCT
fnp-4692	321	22	koelsche	koelsche	PROPN
fnp-4692	321	23	c	c	PROPN
fnp-4692	321	24	,	,	PUNCT
fnp-4692	321	25	reuss	reuss	PROPN
fnp-4692	321	26	de	de	PROPN
fnp-4692	321	27	,	,	PUNCT
fnp-4692	321	28	capper	capper	NOUN
fnp-4692	321	29	d	d	PROPN
fnp-4692	321	30	,	,	PUNCT
fnp-4692	321	31	sturm	sturm	PROPN
fnp-4692	321	32	d	d	PROPN
fnp-4692	321	33	,	,	PUNCT
fnp-4692	321	34	wirsching	wirsche	VERB
fnp-4692	321	35	hg	hg	NOUN
fnp-4692	321	36	,	,	PUNCT
fnp-4692	321	37	berghoff	berghoff	INTJ
fnp-4692	321	38	as	as	ADP
fnp-4692	321	39	,	,	PUNCT
fnp-4692	321	40	baumgarten	baumgarten	VERB
fnp-4692	321	41	p	p	PROPN
fnp-4692	321	42	,	,	PUNCT
fnp-4692	321	43	kratz	kratz	PROPN
fnp-4692	321	44	a	a	PROPN
fnp-4692	321	45	,	,	PUNCT
fnp-4692	321	46	huang	huang	PROPN
fnp-4692	321	47	k	k	PROPN
fnp-4692	321	48	,	,	PUNCT
fnp-4692	321	49	wefers	wefers	PROPN
fnp-4692	321	50	ak	ak	PROPN
fnp-4692	321	51	,	,	PUNCT
fnp-4692	321	52	hovestadt	hovestadt	ADJ
fnp-4692	321	53	v	v	NOUN
fnp-4692	321	54	,	,	PUNCT
fnp-4692	321	55	sill	sill	NOUN
fnp-4692	321	56	m	m	PROPN
fnp-4692	321	57	,	,	PUNCT
fnp-4692	321	58	ellis	ellis	PROPN
fnp-4692	321	59	hp	hp	PROPN
fnp-4692	321	60	,	,	PUNCT
fnp-4692	321	61	kurian	kurian	ADJ
fnp-4692	321	62	km	km	PROPN
fnp-4692	321	63	,	,	PUNCT
fnp-4692	321	64	okuducu	okuducu	PROPN
fnp-4692	321	65	af	af	PROPN
fnp-4692	321	66	,	,	PUNCT
fnp-4692	321	67	jungk	jungk	PROPN
fnp-4692	321	68	c	c	NOUN
fnp-4692	321	69	,	,	PUNCT
fnp-4692	321	70	drueschler	drueschler	NOUN
fnp-4692	321	71	k	k	NOUN
fnp-4692	321	72	,	,	PUNCT
fnp-4692	321	73	schick	schick	PROPN
fnp-4692	321	74	m	m	PROPN
fnp-4692	321	75	,	,	PUNCT
fnp-4692	321	76	bewerunge	bewerunge	NOUN
fnp-4692	321	77	-	-	PUNCT
fnp-4692	321	78	hudler	hudler	PROPN
fnp-4692	321	79	m	m	PROPN
fnp-4692	321	80	,	,	PUNCT
fnp-4692	321	81	mawrin	mawrin	NOUN
fnp-4692	321	82	c	c	PROPN
fnp-4692	321	83	,	,	PUNCT
fnp-4692	321	84	seiz	seiz	PROPN
fnp-4692	321	85	-	-	PUNCT
fnp-4692	321	86	rosenhagen	rosenhagen	PROPN
fnp-4692	321	87	m	m	PROPN
fnp-4692	321	88	,	,	PUNCT
fnp-4692	321	89	ketter	ketter	PROPN
fnp-4692	321	90	r	r	NOUN
fnp-4692	321	91	,	,	PUNCT
fnp-4692	321	92	simon	simon	PROPN
fnp-4692	321	93	m	m	PROPN
fnp-4692	321	94	,	,	PUNCT
fnp-4692	321	95	westphal	westphal	PROPN
fnp-4692	321	96	m	m	PROPN
fnp-4692	321	97	,	,	PUNCT
fnp-4692	321	98	lamszus	lamszus	PROPN
fnp-4692	321	99	k	k	PROPN
fnp-4692	321	100	,	,	PUNCT
fnp-4692	321	101	becker	becker	PROPN
fnp-4692	322	1	a	a	PRON
fnp-4692	322	2	,	,	PUNCT
fnp-4692	322	3	koch	koch	PROPN
fnp-4692	322	4	a	a	X
fnp-4692	322	5	,	,	PUNCT
fnp-4692	322	6	schittenhelm	schittenhelm	PROPN
fnp-4692	322	7	j	j	PROPN
fnp-4692	322	8	,	,	PUNCT
fnp-4692	322	9	rushing	rush	VERB
fnp-4692	322	10	ej	ej	PROPN
fnp-4692	322	11	,	,	PUNCT
fnp-4692	322	12	collins	collins	PROPN
fnp-4692	322	13	vp	vp	PROPN
fnp-4692	322	14	,	,	PUNCT
fnp-4692	322	15	brehmer	brehmer	PROPN
fnp-4692	322	16	s	s	PROPN
fnp-4692	322	17	,	,	PUNCT
fnp-4692	322	18	chavez	chavez	PROPN
fnp-4692	322	19	l	l	PROPN
fnp-4692	322	20	,	,	PUNCT
fnp-4692	322	21	platten	platten	PROPN
fnp-4692	322	22	m	m	PROPN
fnp-4692	322	23	,	,	PUNCT
fnp-4692	322	24	hänggi	hänggi	PROPN
fnp-4692	322	25	d	d	PROPN
fnp-4692	322	26	,	,	PUNCT
fnp-4692	322	27	unterberg	unterberg	PROPN
fnp-4692	322	28	a	a	PRON
fnp-4692	322	29	,	,	PUNCT
fnp-4692	322	30	paulus	paulus	PROPN
fnp-4692	322	31	w	w	PROPN
fnp-4692	322	32	,	,	PUNCT
fnp-4692	322	33	wick	wick	PROPN
fnp-4692	322	34	w	w	PROPN
fnp-4692	322	35	,	,	PUNCT
fnp-4692	322	36	pfister	pfister	PROPN
fnp-4692	322	37	sm	sm	PROPN
fnp-4692	322	38	,	,	PUNCT
fnp-4692	322	39	mittelbronn	mittelbronn	PROPN
fnp-4692	322	40	m	m	PROPN
fnp-4692	322	41	,	,	PUNCT
fnp-4692	322	42	preusser	preusser	PROPN
fnp-4692	322	43	m	m	PROPN
fnp-4692	322	44	,	,	PUNCT
fnp-4692	322	45	herold	herold	PROPN
fnp-4692	322	46	-	-	PUNCT
fnp-4692	322	47	mende	mende	PROPN
fnp-4692	322	48	c	c	PROPN
fnp-4692	322	49	,	,	PUNCT
fnp-4692	322	50	weller	weller	PROPN
fnp-4692	322	51	m	m	PROPN
fnp-4692	322	52	,	,	PUNCT
fnp-4692	322	53	von	von	PROPN
fnp-4692	322	54	deimling	deimle	VERB
fnp-4692	322	55	a.	a.	PROPN
fnp-4692	322	56	dna	dna	PROPN
fnp-4692	322	57	methylation	methylation	NOUN
fnp-4692	322	58	-	-	PUNCT
fnp-4692	322	59	based	base	VERB
fnp-4692	322	60	classification	classification	NOUN
fnp-4692	322	61	and	and	CCONJ
fnp-4692	322	62	grading	grade	VERB
fnp-4692	322	63	system	system	NOUN
fnp-4692	322	64	for	for	ADP
fnp-4692	322	65	meningioma	meningioma	NOUN
fnp-4692	322	66	:	:	PUNCT
fnp-4692	322	67	a	a	DET
fnp-4692	322	68	multicentre	multicentre	NOUN
fnp-4692	322	69	,	,	PUNCT
fnp-4692	322	70	retrospective	retrospective	ADJ
fnp-4692	322	71	analysis	analysis	NOUN
fnp-4692	322	72	.	.	PUNCT
fnp-4692	323	1	lancet	lancet	PROPN
fnp-4692	323	2	oncol	oncol	PROPN
fnp-4692	323	3	.	.	PUNCT
fnp-4692	324	1	2017	2017	NUM
fnp-4692	324	2	may;18(5):682	may;18(5):682	NUM
fnp-4692	324	3	-	-	PUNCT
fnp-4692	324	4	694	694	NUM
fnp-4692	324	5	.	.	PUNCT
fnp-4692	325	1	https://doi.org/10.1016/s1470-2045(17)30155-9	https://doi.org/10.1016/s1470-2045(17)30155-9	PROPN
fnp-4692	325	2	.	.	PUNCT
fnp-4692	326	1	epub	epub	PROPN
fnp-4692	326	2	2017	2017	NUM
fnp-4692	326	3	mar	mar	PROPN
fnp-4692	326	4	15	15	NUM
fnp-4692	326	5	.	.	PUNCT
fnp-4692	327	1	pmid	pmid	NOUN
fnp-4692	327	2	:	:	PUNCT
fnp-4692	327	3	28314689	28314689	NUM
fnp-4692	327	4	.	.	PUNCT
fnp-4692	328	1	18	18	NUM
fnp-4692	328	2	.	.	X
fnp-4692	328	3	wesseling	wessele	VERB
fnp-4692	328	4	p	p	NOUN
fnp-4692	328	5	,	,	PUNCT
fnp-4692	328	6	rozowsky	rozowsky	ADJ
fnp-4692	328	7	js	js	PROPN
fnp-4692	328	8	.	.	PUNCT
fnp-4692	329	1	neurooncology	neurooncology	NOUN
fnp-4692	329	2	:	:	PUNCT
fnp-4692	329	3	2022	2022	NUM
fnp-4692	329	4	update	update	NOUN
fnp-4692	329	5	.	.	PUNCT
fnp-4692	330	1	free	free	ADJ
fnp-4692	330	2	neuropathology	neuropathology	NOUN
fnp-4692	330	3	3:4	3:4	NUM
fnp-4692	330	4	.	.	PUNCT
fnp-4692	330	5	2022	2022	NUM
fnp-4692	330	6	.	.	PUNCT
fnp-4692	331	1	https://doi.org/10.17879/freeneuropathology-2022-3804/.	https://doi.org/10.17879/freeneuropathology-2022-3804/.	PROPN
fnp-4692	331	2	19	19	NUM
fnp-4692	331	3	.	.	PUNCT
fnp-4692	332	1	hielscher	hielscher	PROPN
fnp-4692	332	2	t	t	PROPN
fnp-4692	332	3	,	,	PUNCT
fnp-4692	332	4	sill	sill	NOUN
fnp-4692	332	5	m	m	PROPN
fnp-4692	332	6	,	,	PUNCT
fnp-4692	332	7	sievers	sievers	PROPN
fnp-4692	332	8	p	p	PROPN
fnp-4692	332	9	,	,	PUNCT
fnp-4692	332	10	stichel	stichel	PROPN
fnp-4692	332	11	d	d	PROPN
fnp-4692	332	12	,	,	PUNCT
fnp-4692	332	13	brandner	brandner	PROPN
fnp-4692	332	14	s	s	PROPN
fnp-4692	332	15	,	,	PUNCT
fnp-4692	332	16	jones	jones	PROPN
fnp-4692	332	17	dtw	dtw	PROPN
fnp-4692	332	18	,	,	PUNCT
fnp-4692	332	19	von	von	PROPN
fnp-4692	332	20	deimling	deimle	VERB
fnp-4692	332	21	a	a	PRON
fnp-4692	332	22	,	,	PUNCT
fnp-4692	332	23	sahm	sahm	PROPN
fnp-4692	332	24	f	f	PROPN
fnp-4692	332	25	,	,	PUNCT
fnp-4692	332	26	maas	maas	PROPN
fnp-4692	332	27	sln	sln	PROPN
fnp-4692	332	28	.	.	PUNCT
fnp-4692	333	1	clinical	clinical	ADJ
fnp-4692	333	2	implementation	implementation	NOUN
fnp-4692	333	3	of	of	ADP
fnp-4692	333	4	integrated	integrate	VERB
fnp-4692	333	5	molecular	molecular	ADJ
fnp-4692	333	6	-	-	PUNCT
fnp-4692	333	7	morphologic	morphologic	ADJ
fnp-4692	333	8	risk	risk	NOUN
fnp-4692	333	9	prediction	prediction	NOUN
fnp-4692	333	10	for	for	ADP
fnp-4692	333	11	meningioma	meningioma	NOUN
fnp-4692	333	12	.	.	PUNCT
fnp-4692	334	1	brain	brain	NOUN
fnp-4692	334	2	pathol	pathol	NOUN
fnp-4692	334	3	.	.	PUNCT
fnp-4692	335	1	2022	2022	NUM
fnp-4692	335	2	nov	nov	NOUN
fnp-4692	335	3	14	14	NUM
fnp-4692	335	4	:	:	PUNCT
fnp-4692	335	5	e13132	e13132	NOUN
fnp-4692	335	6	.	.	PUNCT
fnp-4692	336	1	https://doi.org/10.1111/bpa.13132	https://doi.org/10.1111/bpa.13132	PROPN
fnp-4692	336	2	.	.	PUNCT
fnp-4692	337	1	online	online	ADV
fnp-4692	337	2	ahead	ahead	ADV
fnp-4692	337	3	of	of	ADP
fnp-4692	337	4	print	print	NOUN
fnp-4692	337	5	.	.	PUNCT
fnp-4692	338	1	pmid	pmid	NOUN
fnp-4692	338	2	:	:	PUNCT
fnp-4692	338	3	36377252	36377252	NUM
fnp-4692	338	4	.	.	PUNCT
fnp-4692	339	1	20	20	NUM
fnp-4692	339	2	.	.	PUNCT
fnp-4692	340	1	world	world	PROPN
fnp-4692	340	2	health	health	PROPN
fnp-4692	340	3	organization	organization	PROPN
fnp-4692	340	4	classification	classification	NOUN
fnp-4692	340	5	of	of	ADP
fnp-4692	340	6	tumours	tumour	NOUN
fnp-4692	340	7	of	of	ADP
fnp-4692	340	8	the	the	DET
fnp-4692	340	9	central	central	ADJ
fnp-4692	340	10	nervous	nervous	ADJ
fnp-4692	340	11	system	system	NOUN
fnp-4692	340	12	.	.	PUNCT
fnp-4692	341	1	5th	5th	ADJ
fnp-4692	341	2	ed.lyon	ed.lyon	ADJ
fnp-4692	341	3	:	:	PUNCT
fnp-4692	341	4	international	international	ADJ
fnp-4692	341	5	agency	agency	NOUN
fnp-4692	341	6	for	for	ADP
fnp-4692	341	7	research	research	NOUN
fnp-4692	341	8	on	on	ADP
fnp-4692	341	9	cancer	cancer	NOUN
fnp-4692	341	10	;	;	PUNCT
fnp-4692	341	11	2021	2021	NUM
fnp-4692	341	12	.	.	PUNCT
fnp-4692	342	1	21	21	NUM
fnp-4692	342	2	.	.	X
fnp-4692	343	1	fangazio	fangazio	PROPN
fnp-4692	343	2	m	m	PROPN
fnp-4692	343	3	,	,	PUNCT
fnp-4692	343	4	ladewig	ladewig	PROPN
fnp-4692	343	5	e	e	PROPN
fnp-4692	343	6	,	,	PUNCT
fnp-4692	343	7	gomez	gomez	PROPN
fnp-4692	343	8	k	k	PROPN
fnp-4692	343	9	,	,	PUNCT
fnp-4692	343	10	garcia	garcia	PROPN
fnp-4692	343	11	-	-	PUNCT
fnp-4692	343	12	ibanez	ibanez	PROPN
fnp-4692	343	13	l	l	PROPN
fnp-4692	343	14	,	,	PUNCT
fnp-4692	343	15	kumar	kumar	PROPN
fnp-4692	343	16	r	r	PROPN
fnp-4692	343	17	,	,	PUNCT
fnp-4692	343	18	teruya	teruya	NOUN
fnp-4692	343	19	-	-	PUNCT
fnp-4692	343	20	feldstein	feldstein	NOUN
fnp-4692	343	21	j	j	PROPN
fnp-4692	343	22	,	,	PUNCT
fnp-4692	343	23	rossi	rossi	PROPN
fnp-4692	343	24	d	d	X
fnp-4692	343	25	,	,	PUNCT
fnp-4692	343	26	filip	filip	PROPN
fnp-4692	343	27	i	i	PRON
fnp-4692	343	28	,	,	PUNCT
fnp-4692	343	29	pan	pan	ADJ
fnp-4692	343	30	-	-	ADJ
fnp-4692	343	31	hammarström	hammarström	ADJ
fnp-4692	343	32	q	q	NOUN
fnp-4692	343	33	,	,	PUNCT
fnp-4692	343	34	inghirami	inghirami	NOUN
fnp-4692	343	35	g	g	NOUN
fnp-4692	343	36	,	,	PUNCT
fnp-4692	343	37	boldorini	boldorini	X
fnp-4692	343	38	r	r	NOUN
fnp-4692	343	39	,	,	PUNCT
fnp-4692	343	40	ott	ott	PROPN
fnp-4692	343	41	g	g	PROPN
fnp-4692	343	42	,	,	PUNCT
fnp-4692	343	43	staiger	staiger	NOUN
fnp-4692	343	44	am	be	AUX
fnp-4692	343	45	,	,	PUNCT
fnp-4692	343	46	chapuy	chapuy	ADJ
fnp-4692	343	47	b	b	NOUN
fnp-4692	343	48	,	,	PUNCT
fnp-4692	343	49	gaidano	gaidano	VERB
fnp-4692	343	50	g	g	NOUN
fnp-4692	343	51	,	,	PUNCT
fnp-4692	343	52	bhagat	bhagat	PROPN
fnp-4692	343	53	g	g	PROPN
fnp-4692	343	54	,	,	PUNCT
fnp-4692	343	55	basso	basso	PROPN
fnp-4692	343	56	k	k	PROPN
fnp-4692	343	57	,	,	PUNCT
fnp-4692	343	58	rabadan	rabadan	PROPN
fnp-4692	343	59	r	r	PROPN
fnp-4692	343	60	,	,	PUNCT
fnp-4692	343	61	pasqualucci	pasqualucci	NOUN
fnp-4692	343	62	l	l	PROPN
fnp-4692	343	63	,	,	PUNCT
fnp-4692	343	64	dalla	dalla	NOUN
fnp-4692	343	65	-	-	PUNCT
fnp-4692	343	66	favera	favera	NOUN
fnp-4692	343	67	r.	r.	PROPN
fnp-4692	343	68	genetic	genetic	ADJ
fnp-4692	343	69	mechanisms	mechanism	NOUN
fnp-4692	343	70	of	of	ADP
fnp-4692	343	71	hla	hla	PROPN
fnp-4692	343	72	-	-	PUNCT
fnp-4692	343	73	i	i	NOUN
fnp-4692	343	74	loss	loss	NOUN
fnp-4692	343	75	and	and	CCONJ
fnp-4692	343	76	immune	immune	ADJ
fnp-4692	343	77	escape	escape	NOUN
fnp-4692	343	78	in	in	ADP
fnp-4692	343	79	diffuse	diffuse	PROPN
fnp-4692	343	80	large	large	ADJ
fnp-4692	343	81	b	b	NOUN
fnp-4692	343	82	cell	cell	NOUN
fnp-4692	343	83	lymphoma	lymphoma	NOUN
fnp-4692	343	84	.	.	PUNCT
fnp-4692	344	1	proc	proc	PROPN
fnp-4692	344	2	natl	natl	PROPN
fnp-4692	344	3	acad	acad	PROPN
fnp-4692	344	4	sci	sci	PROPN
fnp-4692	344	5	u	u	PROPN
fnp-4692	344	6	s	s	NOUN
fnp-4692	344	7	a.	a.	NOUN
fnp-4692	344	8	2021	2021	NUM
fnp-4692	344	9	jun	jun	PROPN
fnp-4692	344	10	1;118(22):e2104504118	1;118(22):e2104504118	NUM
fnp-4692	344	11	.	.	PUNCT
fnp-4692	344	12	https://doi.org/10.1073/pnas.2104504118	https://doi.org/10.1073/pnas.2104504118	PROPN
fnp-4692	344	13	.	.	PUNCT
fnp-4692	345	1	pmid	pmid	NOUN
fnp-4692	345	2	:	:	PUNCT
fnp-4692	345	3	34050029	34050029	NUM
fnp-4692	345	4	.	.	PUNCT
fnp-4692	346	1	22	22	NUM
fnp-4692	346	2	.	.	PUNCT
fnp-4692	347	1	zhu	zhu	PROPN
fnp-4692	347	2	y	y	PROPN
fnp-4692	347	3	,	,	PUNCT
fnp-4692	347	4	weiss	weiss	PROPN
fnp-4692	347	5	t	t	PROPN
fnp-4692	347	6	,	,	PUNCT
fnp-4692	347	7	zhang	zhang	PROPN
fnp-4692	347	8	q	q	PROPN
fnp-4692	347	9	,	,	PUNCT
fnp-4692	347	10	sun	sun	NOUN
fnp-4692	347	11	r	r	NOUN
fnp-4692	347	12	,	,	PUNCT
fnp-4692	347	13	wang	wang	PROPN
fnp-4692	347	14	b	b	PROPN
fnp-4692	347	15	,	,	PUNCT
fnp-4692	347	16	yi	yi	PROPN
fnp-4692	347	17	x	x	NOUN
fnp-4692	347	18	,	,	PUNCT
fnp-4692	347	19	wu	wu	PROPN
fnp-4692	347	20	z	z	PROPN
fnp-4692	347	21	,	,	PUNCT
fnp-4692	347	22	gao	gao	PROPN
fnp-4692	347	23	h	h	PROPN
fnp-4692	347	24	,	,	PUNCT
fnp-4692	347	25	cai	cai	PROPN
fnp-4692	348	1	x	x	PROPN
fnp-4692	348	2	,	,	PUNCT
fnp-4692	348	3	ruan	ruan	PROPN
fnp-4692	348	4	g	g	PROPN
fnp-4692	348	5	,	,	PUNCT
fnp-4692	348	6	zhu	zhu	PROPN
fnp-4692	348	7	t	t	PROPN
fnp-4692	348	8	,	,	PUNCT
fnp-4692	348	9	xu	xu	PROPN
fnp-4692	349	1	c	c	X
fnp-4692	349	2	,	,	PUNCT
fnp-4692	349	3	lou	lou	PROPN
fnp-4692	349	4	s	s	PROPN
fnp-4692	349	5	,	,	PUNCT
fnp-4692	349	6	yu	yu	PROPN
fnp-4692	349	7	x	x	PROPN
fnp-4692	349	8	,	,	PUNCT
fnp-4692	349	9	gillet	gillet	PROPN
fnp-4692	349	10	l	l	PROPN
fnp-4692	349	11	,	,	PUNCT
fnp-4692	349	12	blattmann	blattmann	NOUN
fnp-4692	349	13	p	p	X
fnp-4692	349	14	,	,	PUNCT
fnp-4692	349	15	saba	saba	PROPN
fnp-4692	349	16	k	k	PROPN
fnp-4692	349	17	,	,	PUNCT
fnp-4692	349	18	fankhauser	fankhauser	PROPN
fnp-4692	349	19	cd	cd	PROPN
fnp-4692	349	20	,	,	PUNCT
fnp-4692	349	21	schmid	schmid	PROPN
fnp-4692	349	22	mb	mb	PROPN
fnp-4692	349	23	,	,	PUNCT
fnp-4692	349	24	rutishauser	rutishauser	ADJ
fnp-4692	349	25	d	d	NOUN
fnp-4692	349	26	,	,	PUNCT
fnp-4692	349	27	ljubicic	ljubicic	PROPN
fnp-4692	349	28	j	j	PROPN
fnp-4692	349	29	,	,	PUNCT
fnp-4692	349	30	christiansen	christiansen	PROPN
fnp-4692	349	31	a	a	PROPN
fnp-4692	349	32	,	,	PUNCT
fnp-4692	349	33	fritz	fritz	PROPN
fnp-4692	349	34	c	c	PROPN
fnp-4692	349	35	,	,	PUNCT
fnp-4692	349	36	rupp	rupp	PROPN
fnp-4692	349	37	nj	nj	PROPN
fnp-4692	349	38	,	,	PUNCT
fnp-4692	349	39	poyet	poyet	NOUN
fnp-4692	349	40	c	c	NOUN
fnp-4692	349	41	,	,	PUNCT
fnp-4692	349	42	rushing	rush	VERB
fnp-4692	349	43	e	e	NOUN
fnp-4692	349	44	,	,	PUNCT
fnp-4692	349	45	weller	weller	PROPN
fnp-4692	349	46	m	m	PROPN
fnp-4692	349	47	,	,	PUNCT
fnp-4692	349	48	roth	roth	PROPN
fnp-4692	349	49	p	p	X
fnp-4692	349	50	,	,	PUNCT
fnp-4692	349	51	haralambieva	haralambieva	PROPN
fnp-4692	349	52	e	e	PROPN
fnp-4692	349	53	,	,	PUNCT
fnp-4692	349	54	hofer	hofer	PROPN
fnp-4692	349	55	s	s	PROPN
fnp-4692	349	56	,	,	PUNCT
fnp-4692	349	57	chen	chen	PROPN
fnp-4692	349	58	c	c	AUX
fnp-4692	349	59	,	,	PUNCT
fnp-4692	349	60	jochum	jochum	PROPN
fnp-4692	349	61	w	w	PROPN
fnp-4692	349	62	,	,	PUNCT
fnp-4692	349	63	gao	gao	PROPN
fnp-4692	349	64	x	x	PROPN
fnp-4692	349	65	,	,	PUNCT
fnp-4692	349	66	teng	teng	PROPN
fnp-4692	349	67	x	x	PROPN
fnp-4692	349	68	,	,	PUNCT
fnp-4692	349	69	chen	chen	PROPN
fnp-4692	349	70	l	l	PROPN
fnp-4692	349	71	,	,	PUNCT
fnp-4692	349	72	zhong	zhong	PROPN
fnp-4692	349	73	q	q	ADJ
fnp-4692	349	74	,	,	PUNCT
fnp-4692	349	75	wild	wild	PROPN
fnp-4692	349	76	pj	pj	PROPN
fnp-4692	349	77	,	,	PUNCT
fnp-4692	349	78	aebersold	aebersold	PROPN
fnp-4692	349	79	r	r	PROPN
fnp-4692	349	80	,	,	PUNCT
fnp-4692	349	81	guo	guo	PROPN
fnp-4692	349	82	t.	t.	PROPN
fnp-4692	349	83	high	high	ADJ
fnp-4692	349	84	-	-	PUNCT
fnp-4692	349	85	throughput	throughput	NOUN
fnp-4692	349	86	proteomic	proteomic	ADJ
fnp-4692	349	87	analysis	analysis	NOUN
fnp-4692	349	88	of	of	ADP
fnp-4692	349	89	ffpe	ffpe	ADJ
fnp-4692	349	90	tissue	tissue	NOUN
fnp-4692	349	91	samples	sample	NOUN
fnp-4692	349	92	facilitates	facilitate	VERB
fnp-4692	349	93	tumor	tumor	NOUN
fnp-4692	349	94	stratification	stratification	NOUN
fnp-4692	349	95	.	.	PUNCT
fnp-4692	350	1	mol	mol	ADP
fnp-4692	350	2	oncol	oncol	ADJ
fnp-4692	350	3	.	.	PUNCT
fnp-4692	351	1	2019	2019	NUM
fnp-4692	351	2	nov;13(11):2305	nov;13(11):2305	ADJ
fnp-4692	351	3	-	-	PUNCT
fnp-4692	351	4	2328	2328	NUM
fnp-4692	351	5	.	.	PUNCT
fnp-4692	352	1	https://doi.org/10.1002/1878-0261.12570	https://doi.org/10.1002/1878-0261.12570	PROPN
fnp-4692	352	2	.	.	PUNCT
fnp-4692	353	1	epub	epub	PROPN
fnp-4692	353	2	2019	2019	NUM
fnp-4692	353	3	sep	sep	PROPN
fnp-4692	353	4	18	18	NUM
fnp-4692	353	5	.	.	PUNCT
fnp-4692	354	1	pmid	pmid	NOUN
fnp-4692	354	2	:	:	PUNCT
fnp-4692	354	3	31495056	31495056	NUM
fnp-4692	354	4	.	.	PUNCT
fnp-4692	355	1	23	23	NUM
fnp-4692	355	2	.	.	PUNCT
fnp-4692	356	1	nassiri	nassiri	NOUN
fnp-4692	356	2	f	f	NOUN
fnp-4692	356	3	,	,	PUNCT
fnp-4692	356	4	chakravarthy	chakravarthy	ADJ
fnp-4692	356	5	a	a	PRON
fnp-4692	356	6	,	,	PUNCT
fnp-4692	356	7	feng	feng	PROPN
fnp-4692	356	8	s	s	PROPN
fnp-4692	356	9	,	,	PUNCT
fnp-4692	356	10	shen	shen	PROPN
fnp-4692	356	11	sy	sy	PROPN
fnp-4692	356	12	,	,	PUNCT
fnp-4692	356	13	nejad	nejad	PROPN
fnp-4692	356	14	r	r	PROPN
fnp-4692	356	15	,	,	PUNCT
fnp-4692	356	16	zuccato	zuccato	PROPN
fnp-4692	356	17	ja	ja	PROPN
fnp-4692	356	18	,	,	PUNCT
fnp-4692	356	19	voisin	voisin	PROPN
fnp-4692	356	20	mr	mr	PROPN
fnp-4692	356	21	,	,	PUNCT
fnp-4692	356	22	patil	patil	PROPN
fnp-4692	356	23	v	v	PROPN
fnp-4692	356	24	,	,	PUNCT
fnp-4692	356	25	horbinski	horbinski	PROPN
fnp-4692	356	26	c	c	NOUN
fnp-4692	356	27	,	,	PUNCT
fnp-4692	356	28	aldape	aldape	PROPN
fnp-4692	356	29	k	k	PROPN
fnp-4692	356	30	,	,	PUNCT
fnp-4692	356	31	zadeh	zadeh	PROPN
fnp-4692	356	32	g	g	PROPN
fnp-4692	356	33	,	,	PUNCT
fnp-4692	356	34	de	de	PROPN
fnp-4692	356	35	carvalho	carvalho	PROPN
fnp-4692	356	36	dd	dd	PROPN
fnp-4692	356	37	.	.	PUNCT
fnp-4692	356	38	detection	detection	NOUN
fnp-4692	356	39	and	and	CCONJ
fnp-4692	356	40	discrimination	discrimination	NOUN
fnp-4692	356	41	of	of	ADP
fnp-4692	356	42	intracranial	intracranial	ADJ
fnp-4692	356	43	tumors	tumor	NOUN
fnp-4692	356	44	using	use	VERB
fnp-4692	356	45	plasma	plasma	NOUN
fnp-4692	356	46	cell	cell	NOUN
fnp-4692	356	47	-	-	PUNCT
fnp-4692	356	48	free	free	ADJ
fnp-4692	356	49	dna	dna	PROPN
fnp-4692	356	50	methylomes	methylome	NOUN
fnp-4692	356	51	.	.	PUNCT
fnp-4692	357	1	nat	nat	PROPN
fnp-4692	357	2	med	med	PROPN
fnp-4692	357	3	.	.	PUNCT
fnp-4692	357	4	2020	2020	NUM
fnp-4692	358	1	jul;26(7):1044	jul;26(7):1044	PROPN
fnp-4692	358	2	-	-	PUNCT
fnp-4692	358	3	1047	1047	NUM
fnp-4692	358	4	.	.	PUNCT
fnp-4692	359	1	https://doi.org/10.1038/s41591-020-0932-2	https://doi.org/10.1038/s41591-020-0932-2	X
fnp-4692	359	2	.	.	PUNCT
fnp-4692	360	1	epub	epub	PROPN
fnp-4692	360	2	2020	2020	NUM
fnp-4692	360	3	jun	jun	PROPN
fnp-4692	360	4	22	22	NUM
fnp-4692	360	5	.	.	PUNCT
fnp-4692	361	1	pmid	pmid	NOUN
fnp-4692	361	2	:	:	PUNCT
fnp-4692	361	3	32572265	32572265	NUM
fnp-4692	361	4	.	.	PUNCT
fnp-4692	362	1	24	24	NUM
fnp-4692	362	2	.	.	PUNCT
fnp-4692	362	3	shen	shen	PROPN
fnp-4692	362	4	sy	sy	PROPN
fnp-4692	362	5	,	,	PUNCT
fnp-4692	362	6	singhania	singhania	NOUN
fnp-4692	362	7	r	r	NOUN
fnp-4692	362	8	,	,	PUNCT
fnp-4692	362	9	fehringer	fehringer	NOUN
fnp-4692	362	10	g	g	NOUN
fnp-4692	362	11	,	,	PUNCT
fnp-4692	362	12	chakravarthy	chakravarthy	ADJ
fnp-4692	362	13	a	a	PRON
fnp-4692	362	14	,	,	PUNCT
fnp-4692	362	15	roehrl	roehrl	PROPN
fnp-4692	362	16	mha	mha	PROPN
fnp-4692	362	17	,	,	PUNCT
fnp-4692	362	18	chadwick	chadwick	PROPN
fnp-4692	362	19	d	d	PROPN
fnp-4692	362	20	,	,	PUNCT
fnp-4692	362	21	zuzarte	zuzarte	NOUN
fnp-4692	362	22	pc	pc	NOUN
fnp-4692	362	23	,	,	PUNCT
fnp-4692	362	24	borgida	borgida	PROPN
fnp-4692	362	25	a	a	PROPN
fnp-4692	362	26	,	,	PUNCT
fnp-4692	362	27	wang	wang	PROPN
fnp-4692	362	28	tt	tt	PROPN
fnp-4692	362	29	,	,	PUNCT
fnp-4692	362	30	li	li	PROPN
fnp-4692	362	31	t	t	PROPN
fnp-4692	362	32	,	,	PUNCT
fnp-4692	362	33	kis	kis	PROPN
fnp-4692	362	34	o	o	PROPN
fnp-4692	362	35	,	,	PUNCT
fnp-4692	362	36	zhao	zhao	PROPN
fnp-4692	362	37	z	z	PROPN
fnp-4692	362	38	,	,	PUNCT
fnp-4692	362	39	spreafico	spreafico	ADV
fnp-4692	362	40	a	a	PRON
fnp-4692	362	41	,	,	PUNCT
fnp-4692	362	42	medina	medina	PROPN
fnp-4692	362	43	tds	tds	PROPN
fnp-4692	362	44	,	,	PUNCT
fnp-4692	362	45	wang	wang	PROPN
fnp-4692	362	46	y	y	PROPN
fnp-4692	362	47	,	,	PUNCT
fnp-4692	362	48	roulois	roulois	PROPN
fnp-4692	362	49	d	d	PROPN
fnp-4692	362	50	,	,	PUNCT
fnp-4692	362	51	ettayebi	ettayebi	PROPN
fnp-4692	362	52	i	i	PRON
fnp-4692	362	53	,	,	PUNCT
fnp-4692	363	1	chen	chen	PROPN
fnp-4692	363	2	z	z	PROPN
fnp-4692	363	3	,	,	PUNCT
fnp-4692	363	4	chow	chow	PROPN
fnp-4692	363	5	s	s	PROPN
fnp-4692	363	6	,	,	PUNCT
fnp-4692	363	7	murphy	murphy	PROPN
fnp-4692	363	8	t	t	PROPN
fnp-4692	363	9	,	,	PUNCT
fnp-4692	363	10	arruda	arruda	PROPN
fnp-4692	363	11	a	a	PROPN
fnp-4692	363	12	,	,	PUNCT
fnp-4692	363	13	o'kane	o'kane	PROPN
fnp-4692	363	14	gm	gm	PROPN
fnp-4692	363	15	,	,	PUNCT
fnp-4692	363	16	liu	liu	PROPN
fnp-4692	363	17	j	j	PROPN
fnp-4692	363	18	,	,	PUNCT
fnp-4692	363	19	mansour	mansour	PROPN
fnp-4692	363	20	m	m	PROPN
fnp-4692	363	21	,	,	PUNCT
fnp-4692	363	22	mcpherson	mcpherson	PROPN
fnp-4692	363	23	jd	jd	PROPN
fnp-4692	363	24	,	,	PUNCT
fnp-4692	363	25	o'brien	o'brien	PROPN
fnp-4692	363	26	c	c	PROPN
fnp-4692	363	27	,	,	PUNCT
fnp-4692	363	28	leighl	leighl	NOUN
fnp-4692	363	29	n	n	CCONJ
fnp-4692	363	30	,	,	PUNCT
fnp-4692	363	31	bedard	bedard	PROPN
fnp-4692	363	32	pl	pl	PROPN
fnp-4692	363	33	,	,	PUNCT
fnp-4692	363	34	fleshner	fleshner	NOUN
fnp-4692	363	35	n	n	CCONJ
fnp-4692	363	36	,	,	PUNCT
fnp-4692	363	37	liu	liu	PROPN
fnp-4692	363	38	g	g	PROPN
fnp-4692	363	39	,	,	PUNCT
fnp-4692	363	40	minden	minden	PROPN
fnp-4692	363	41	md	md	PROPN
fnp-4692	363	42	,	,	PUNCT
fnp-4692	363	43	gallinger	gallinger	NOUN
fnp-4692	363	44	s	s	PROPN
fnp-4692	363	45	,	,	PUNCT
fnp-4692	363	46	goldenberg	goldenberg	PROPN
fnp-4692	363	47	a	a	PROPN
fnp-4692	363	48	,	,	PUNCT
fnp-4692	363	49	pugh	pugh	PROPN
fnp-4692	363	50	tj	tj	PROPN
fnp-4692	363	51	,	,	PUNCT
fnp-4692	363	52	hoffman	hoffman	NOUN
fnp-4692	363	53	mm	mm	PROPN
fnp-4692	363	54	,	,	PUNCT
fnp-4692	363	55	bratman	bratman	PROPN
fnp-4692	363	56	sv	sv	PROPN
fnp-4692	363	57	,	,	PUNCT
fnp-4692	363	58	hung	hung	PROPN
fnp-4692	363	59	rj	rj	PROPN
fnp-4692	363	60	,	,	PUNCT
fnp-4692	363	61	de	de	PROPN
fnp-4692	363	62	carvalho	carvalho	PROPN
fnp-4692	363	63	dd	dd	PROPN
fnp-4692	363	64	.	.	PROPN
fnp-4692	363	65	sensitive	sensitive	ADJ
fnp-4692	363	66	tumour	tumour	NOUN
fnp-4692	363	67	detection	detection	NOUN
fnp-4692	363	68	and	and	CCONJ
fnp-4692	363	69	classification	classification	NOUN
fnp-4692	363	70	using	use	VERB
fnp-4692	363	71	plasma	plasma	NOUN
fnp-4692	363	72	cell	cell	NOUN
fnp-4692	363	73	-	-	PUNCT
fnp-4692	363	74	free	free	ADJ
fnp-4692	363	75	dna	dna	PROPN
fnp-4692	363	76	methylomes	methylome	NOUN
fnp-4692	363	77	.	.	PUNCT
fnp-4692	364	1	nature	nature	NOUN
fnp-4692	364	2	.	.	PUNCT
fnp-4692	365	1	2018	2018	NUM
fnp-4692	365	2	nov;563(7732):579	nov;563(7732):579	NOUN
fnp-4692	365	3	-	-	PUNCT
fnp-4692	365	4	583	583	NUM
fnp-4692	365	5	.	.	PUNCT
fnp-4692	366	1	https://doi.org/10.1038/s41586-018-0703-0	https://doi.org/10.1038/s41586-018-0703-0	PROPN
fnp-4692	366	2	.	.	PUNCT
fnp-4692	367	1	epub	epub	PROPN
fnp-4692	367	2	2018	2018	NUM
fnp-4692	367	3	nov	nov	PROPN
fnp-4692	367	4	14	14	NUM
fnp-4692	367	5	.	.	PUNCT
fnp-4692	368	1	pmid	pmid	NOUN
fnp-4692	368	2	:	:	PUNCT
fnp-4692	368	3	30429608	30429608	NUM
fnp-4692	368	4	.	.	PUNCT
fnp-4692	369	1	25	25	NUM
fnp-4692	369	2	.	.	PUNCT
fnp-4692	370	1	yadav	yadav	PROPN
fnp-4692	370	2	m	m	PROPN
fnp-4692	370	3	,	,	PUNCT
fnp-4692	370	4	sharma	sharma	PROPN
fnp-4692	370	5	p	p	X
fnp-4692	370	6	,	,	PUNCT
fnp-4692	370	7	singh	singh	PROPN
fnp-4692	370	8	v	v	NOUN
fnp-4692	370	9	,	,	PUNCT
fnp-4692	370	10	tewari	tewari	PROPN
fnp-4692	370	11	r	r	PROPN
fnp-4692	370	12	,	,	PUNCT
fnp-4692	370	13	mishra	mishra	PROPN
fnp-4692	370	14	ps	ps	PROPN
fnp-4692	370	15	,	,	PUNCT
fnp-4692	370	16	roy	roy	PROPN
fnp-4692	370	17	k.	k.	PROPN
fnp-4692	370	18	an	an	DET
fnp-4692	370	19	audit	audit	NOUN
fnp-4692	370	20	of	of	ADP
fnp-4692	370	21	diagnostic	diagnostic	ADJ
fnp-4692	370	22	disparity	disparity	NOUN
fnp-4692	370	23	between	between	ADP
fnp-4692	370	24	intraoperative	intraoperative	ADJ
fnp-4692	370	25	frozen	frozen	ADJ
fnp-4692	370	26	section	section	NOUN
fnp-4692	370	27	diagnosis	diagnosis	NOUN
fnp-4692	370	28	and	and	CCONJ
fnp-4692	370	29	final	final	ADJ
fnp-4692	370	30	histopathological	histopathological	ADJ
fnp-4692	370	31	diagnosis	diagnosis	NOUN
fnp-4692	370	32	of	of	ADP
fnp-4692	370	33	central	central	ADJ
fnp-4692	370	34	nervous	nervous	ADJ
fnp-4692	370	35	system	system	NOUN
fnp-4692	370	36	lesions	lesion	NOUN
fnp-4692	370	37	at	at	ADP
fnp-4692	370	38	a	a	DET
fnp-4692	370	39	tertiary	tertiary	ADJ
fnp-4692	370	40	care	care	NOUN
fnp-4692	370	41	center	center	NOUN
fnp-4692	370	42	.	.	PUNCT
fnp-4692	371	1	j	j	PROPN
fnp-4692	371	2	lab	lab	PROPN
fnp-4692	371	3	physicians	physician	NOUN
fnp-4692	371	4	.	.	PUNCT
fnp-4692	372	1	2022	2022	NUM
fnp-4692	372	2	aug	aug	PROPN
fnp-4692	372	3	17;14(4):384	17;14(4):384	NUM
fnp-4692	372	4	-	-	SYM
fnp-4692	372	5	393	393	NUM
fnp-4692	372	6	.	.	PUNCT
fnp-4692	373	1	https://doi.org/10.1055/s-0042-1750064	https://doi.org/10.1055/s-0042-1750064	NOUN
fnp-4692	373	2	.	.	PUNCT
fnp-4692	374	1	ecollection	ecollection	NOUN
fnp-4692	374	2	2022	2022	NUM
fnp-4692	374	3	dec	dec	PROPN
fnp-4692	374	4	.	.	PUNCT
fnp-4692	375	1	pmid	pmid	PROPN
fnp-4692	375	2	:	:	PUNCT
fnp-4692	375	3	36531541	36531541	NUM
fnp-4692	375	4	.	.	PUNCT
fnp-4692	376	1	26	26	NUM
fnp-4692	376	2	.	.	X
fnp-4692	376	3	hollon	hollon	PROPN
fnp-4692	376	4	tc	tc	PROPN
fnp-4692	376	5	,	,	PUNCT
fnp-4692	376	6	pandian	pandian	PROPN
fnp-4692	376	7	b	b	PROPN
fnp-4692	376	8	,	,	PUNCT
fnp-4692	376	9	adapa	adapa	PROPN
fnp-4692	376	10	ar	ar	PROPN
fnp-4692	376	11	,	,	PUNCT
fnp-4692	376	12	urias	urias	PROPN
fnp-4692	376	13	e	e	PROPN
fnp-4692	376	14	,	,	PUNCT
fnp-4692	376	15	save	save	VERB
fnp-4692	376	16	av	av	PROPN
fnp-4692	376	17	,	,	PUNCT
fnp-4692	376	18	khalsa	khalsa	PROPN
fnp-4692	376	19	sss	sss	PROPN
fnp-4692	376	20	,	,	PUNCT
fnp-4692	376	21	eichberg	eichberg	PROPN
fnp-4692	376	22	dg	dg	PROPN
fnp-4692	376	23	,	,	PUNCT
fnp-4692	376	24	d'amico	d'amico	PROPN
fnp-4692	376	25	rs	rs	NOUN
fnp-4692	376	26	,	,	PUNCT
fnp-4692	376	27	farooq	farooq	PROPN
fnp-4692	376	28	zu	zu	PROPN
fnp-4692	376	29	,	,	PUNCT
fnp-4692	376	30	lewis	lewis	PROPN
fnp-4692	376	31	s	s	PROPN
fnp-4692	376	32	,	,	PUNCT
fnp-4692	376	33	petridis	petridi	VERB
fnp-4692	376	34	pd	pd	PROPN
fnp-4692	376	35	,	,	PUNCT
fnp-4692	376	36	marie	marie	PROPN
fnp-4692	376	37	t	t	PROPN
fnp-4692	376	38	,	,	PUNCT
fnp-4692	376	39	shah	shah	PROPN
fnp-4692	376	40	ah	ah	INTJ
fnp-4692	376	41	,	,	PUNCT
fnp-4692	376	42	garton	garton	PROPN
fnp-4692	376	43	hjl	hjl	PROPN
fnp-4692	376	44	,	,	PUNCT
fnp-4692	376	45	maher	maher	PROPN
fnp-4692	376	46	co	co	PROPN
fnp-4692	376	47	,	,	PUNCT
fnp-4692	376	48	heth	heth	PROPN
fnp-4692	376	49	ja	ja	PROPN
fnp-4692	376	50	,	,	PUNCT
fnp-4692	376	51	mckean	mckean	PROPN
fnp-4692	376	52	el	el	PROPN
fnp-4692	376	53	,	,	PUNCT
fnp-4692	376	54	sullivan	sullivan	PROPN
fnp-4692	376	55	se	se	PROPN
fnp-4692	376	56	,	,	PUNCT
fnp-4692	376	57	hervey	hervey	NOUN
fnp-4692	376	58	-	-	PUNCT
fnp-4692	376	59	jumper	jumper	NOUN
fnp-4692	376	60	sl	sl	NOUN
fnp-4692	376	61	,	,	PUNCT
fnp-4692	376	62	patil	patil	PROPN
fnp-4692	376	63	pg	pg	PROPN
fnp-4692	376	64	,	,	PUNCT
fnp-4692	376	65	thompson	thompson	PROPN
fnp-4692	376	66	bg	bg	PROPN
fnp-4692	376	67	,	,	PUNCT
fnp-4692	376	68	sagher	sagher	ADJ
fnp-4692	376	69	o	o	NOUN
fnp-4692	376	70	,	,	PUNCT
fnp-4692	376	71	mckhann	mckhann	PROPN
fnp-4692	376	72	gm	gm	PROPN
fnp-4692	376	73	2nd	2nd	PROPN
fnp-4692	376	74	,	,	PUNCT
fnp-4692	376	75	komotar	komotar	PROPN
fnp-4692	376	76	rj	rj	PROPN
fnp-4692	376	77	,	,	PUNCT
fnp-4692	376	78	ivan	ivan	PROPN
fnp-4692	376	79	me	i	PRON
fnp-4692	376	80	,	,	PUNCT
fnp-4692	376	81	snuderl	snuderl	PROPN
fnp-4692	376	82	m	m	PROPN
fnp-4692	376	83	,	,	PUNCT
fnp-4692	376	84	otten	otten	PROPN
fnp-4692	376	85	ml	ml	PROPN
fnp-4692	376	86	,	,	PUNCT
fnp-4692	376	87	johnson	johnson	PROPN
fnp-4692	376	88	td	td	PROPN
fnp-4692	376	89	,	,	PUNCT
fnp-4692	376	90	sisti	sisti	PROPN
fnp-4692	376	91	mb	mb	PROPN
fnp-4692	376	92	,	,	PUNCT
fnp-4692	376	93	bruce	bruce	PROPN
fnp-4692	376	94	jn	jn	PROPN
fnp-4692	376	95	,	,	PUNCT
fnp-4692	376	96	muraszko	muraszko	PROPN
fnp-4692	376	97	km	km	PROPN
fnp-4692	376	98	,	,	PUNCT
fnp-4692	376	99	trautman	trautman	NOUN
fnp-4692	376	100	j	j	PROPN
fnp-4692	376	101	,	,	PUNCT
fnp-4692	376	102	freudiger	freudiger	PROPN
fnp-4692	376	103	cw	cw	PROPN
fnp-4692	376	104	,	,	PUNCT
fnp-4692	376	105	canoll	canoll	NOUN
fnp-4692	376	106	p	p	PROPN
fnp-4692	376	107	,	,	PUNCT
fnp-4692	376	108	lee	lee	PROPN
fnp-4692	376	109	h	h	NOUN
fnp-4692	376	110	,	,	PUNCT
fnp-4692	376	111	camelo	camelo	NOUN
fnp-4692	376	112	-	-	PUNCT
fnp-4692	376	113	piragua	piragua	NOUN
fnp-4692	376	114	s	s	NOUN
fnp-4692	376	115	,	,	PUNCT
fnp-4692	376	116	orringer	orringer	ADJ
fnp-4692	376	117	da	da	NOUN
fnp-4692	376	118	.	.	PROPN
fnp-4692	377	1	near	near	ADP
fnp-4692	377	2	real	real	ADJ
fnp-4692	377	3	-	-	PUNCT
fnp-4692	377	4	time	time	NOUN
fnp-4692	377	5	intraoperative	intraoperative	ADJ
fnp-4692	377	6	brain	brain	NOUN
fnp-4692	377	7	tumor	tumor	NOUN
fnp-4692	377	8	diagnosis	diagnosis	NOUN
fnp-4692	377	9	using	use	VERB
fnp-4692	377	10	stimulated	stimulated	ADJ
fnp-4692	377	11	raman	raman	NOUN
fnp-4692	377	12	histology	histology	NOUN
fnp-4692	377	13	and	and	CCONJ
fnp-4692	377	14	deep	deep	ADJ
fnp-4692	377	15	neural	neural	ADJ
fnp-4692	377	16	networks	network	NOUN
fnp-4692	377	17	.	.	PUNCT
fnp-4692	378	1	nat	nat	PROPN
fnp-4692	378	2	med	med	PROPN
fnp-4692	378	3	.	.	PUNCT
fnp-4692	378	4	2020	2020	NUM
fnp-4692	379	1	jan;26(1):52	jan;26(1):52	PROPN
fnp-4692	379	2	-	-	PUNCT
fnp-4692	379	3	58	58	NUM
fnp-4692	379	4	.	.	PUNCT
fnp-4692	380	1	https://doi.org/10.1038/s41591-019-0715-9	https://doi.org/10.1038/s41591-019-0715-9	NUM
fnp-4692	380	2	.	.	PUNCT
fnp-4692	381	1	epub	epub	NOUN
fnp-4692	381	2	2020	2020	NUM
fnp-4692	381	3	jan	jan	PROPN
fnp-4692	381	4	6	6	NUM
fnp-4692	381	5	.	.	PUNCT
fnp-4692	381	6	pmid	pmid	NOUN
fnp-4692	381	7	:	:	PUNCT
fnp-4692	381	8	31907460	31907460	NUM
fnp-4692	381	9	.	.	PUNCT
fnp-4692	382	1	27	27	NUM
fnp-4692	382	2	.	.	PUNCT
fnp-4692	382	3	klamminger	klamminger	PROPN
fnp-4692	382	4	gg	gg	PROPN
fnp-4692	382	5	,	,	PUNCT
fnp-4692	382	6	frauenknecht	frauenknecht	PROPN
fnp-4692	382	7	k	k	PROPN
fnp-4692	382	8	,	,	PUNCT
fnp-4692	382	9	mittelbronn	mittelbronn	PROPN
fnp-4692	382	10	m	m	PROPN
fnp-4692	382	11	,	,	PUNCT
fnp-4692	382	12	kleine	kleine	PROPN
fnp-4692	382	13	borgmann	borgmann	PROPN
fnp-4692	383	1	fb	fb	INTJ
fnp-4692	383	2	.	.	PROPN
fnp-4692	384	1	from	from	ADP
fnp-4692	384	2	research	research	NOUN
fnp-4692	384	3	to	to	ADP
fnp-4692	384	4	diagnostic	diagnostic	ADJ
fnp-4692	384	5	application	application	NOUN
fnp-4692	384	6	of	of	ADP
fnp-4692	384	7	raman	raman	NOUN
fnp-4692	384	8	spectroscopy	spectroscopy	NOUN
fnp-4692	384	9	in	in	ADP
fnp-4692	384	10	neurosciences	neuroscience	NOUN
fnp-4692	384	11	:	:	PUNCT
fnp-4692	384	12	past	past	NOUN
fnp-4692	384	13	and	and	CCONJ
fnp-4692	384	14	perspectives	perspective	NOUN
fnp-4692	384	15	.	.	PUNCT
fnp-4692	385	1	2022	2022	NUM
fnp-4692	385	2	.	.	PUNCT
fnp-4692	386	1	free	free	ADJ
fnp-4692	386	2	neuropathology	neuropathology	NOUN
fnp-4692	386	3	,	,	PUNCT
fnp-4692	386	4	3	3	NUM
fnp-4692	386	5	,	,	PUNCT
fnp-4692	386	6	19	19	NUM
fnp-4692	386	7	.	.	PUNCT
fnp-4692	387	1	https://doi.org/10.17879/freeneuropathology-2022-4210	https://doi.org/10.17879/freeneuropathology-2022-4210	NOUN
fnp-4692	387	2	.	.	PUNCT
fnp-4692	388	1	28	28	NUM
fnp-4692	388	2	.	.	PUNCT
fnp-4692	389	1	wisoff	wisoff	PROPN
fnp-4692	389	2	jh	jh	PROPN
fnp-4692	389	3	,	,	PUNCT
fnp-4692	389	4	sanford	sanford	PROPN
fnp-4692	389	5	ra	ra	PROPN
fnp-4692	389	6	,	,	PUNCT
fnp-4692	389	7	heier	heier	X
fnp-4692	389	8	la	la	PROPN
fnp-4692	389	9	,	,	PUNCT
fnp-4692	389	10	sposto	sposto	ADJ
fnp-4692	389	11	r	r	NOUN
fnp-4692	389	12	,	,	PUNCT
fnp-4692	389	13	burger	burger	NOUN
fnp-4692	389	14	pc	pc	NOUN
fnp-4692	389	15	,	,	PUNCT
fnp-4692	389	16	yates	yates	PROPN
fnp-4692	389	17	aj	aj	PROPN
fnp-4692	389	18	,	,	PUNCT
fnp-4692	389	19	holmes	holmes	PROPN
fnp-4692	389	20	ej	ej	PROPN
fnp-4692	389	21	,	,	PUNCT
fnp-4692	389	22	kun	kun	PROPN
fnp-4692	389	23	le	le	PROPN
fnp-4692	389	24	.	.	PUNCT
fnp-4692	389	25	primary	primary	ADJ
fnp-4692	389	26	neurosurgery	neurosurgery	NOUN
fnp-4692	389	27	for	for	ADP
fnp-4692	389	28	pediatric	pediatric	ADJ
fnp-4692	389	29	low	low	ADJ
fnp-4692	389	30	-	-	PUNCT
fnp-4692	389	31	grade	grade	NOUN
fnp-4692	389	32	gliomas	glioma	NOUN
fnp-4692	389	33	:	:	PUNCT
fnp-4692	389	34	a	a	DET
fnp-4692	389	35	prospective	prospective	ADJ
fnp-4692	389	36	multi	multi	ADJ
fnp-4692	389	37	-	-	ADJ
fnp-4692	389	38	institutional	institutional	ADJ
fnp-4692	389	39	study	study	NOUN
fnp-4692	389	40	from	from	ADP
fnp-4692	389	41	the	the	DET
fnp-4692	389	42	children	child	NOUN
fnp-4692	389	43	's	's	PART
fnp-4692	389	44	oncology	oncology	NOUN
fnp-4692	389	45	group	group	NOUN
fnp-4692	389	46	.	.	PUNCT
fnp-4692	390	1	neurosurgery	neurosurgery	NOUN
fnp-4692	390	2	.	.	PUNCT
fnp-4692	391	1	2011	2011	NUM
fnp-4692	391	2	jun;68(6):1548	jun;68(6):1548	PROPN
fnp-4692	391	3	-	-	PUNCT
fnp-4692	391	4	54	54	NUM
fnp-4692	391	5	;	;	PUNCT
fnp-4692	391	6	discussion	discussion	NOUN
fnp-4692	391	7	1554	1554	NUM
fnp-4692	391	8	-	-	SYM
fnp-4692	391	9	5	5	NUM
fnp-4692	391	10	.	.	PUNCT
fnp-4692	392	1	https://doi.org/10.1227/neu.0b013e318214a66e	https://doi.org/10.1227/neu.0b013e318214a66e	PROPN
fnp-4692	392	2	.	.	PUNCT
fnp-4692	393	1	pmid	pmid	NOUN
fnp-4692	393	2	:	:	PUNCT
fnp-4692	393	3	21368693	21368693	NUM
fnp-4692	393	4	.	.	PUNCT
fnp-4692	394	1	29	29	NUM
fnp-4692	394	2	.	.	PUNCT
fnp-4692	394	3	jahn	jahn	PROPN
fnp-4692	394	4	a	a	X
fnp-4692	394	5	,	,	PUNCT
fnp-4692	394	6	rump	rump	VERB
fnp-4692	394	7	a	a	DET
fnp-4692	394	8	,	,	PUNCT
fnp-4692	394	9	widmann	widmann	NOUN
fnp-4692	394	10	tj	tj	NOUN
fnp-4692	394	11	,	,	PUNCT
fnp-4692	394	12	heining	heine	VERB
fnp-4692	394	13	c	c	NOUN
fnp-4692	394	14	,	,	PUNCT
fnp-4692	394	15	horak	horak	NOUN
fnp-4692	394	16	p	p	NOUN
fnp-4692	394	17	,	,	PUNCT
fnp-4692	394	18	hutter	hutter	NOUN
fnp-4692	394	19	b	b	PROPN
fnp-4692	394	20	,	,	PUNCT
fnp-4692	394	21	paramasivam	paramasivam	ADJ
fnp-4692	394	22	n	n	CCONJ
fnp-4692	394	23	,	,	PUNCT
fnp-4692	394	24	uhrig	uhrig	PROPN
fnp-4692	394	25	s	s	PROPN
fnp-4692	394	26	,	,	PUNCT
fnp-4692	394	27	gieldon	gieldon	ADJ
fnp-4692	394	28	l	l	NOUN
fnp-4692	394	29	,	,	PUNCT
fnp-4692	394	30	drukewitz	drukewitz	PROPN
fnp-4692	394	31	s	s	PROPN
fnp-4692	394	32	,	,	PUNCT
fnp-4692	394	33	kübler	kübler	PROPN
fnp-4692	394	34	a	a	PROPN
fnp-4692	394	35	,	,	PUNCT
fnp-4692	394	36	bermudez	bermudez	PROPN
fnp-4692	394	37	m	m	PROPN
fnp-4692	394	38	,	,	PUNCT
fnp-4692	394	39	hackmann	hackmann	PROPN
fnp-4692	395	1	k	k	NOUN
fnp-4692	395	2	,	,	PUNCT
fnp-4692	395	3	porrmann	porrmann	PROPN
fnp-4692	395	4	j	j	PROPN
fnp-4692	395	5	,	,	PUNCT
fnp-4692	395	6	wagner	wagner	PROPN
fnp-4692	395	7	j	j	PROPN
fnp-4692	395	8	,	,	PUNCT
fnp-4692	395	9	arlt	arlt	NOUN
fnp-4692	395	10	m	m	PROPN
fnp-4692	395	11	,	,	PUNCT
fnp-4692	395	12	franke	franke	PROPN
fnp-4692	395	13	m	m	PROPN
fnp-4692	395	14	,	,	PUNCT
fnp-4692	395	15	fischer	fischer	PROPN
fnp-4692	395	16	j	j	PROPN
fnp-4692	395	17	,	,	PUNCT
fnp-4692	395	18	kowalzyk	kowalzyk	PROPN
fnp-4692	395	19	z	z	PROPN
fnp-4692	395	20	,	,	PUNCT
fnp-4692	395	21	william	william	PROPN
fnp-4692	395	22	d	d	PROPN
fnp-4692	395	23	,	,	PUNCT
fnp-4692	395	24	weth	weth	VERB
fnp-4692	395	25	v	v	NOUN
fnp-4692	395	26	,	,	PUNCT
fnp-4692	395	27	oster	oster	PROPN
fnp-4692	395	28	s	s	PROPN
fnp-4692	395	29	,	,	PUNCT
fnp-4692	395	30	fröhlich	fröhlich	PROPN
fnp-4692	395	31	m	m	PROPN
fnp-4692	395	32	,	,	PUNCT
fnp-4692	395	33	hüllein	hüllein	PROPN
fnp-4692	395	34	j	j	PROPN
fnp-4692	395	35	,	,	PUNCT
fnp-4692	395	36	valle	valle	PROPN
fnp-4692	395	37	gonzález	gonzález	PROPN
fnp-4692	396	1	c	c	AUX
fnp-4692	396	2	,	,	PUNCT
fnp-4692	396	3	kreutzfeldt	kreutzfeldt	PROPN
fnp-4692	396	4	s	s	PART
fnp-4692	396	5	,	,	PUNCT
fnp-4692	396	6	mock	mock	ADJ
fnp-4692	396	7	a	a	PRON
fnp-4692	396	8	,	,	PUNCT
fnp-4692	396	9	heilig	heilig	PROPN
fnp-4692	396	10	ce	ce	PROPN
fnp-4692	396	11	,	,	PUNCT
fnp-4692	396	12	lipka	lipka	PROPN
fnp-4692	396	13	db	db	PROPN
fnp-4692	396	14	,	,	PUNCT
fnp-4692	396	15	möhrmann	möhrmann	PROPN
fnp-4692	396	16	l	l	PROPN
fnp-4692	396	17	,	,	PUNCT
fnp-4692	396	18	hanf	hanf	PROPN
fnp-4692	397	1	d	d	NOUN
fnp-4692	397	2	,	,	PUNCT
fnp-4692	397	3	oleś	oleś	PROPN
fnp-4692	397	4	m	m	PROPN
fnp-4692	397	5	,	,	PUNCT
fnp-4692	397	6	teleanu	teleanu	PROPN
fnp-4692	397	7	v	v	NOUN
fnp-4692	397	8	,	,	PUNCT
fnp-4692	397	9	allgäuer	allgäuer	PROPN
fnp-4692	397	10	m	m	PROPN
fnp-4692	397	11	,	,	PUNCT
fnp-4692	397	12	ruhnke	ruhnke	PROPN
fnp-4692	397	13	l	l	PROPN
fnp-4692	397	14	,	,	PUNCT
fnp-4692	397	15	kutz	kutz	PROPN
fnp-4692	397	16	o	o	PROPN
fnp-4692	397	17	,	,	PUNCT
fnp-4692	397	18	knurr	knurr	PROPN
fnp-4692	397	19	a	a	PROPN
fnp-4692	397	20	,	,	PUNCT
fnp-4692	397	21	laßmann	laßmann	PROPN
fnp-4692	397	22	a	a	PRON
fnp-4692	397	23	,	,	PUNCT
fnp-4692	397	24	endris	endris	PROPN
fnp-4692	397	25	v	v	PROPN
fnp-4692	397	26	,	,	PUNCT
fnp-4692	397	27	neumann	neumann	PROPN
fnp-4692	397	28	o	o	PROPN
fnp-4692	397	29	,	,	PUNCT
fnp-4692	397	30	penzel	penzel	ADJ
fnp-4692	397	31	r	r	NOUN
fnp-4692	397	32	,	,	PUNCT
fnp-4692	397	33	beck	beck	PROPN
fnp-4692	397	34	k	k	PROPN
fnp-4692	397	35	,	,	PUNCT
fnp-4692	397	36	richter	richter	PROPN
fnp-4692	397	37	d	d	PROPN
fnp-4692	397	38	,	,	PUNCT
fnp-4692	397	39	winter	winter	NOUN
fnp-4692	397	40	u	u	NOUN
fnp-4692	397	41	,	,	PUNCT
fnp-4692	397	42	wolf	wolf	PROPN
fnp-4692	397	43	s	s	PROPN
fnp-4692	397	44	,	,	PUNCT
fnp-4692	397	45	pfütze	pfütze	PROPN
fnp-4692	397	46	k	k	NOUN
fnp-4692	397	47	,	,	PUNCT
fnp-4692	397	48	geörg	geörg	NOUN
fnp-4692	397	49	c	c	NOUN
fnp-4692	397	50	,	,	PUNCT
fnp-4692	397	51	meißburger	meißburger	NOUN
fnp-4692	397	52	b	b	PROPN
fnp-4692	397	53	,	,	PUNCT
fnp-4692	397	54	buchhalter	buchhalter	PROPN
fnp-4692	397	55	i	i	PROPN
fnp-4692	397	56	,	,	PUNCT
fnp-4692	397	57	augustin	augustin	PROPN
fnp-4692	397	58	m	m	PROPN
fnp-4692	397	59	,	,	PUNCT
fnp-4692	397	60	aulitzky	aulitzky	VERB
fnp-4692	397	61	we	we	PRON
fnp-4692	397	62	,	,	PUNCT
fnp-4692	397	63	hohenberger	hohenberger	NOUN
fnp-4692	397	64	p	p	NOUN
fnp-4692	397	65	,	,	PUNCT
fnp-4692	397	66	kroiss	kroiss	VERB
fnp-4692	397	67	m	m	PROPN
fnp-4692	397	68	,	,	PUNCT
fnp-4692	397	69	schirmacher	schirmacher	ADP
fnp-4692	397	70	p	p	X
fnp-4692	397	71	,	,	PUNCT
fnp-4692	397	72	schlenk	schlenk	NOUN
fnp-4692	397	73	rf	rf	PROPN
fnp-4692	397	74	,	,	PUNCT
fnp-4692	397	75	keilholz	keilholz	PROPN
fnp-4692	397	76	u	u	NOUN
fnp-4692	397	77	,	,	PUNCT
fnp-4692	397	78	klauschen	klauschen	PUNCT
fnp-4692	397	79	f	f	X
fnp-4692	397	80	,	,	PUNCT
fnp-4692	397	81	folprecht	folprecht	VERB
fnp-4692	397	82	g	g	PROPN
fnp-4692	397	83	,	,	PUNCT
fnp-4692	397	84	bauer	bauer	PROPN
fnp-4692	397	85	s	s	PROPN
fnp-4692	397	86	,	,	PUNCT
fnp-4692	397	87	siveke	siveke	ADJ
fnp-4692	397	88	jt	jt	PROPN
fnp-4692	397	89	,	,	PUNCT
fnp-4692	397	90	brandts	brandts	VERB
fnp-4692	397	91	ch	ch	NOUN
fnp-4692	397	92	,	,	PUNCT
fnp-4692	397	93	kindler	kindl	ADJ
fnp-4692	397	94	t	t	PROPN
fnp-4692	397	95	,	,	PUNCT
fnp-4692	397	96	boerries	boerrie	NOUN
fnp-4692	397	97	m	m	PROPN
fnp-4692	397	98	,	,	PUNCT
fnp-4692	397	99	illert	illert	PROPN
fnp-4692	397	100	al	al	PROPN
fnp-4692	397	101	,	,	PUNCT
fnp-4692	397	102	von	von	PROPN
fnp-4692	397	103	bubnoff	bubnoff	PROPN
fnp-4692	397	104	n	n	CCONJ
fnp-4692	397	105	,	,	PUNCT
fnp-4692	397	106	jost	jost	PROPN
fnp-4692	397	107	pj	pj	PROPN
fnp-4692	397	108	,	,	PUNCT
fnp-4692	397	109	metzeler	metzeler	PROPN
fnp-4692	397	110	kh	kh	PROPN
fnp-4692	397	111	,	,	PUNCT
fnp-4692	397	112	bitzer	bitzer	PROPN
fnp-4692	397	113	m	m	PROPN
fnp-4692	397	114	,	,	PUNCT
fnp-4692	397	115	schulze	schulze	NOUN
fnp-4692	397	116	-	-	PUNCT
fnp-4692	397	117	osthoff	osthoff	NOUN
fnp-4692	397	118	k	k	PROPN
fnp-4692	397	119	,	,	PUNCT
fnp-4692	397	120	von	von	PROPN
fnp-4692	397	121	kalle	kalle	PROPN
fnp-4692	397	122	c	c	PROPN
fnp-4692	397	123	,	,	PUNCT
fnp-4692	397	124	brors	brors	PROPN
fnp-4692	397	125	b	b	NUM
fnp-4692	397	126	,	,	PUNCT
fnp-4692	397	127	stenzinger	stenzinger	VERB
fnp-4692	397	128	a	a	PRON
fnp-4692	397	129	,	,	PUNCT
fnp-4692	397	130	weichert	weichert	PROPN
fnp-4692	397	131	w	w	PROPN
fnp-4692	397	132	,	,	PUNCT
fnp-4692	397	133	hübschmann	hübschmann	PROPN
fnp-4692	397	134	d	d	PROPN
fnp-4692	397	135	,	,	PUNCT
fnp-4692	397	136	fröhling	fröhle	VERB
fnp-4692	397	137	s	s	PRON
fnp-4692	397	138	,	,	PUNCT
fnp-4692	397	139	glimm	glimm	NOUN
fnp-4692	397	140	h	h	NOUN
fnp-4692	397	141	,	,	PUNCT
fnp-4692	397	142	schröck	schröck	PROPN
fnp-4692	397	143	e	e	NOUN
fnp-4692	397	144	,	,	PUNCT
fnp-4692	397	145	klink	klink	PROPN
fnp-4692	397	146	b.	b.	PROPN
fnp-4692	398	1	comprehensive	comprehensive	PROPN
fnp-4692	398	2	cancer	cancer	NOUN
fnp-4692	398	3	predisposition	predisposition	NOUN
fnp-4692	398	4	testing	testing	NOUN
fnp-4692	398	5	within	within	ADP
fnp-4692	398	6	the	the	DET
fnp-4692	398	7	prospective	prospective	ADJ
fnp-4692	398	8	master	master	NOUN
fnp-4692	398	9	trial	trial	NOUN
fnp-4692	398	10	identifies	identify	VERB
fnp-4692	398	11	hereditary	hereditary	ADJ
fnp-4692	398	12	cancer	cancer	NOUN
fnp-4692	398	13	patients	patient	NOUN
fnp-4692	398	14	and	and	CCONJ
fnp-4692	398	15	supports	support	VERB
fnp-4692	398	16	treatment	treatment	NOUN
fnp-4692	398	17	decisions	decision	NOUN
fnp-4692	398	18	for	for	ADP
fnp-4692	398	19	rare	rare	ADJ
fnp-4692	398	20	cancers	cancer	NOUN
fnp-4692	398	21	.	.	PUNCT
fnp-4692	399	1	ann	ann	PROPN
fnp-4692	399	2	oncol	oncol	PROPN
fnp-4692	399	3	.	.	PUNCT
fnp-4692	400	1	2022	2022	NUM
fnp-4692	400	2	nov;33(11):1186	nov;33(11):1186	PROPN
fnp-4692	400	3	-	-	PUNCT
fnp-4692	400	4	1199	1199	NUM
fnp-4692	400	5	.	.	PUNCT
fnp-4692	401	1	https://doi.org/10.1016/j.annonc.2022.07.008	https://doi.org/10.1016/j.annonc.2022.07.008	NOUN
fnp-4692	401	2	.	.	PUNCT
fnp-4692	402	1	epub	epub	NOUN
fnp-4692	402	2	2022	2022	NUM
fnp-4692	402	3	aug	aug	PROPN
fnp-4692	402	4	18	18	NUM
fnp-4692	402	5	.	.	PUNCT
fnp-4692	403	1	pmid	pmid	NOUN
fnp-4692	403	2	:	:	PUNCT
fnp-4692	403	3	35988656	35988656	NUM
fnp-4692	403	4	.	.	PUNCT
fnp-4692	404	1	30	30	NUM
fnp-4692	404	2	.	.	PUNCT
fnp-4692	404	3	method	method	NOUN
fnp-4692	404	4	of	of	ADP
fnp-4692	404	5	the	the	DET
fnp-4692	404	6	year	year	NOUN
fnp-4692	404	7	2022	2022	NUM
fnp-4692	404	8	:	:	PUNCT
fnp-4692	404	9	long	long	ADV
fnp-4692	404	10	-	-	PUNCT
fnp-4692	404	11	read	read	VERB
fnp-4692	404	12	sequencing	sequencing	NOUN
fnp-4692	404	13	.	.	PUNCT
fnp-4692	405	1	nat	nat	NOUN
fnp-4692	405	2	methods	method	NOUN
fnp-4692	405	3	.	.	PUNCT
fnp-4692	406	1	2023	2023	NUM
fnp-4692	406	2	jan;20(1):1	jan;20(1):1	NOUN
fnp-4692	406	3	.	.	PUNCT
fnp-4692	407	1	https://doi.org/10.1038/s41592-022-01759-x	https://doi.org/10.1038/s41592-022-01759-x	PROPN
fnp-4692	407	2	.	.	PUNCT
fnp-4692	408	1	pmid	pmid	NOUN
fnp-4692	408	2	:	:	PUNCT
fnp-4692	408	3	36635552	36635552	NUM
fnp-4692	408	4	.	.	PUNCT
fnp-4692	409	1	31	31	NUM
fnp-4692	409	2	.	.	PUNCT
fnp-4692	410	1	djirackor	djirackor	PROPN
fnp-4692	410	2	l	l	PROPN
fnp-4692	410	3	,	,	PUNCT
fnp-4692	410	4	halldorsson	halldorsson	PROPN
fnp-4692	410	5	s	s	PROPN
fnp-4692	410	6	,	,	PUNCT
fnp-4692	410	7	niehusmann	niehusmann	PROPN
fnp-4692	410	8	p	p	NOUN
fnp-4692	410	9	,	,	PUNCT
fnp-4692	410	10	leske	leske	PROPN
fnp-4692	410	11	h	h	NOUN
fnp-4692	410	12	,	,	PUNCT
fnp-4692	410	13	capper	capper	NOUN
fnp-4692	410	14	d	d	PROPN
fnp-4692	410	15	,	,	PUNCT
fnp-4692	410	16	kuschel	kuschel	PROPN
fnp-4692	410	17	lp	lp	PROPN
fnp-4692	410	18	,	,	PUNCT
fnp-4692	410	19	pahnke	pahnke	PROPN
fnp-4692	410	20	j	j	PROPN
fnp-4692	410	21	,	,	PUNCT
fnp-4692	410	22	due	due	ADJ
fnp-4692	410	23	-	-	PUNCT
fnp-4692	410	24	tønnessen	tønnessen	ADJ
fnp-4692	410	25	bj	bj	NOUN
fnp-4692	410	26	,	,	PUNCT
fnp-4692	410	27	langmoen	langmoen	PROPN
fnp-4692	410	28	ia	ia	PROPN
fnp-4692	410	29	,	,	PUNCT
fnp-4692	410	30	sandberg	sandberg	PROPN
fnp-4692	410	31	cj	cj	PROPN
fnp-4692	410	32	,	,	PUNCT
fnp-4692	410	33	euskirchen	euskirchen	ADV
fnp-4692	410	34	p	p	NOUN
fnp-4692	410	35	,	,	PUNCT
fnp-4692	410	36	vik	vik	PROPN
fnp-4692	410	37	-	-	PROPN
fnp-4692	410	38	mo	mo	ADJ
fnp-4692	410	39	eo	eo	PROPN
fnp-4692	410	40	.	.	PROPN
fnp-4692	410	41	intraoperative	intraoperative	ADJ
fnp-4692	410	42	dna	dna	PROPN
fnp-4692	410	43	methylation	methylation	NOUN
fnp-4692	410	44	classification	classification	NOUN
fnp-4692	410	45	of	of	ADP
fnp-4692	410	46	brain	brain	NOUN
fnp-4692	410	47	tumors	tumor	NOUN
fnp-4692	410	48	impacts	impact	VERB
fnp-4692	410	49	neurosurgical	neurosurgical	ADJ
fnp-4692	410	50	strategy	strategy	NOUN
fnp-4692	410	51	.	.	PUNCT
fnp-4692	411	1	neurooncol	neurooncol	PROPN
fnp-4692	411	2	adv	adv	PROPN
fnp-4692	411	3	.	.	PROPN
fnp-4692	411	4	2021	2021	NUM
fnp-4692	411	5	oct	oct	NOUN
fnp-4692	411	6	10;3(1):vdab149	10;3(1):vdab149	NUM
fnp-4692	411	7	.	.	PUNCT
fnp-4692	412	1	https://doi.org/10.1093/noajnl/vdab149	https://doi.org/10.1093/noajnl/vdab149	PROPN
fnp-4692	412	2	.	.	PUNCT
fnp-4692	413	1	ecollection	ecollection	NOUN
fnp-4692	413	2	2021	2021	NUM
fnp-4692	413	3	jan	jan	PROPN
fnp-4692	413	4	-	-	PUNCT
fnp-4692	413	5	dec	dec	PROPN
fnp-4692	413	6	.	.	PUNCT
fnp-4692	414	1	pmid	pmid	PROPN
fnp-4692	414	2	:	:	PUNCT
fnp-4692	414	3	34729487	34729487	NUM
fnp-4692	414	4	.	.	PUNCT
fnp-4692	415	1	32	32	NUM
fnp-4692	415	2	.	.	PUNCT
fnp-4692	416	1	aizer	aizer	NOUN
fnp-4692	416	2	aa	aa	PROPN
fnp-4692	416	3	,	,	PUNCT
fnp-4692	416	4	lamba	lamba	NOUN
fnp-4692	416	5	n	n	CCONJ
fnp-4692	416	6	,	,	PUNCT
fnp-4692	416	7	ahluwalia	ahluwalia	PROPN
fnp-4692	416	8	ms	ms	PROPN
fnp-4692	416	9	,	,	PUNCT
fnp-4692	416	10	aldape	aldape	PROPN
fnp-4692	416	11	k	k	PROPN
fnp-4692	416	12	,	,	PUNCT
fnp-4692	416	13	boire	boire	X
fnp-4692	416	14	a	a	NOUN
fnp-4692	416	15	,	,	PUNCT
fnp-4692	416	16	brastianos	brastiano	NOUN
fnp-4692	416	17	pk	pk	PROPN
fnp-4692	416	18	,	,	PUNCT
fnp-4692	416	19	brown	brown	ADJ
fnp-4692	416	20	pd	pd	PROPN
fnp-4692	416	21	,	,	PUNCT
fnp-4692	416	22	camidge	camidge	PROPN
fnp-4692	416	23	dr	dr	PROPN
fnp-4692	416	24	,	,	PUNCT
fnp-4692	416	25	chiang	chiang	PROPN
fnp-4692	416	26	vl	vl	PROPN
fnp-4692	416	27	,	,	PUNCT
fnp-4692	416	28	davies	davies	PROPN
fnp-4692	416	29	ma	ma	PROPN
fnp-4692	416	30	,	,	PUNCT
fnp-4692	416	31	hu	hu	PROPN
fnp-4692	416	32	ls	ls	PROPN
fnp-4692	416	33	,	,	PUNCT
fnp-4692	416	34	huang	huang	PROPN
fnp-4692	416	35	ry	ry	PROPN
fnp-4692	416	36	,	,	PUNCT
fnp-4692	416	37	kaufmann	kaufmann	PROPN
fnp-4692	416	38	t	t	PROPN
fnp-4692	416	39	,	,	PUNCT
fnp-4692	416	40	kumthekar	kumthekar	PROPN
fnp-4692	416	41	p	p	X
fnp-4692	416	42	,	,	PUNCT
fnp-4692	416	43	lam	lam	PROPN
fnp-4692	416	44	k	k	PROPN
fnp-4692	416	45	,	,	PUNCT
fnp-4692	416	46	lee	lee	PROPN
fnp-4692	416	47	eq	eq	PROPN
fnp-4692	416	48	,	,	PUNCT
fnp-4692	416	49	lin	lin	PROPN
fnp-4692	416	50	nu	nu	PROPN
fnp-4692	416	51	,	,	PUNCT
fnp-4692	416	52	mehta	mehta	PROPN
fnp-4692	416	53	m	m	PROPN
fnp-4692	416	54	,	,	PUNCT
fnp-4692	416	55	parsons	parsons	PROPN
fnp-4692	416	56	m	m	PROPN
fnp-4692	416	57	,	,	PUNCT
fnp-4692	416	58	reardon	reardon	PROPN
fnp-4692	416	59	da	da	PROPN
fnp-4692	416	60	,	,	PUNCT
fnp-4692	416	61	sheehan	sheehan	PROPN
fnp-4692	416	62	j	j	PROPN
fnp-4692	416	63	,	,	PUNCT
fnp-4692	416	64	soffietti	soffietti	ADJ
fnp-4692	416	65	r	r	NOUN
fnp-4692	416	66	,	,	PUNCT
fnp-4692	416	67	tawbi	tawbi	NOUN
fnp-4692	416	68	h	h	NOUN
fnp-4692	416	69	,	,	PUNCT
fnp-4692	416	70	weller	weller	PROPN
fnp-4692	416	71	m	m	PROPN
fnp-4692	416	72	,	,	PUNCT
fnp-4692	416	73	wen	wen	PROPN
fnp-4692	416	74	py	py	PROPN
fnp-4692	416	75	.	.	PUNCT
fnp-4692	417	1	brain	brain	NOUN
fnp-4692	417	2	metastases	metastasis	NOUN
fnp-4692	417	3	:	:	PUNCT
fnp-4692	417	4	a	a	DET
fnp-4692	417	5	society	society	NOUN
fnp-4692	417	6	for	for	ADP
fnp-4692	417	7	neuro	neuro	NOUN
fnp-4692	417	8	-	-	PUNCT
fnp-4692	417	9	oncology	oncology	NOUN
fnp-4692	417	10	(	(	PUNCT
fnp-4692	417	11	sno	sno	NOUN
fnp-4692	417	12	)	)	PUNCT
fnp-4692	417	13	consensus	consensus	NOUN
fnp-4692	417	14	review	review	NOUN
fnp-4692	417	15	on	on	ADP
fnp-4692	417	16	current	current	ADJ
fnp-4692	417	17	management	management	NOUN
fnp-4692	417	18	and	and	CCONJ
fnp-4692	417	19	future	future	ADJ
fnp-4692	417	20	directions	direction	NOUN
fnp-4692	417	21	.	.	PUNCT
fnp-4692	418	1	neuro	neuro	PROPN
fnp-4692	418	2	oncol	oncol	PROPN
fnp-4692	418	3	.	.	PUNCT
fnp-4692	419	1	2022	2022	NUM
fnp-4692	419	2	oct	oct	PROPN
fnp-4692	419	3	3;24(10):1613	3;24(10):1613	PROPN
fnp-4692	419	4	-	-	SYM
fnp-4692	419	5	1646	1646	NUM
fnp-4692	419	6	.	.	PUNCT
fnp-4692	420	1	https://doi.org/10.1093/neuonc/noac118	https://doi.org/10.1093/neuonc/noac118	X
fnp-4692	420	2	.	.	PUNCT
fnp-4692	421	1	pmid	pmid	NOUN
fnp-4692	421	2	:	:	PUNCT
fnp-4692	421	3	35762249	35762249	NUM
fnp-4692	421	4	.	.	PUNCT
fnp-4692	422	1	33	33	NUM
fnp-4692	422	2	.	.	PUNCT
fnp-4692	423	1	sacks	sack	NOUN
fnp-4692	423	2	p	p	NOUN
fnp-4692	423	3	,	,	PUNCT
fnp-4692	423	4	rahman	rahman	PROPN
fnp-4692	423	5	m.	m.	PROPN
fnp-4692	423	6	epidemiology	epidemiology	NOUN
fnp-4692	423	7	of	of	ADP
fnp-4692	423	8	brain	brain	NOUN
fnp-4692	423	9	metastases	metastasis	NOUN
fnp-4692	423	10	.	.	PUNCT
fnp-4692	424	1	neurosurg	neurosurg	PROPN
fnp-4692	424	2	clin	clin	PROPN
fnp-4692	424	3	n	n	PRON
fnp-4692	424	4	am	be	AUX
fnp-4692	424	5	.	.	PUNCT
fnp-4692	425	1	2020	2020	NUM
fnp-4692	425	2	oct;31(4):481	oct;31(4):481	NUM
fnp-4692	425	3	-	-	PUNCT
fnp-4692	425	4	488	488	NUM
fnp-4692	425	5	.	.	PUNCT
fnp-4692	426	1	https://doi.org/10.1016/j.nec.2020.06.001	https://doi.org/10.1016/j.nec.2020.06.001	NOUN
fnp-4692	426	2	.	.	PUNCT
fnp-4692	427	1	pmid	pmid	NOUN
fnp-4692	427	2	:	:	PUNCT
fnp-4692	427	3	32921345	32921345	NUM
fnp-4692	427	4	.	.	PUNCT
fnp-4692	428	1	34	34	NUM
fnp-4692	428	2	.	.	PUNCT
fnp-4692	429	1	kim	kim	PROPN
fnp-4692	429	2	h	h	PROPN
fnp-4692	429	3	,	,	PUNCT
fnp-4692	429	4	el	el	PROPN
fnp-4692	429	5	-	-	PUNCT
fnp-4692	429	6	khoury	khoury	PROPN
fnp-4692	429	7	v	v	PROPN
fnp-4692	429	8	,	,	PUNCT
fnp-4692	429	9	schulte	schulte	PROPN
fnp-4692	429	10	n	n	CCONJ
fnp-4692	429	11	,	,	PUNCT
fnp-4692	429	12	zhan	zhan	PROPN
fnp-4692	429	13	t	t	PROPN
fnp-4692	429	14	,	,	PUNCT
fnp-4692	429	15	betge	betge	ADJ
fnp-4692	429	16	j	j	PROPN
fnp-4692	429	17	,	,	PUNCT
fnp-4692	429	18	cousin	cousin	PROPN
fnp-4692	429	19	l	l	PROPN
fnp-4692	429	20	,	,	PUNCT
fnp-4692	429	21	felli	felli	NOUN
fnp-4692	429	22	e	e	NOUN
fnp-4692	429	23	,	,	PUNCT
fnp-4692	429	24	pessaux	pessaux	PROPN
fnp-4692	429	25	p	p	X
fnp-4692	429	26	,	,	PUNCT
fnp-4692	429	27	ogier	ogier	X
fnp-4692	429	28	a	a	PRON
fnp-4692	429	29	,	,	PUNCT
fnp-4692	429	30	opitz	opitz	PROPN
fnp-4692	429	31	o	o	NOUN
fnp-4692	429	32	,	,	PUNCT
fnp-4692	429	33	ku	ku	PROPN
fnp-4692	429	34	b	b	PROPN
fnp-4692	429	35	,	,	PUNCT
fnp-4692	429	36	ebert	ebert	PROPN
fnp-4692	429	37	mp	mp	PROPN
fnp-4692	429	38	,	,	PUNCT
fnp-4692	429	39	kwon	kwon	PROPN
fnp-4692	429	40	yj	yj	PROPN
fnp-4692	429	41	.	.	PROPN
fnp-4692	429	42	personalized	personalize	VERB
fnp-4692	429	43	functional	functional	ADJ
fnp-4692	429	44	profiling	profiling	NOUN
fnp-4692	429	45	using	use	VERB
fnp-4692	429	46	ex	ex	ADJ
fnp-4692	429	47	-	-	ADJ
fnp-4692	429	48	vivo	vivo	ADJ
fnp-4692	429	49	patient	patient	NOUN
fnp-4692	429	50	-	-	PUNCT
fnp-4692	429	51	derived	derive	VERB
fnp-4692	429	52	spheroids	spheroid	NOUN
fnp-4692	429	53	points	point	VERB
fnp-4692	429	54	out	out	ADP
fnp-4692	429	55	the	the	DET
fnp-4692	429	56	potential	potential	NOUN
fnp-4692	429	57	of	of	ADP
fnp-4692	429	58	an	an	DET
fnp-4692	429	59	antiangiogenic	antiangiogenic	ADJ
fnp-4692	429	60	treatment	treatment	NOUN
fnp-4692	429	61	in	in	ADP
fnp-4692	429	62	a	a	DET
fnp-4692	429	63	patient	patient	NOUN
fnp-4692	429	64	with	with	ADP
fnp-4692	429	65	a	a	DET
fnp-4692	429	66	metastatic	metastatic	ADJ
fnp-4692	429	67	lung	lung	NOUN
fnp-4692	429	68	atypical	atypical	ADJ
fnp-4692	429	69	carcinoid	carcinoid	NOUN
fnp-4692	429	70	.	.	PUNCT
fnp-4692	430	1	cancer	cancer	NOUN
fnp-4692	430	2	biol	biol	PROPN
fnp-4692	430	3	ther	ther	ADV
fnp-4692	430	4	.	.	PUNCT
fnp-4692	431	1	2022	2022	NUM
fnp-4692	431	2	dec	dec	PROPN
fnp-4692	431	3	31;23(1):96	31;23(1):96	PROPN
fnp-4692	431	4	-	-	SYM
fnp-4692	431	5	102	102	NUM
fnp-4692	431	6	.	.	PUNCT
fnp-4692	432	1	https://doi.org/10.1080/15384047.2021.2021042	https://doi.org/10.1080/15384047.2021.2021042	PROPN
fnp-4692	432	2	.	.	PUNCT
fnp-4692	433	1	pmid	pmid	NOUN
fnp-4692	433	2	:	:	PUNCT
fnp-4692	433	3	35193475	35193475	NUM
fnp-4692	433	4	.	.	PUNCT
fnp-4692	434	1	35	35	NUM
fnp-4692	434	2	.	.	PUNCT
fnp-4692	435	1	sinn	sinn	PROPN
fnp-4692	435	2	p	p	PROPN
fnp-4692	435	3	,	,	PUNCT
fnp-4692	435	4	aulmann	aulmann	VERB
fnp-4692	435	5	s	s	PROPN
fnp-4692	435	6	,	,	PUNCT
fnp-4692	435	7	wirtz	wirtz	PROPN
fnp-4692	435	8	r	r	PROPN
fnp-4692	435	9	,	,	PUNCT
fnp-4692	435	10	schott	schott	NOUN
fnp-4692	435	11	s	s	PROPN
fnp-4692	435	12	,	,	PUNCT
fnp-4692	435	13	marmé	marmé	PROPN
fnp-4692	435	14	f	f	PROPN
fnp-4692	435	15	,	,	PUNCT
fnp-4692	435	16	varga	varga	PROPN
fnp-4692	435	17	z	z	PROPN
fnp-4692	435	18	,	,	PUNCT
fnp-4692	435	19	lebeau	lebeau	PROPN
fnp-4692	435	20	a	a	PRON
fnp-4692	435	21	,	,	PUNCT
fnp-4692	435	22	kreipe	kreipe	NOUN
fnp-4692	435	23	h	h	NOUN
fnp-4692	435	24	,	,	PUNCT
fnp-4692	435	25	schneeweiss	schneeweiss	PROPN
fnp-4692	435	26	a.	a.	NOUN
fnp-4692	435	27	multigene	multigene	NOUN
fnp-4692	435	28	assays	assay	NOUN
fnp-4692	435	29	for	for	ADP
fnp-4692	435	30	classification	classification	NOUN
fnp-4692	435	31	,	,	PUNCT
fnp-4692	435	32	prognosis	prognosis	NOUN
fnp-4692	435	33	,	,	PUNCT
fnp-4692	435	34	and	and	CCONJ
fnp-4692	435	35	prediction	prediction	NOUN
fnp-4692	435	36	in	in	ADP
fnp-4692	435	37	breast	breast	NOUN
fnp-4692	435	38	cancer	cancer	NOUN
fnp-4692	435	39	:	:	PUNCT
fnp-4692	435	40	a	a	DET
fnp-4692	435	41	critical	critical	ADJ
fnp-4692	435	42	review	review	NOUN
fnp-4692	435	43	on	on	ADP
fnp-4692	435	44	the	the	DET
fnp-4692	435	45	background	background	NOUN
fnp-4692	435	46	and	and	CCONJ
fnp-4692	435	47	clinical	clinical	ADJ
fnp-4692	435	48	utility	utility	NOUN
fnp-4692	435	49	.	.	PUNCT
fnp-4692	436	1	geburtshilfe	geburtshilfe	VERB
fnp-4692	436	2	frauenheilkd	frauenheilkd	NOUN
fnp-4692	436	3	.	.	PUNCT
fnp-4692	437	1	2013	2013	NUM
fnp-4692	437	2	sep;73(9):932	sep;73(9):932	NUM
fnp-4692	437	3	-	-	PUNCT
fnp-4692	437	4	940	940	NUM
fnp-4692	437	5	.	.	PUNCT
fnp-4692	438	1	https://doi.org/10.1055/s-0033-1350831	https://doi.org/10.1055/s-0033-1350831	NOUN
fnp-4692	438	2	.	.	PUNCT
fnp-4692	439	1	pmid	pmid	NOUN
fnp-4692	439	2	:	:	PUNCT
fnp-4692	439	3	24771945	24771945	NUM
fnp-4692	439	4	.	.	PUNCT
fnp-4692	440	1	36	36	NUM
fnp-4692	440	2	.	.	PUNCT
fnp-4692	441	1	rogers	rogers	PROPN
fnp-4692	441	2	w	w	PROPN
fnp-4692	441	3	,	,	PUNCT
fnp-4692	441	4	thulasi	thulasi	X
fnp-4692	441	5	seetha	seetha	NOUN
fnp-4692	441	6	s	s	PROPN
fnp-4692	441	7	,	,	PUNCT
fnp-4692	441	8	refaee	refaee	ADJ
fnp-4692	441	9	tag	tag	NOUN
fnp-4692	441	10	,	,	PUNCT
fnp-4692	441	11	lieverse	lieverse	PROPN
fnp-4692	441	12	riy	riy	PROPN
fnp-4692	441	13	,	,	PUNCT
fnp-4692	441	14	granzier	granzier	PROPN
fnp-4692	441	15	rwy	rwy	PROPN
fnp-4692	441	16	,	,	PUNCT
fnp-4692	441	17	ibrahim	ibrahim	PROPN
fnp-4692	441	18	a	a	PRON
fnp-4692	441	19	,	,	PUNCT
fnp-4692	441	20	keek	keek	PROPN
fnp-4692	441	21	sa	sa	PROPN
fnp-4692	441	22	,	,	PUNCT
fnp-4692	441	23	sanduleanu	sanduleanu	PROPN
fnp-4692	441	24	s	s	PROPN
fnp-4692	441	25	,	,	PUNCT
fnp-4692	441	26	primakov	primakov	PROPN
fnp-4692	441	27	sp	sp	PROPN
fnp-4692	441	28	,	,	PUNCT
fnp-4692	441	29	beuque	beuque	PROPN
fnp-4692	441	30	mpl	mpl	PROPN
fnp-4692	441	31	,	,	PUNCT
fnp-4692	441	32	marcus	marcus	PROPN
fnp-4692	441	33	d	d	PROPN
fnp-4692	441	34	,	,	PUNCT
fnp-4692	441	35	van	van	PROPN
fnp-4692	441	36	der	der	PROPN
fnp-4692	441	37	wiel	wiel	PROPN
fnp-4692	441	38	ama	ama	PROPN
fnp-4692	441	39	,	,	PUNCT
fnp-4692	441	40	zerka	zerka	NOUN
fnp-4692	441	41	f	f	NOUN
fnp-4692	441	42	,	,	PUNCT
fnp-4692	441	43	oberije	oberije	PROPN
fnp-4692	441	44	cjg	cjg	PROPN
fnp-4692	441	45	,	,	PUNCT
fnp-4692	441	46	van	van	PROPN
fnp-4692	441	47	timmeren	timmeren	PROPN
fnp-4692	441	48	je	je	PROPN
fnp-4692	441	49	,	,	PUNCT
fnp-4692	441	50	woodruff	woodruff	PROPN
fnp-4692	441	51	hc	hc	PROPN
fnp-4692	441	52	,	,	PUNCT
fnp-4692	441	53	lambin	lambin	PROPN
fnp-4692	441	54	p.	p.	PROPN
fnp-4692	441	55	radiomics	radiomic	NOUN
fnp-4692	441	56	:	:	PUNCT
fnp-4692	441	57	from	from	ADP
fnp-4692	441	58	qualitative	qualitative	NOUN
fnp-4692	441	59	to	to	ADP
fnp-4692	441	60	quantitative	quantitative	ADJ
fnp-4692	441	61	imaging	imaging	NOUN
fnp-4692	441	62	.	.	PUNCT
fnp-4692	442	1	br	br	PROPN
fnp-4692	442	2	j	j	PROPN
fnp-4692	442	3	radiol	radiol	PROPN
fnp-4692	442	4	.	.	PUNCT
fnp-4692	443	1	2020	2020	NUM
fnp-4692	443	2	apr;93(1108):20190948	apr;93(1108):20190948	PROPN
fnp-4692	443	3	.	.	PUNCT
fnp-4692	444	1	https://doi.org/10.1259/bjr.20190948	https://doi.org/10.1259/bjr.20190948	PROPN
fnp-4692	444	2	.	.	PUNCT
fnp-4692	445	1	epub	epub	PROPN
fnp-4692	445	2	2020	2020	NUM
fnp-4692	445	3	feb	feb	PROPN
fnp-4692	445	4	26	26	NUM
fnp-4692	445	5	.	.	PUNCT
fnp-4692	446	1	pmid	pmid	NOUN
fnp-4692	446	2	:	:	PUNCT
fnp-4692	446	3	32101448	32101448	NUM
fnp-4692	446	4	.	.	PUNCT
fnp-4692	447	1	37	37	NUM
fnp-4692	447	2	.	.	PUNCT
fnp-4692	447	3	venkataramani	venkataramani	PROPN
fnp-4692	447	4	v	v	PROPN
fnp-4692	447	5	,	,	PUNCT
fnp-4692	447	6	yang	yang	PROPN
fnp-4692	447	7	y	y	PROPN
fnp-4692	447	8	,	,	PUNCT
fnp-4692	447	9	schubert	schubert	PROPN
fnp-4692	447	10	mc	mc	PROPN
fnp-4692	447	11	,	,	PUNCT
fnp-4692	447	12	reyhan	reyhan	PROPN
fnp-4692	447	13	e	e	PROPN
fnp-4692	447	14	,	,	PUNCT
fnp-4692	447	15	tetzlaff	tetzlaff	PROPN
fnp-4692	447	16	sk	sk	PROPN
fnp-4692	447	17	,	,	PUNCT
fnp-4692	447	18	wißmann	wißmann	NOUN
fnp-4692	447	19	n	n	PART
fnp-4692	447	20	,	,	PUNCT
fnp-4692	447	21	botz	botz	PROPN
fnp-4692	447	22	m	m	PROPN
fnp-4692	447	23	,	,	PUNCT
fnp-4692	447	24	soyka	soyka	PROPN
fnp-4692	447	25	sj	sj	PROPN
fnp-4692	447	26	,	,	PUNCT
fnp-4692	447	27	beretta	beretta	PROPN
fnp-4692	447	28	ca	can	AUX
fnp-4692	447	29	,	,	PUNCT
fnp-4692	447	30	pramatarov	pramatarov	PROPN
fnp-4692	447	31	rl	rl	PROPN
fnp-4692	447	32	,	,	PUNCT
fnp-4692	447	33	fankhauser	fankhauser	NOUN
fnp-4692	447	34	l	l	NOUN
fnp-4692	447	35	,	,	PUNCT
fnp-4692	447	36	garofano	garofano	ADJ
fnp-4692	447	37	l	l	NOUN
fnp-4692	447	38	,	,	PUNCT
fnp-4692	447	39	freudenberg	freudenberg	PROPN
fnp-4692	447	40	a	a	X
fnp-4692	447	41	,	,	PUNCT
fnp-4692	447	42	wagner	wagner	PROPN
fnp-4692	447	43	j	j	PROPN
fnp-4692	447	44	,	,	PUNCT
fnp-4692	447	45	tanev	tanev	PROPN
fnp-4692	447	46	di	di	PROPN
fnp-4692	447	47	,	,	PUNCT
fnp-4692	447	48	ratliff	ratliff	PROPN
fnp-4692	447	49	m	m	PROPN
fnp-4692	447	50	,	,	PUNCT
fnp-4692	447	51	xie	xie	PROPN
fnp-4692	447	52	r	r	PROPN
fnp-4692	447	53	,	,	PUNCT
fnp-4692	447	54	kessler	kessler	PROPN
fnp-4692	447	55	t	t	PROPN
fnp-4692	447	56	,	,	PUNCT
fnp-4692	447	57	hoffmann	hoffmann	PROPN
fnp-4692	447	58	dc	dc	PROPN
fnp-4692	447	59	,	,	PUNCT
fnp-4692	447	60	hai	hai	PROPN
fnp-4692	447	61	l	l	PROPN
fnp-4692	447	62	,	,	PUNCT
fnp-4692	447	63	dörflinger	dörflinger	PROPN
fnp-4692	447	64	y	y	PROPN
fnp-4692	447	65	,	,	PUNCT
fnp-4692	447	66	hoppe	hoppe	PROPN
fnp-4692	447	67	s	s	PROPN
fnp-4692	447	68	,	,	PUNCT
fnp-4692	447	69	yabo	yabo	PROPN
fnp-4692	447	70	ya	ya	PROPN
fnp-4692	447	71	,	,	PUNCT
fnp-4692	447	72	golebiewska	golebiewska	VERB
fnp-4692	447	73	a	a	DET
fnp-4692	447	74	,	,	PUNCT
fnp-4692	447	75	niclou	niclou	ADJ
fnp-4692	447	76	sp	sp	PROPN
fnp-4692	447	77	,	,	PUNCT
fnp-4692	447	78	sahm	sahm	PROPN
fnp-4692	447	79	f	f	PROPN
fnp-4692	447	80	,	,	PUNCT
fnp-4692	447	81	lasorella	lasorella	PROPN
fnp-4692	447	82	a	a	PROPN
fnp-4692	447	83	,	,	PUNCT
fnp-4692	447	84	slowik	slowik	PROPN
fnp-4692	447	85	m	m	PROPN
fnp-4692	447	86	,	,	PUNCT
fnp-4692	447	87	döring	döre	VERB
fnp-4692	447	88	l	l	NOUN
fnp-4692	447	89	,	,	PUNCT
fnp-4692	447	90	iavarone	iavarone	NOUN
fnp-4692	447	91	a	a	NOUN
fnp-4692	447	92	,	,	PUNCT
fnp-4692	447	93	wick	wick	PROPN
fnp-4692	447	94	w	w	PROPN
fnp-4692	447	95	,	,	PUNCT
fnp-4692	447	96	kuner	kuner	PROPN
fnp-4692	447	97	t	t	PROPN
fnp-4692	447	98	,	,	PUNCT
fnp-4692	447	99	winkler	winkler	PROPN
fnp-4692	447	100	f.	f.	PROPN
fnp-4692	447	101	glioblastoma	glioblastoma	PROPN
fnp-4692	447	102	hijacks	hijack	VERB
fnp-4692	447	103	neuronal	neuronal	ADJ
fnp-4692	447	104	mechanisms	mechanism	NOUN
fnp-4692	447	105	for	for	ADP
fnp-4692	447	106	brain	brain	NOUN
fnp-4692	447	107	invasion	invasion	NOUN
fnp-4692	447	108	.	.	PUNCT
fnp-4692	448	1	cell	cell	NOUN
fnp-4692	448	2	.	.	PUNCT
fnp-4692	449	1	2022	2022	NUM
fnp-4692	449	2	aug	aug	PROPN
fnp-4692	449	3	4;185(16):2899	4;185(16):2899	PROPN
fnp-4692	449	4	-	-	PUNCT
fnp-4692	449	5	2917.e31	2917.e31	PROPN
fnp-4692	449	6	.	.	PUNCT
fnp-4692	450	1	https://doi.org/10.1016/j.cell.2022.06.054	https://doi.org/10.1016/j.cell.2022.06.054	PROPN
fnp-4692	450	2	.	.	PUNCT
fnp-4692	451	1	epub	epub	PROPN
fnp-4692	451	2	2022	2022	NUM
fnp-4692	451	3	jul	jul	PROPN
fnp-4692	451	4	31	31	NUM
fnp-4692	451	5	.	.	PUNCT
fnp-4692	452	1	pmid	pmid	NOUN
fnp-4692	452	2	:	:	PUNCT
fnp-4692	452	3	35914528	35914528	NUM
fnp-4692	452	4	.	.	PUNCT
fnp-4692	453	1	38	38	NUM
fnp-4692	453	2	.	.	PUNCT
fnp-4692	454	1	kilian	kilian	PROPN
fnp-4692	454	2	m	m	PROPN
fnp-4692	454	3	,	,	PUNCT
fnp-4692	454	4	sheinin	sheinin	PROPN
fnp-4692	454	5	r	r	NOUN
fnp-4692	454	6	,	,	PUNCT
fnp-4692	454	7	tan	tan	PROPN
fnp-4692	454	8	cl	cl	NOUN
fnp-4692	454	9	,	,	PUNCT
fnp-4692	454	10	friedrich	friedrich	PROPN
fnp-4692	454	11	m	m	PROPN
fnp-4692	454	12	,	,	PUNCT
fnp-4692	454	13	krämer	krämer	PROPN
fnp-4692	454	14	c	c	PROPN
fnp-4692	454	15	,	,	PUNCT
fnp-4692	454	16	kaminitz	kaminitz	PROPN
fnp-4692	454	17	a	a	X
fnp-4692	454	18	,	,	PUNCT
fnp-4692	454	19	sanghvi	sanghvi	PROPN
fnp-4692	454	20	k	k	PROPN
fnp-4692	454	21	,	,	PUNCT
fnp-4692	454	22	lindner	lindner	PROPN
fnp-4692	454	23	k	k	PROPN
fnp-4692	454	24	,	,	PUNCT
fnp-4692	454	25	chih	chih	PROPN
fnp-4692	454	26	yc	yc	PROPN
fnp-4692	454	27	,	,	PUNCT
fnp-4692	454	28	cichon	cichon	PROPN
fnp-4692	454	29	f	f	X
fnp-4692	454	30	,	,	PUNCT
fnp-4692	454	31	richter	richter	PROPN
fnp-4692	454	32	b	b	PROPN
fnp-4692	454	33	,	,	PUNCT
fnp-4692	454	34	jung	jung	PROPN
fnp-4692	454	35	s	s	PROPN
fnp-4692	454	36	,	,	PUNCT
fnp-4692	454	37	jähne	jähne	PROPN
fnp-4692	454	38	k	k	PROPN
fnp-4692	454	39	,	,	PUNCT
fnp-4692	454	40	ratliff	ratliff	PROPN
fnp-4692	454	41	m	m	PROPN
fnp-4692	454	42	,	,	PUNCT
fnp-4692	454	43	prins	prins	PROPN
fnp-4692	454	44	rm	rm	PROPN
fnp-4692	454	45	,	,	PUNCT
fnp-4692	454	46	etminan	etminan	PROPN
fnp-4692	454	47	n	n	CCONJ
fnp-4692	454	48	,	,	PUNCT
fnp-4692	454	49	von	von	PROPN
fnp-4692	454	50	deimling	deimle	VERB
fnp-4692	454	51	a	a	PRON
fnp-4692	454	52	,	,	PUNCT
fnp-4692	454	53	wick	wick	PROPN
fnp-4692	454	54	w	w	PROPN
fnp-4692	454	55	,	,	PUNCT
fnp-4692	454	56	madi	madi	PROPN
fnp-4692	454	57	a	a	PRON
fnp-4692	454	58	,	,	PUNCT
fnp-4692	454	59	bunse	bunse	NOUN
fnp-4692	454	60	l	l	NOUN
fnp-4692	454	61	,	,	PUNCT
fnp-4692	454	62	platten	platten	PROPN
fnp-4692	454	63	m.	m.	NOUN
fnp-4692	454	64	mhc	mhc	PROPN
fnp-4692	454	65	class	class	PROPN
fnp-4692	454	66	ii	ii	PROPN
fnp-4692	454	67	-	-	PUNCT
fnp-4692	454	68	restricted	restrict	VERB
fnp-4692	454	69	antigen	antigen	ADJ
fnp-4692	454	70	presentation	presentation	NOUN
fnp-4692	454	71	is	be	AUX
fnp-4692	454	72	required	require	VERB
fnp-4692	454	73	to	to	PART
fnp-4692	454	74	prevent	prevent	VERB
fnp-4692	454	75	dysfunction	dysfunction	NOUN
fnp-4692	454	76	of	of	ADP
fnp-4692	454	77	cytotoxic	cytotoxic	ADJ
fnp-4692	454	78	t	t	NOUN
fnp-4692	454	79	cells	cell	NOUN
fnp-4692	454	80	by	by	ADP
fnp-4692	454	81	blood	blood	NOUN
fnp-4692	454	82	-	-	PUNCT
fnp-4692	454	83	borne	bear	VERB
fnp-4692	454	84	myeloids	myeloid	NOUN
fnp-4692	454	85	in	in	ADP
fnp-4692	454	86	brain	brain	NOUN
fnp-4692	454	87	tumors	tumor	NOUN
fnp-4692	454	88	.	.	PUNCT
fnp-4692	455	1	cancer	cancer	NOUN
fnp-4692	455	2	cell	cell	NOUN
fnp-4692	455	3	.	.	PUNCT
fnp-4692	456	1	2023	2023	NUM
fnp-4692	456	2	feb	feb	NOUN
fnp-4692	456	3	13;41(2):235	13;41(2):235	NUM
fnp-4692	456	4	-	-	PUNCT
fnp-4692	456	5	251.e9	251.e9	NUM
fnp-4692	456	6	.	.	PUNCT
fnp-4692	457	1	https://doi.org/10.1016/j.ccell.2022.12.007	https://doi.org/10.1016/j.ccell.2022.12.007	NOUN
fnp-4692	457	2	.	.	PUNCT
fnp-4692	458	1	pmid	pmid	NOUN
fnp-4692	458	2	:	:	PUNCT
fnp-4692	458	3	36638785	36638785	NUM
fnp-4692	458	4	.	.	PUNCT
fnp-4692	459	1	copyright	copyright	NOUN
fnp-4692	459	2	:	:	PUNCT
fnp-4692	459	3	©	©	PROPN
fnp-4692	459	4	2023	2023	NUM
fnp-4692	459	5	the	the	DET
fnp-4692	459	6	author(s	author(s	NOUN
fnp-4692	459	7	)	)	PUNCT
fnp-4692	459	8	.	.	PUNCT
fnp-4692	460	1	this	this	PRON
fnp-4692	460	2	is	be	AUX
fnp-4692	460	3	an	an	DET
fnp-4692	460	4	open	open	ADJ
fnp-4692	460	5	access	access	NOUN
fnp-4692	460	6	article	article	NOUN
fnp-4692	460	7	distributed	distribute	VERB
fnp-4692	460	8	under	under	ADP
fnp-4692	460	9	the	the	DET
fnp-4692	460	10	terms	term	NOUN
fnp-4692	460	11	of	of	ADP
fnp-4692	460	12	the	the	DET
fnp-4692	460	13	creative	creative	ADJ
fnp-4692	460	14	commons	common	NOUN
fnp-4692	460	15	attribution	attribution	NOUN
fnp-4692	460	16	4.0	4.0	NUM
fnp-4692	460	17	international	international	ADJ
fnp-4692	460	18	license	license	NOUN
fnp-4692	460	19	(	(	PUNCT
fnp-4692	460	20	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
fnp-4692	460	21	)	)	PUNCT
fnp-4692	460	22	,	,	PUNCT
fnp-4692	460	23	which	which	PRON
fnp-4692	460	24	permits	permit	VERB
fnp-4692	460	25	unrestricted	unrestricted	ADJ
fnp-4692	460	26	use	use	NOUN
fnp-4692	460	27	,	,	PUNCT
fnp-4692	460	28	distribution	distribution	NOUN
fnp-4692	460	29	,	,	PUNCT
fnp-4692	460	30	and	and	CCONJ
fnp-4692	460	31	reproduction	reproduction	NOUN
fnp-4692	460	32	in	in	ADP
fnp-4692	460	33	any	any	DET
fnp-4692	460	34	medium	medium	NOUN
fnp-4692	460	35	,	,	PUNCT
fnp-4692	460	36	provided	provide	VERB
fnp-4692	460	37	the	the	DET
fnp-4692	460	38	original	original	ADJ
fnp-4692	460	39	author	author	NOUN
fnp-4692	460	40	and	and	CCONJ
fnp-4692	460	41	source	source	NOUN
fnp-4692	460	42	are	be	AUX
fnp-4692	460	43	credited	credit	VERB
fnp-4692	460	44	,	,	PUNCT
fnp-4692	460	45	a	a	DET
fnp-4692	460	46	link	link	NOUN
fnp-4692	460	47	to	to	ADP
fnp-4692	460	48	the	the	DET
fnp-4692	460	49	creative	creative	ADJ
fnp-4692	460	50	commons	common	NOUN
fnp-4692	460	51	license	license	NOUN
fnp-4692	460	52	is	be	AUX
fnp-4692	460	53	provided	provide	VERB
fnp-4692	460	54	,	,	PUNCT
fnp-4692	460	55	and	and	CCONJ
fnp-4692	460	56	any	any	DET
fnp-4692	460	57	changes	change	NOUN
fnp-4692	460	58	are	be	AUX
fnp-4692	460	59	indicated	indicate	VERB
fnp-4692	460	60	.	.	PUNCT
fnp-4692	461	1	the	the	DET
fnp-4692	461	2	creative	creative	ADJ
fnp-4692	461	3	commons	common	NOUN
fnp-4692	461	4	public	public	ADJ
fnp-4692	461	5	domain	domain	NOUN
fnp-4692	461	6	dedication	dedication	NOUN
fnp-4692	461	7	waiver	waiver	NOUN
fnp-4692	461	8	(	(	PUNCT
fnp-4692	461	9	https://creativecommons.org/publicdomain/zero/1.0/	https://creativecommons.org/publicdomain/zero/1.0/	PROPN
fnp-4692	461	10	)	)	PUNCT
fnp-4692	461	11	applies	apply	VERB
fnp-4692	461	12	to	to	ADP
fnp-4692	461	13	the	the	DET
fnp-4692	461	14	data	datum	NOUN
fnp-4692	461	15	made	make	VERB
fnp-4692	461	16	available	available	ADJ
fnp-4692	461	17	in	in	ADP
fnp-4692	461	18	this	this	DET
fnp-4692	461	19	article	article	NOUN
fnp-4692	461	20	,	,	PUNCT
fnp-4692	461	21	unless	unless	SCONJ
fnp-4692	461	22	otherwise	otherwise	ADV
fnp-4692	461	23	stated	state	VERB
fnp-4692	461	24	.	.	PUNCT